concept_id	concept_synonym_name	language_concept_id
40603037	Salmonella llandudno	4180186
40603068	Retired procedure (procedure)	4180186
40603097	Reconstruction of urinary bladder (procedure)	4180186
40603103	Bacteroides buccae (organism)	4180186
40603115	Amniotomy by nurse (procedure)	4180186
40603115	Puncture of membranes by nurse	4180186
40603142	Retired procedure (procedure)	4180186
40603178	Salmonella II, group D3 (organism)	4180186
40603226	Blood group antigen Bg^b^	4180186
40603226	Blood group antigen Bg^b^ (substance)	4180186
40603236	Retired procedure (procedure)	4180186
40603237	Retired procedure (procedure)	4180186
40603239	Fine needle aspiration biopsy of gallbladder	4180186
40603239	Fine needle biopsy of gallbladder (procedure)	4180186
40603253	Chronic pelvic inflammatory disease of the female pelvic organs AND/OR tissues (disorder)	4180186
40603258	Retired procedure (procedure)	4180186
40603266	Superior mesenteric ganglions (body structure)	4180186
40603285	Cervical spasm (disorder)	4180186
40603307	Retired procedure (procedure)	4180186
40603326	Tuberculosis of the ear (disorder)	4180186
40603330	Old laceration of vulva (disorder)	4180186
40603348	Retired procedure (procedure)	4180186
40603366	Fiebre macuculosa	4180186
40603366	Fiebre manchada	4180186
40603366	Fiebre petequial	4180186
40603366	Sao Paulo fever (disorder)	4180186
40603366	Sao Paulo tick typhus	4180186
40603366	South American tick typhus	4180186
40603399	Salmonella III arizonae 16:l,v:z35 (organism)	4180186
40603427	Cerebellar disorder (disorder)	4180186
40603431	Retired procedure (procedure)	4180186
40603434	Dermatitis (disorder)	4180186
40603442	Langur	4180186
40603442	Leaf monkey	4180186
40603442	Presbytis (organism)	4180186
40603445	Sloth bear	4180186
40603445	Ursus ursinus (organism)	4180186
40603454	Contact dermatitis due to hydrocarbon group (disorder)	4180186
40603456	Absent gallbladder function (finding)	4180186
40603474	Juxtaglomerular tumor (morphologic abnormality)	4180186
40603474	Juxtaglomerular tumour	4180186
40603504	Salmonella arizonae 50:z4,z24:-- (organism)	4180186
40603543	Operative procedure on arteriovenous aneurysm (procedure)	4180186
40603554	Fructose measurement, semen (procedure)	4180186
40603558	Retired procedure (procedure)	4180186
40603584	Retired procedure (procedure)	4180186
40603593	Eubacterium alactolyticum (organism)	4180186
40603593	Ramibacterium alactolyticum	4180186
40603610	Hysterosalpingography (procedure)	4180186
40603650	Fracture-dislocation (morphologic abnormality)	4180186
40603671	Retired procedure (procedure)	4180186
40603674	Batch-Spittler-McFaddin amputation	4180186
40603674	Callander's amputation	4180186
40603674	Disarticulation at knee	4180186
40603674	Disarticulation of knee	4180186
40603674	Gritti-Stokes amputation	4180186
40603674	Knee disarticulation (procedure)	4180186
40603674	Mazet amputation	4180186
40603674	S.P. Rogers amputation	4180186
40603684	Clamping	4180186
40603684	Closure by clamp (procedure)	4180186
40603685	Salmonella III arizonae 38:l,v:z (organism)	4180186
40603696	Poisoning by methaqualone compound (disorder)	4180186
40603721	Retired procedure (procedure)	4180186
40603782	Retired procedure (procedure)	4180186
40603784	Space-occupying lesion	4180186
40603784	Space-occupying mass (morphologic abnormality)	4180186
40603800	Retired procedure (procedure)	4180186
40603822	Resection of vessel with replacement (procedure)	4180186
40603831	Retired procedure (procedure)	4180186
40603856	Retired procedure (procedure)	4180186
40603858	Retired procedure (procedure)	4180186
40603865	Streptococcus bovis (organism)	4180186
40603887	American bison	4180186
40603887	Bison bison (organism)	4180186
40603887	Buffalo	4180186
40603887	Plains bison	4180186
40603893	Locked twins obstructing labor (disorder)	4180186
40603893	Locked twins obstructing labour	4180186
40603906	Excision of thyroglossal duct cyst (procedure)	4180186
40603906	Excision of thyroglossal duct fistula	4180186
40603906	Excision of thyroglossal duct sinus	4180186
40603906	Sistrunk operation on thyroglossal duct	4180186
40603916	Retired procedure (procedure)	4180186
40603939	Retired procedure (procedure)	4180186
40604014	Retired procedure (procedure)	4180186
40604039	Beaver	4180186
40604039	Castor (organism)	4180186
40604114	Erwinia cancerogena (organism)	4180186
40604115	Anosmic aphasia (finding)	4180186
40604128	Telephone and telegraph installer (occupation)	4180186
40604163	Salmonella III arizonae 35:z52:z (organism)	4180186
40604177	Chronic idiopathic neutropenia (disorder)	4180186
40604186	Retired procedure (procedure)	4180186
40604201	Salmonella 6,14;m,t;e,n,x	4180186
40604201	Salmonella emmerich	4180186
40604201	Salmonella II 6,14:m,t:e,n,x	4180186
40604201	Salmonella II emmerich (organism)	4180186
40604205	Retired procedure (procedure)	4180186
40604219	Retired procedure (procedure)	4180186
40604251	Salmonella II, group T (organism)	4180186
40604266	Retired procedure (procedure)	4180186
40604304	Failed attempted abortion with specified complication, NEC (disorder)	4180186
40604318	Facioscapulohumeral muscular dystrophy (disorder)	4180186
40604318	Fascioscapulohumeral muscular dystrophy	4180186
40604318	FMD - Facioscapulohumeral muscular dystrophy	4180186
40604318	FSHD - Facioscapulohumeral muscular dystrophy	4180186
40604318	FSH - Facioscapulohumeral muscular dystrophy	4180186
40604318	Landouzy-Dejerine muscular dystrophy	4180186
40604318	Landouzy-Déjérine muscular dystrophy	4180186
40604318	Limb-girdle muscular dystrophy	4180186
40604324	Retired procedure (procedure)	4180186
40604360	Colony-stimulating factor, megakaryocyte (substance)	4180186
40604360	CSF-Mega	4180186
40604368	Mexican free-tailed bat (organism)	4180186
40604380	Retired procedure (procedure)	4180186
40604420	Kaolin and pectin mixture (substance)	4180186
40604438	Retired procedure (procedure)	4180186
40604448	Retired procedure (procedure)	4180186
40604476	Protective headgear	4180186
40604476	Protective helmet, device	4180186
40604476	Protective helmet, device (physical object)	4180186
40604485	Lengthening of extraocular muscle (procedure)	4180186
40604503	Tawny owl (organism)	4180186
40604547	Bastard child	4180186
40604547	Child born to unmarried parents	4180186
40604547	Illegitimate child (person)	4180186
40604558	Retired procedure (procedure)	4180186
40604565	Cutaneous sensory nerve injury of upper limb	4180186
40604565	Injury of cutaneous sensory nerve of upper limb (disorder)	4180186
40604569	Electrolyte agent	4180186
40604569	Electrolyte replenisher (product)	4180186
40604582	Coma (finding)	4180186
40604582	Comatose	4180186
40604582	Exanimation	4180186
40604596	Bartonella bacilliformis (living organism) (organism)	4180186
40604605	Traumatic encephalopathy (disorder)	4180186
40604614	Salmonella 60;g,m,t;z6	4180186
40604614	Salmonella II 60:g,m,t:z6	4180186
40604614	Salmonella II setubal (organism)	4180186
40604614	Salmonella setubal	4180186
40604641	Abnormal position	4180186
40604641	Acquired malposition	4180186
40604641	Malposition (morphologic abnormality)	4180186
40604643	Gooneybird	4180186
40604643	Laysan albatross (organism)	4180186
40604646	Fibrinogen Essen (substance)	4180186
40604647	Retired procedure (procedure)	4180186
40604662	Salmonella 1,9,12;b;z6	4180186
40604662	Salmonella II blankenese (organism)	4180186
40604688	Retired procedure (procedure)	4180186
40604703	Sprain of carpal joint (disorder)	4180186
40604718	Retired procedure (procedure)	4180186
40604742	Micrococcus mucilaginosus	4180186
40604742	Stomatococcus mucilaginosus (organism)	4180186
40604752	Anal fistula (disorder)	4180186
40604752	Fissure-in-ano	4180186
40604766	Xanthoma diabeticorum (disorder)	4180186
40604773	Amebiasis affecting skin	4180186
40604773	Amebic skin ulceration	4180186
40604773	Amebic ulcer of skin	4180186
40604773	Amoebiasis affecting skin	4180186
40604773	Amoebic skin ulceration	4180186
40604773	Amoebic ulcer of skin	4180186
40604773	Cutaneous amebiasis (disorder)	4180186
40604773	Cutaneous amoebiasis	4180186
40604800	Retired procedure (procedure)	4180186
40604835	Tritiarchium (organism)	4180186
40604841	Pharyngeal fornix	4180186
40604841	Structure of pharyngeal fornix (body structure)	4180186
40604843	Adjustment - attribute	4180186
40604843	Adjustment (procedure)	4180186
40604851	Amniotic adhesion	4180186
40604851	Amniotic band (disorder)	4180186
40604851	Amniotic constriction band	4180186
40604878	Erythrodermic psoriasis	4180186
40604878	Exfoliative dermatitis due to psoriasis	4180186
40604878	Exfoliative psoriasis	4180186
40604878	Psoriasis vulgaris (disorder)	4180186
40604889	Retired procedure (procedure)	4180186
40604890	Retired procedure (procedure)	4180186
40604910	Open wound of back without complication (disorder)	4180186
40604925	Retired procedure (procedure)	4180186
40604931	Retired procedure (procedure)	4180186
40604982	HLA-DPw3 antigen (substance)	4180186
40604984	Interstitial radioactive colloid therapy	4180186
40604984	Interstitial radionuclide therapy	4180186
40604984	Radioisotope teleradiotherapy	4180186
40604984	Radioisotope therapy	4180186
40604984	Radionuclide therapy (procedure)	4180186
40604984	RI - Radioisotope therapy	4180186
40604984	Unsealed radionuclide procedures	4180186
40605013	Eye, ear, nose AND/OR throat anti-inflammatory agent (product)	4180186
40605032	Caloscypha fulgens (organism)	4180186
40605032	Orange peel	4180186
40605040	Retired procedure (procedure)	4180186
40605048	Black lemur	4180186
40605048	Lemur macaco (organism)	4180186
40605121	Amrinone (product)	4180186
40605129	Tree shrew (organism)	4180186
40605145	Deep third degree burn of lower leg with loss of body part (disorder)	4180186
40605146	Retired procedure (procedure)	4180186
40605152	Partially resolved traumatic cataract (disorder)	4180186
40605155	Phlebitis of popliteal vein (disorder)	4180186
40605168	Retired procedure (procedure)	4180186
40605185	Spiny dormouse (organism)	4180186
40605187	Retired procedure (procedure)	4180186
40605212	Monocytic leukaemia	4180186
40605212	Monocytic leukemia (morphologic abnormality)	4180186
40605231	Haemangiopericytic meningioma	4180186
40605231	Hemangiopericytic meningioma (morphologic abnormality)	4180186
40605234	Ethylene dibromide (substance)	4180186
40605238	Effusion of joint of thigh (disorder)	4180186
40605239	Retired procedure (procedure)	4180186
40605241	Pseudomonas caryophylii (organism)	4180186
40605260	Contact dermatitis due to greases (disorder)	4180186
40605279	Callosciurus (organism)	4180186
40605279	Tricolor squirrel	4180186
40605279	Tricolour squirrel	4180186
40605285	Non-domestic mammal (organism)	4180186
40605309	Renibacterium (organism)	4180186
40605320	Retired procedure (procedure)	4180186
40605323	Retired procedure (procedure)	4180186
40605326	Poikilocyte	4180186
40605326	Poikilocytosis (morphologic abnormality)	4180186
40605399	Retired procedure (procedure)	4180186
40605400	Salmonella III arizonae 47:b:-- (organism)	4180186
40605409	Retired procedure (procedure)	4180186
40605418	Infection due to Clostridium septicum (disorder)	4180186
40605418	Malignant edema of animals	4180186
40605418	Malignant oedema of animals	4180186
40605418	Pseudo-blackleg	4180186
40605418	Vibrion septique	4180186
40605429	Salmonella III arizonae 42:k:z (organism)	4180186
40605430	Gordiacea	4180186
40605430	Nematomorpha (organism)	4180186
40605450	Retired procedure (procedure)	4180186
40605477	Drug lotion, 0,1% (product)	4180186
40605515	Familial combined hyperlipidaemia	4180186
40605515	Familial combined hyperlipidemia (disorder)	4180186
40605522	Acute necrotizing encephalitis, NEC (disorder)	4180186
40605531	Grand galago (organism)	4180186
40605531	Thick-tailed galago	4180186
40605533	Retired procedure (procedure)	4180186
40605557	Suffocation by constriction (disorder)	4180186
40605586	Bacterial endocarditis (disorder)	4180186
40605620	Retired procedure (procedure)	4180186
40605625	Proteolytic enzyme preparation (product)	4180186
40605647	Venous pressure (biological function) (observable entity)	4180186
40605658	Parrot paramyxovirus (organism)	4180186
40605671	Chorea (disorder)	4180186
40605688	Obstetrical pulmonary embolism (disorder)	4180186
40605688	Puerperal pulmonary embolism	4180186
40605688	Pulmonary embolism in pregnancy, childbirth AND/OR puerperium	4180186
40605698	Retired procedure (procedure)	4180186
40605704	Salmonella III arizonae 61:c:z35 (organism)	4180186
40605708	Retired procedure (procedure)	4180186
40605725	Starvation (disorder)	4180186
40605745	Retired procedure (procedure)	4180186
40605753	Hypophysectomy by other specified approach (procedure)	4180186
40605767	Salmonella III arizonae 41:z29:-- (organism)	4180186
40605768	Bastard sister	4180186
40605768	Illegitimate sister (person)	4180186
40605776	Little owl (organism)	4180186
40605803	Klebsiella terrigena (organism)	4180186
40605827	Food allergy	4180186
40605827	Gastrointestinal food allergy (disorder)	4180186
40605827	Gastrointestinal food sensitivity	4180186
40605832	Hodgkin's paragranuloma (morphologic abnormality)	4180186
40605847	Disease of biliary tract (disorder)	4180186
40605853	Flavobacterium heparinum (organism)	4180186
40605862	Salmonella 1,40;z35;e,n,x,z15	4180186
40605862	Salmonella fandran	4180186
40605862	Salmonella II 1,40:z35:e,n,x,z15	4180186
40605862	Salmonella II fandran (organism)	4180186
40605863	Retired procedure (procedure)	4180186
40605868	South American lymphatic blastomycosis (disorder)	4180186
40605871	Retired procedure (procedure)	4180186
40605903	Generalised iris atrophy	4180186
40605903	Generalized iris atrophy (morphologic abnormality)	4180186
40605906	Retired procedure (procedure)	4180186
40605927	Legionella dumoffii (organism)	4180186
40605945	Poorly differentiated (grade) (qualifier value)	4180186
40605962	Destructive procedure of eyeball (procedure)	4180186
40605974	Retired procedure (procedure)	4180186
40605990	Geniculate body	4180186
40605990	Geniculate body structure (body structure)	4180186
40605991	Tarsometatarsal arthrodesis (procedure)	4180186
40605996	Hypertrophy of uterus (disorder)	4180186
40606020	Hypohidrotic ectodermal dysplasia syndrome (disorder)	4180186
40606024	Pentagastrin preparation (product)	4180186
40606056	Arthrolysis	4180186
40606056	Joint synovectomy	4180186
40606056	Synovectomy (procedure)	4180186
40606056	Synoviectomy	4180186
40606056	Villusectomy	4180186
40606061	Retired procedure (procedure)	4180186
40606093	Retired procedure (procedure)	4180186
40606096	Salmonella III arizonae 42:r:-- (organism)	4180186
40606111	Retired procedure (procedure)	4180186
40606119	Liquid petrolatum (substance)	4180186
40606158	Retired procedure (procedure)	4180186
40606177	Radioisotope scan of lymphatic system (procedure)	4180186
40606179	Retired procedure (procedure)	4180186
40606184	Filariasis (disorder)	4180186
40606184	Filariosis	4180186
40606199	Pathological dislocation of upper arm (disorder)	4180186
40606205	Drainage of middle palmar space	4180186
40606205	Drainage of midpalmar space	4180186
40606205	Incision and drainage of palmar space	4180186
40606205	Incision of middle palmar space	4180186
40606205	Incision of midpalmar space (procedure)	4180186
40606212	Retired procedure (procedure)	4180186
40606214	Glycopyrronium bromide (substance)	4180186
40606225	Grafting of tarsal or metatarsal (procedure)	4180186
40606243	Retired procedure (procedure)	4180186
40606256	Open inferior dislocation of humerus (disorder)	4180186
40606275	Retired procedure (procedure)	4180186
40606288	Retired procedure (procedure)	4180186
40606296	Retired procedure (procedure)	4180186
40606309	Retired procedure (procedure)	4180186
40606321	Retired procedure (procedure)	4180186
40606324	Injury of bladder AND/OR urethra without open wound into abdominal cavity (disorder)	4180186
40606328	Retired procedure (procedure)	4180186
40606356	Night terrors	4180186
40606356	Pavor nocturnus (disorder)	4180186
40606372	Retired procedure (procedure)	4180186
40606378	Retired procedure (procedure)	4180186
40606408	Eczema herpeticum (disorder)	4180186
40606419	Ectromelia of lower limb (disorder)	4180186
40606430	Total glossectomy (procedure)	4180186
40606438	Yellow wax (substance)	4180186
40606451	Wild turkey (organism)	4180186
40606470	Retired procedure (procedure)	4180186
40606508	Salmonella 18;z4,z23;-	4180186
40606508	Salmonella II 18:z4,z23:-- (organism)	4180186
40606508	Salmonella III arizonae 18:z4,z23:--	4180186
40606519	Retired procedure (procedure)	4180186
40606574	Body parts for identification (observable entity)	4180186
40606593	North American bat (organism)	4180186
40606607	Ethnic background	4180186
40606607	Ethnic group finding (finding)	4180186
40606607	Ethnic groups	4180186
40606607	Ethnicity	4180186
40606607	Ethnic population	4180186
40606612	Tufted puffin (organism)	4180186
40606663	Drunken gait	4180186
40606663	Reeling gait (finding)	4180186
40606690	Linguatula serrata (living organism) (organism)	4180186
40606694	Salmonella IV seminole (organism)	4180186
40606694	Salmonella seminole	4180186
40606694	Salmonella 1,40;g,z51;-	4180186
40606703	Retired procedure (procedure)	4180186
40606716	Salmonella II group O (organism)	4180186
40606717	Mohs' chemosurgery, fresh tissue technique (procedure)	4180186
40606729	Retired procedure (procedure)	4180186
40606748	Coral (organism)	4180186
40606767	Inoviridae (Enterobacteriaceae, pseudomonad hosts)	4180186
40606767	Inovirus group (organism)	4180186
40606767	Rod-shaped phage	4180186
40606797	Pancuronium bromide (product)	4180186
40606799	Salmonella III arizonae 61:(k):z53 (organism)	4180186
40606810	Tuberculous spondylitis (disorder)	4180186
40606833	Periodic respiration (finding)	4180186
40606862	Retired procedure (procedure)	4180186
40606879	Salmonella 3,10;l,v;z6	4180186
40606879	Salmonella II fuhlsbuettel (organism)	4180186
40606882	Infection by Babesia bigemina (disorder)	4180186
40606891	Retired procedure (procedure)	4180186
40606931	Pseudomonas mallei (organism)	4180186
40606946	Congenital fissure of epiglottis (disorder)	4180186
40606951	Retired procedure (procedure)	4180186
40606963	Hermaphroditism (disorder)	4180186
40606969	Felis concolor (living organism) (organism)	4180186
40606971	Diethylstilbestrol diphosphate preparation (product)	4180186
40606971	Diethylstilboestrol diphosphate preparation	4180186
40606997	Damaliscus dorcas (organism)	4180186
40606997	Blesbok	4180186
40606997	Bontebok	4180186
40607002	Retired procedure (procedure)	4180186
40607003	Injection of anaesthetic agent into peripheral nerve for analgesia	4180186
40607003	Injection of anesthetic agent into peripheral nerve for analgesia (procedure)	4180186
40607011	Retired procedure (procedure)	4180186
40607044	Myringoplasty epitympanic, type I (procedure)	4180186
40607055	Cellulitis of floor of mouth (disorder)	4180186
40607083	Residual urine (finding)	4180186
40607084	Prostaglandin PGD (substance)	4180186
40607093	Retired procedure (procedure)	4180186
40607112	Avian reovirus (organism)	4180186
40607122	Retired procedure (procedure)	4180186
40607140	Sodium fluoride F^18^	4180186
40607140	Sodium fluoride F^18^ (substance)	4180186
40607144	Retired procedure (procedure)	4180186
40607174	Streptomyces griseus neutral proteinase (substance)	4180186
40607183	Family: Marburg virus group	4180186
40607183	Filoviridae	4180186
40607183	Marburg/Ebola virus group (organism)	4180186
40607216	Repair of arteriovenous fistula of coronary artery by ligation (procedure)	4180186
40607226	Retired procedure (procedure)	4180186
40607236	Polynesian race (finding)	4180186
40607269	Retired procedure (procedure)	4180186
40607276	Retired procedure (procedure)	4180186
40607281	Black rail (organism)	4180186
40607287	Serpula hyodysenteriae	4180186
40607287	Serpulina hyodysenteriae	4180186
40607287	Treponema hyodysenteriae (organism)	4180186
40607295	Apis (organism)	4180186
40607339	Retired procedure (procedure)	4180186
40607380	Replacement of artificial urinary bladder sphincter (procedure)	4180186
40607391	Retired procedure (procedure)	4180186
40607393	Deep third degree burn of knee with loss of body part (disorder)	4180186
40607399	Retired procedure (procedure)	4180186
40607413	Retired procedure (procedure)	4180186
40607424	Legal abortion complicated by genital-pelvic infection (finding)	4180186
40607428	Retired procedure (procedure)	4180186
40607435	Refractory anaemia with ringed sideroblasts	4180186
40607435	Refractory anemia with ringed sideroblasts (morphologic abnormality)	4180186
40607449	Tick-borne viral encephalitis (disorder)	4180186
40607450	Electrolysis procedure (procedure)	4180186
40607476	Retired procedure (procedure)	4180186
40607486	Retired procedure (procedure)	4180186
40607510	Mammectomy	4180186
40607510	Mastectomy (procedure)	4180186
40607513	Contact dermatitis due to caustic agent (disorder)	4180186
40607539	Retired procedure (procedure)	4180186
40607553	Retired procedure (procedure)	4180186
40607560	Retired procedure (procedure)	4180186
40607572	ABO blood group antibody system (qualifier value)	4180186
40607594	Desoxyephedrine hydrochloride	4180186
40607594	Metamfetamine hydrochloride	4180186
40607594	Methamphetamine hydrochloride (product)	4180186
40607596	Hairy leukoplakia of tongue (disorder)	4180186
40607596	Hairy leukoplakia	4180186
40607596	Hairy leucoplakia	4180186
40607596	Hairy leucoplakia of tongue	4180186
40607596	OHL - Oral hairy leucoplakia	4180186
40607596	OHL - Oral hairy leukoplakia	4180186
40607596	Oral hairy leucoplakia	4180186
40607596	Oral hairy leukoplakia	4180186
40607601	Retired procedure (procedure)	4180186
40607609	Retired procedure (procedure)	4180186
40607612	AIDS with bacterial pneumonia (disorder)	4180186
40607625	Ability to taste	4180186
40607625	Sense of taste	4180186
40607625	Taste, function (observable entity)	4180186
40607625	Taste sensation	4180186
40607625	Tasting	4180186
40607644	Retired procedure (procedure)	4180186
40607649	Ferret (organism)	4180186
40607679	Retired procedure (procedure)	4180186
40607733	Retired procedure (procedure)	4180186
40607758	Retired procedure (procedure)	4180186
40607765	Percutaneous aspiration of gallbladder for drainage (procedure)	4180186
40607789	Serum cholinesterase defect (disorder)	4180186
40607794	Retired procedure (procedure)	4180186
40607803	Haematocornea	4180186
40607803	Hematocornea (disorder)	4180186
40607809	Cellulitis of head, except face (disorder)	4180186
40607810	Salmonella II, group C1 (organism)	4180186
40607832	Salmonella III arizonae 53:k:e,n,x,z15 (organism)	4180186
40607836	RKV virus (organism)	4180186
40607860	Disease of liver (disorder)	4180186
40607880	Partial ostectomy of facial bone (procedure)	4180186
40607899	Retired procedure (procedure)	4180186
40607924	Retired procedure (procedure)	4180186
40607936	Retired procedure (procedure)	4180186
40607965	Retired procedure (procedure)	4180186
40607966	Retired procedure (procedure)	4180186
40608007	Retired procedure (procedure)	4180186
40608021	Retired procedure (procedure)	4180186
40608047	Blood group antigen Dp (substance)	4180186
40608087	Parainfluenza 5 virus (organism)	4180186
40608087	Simian parainfluenza virus 5	4180186
40608104	Special nursing care of unconscious patient (procedure)	4180186
40608110	Partial excision of lacrimal gland (procedure)	4180186
40608154	Densovirus (organism)	4180186
40608154	Insect parvovirus group	4180186
40608176	Retired procedure (procedure)	4180186
40608191	Pseudomonas pseudomallei (organism)	4180186
40608197	Palpation of liver (procedure)	4180186
40608205	Eastern mole (organism)	4180186
40608215	Retired procedure (procedure)	4180186
40608228	Excessive body weight loss (finding)	4180186
40608233	Poisoning by vasodilator, NEC (disorder)	4180186
40608271	Poisoning by giant toad (disorder)	4180186
40608282	Retired procedure (procedure)	4180186
40608288	Chest mass (disorder)	4180186
40608288	Lump in chest	4180186
40608288	Swelling in chest	4180186
40608292	Retired procedure (procedure)	4180186
40608309	Leptospira interrogans	4180186
40608309	Leptospira interrogans interrogans (organism)	4180186
40608313	Congenital ptosis of upper eyelid (disorder)	4180186
40608342	Osmotic fragility, function (observable entity)	4180186
40608346	Retired procedure (procedure)	4180186
40608353	Retired procedure (procedure)	4180186
40608368	Retired procedure (procedure)	4180186
40608390	Open posterior dislocation of elbow (disorder)	4180186
40608399	Familial white folded mucosal dysplasia	4180186
40608399	Hereditary leukokeratosis of mucosa	4180186
40608399	Hereditary oral keratosis	4180186
40608399	Hereditary white sponge naevus	4180186
40608399	Hereditary white sponge nevus	4180186
40608399	Leucokeratosis mucosae oris	4180186
40608399	Leucoplakia of oral mucosa	4180186
40608399	Leukokeratosis mucosae oris	4180186
40608399	Leukokeratosis of oral mucosa	4180186
40608399	Leukoplakia of oral mucosa (disorder)	4180186
40608399	White folded gingivostomatosis	4180186
40608399	White folded stomatitis	4180186
40608399	White sponge naevus	4180186
40608399	White sponge naevus of mucosa	4180186
40608399	White sponge nevus	4180186
40608399	White sponge nevus of mucosa	4180186
40608400	Salmonella III arizonae 47:r:-- (organism)	4180186
40608424	Repair of eyelid, partial-thickness (procedure)	4180186
40608467	Retired procedure (procedure)	4180186
40608469	Whispered pectoriloquy (finding)	4180186
40608476	Retired procedure (procedure)	4180186
40608555	Retired procedure (procedure)	4180186
40608559	Imperial woodpecker (organism)	4180186
40608636	Retired procedure (procedure)	4180186
40608657	Retired procedure (procedure)	4180186
40608662	Dermatophytosis of groin	4180186
40608662	Dermatophytosis of groin and perianal area	4180186
40608662	Dermatophytosis of groin and pubic area	4180186
40608662	Dhobie itch	4180186
40608662	Eczema marginatum	4180186
40608662	Hebrae	4180186
40608662	Jock itch	4180186
40608662	Ringworm of genitocrural region	4180186
40608662	Tinea cruris (disorder)	4180186
40608662	Tinea inguinalis	4180186
40608662	Tinea of groin	4180186
40608662	Tinea of perianal region	4180186
40608677	Closed fracture of tuberosity of tibia (disorder)	4180186
40608701	Retired procedure (procedure)	4180186
40608711	Contracture of forearm	4180186
40608711	Contracture of joint of forearm (disorder)	4180186
40608711	Joint contracture of forearm	4180186
40608759	Grebe (organism)	4180186
40608785	Retired procedure (procedure)	4180186
40608796	Retired procedure (procedure)	4180186
40608801	Cephalopelvic disproportion (disorder)	4180186
40608804	Retired procedure (procedure)	4180186
40608805	Retired procedure (procedure)	4180186
40608818	Retired procedure (procedure)	4180186
40608869	Retired procedure (procedure)	4180186
40608873	Hyperplasia of prostate (disorder)	4180186
40608879	Polymorphous light eruption (disorder)	4180186
40608893	Syncytial endometritis (morphologic abnormality)	4180186
40608904	Lymphotropic virus (organism)	4180186
40608906	Infection of genitourinary tract in pregnancy (disorder)	4180186
40608923	Salmonella 3,10;l,z28;e,n,x	4180186
40608923	Salmonella II westpark (organism)	4180186
40608940	Retired procedure (procedure)	4180186
40608942	Sprain of atlanto-axial joint (disorder)	4180186
40608947	Retired procedure (procedure)	4180186
40608960	Living organism not identified (organism)	4180186
40608964	Amethyst starling (organism)	4180186
40608970	Retired procedure (procedure)	4180186
40608979	Malignant lymphoma, small cleaved cell, diffuse (morphologic abnormality)	4180186
40609014	Elbow sprain	4180186
40609014	Sprain of elbow (disorder)	4180186
40609014	Sprain of elbow joint	4180186
40609018	Retired procedure (procedure)	4180186
40609031	Unilateral traumatic amputation of foot with complication (disorder)	4180186
40609052	Pleuritic breathing (finding)	4180186
40609052	Pleuritic respiration	4180186
40609052	Restrained breathing	4180186
40609052	Restrained respiration	4180186
40609057	Salmonella III arizonae 38:k:z53 (organism)	4180186
40609067	Grieving support by nurse (procedure)	4180186
40609068	Ankylosis of joint of ankle AND/OR foot (disorder)	4180186
40609071	Retired procedure (procedure)	4180186
40609079	Eosinophilic leukaemia	4180186
40609079	Eosinophilic leukemia (morphologic abnormality)	4180186
40609081	Tenosynovitis of hand and wrist, NEC (disorder)	4180186
40609086	Menometrorrhagia (finding)	4180186
40609099	Yellow-billed tickbird (organism)	4180186
40609141	Disseminated hyalohyphomycosis	4180186
40609141	Disseminated mycosis	4180186
40609141	Fungaemia	4180186
40609141	Fungemia	4180186
40609141	Systemic fungal infection	4180186
40609141	Systemic mycosis (disorder)	4180186
40609147	Shy-Gonatas syndrome (disorder)	4180186
40609164	Microangiopathy (disorder)	4180186
40609172	Retired procedure (procedure)	4180186
40609192	Retired procedure (procedure)	4180186
40609200	Retired procedure (procedure)	4180186
40609205	Primary localised osteoarthrosis of lower leg	4180186
40609205	Primary localised osteoarthrosis of the knee	4180186
40609205	Primary localized osteoarthrosis of lower leg (disorder)	4180186
40609205	Primary localized osteoarthrosis of the knee	4180186
40609219	Retired procedure (procedure)	4180186
40609245	Suture of fascia to skeletal attachment (procedure)	4180186
40609284	Retired procedure (procedure)	4180186
40609342	Retired procedure (procedure)	4180186
40609354	Anisochromasia (morphologic abnormality)	4180186
40609366	Macronyssidae (organism)	4180186
40609370	Retired procedure (procedure)	4180186
40609386	Congenital vascular abnormality	4180186
40609386	Congenital vascular disease (disorder)	4180186
40609386	Vascular malformation	4180186
40609386	VM - Vascular malformation	4180186
40609390	Condition in fetus originating in the perinatal period, NEC (disorder)	4180186
40609392	Deep third degree burn of wrist with loss of body part (disorder)	4180186
40609424	Retired procedure (procedure)	4180186
40609453	Retired procedure (procedure)	4180186
40609470	Retired procedure (procedure)	4180186
40609481	Retired procedure (procedure)	4180186
40609533	Maternity counseling (regime/therapy)	4180186
40609533	Maternity counselling	4180186
40609546	Blood group antibody Allen S (substance)	4180186
40609548	Eversion of hydrocele sac	4180186
40609548	Inversion of tunica vaginalis (procedure)	4180186
40609548	Jaboulay's eversion of hydrocele	4180186
40609548	Jaboulay's operation for hydrocele	4180186
40609574	Split thickness skin transplantation (procedure)	4180186
40609584	Eubacterium formicigenerans (organism)	4180186
40609625	Retired procedure (procedure)	4180186
40609657	Deep third degree burn of foot with loss of body part (disorder)	4180186
40609662	Retired procedure (procedure)	4180186
40609669	Retired procedure (procedure)	4180186
40609689	Retired procedure (procedure)	4180186
40609701	Histiocyte chemotaxis (biological function) (observable entity)	4180186
40609709	Benign familial hematuria	4180186
40609709	Familial haematuria	4180186
40609709	Familial hematuria	4180186
40609709	Familial nephritis	4180186
40609709	GN - Hereditary glomerulonephritis	4180186
40609709	Alport's syndrome	4180186
40609709	Benign familial haematuria	4180186
40609709	Hereditary glomerulonephritis	4180186
40609709	Hereditary nephritis (disorder)	4180186
40609709	Non-progressive hereditary glomerulonephritis	4180186
40609710	Symptomatic early syphilis (disorder)	4180186
40609716	Retired procedure (procedure)	4180186
40609729	Retired procedure (procedure)	4180186
40609736	Salmonella 50;z42;1,7	4180186
40609736	Salmonella faure	4180186
40609736	Salmonella II 50:z42:1,7	4180186
40609736	Salmonella II faure (organism)	4180186
40609736	Salmonella III arizonae 50:z42:1,7	4180186
40609777	Flavobacterium balustinum (organism)	4180186
40609781	Retired procedure (procedure)	4180186
40609786	Alternating intermittent exotropia (disorder)	4180186
40609786	Intermittent alternating exotropia	4180186
40609815	Retired procedure (procedure)	4180186
40609831	Proximal interphalangeal joint of middle finger	4180186
40609831	Proximal interphalangeal joint of third digit of forelimb	4180186
40609831	Proximal interphalangeal joint of third finger	4180186
40609831	Proximal interphalangeal joint structure of third finger (body structure)	4180186
40609832	Retired procedure (procedure)	4180186
40609851	Congenital pigmentary anomaly of skin (disorder)	4180186
40609858	Retired procedure (procedure)	4180186
40609860	Retired procedure (procedure)	4180186
40609881	Salmonella III arizonae 42:l,v:e,n,x,z15 (organism)	4180186
40609904	Retired procedure (procedure)	4180186
40609919	Retired procedure (procedure)	4180186
40609948	Retired procedure (procedure)	4180186
40609983	Removal of foreign body of hindlimb	4180186
40609983	Removal of foreign body of lower limb, except foot (procedure)	4180186
40609983	Removal of foreign body without incision from lower limb, except foot	4180186
40609994	Retired procedure (procedure)	4180186
40610016	Retired procedure (procedure)	4180186
40610034	Schistosome (organism)	4180186
40610054	Other disorder of corticoadrenal overactivity, NEC (disorder)	4180186
40610075	Patagonian parakeet (organism)	4180186
40610100	Retired procedure (procedure)	4180186
40610103	Perineorrhaphy (procedure)	4180186
40610133	Congenital posterior cleft of cricoid cartilage (disorder)	4180186
40610136	Retired procedure (procedure)	4180186
40610185	Anticardiolipin antibody (substance)	4180186
40610192	Deep third degree burn of lip with loss of body part (disorder)	4180186
40610217	Retired procedure (procedure)	4180186
40610219	Salmonella III arizonae, group 65 (organism)	4180186
40610228	Mink (organism)	4180186
40610263	Deoxyribonuclease (apurinic or apyrimidinic) (substance)	4180186
40610263	Endodeoxyribonuclease (apurinic or apyrimidinic)	4180186
40610269	Esophagobronchial fistula (disorder)	4180186
40610269	Oesophagobronchial fistula	4180186
40610280	Trigger	4180186
40610280	Triggered by	4180186
40610280	Provoking factor	4180186
40610280	Evoked (qualifier value)	4180186
40610280	Precipitated by	4180186
40610280	Precipitating factor	4180186
40610280	Provoked	4180186
40610280	Provoked by	4180186
40610299	Retired procedure (procedure)	4180186
40610317	Retired procedure (procedure)	4180186
40610410	Retired procedure (procedure)	4180186
40610427	Eosinophilic syndrome (disorder)	4180186
40610429	Retired procedure (procedure)	4180186
40610449	Retired procedure (procedure)	4180186
40610471	Retired procedure (procedure)	4180186
40610505	Blood group antigen Hov (substance)	4180186
40610516	Retired procedure (procedure)	4180186
40610521	Salmonella III arizonae 11:l,v:z53 (organism)	4180186
40610553	Retired procedure (procedure)	4180186
40610558	Retired procedure (procedure)	4180186
40610567	Blood group A>3<	4180186
40610567	Blood group A>3< (substance)	4180186
40610569	Boil in nose	4180186
40610569	Furuncle of nose (disorder)	4180186
40610569	Nasal boil	4180186
40610600	Islam (religion/philosophy)	4180186
40610645	Other complication of pregnancy, NEC (disorder)	4180186
40610681	Retired procedure (procedure)	4180186
40610723	Cephalic presentation (finding)	4180186
40610736	Flatulence (finding)	4180186
40610750	Salmonella III arizonae, group L (organism)	4180186
40610764	Purpura simplex (disorder)	4180186
40610774	Incision of salivary duct (procedure)	4180186
40610777	Retired procedure (procedure)	4180186
40610786	Blackout	4180186
40610786	BO - Blackout	4180186
40610786	Passed out (disorder)	4180186
40610802	Retired procedure (procedure)	4180186
40610808	Retired procedure (procedure)	4180186
40610811	Malignant lymphoma, large cell, cleaved, diffuse (morphologic abnormality)	4180186
40610837	Retired procedure (procedure)	4180186
40610847	Gestational trophoblastic disease	4180186
40610847	GTD - Gestational trophoblastic disease	4180186
40610847	Trophoblastic disease (disorder)	4180186
40610869	Retired procedure (procedure)	4180186
40610880	Anastomosis of esophagus, antethoracic (procedure)	4180186
40610880	Anastomosis of oesophagus, antethoracic	4180186
40610918	Transfusion of antihaemophilic factor	4180186
40610918	Transfusion of antihemophilic factor (procedure)	4180186
40610959	Delayed hypersensitivity skin test for tuberculin PPD (procedure)	4180186
40610959	Intradermal skin test for tuberculosis	4180186
40610959	Mantoux test	4180186
40610959	Skin test for tuberculosis	4180186
40610959	Tuberculin skin test	4180186
40610959	Tuberculin test	4180186
40610959	Tuberculin test - mantoux	4180186
40610966	Degeneration of iris AND/OR ciliary body (disorder)	4180186
40611009	Alveolus of maxilla	4180186
40611009	Maxillary alveolus	4180186
40611009	Alveolar process of maxilla (body structure)	4180186
40611009	Alveolar ridge of maxilla	4180186
40611055	Retired procedure (procedure)	4180186
40611066	Amniotomy to induce labor (procedure)	4180186
40611066	Amniotomy to induce labour	4180186
40611073	Small pupil	4180186
40611073	Miosis (disorder)	4180186
40611073	Pupil constriction	4180186
40611075	Retired procedure (procedure)	4180186
40611081	Retired procedure (procedure)	4180186
40611117	Retired procedure (procedure)	4180186
40611137	Retired procedure (procedure)	4180186
40611153	Retired procedure (procedure)	4180186
40611164	AIDS with toxoplasmosis (disorder)	4180186
40611188	Salmonella III arizonae 53:z29:-- (organism)	4180186
40611202	AIDS with primary lymphoma of the brain (disorder)	4180186
40611209	Sodium hyposulfite (substance)	4180186
40611209	Sodium hyposulphite	4180186
40611211	Articular cartilage disorder of thigh (disorder)	4180186
40611223	Subdural haemorrhage following injury with open intracranial wound AND no loss of consciousness	4180186
40611223	Subdural hemorrhage following injury with open intracranial wound AND no loss of consciousness (disorder)	4180186
40611245	Arthrotomy of knee for infection with exploration (procedure)	4180186
40611246	Closed traumatic dislocation of midcarpal joint of wrist (disorder)	4180186
40611292	Retired procedure (procedure)	4180186
40611308	Blight	4180186
40611308	Bovine infectious keratoconjunctivitis (disorder)	4180186
40611308	Bovine infectious ophthalmia	4180186
40611308	Infectious bovine keratoconjunctivitis	4180186
40611308	Keratoconjunctivitis due to Moraxella bovis	4180186
40611308	New Forest disease	4180186
40611308	Ophthalmia of sheep AND/OR goats	4180186
40611308	Pinkeye in animals	4180186
40611313	Retired procedure (procedure)	4180186
40611328	Throat preparation (product)	4180186
40611340	Cytochrome-b reductase deficiency (disorder)	4180186
40611354	Fin isolate virus (organism)	4180186
40611355	Retired procedure (procedure)	4180186
40611357	Infantile cataract	4180186
40611357	Juvenile cataract	4180186
40611357	Nonsenile cataract (disorder)	4180186
40611357	Presenile cataract	4180186
40611369	Degenerative joint disease of pelvic region (disorder)	4180186
40611378	Removal of hydatidiform mole (procedure)	4180186
40611386	Pendulous pregnant abdomen (disorder)	4180186
40611386	Venter propendens	4180186
40611388	Peppershrike (organism)	4180186
40611396	Salmonella 38;g,z51;-	4180186
40611396	Salmonella III arizonae 38:g:z51 (organism)	4180186
40611404	Other anterior pituitary disorder, NEC (disorder)	4180186
40611421	EKG findings of ischaemia	4180186
40611421	Electrocardiogram finding of ischaemia	4180186
40611421	Electrocardiogram finding of ischemia	4180186
40611421	Electrocardiogram finding of ischemia (finding)	4180186
40611501	Open dislocation of sternoclavicular joint (disorder)	4180186
40611505	Other specified family circumstances (finding)	4180186
40611508	Derangement of joint other than knee (disorder)	4180186
40611511	Cladosporiosis (disorder)	4180186
40611519	Retired procedure (procedure)	4180186
40611520	Retired procedure (procedure)	4180186
40611526	Retired procedure (procedure)	4180186
40611547	Retired procedure (procedure)	4180186
40611548	Gray-rumped swiftlet (organism)	4180186
40611599	Complete amputation of penis (procedure)	4180186
40611600	Streptococcus mitior (organism)	4180186
40611601	Retired procedure (procedure)	4180186
40611608	Fish poisoning (disorder)	4180186
40611628	Orange-crowned warbler (organism)	4180186
40611648	Legionella gormanii (organism)	4180186
40611655	Complete uterine prolapse (disorder)	4180186
40611677	Retired procedure (procedure)	4180186
40611682	Injury of vas deferens with open wound into abdominal cavity (disorder)	4180186
40611692	Salmonella III arizonae 50:i:e,n,x,z15 (organism)	4180186
40611695	Retired procedure (procedure)	4180186
40611729	Retired procedure (procedure)	4180186
40611750	Retired procedure (procedure)	4180186
40611756	Cerclage of uterine cervix (procedure)	4180186
40611805	Retired procedure (procedure)	4180186
40611814	Retired procedure (procedure)	4180186
40611815	Retired procedure (procedure)	4180186
40611824	Launois-Bensaude's lipomatosis (disorder)	4180186
40611858	Retired procedure (procedure)	4180186
40611873	Salmonella III arizonae 16:l,v:1,5,7 (organism)	4180186
40611890	Retired procedure (procedure)	4180186
40611926	Retired procedure (procedure)	4180186
40611937	Blood group antigen El (substance)	4180186
40611949	Amputation of hinddigit	4180186
40611949	Amputation of toe (procedure)	4180186
40611954	Open fracture of greater tuberosity of humerus (disorder)	4180186
40611970	Perinatal state (finding)	4180186
40611971	Fumarate hydratase (substance)	4180186
40611981	alpha>1< Glycoprotein	4180186
40611981	alpha>1< Glycoprotein (substance)	4180186
40611981	alpha>1< Seromucoid	4180186
40611981	Orosomucoid	4180186
40611982	Poisoning by pipazethate (disorder)	4180186
40612008	Other specified indication for action related to labor and delivery, NEC (disorder)	4180186
40612008	Other specified indication for action related to labour and delivery, NEC	4180186
40612024	Piculet (organism)	4180186
40612039	Steroid abuse (disorder)	4180186
40612048	Retired procedure (procedure)	4180186
40612072	Heteronymous bilateral visual field defects (finding)	4180186
40612083	Tritiarchium oryzae (organism)	4180186
40612088	Retired procedure (procedure)	4180186
40612093	Contusion of knee AND/OR lower leg (disorder)	4180186
40612105	Retired procedure (procedure)	4180186
40612108	Trigeminal nerve division (body structure)	4180186
40612116	Retired procedure (procedure)	4180186
40612142	Staphylococcus iniae (organism)	4180186
40612149	Closure of skin by suture (procedure)	4180186
40612149	Closure of skin laceration by suture	4180186
40612149	Closure of skin wound by suture	4180186
40612149	Repair of skin wound without graft	4180186
40612149	Suture of skin	4180186
40612149	Suture of skin laceration	4180186
40612149	Suture of skin without graft	4180186
40612149	Suture of skin wound	4180186
40612152	Retired procedure (procedure)	4180186
40612160	Spider monkey	4180186
40612160	Ateles (organism)	4180186
40612168	Retired procedure (procedure)	4180186
40612176	Suture of laceration of trachea	4180186
40612176	Suture of trachea (procedure)	4180186
40612176	Tracheal wall reinforcement	4180186
40612176	Tracheorrhaphy	4180186
40612186	Radiation therapy (procedure)	4180186
40612196	Retired procedure (procedure)	4180186
40612200	Retired procedure (procedure)	4180186
40612215	Acute right-sided heart failure (disorder)	4180186
40612217	Pleurolysis (procedure)	4180186
40612253	Salmonella III arizonae 38:(k):z35:(z56) (organism)	4180186
40612285	Hyperpnea (finding)	4180186
40612285	Hyperpnoea	4180186
40612298	Retired procedure (procedure)	4180186
40612311	Schmidt's syndrome (disorder)	4180186
40612313	Retired procedure (procedure)	4180186
40612356	Small intestinal gland (body structure)	4180186
40612371	Retired procedure (procedure)	4180186
40612395	Salmonella III arizonae 48:z52:e,n,x,z15 (organism)	4180186
40612406	Amniotic fluid analysis for erythroblastosis fetalis (procedure)	4180186
40612407	Excision of lesion of labia	4180186
40612407	Excision of lesion of vulva (procedure)	4180186
40612407	Local excision of lesion of vulva	4180186
40612428	Supradiaphragmatic total anomalous pulmonary venous return (disorder)	4180186
40612431	Pasteurella anatipestifer (organism)	4180186
40612435	Retired procedure (procedure)	4180186
40612438	Retired procedure (procedure)	4180186
40612440	Erwinia rhapontici (organism)	4180186
40612440	Pectobacterium rhapontici	4180186
40612462	Retired procedure (procedure)	4180186
40612465	Implantation of heart pacemaker (procedure)	4180186
40612472	Remains of cremated body (observable entity)	4180186
40612475	Fragment of torsion dystonia (disorder)	4180186
40612496	Homeotherm	4180186
40612496	Homoiotherm (organism)	4180186
40612496	Warm-blooded animal	4180186
40612505	Decreased cerebrospinal fluid pressure (finding)	4180186
40612532	Salmonella III arizonae 38:r:1,5,7 (organism)	4180186
40612549	Temporary code for ultrastructural feature (navigational concept)	4180186
40612564	Retired procedure (procedure)	4180186
40612572	Salmonella 3,10;z;1,5	4180186
40612572	Salmonella II alexander (organism)	4180186
40612582	Fungal corneal ulcer	4180186
40612582	Fungal infection of cornea	4180186
40612582	Keratomycosis	4180186
40612582	Mycotic corneal ulcer (disorder)	4180186
40612582	Mycotic keratitis	4180186
40612616	Infection by Grahamella peromysci (disorder)	4180186
40612636	Retired procedure (procedure)	4180186
40612650	Retired procedure (procedure)	4180186
40612666	Ocellated turkey (organism)	4180186
40612667	Salmonella thielallee (organism)	4180186
40612702	Quinine and urea hydrochloride (substance)	4180186
40612707	Retired procedure (procedure)	4180186
40612717	Pocket gopher (organism)	4180186
40612742	Bovine tuberculosis (disorder)	4180186
40612750	Ureteroureterostomy (procedure)	4180186
40612764	Salmonella 17;g,t;e,n,x,z15	4180186
40612764	Salmonella bleadon	4180186
40612764	Salmonella II bleadon (organism)	4180186
40612795	Retired procedure (procedure)	4180186
40612816	California condor (organism)	4180186
40612826	Removal of encircling tube of eye (procedure)	4180186
40612826	Removal of scleral buckle	4180186
40612836	Cholera due to Vibrio cholerae (disorder)	4180186
40612836	Cholera - O1 group Vibrio cholerae	4180186
40612836	Vibrio cholerae infection	4180186
40612865	Retired procedure (procedure)	4180186
40612895	Anhydrohydroxy progesterone preparation (product)	4180186
40612910	Lower leg reattachment	4180186
40612910	Reattachment of lower extremity (procedure)	4180186
40612910	Replantation of lower limb	4180186
40612911	Toxic porphyria, NEC (disorder)	4180186
40612992	Chronic female pelvic peritonitis (disorder)	4180186
40612998	Retired procedure (procedure)	4180186
40613001	Retired procedure (procedure)	4180186
40613003	Grynfeldt's triangle	4180186
40613003	Superior lumbar trigone (body structure)	4180186
40613004	Retired procedure (procedure)	4180186
40613033	Retired procedure (procedure)	4180186
40613040	Aspiration of unspecified fluid (procedure)	4180186
40613057	2-Nitro-1,1-bis(p-chlorophenyl) butane (substance)	4180186
40613088	Densovirus of Sibine (organism)	4180186
40613099	Actinomadura turkmeniaca (organism)	4180186
40613106	Blister of testis without infection (disorder)	4180186
40613116	Skin of perineum and lower extremities (body structure)	4180186
40613126	Open dislocation of midtarsal joint (disorder)	4180186
40613141	Disturbance in form of thinking (disorder)	4180186
40613144	Chromobacterium fluviatile (organism)	4180186
40613158	Acquired von Willebrand disease	4180186
40613158	Acquired von Willebrand syndrome (disorder)	4180186
40613185	Retired procedure (procedure)	4180186
40613191	Indication for	4180186
40613191	Reason for (contextual qualifier) (qualifier value)	4180186
40613208	Epilation of skin (procedure)	4180186
40613257	Retired procedure (procedure)	4180186
40613270	Primary localised cutaneous amyloidosis	4180186
40613270	Primary localized cutaneous amyloidosis (disorder)	4180186
40613273	Oil of fir (substance)	4180186
40613273	Oil of silver fir	4180186
40613273	Oil of silver pine	4180186
40613283	Clitoridectomy (procedure)	4180186
40613306	Retired procedure (procedure)	4180186
40613307	Jellyfish (organism)	4180186
40613308	Retired procedure (procedure)	4180186
40613309	Weight reduction consultation and regimen (procedure)	4180186
40613309	Weight reduction regimen	4180186
40613321	Ligation of vas deferens (procedure)	4180186
40613348	Retired procedure (procedure)	4180186
40613356	Other hypersensitivity (finding)	4180186
40613371	Wood shipwright (occupation)	4180186
40613377	Deep third degree burn of neck with loss of body part (disorder)	4180186
40613387	1,25-Dihydroxy cholecalciferol (substance)	4180186
40613387	1-alpha, 25-Dihydroxy cholecalciferol	4180186
40613387	Calcitriol	4180186
40613388	Retired procedure (procedure)	4180186
40613393	Retired procedure (procedure)	4180186
40613400	Kaka (organism)	4180186
40613401	AIDS with presenile dementia (disorder)	4180186
40613402	Retired procedure (procedure)	4180186
40613438	Esophageal injury (disorder)	4180186
40613438	Oesophageal injury	4180186
40613440	Retired procedure (procedure)	4180186
40613489	Incision of soft tissue of hand (procedure)	4180186
40613515	Rupture of gastrocnemius muscle AND/OR tendon (disorder)	4180186
40613596	Operation on ureter (procedure)	4180186
40613596	Procedure on ureter	4180186
40613596	Ureter operation	4180186
40613600	Dusky broadbill (organism)	4180186
40613607	Salmonella 17;z36;-	4180186
40613607	Salmonella III arizonae 17:z36:-- (organism)	4180186
40613638	Clostridium quercicolum (organism)	4180186
40613659	Blood group antibody Le^ns^	4180186
40613659	Blood group antibody Le^ns^ (substance)	4180186
40613669	Antimony sodium stibogluconate (substance)	4180186
40613672	Hair	4180186
40613672	Hair structure (body structure)	4180186
40613672	Human hair	4180186
40613680	Retired procedure (procedure)	4180186
40613696	Retired procedure (procedure)	4180186
40613703	Debaromyces (organism)	4180186
40613734	Retired procedure (procedure)	4180186
40613771	Retired procedure (procedure)	4180186
40613772	Retired procedure (procedure)	4180186
40613789	Hermansky-Pudlack syndrome (disorder)	4180186
40613806	Benzhexol hydrochloride	4180186
40613806	Trihexyphenidyl hydrochloride (product)	4180186
40613832	Recurrent ventral hernia (disorder)	4180186
40613837	Glossy water snake (organism)	4180186
40613840	Blood coagulation procedure (procedure)	4180186
40613849	Medical procedure on pineal gland (procedure)	4180186
40613868	Retired procedure (procedure)	4180186
40613872	Loris (organism)	4180186
40613876	Retired procedure (procedure)	4180186
40613959	Administration of tetanus antitoxin (procedure)	4180186
40613959	Anti-tetanus immunoglobulin injection	4180186
40613959	Infusion of tetanus antitoxin	4180186
40613959	Injection of tetanus antitoxin	4180186
40613968	Retired procedure (procedure)	4180186
40614008	Retired procedure (procedure)	4180186
40614013	Advancement of eye muscle	4180186
40614013	Advancement of eyelid muscle (procedure)	4180186
40614021	Salmonella III arizonae 35:z52:1,5,7 (organism)	4180186
40614026	Flavobacterium marinotypicum (organism)	4180186
40614049	Systematised elastorrhexis	4180186
40614049	Systematized elastorrhexis	4180186
40614049	Systemic elastorrhexis (disorder)	4180186
40614050	Retired procedure (procedure)	4180186
40614065	Retired procedure (procedure)	4180186
40614093	Salmonella III arizonae 62:z4,z32:-- (organism)	4180186
40614132	Salmonella III arizonae 40:g,z51:e,n,x,z15 (organism)	4180186
40614136	Other enthesopathy of ankle and tarsus, NEC (disorder)	4180186
40614161	Coffin joint	4180186
40614161	Distal interphalangeal joint of hindlimb	4180186
40614161	Distal interphalangeal joint of toe	4180186
40614161	Distal interphalangeal joint structure of toe (body structure)	4180186
40614194	Retired procedure (procedure)	4180186
40614217	Mastectomy with preservation of skin and nipple with synchronous implant (procedure)	4180186
40614218	Retired procedure (procedure)	4180186
40614223	Stricture of cervix (disorder)	4180186
40614231	Antitrypanosomal drug (product)	4180186
40614235	Nephrectomy of remaining kidney (procedure)	4180186
40614261	Retired procedure (procedure)	4180186
40614267	Atrial ectopic	4180186
40614267	Atrial extrasystoles	4180186
40614267	Atrial premature contractions	4180186
40614267	Atrial premature systoles	4180186
40614267	Supraventricular ectopic beats (disorder)	4180186
40614278	Retired procedure (procedure)	4180186
40614293	African bee-eater (organism)	4180186
40614302	Aspiration curettage of uterus for termination of pregnancy (procedure)	4180186
40614302	STOP - Suction termination of pregnancy	4180186
40614302	Suction curettage of uterus for termination of pregnancy	4180186
40614302	Suction evacuation of pregnancy	4180186
40614302	Therapeutic abortion by aspiration curettage	4180186
40614302	VAT - Vacuum aspiration termination of pregnancy	4180186
40614302	VTOP - Vacuum termination of pregnancy	4180186
40614329	Salmonella 48;g,z51;-	4180186
40614329	Salmonella III arizonae 48:g,z51:-	4180186
40614329	Salmonella IV 48:g,z51:-	4180186
40614329	Salmonella IV marina (organism)	4180186
40614329	Salmonella marina	4180186
40614336	Retired procedure (procedure)	4180186
40614339	Pneumonia (disorder)	4180186
40614352	Catheterisation of bladder by indwelling suprapubic catheter	4180186
40614352	Catheterization of bladder by indwelling suprapubic catheter (procedure)	4180186
40614352	Drainage of bladder by indwelling suprapubic catheter	4180186
40614352	Insertion of indwelling suprapubic catheter	4180186
40614360	Dioctyl sodium sulfosuccinate (substance)	4180186
40614360	Dioctyl sodium sulphosuccinate	4180186
40614376	Retired procedure (procedure)	4180186
40614390	Cephalotrichium (organism)	4180186
40614498	Closure of gallbladder fistula	4180186
40614498	Repair of gallbladder fistula (procedure)	4180186
40614543	Cinnamic acid	4180186
40614543	Cinnamic acid ester (substance)	4180186
40614555	Nonsuppurative polyarthritis in lambs (disorder)	4180186
40614557	Retired procedure (procedure)	4180186
40614566	Aortic bifurcation syndrome (disorder)	4180186
40614632	Aphthovirus 0 (organism)	4180186
40614644	Specific or special nursing care (procedure)	4180186
40614646	Repair of epigastric hernia (procedure)	4180186
40614660	Poisoning by vitamin, NEC (disorder)	4180186
40614663	Cortisol (substance)	4180186
40614678	Retired procedure (procedure)	4180186
40614724	Retired procedure (procedure)	4180186
40614751	Retired procedure (procedure)	4180186
40614755	Pituitary pars intermedia (body structure)	4180186
40614756	Coordination disorder (finding)	4180186
40614762	Periosteotomy (procedure)	4180186
40614773	Bay lynx	4180186
40614773	Bobcat	4180186
40614773	Felis rufus (organism)	4180186
40614796	Abortion complicated by damage to pelvic organs AND/OR tissues (finding)	4180186
40614801	Vernix caseosa (body structure)	4180186
40614807	Avian leukosis (disorder)	4180186
40614807	Avian leukosis-sarcoma group	4180186
40614807	Lymphoid leukosis	4180186
40614824	Retired procedure (procedure)	4180186
40614829	Butyl chloride (substance)	4180186
40614832	Cerebral meningeal adhesions (disorder)	4180186
40614854	Retired procedure (procedure)	4180186
40614870	Ureteroscopy with biopsy (procedure)	4180186
40614893	Clostridium pfennigii (organism)	4180186
40614894	Contraction stress test	4180186
40614894	CST - Contraction stress test	4180186
40614894	Fetal oxytocin stress test (procedure)	4180186
40614894	OCT - Oxytocin challenge test	4180186
40614894	Oxytocin challenge test	4180186
40614903	Toxic effect (disorder)	4180186
40614939	Proximal interphalangeal joint of fifth digit of forelimb	4180186
40614939	Proximal interphalangeal joint of fifth finger	4180186
40614939	Proximal interphalangeal joint of little finger	4180186
40614939	Proximal interphalangeal joint structure of fifth finger (body structure)	4180186
40614944	Autosomal dominant epidermolysis bullosa simplex (disorder)	4180186
40614944	EBS 1	4180186
40614944	Epidermolysis bullosa simplex of Ogna	4180186
40614944	Epidermolysis bullosa simplex, Ogna type	4180186
40614980	Granulocyte granule deficiency (disorder)	4180186
40614990	Retired procedure (procedure)	4180186
40615021	Retired procedure (procedure)	4180186
40615045	Retired procedure (procedure)	4180186
40615046	Glasser's disease (disorder)	4180186
40615046	Infectious polyarthritis	4180186
40615046	Porcine polyserositis	4180186
40615076	Suture of small intestine (procedure)	4180186
40615088	Monochloroacetic acid (substance)	4180186
40615094	Salmonella 11;a;d:e,n,z15	4180186
40615094	Salmonella II 11:a:d:e,n,z15	4180186
40615094	Salmonella II montgomery (organism)	4180186
40615094	Salmonella montgomery	4180186
40615118	Retired procedure (procedure)	4180186
40615143	Retired procedure (procedure)	4180186
40615146	Retired procedure (procedure)	4180186
40615148	Giant toad (organism)	4180186
40615155	Salmonella II, group E1 (organism)	4180186
40615162	Nephrolithiasis (disorder)	4180186
40615167	Retired procedure (procedure)	4180186
40615175	Retired procedure (procedure)	4180186
40615180	Tea-factory cough	4180186
40615180	Tea-makers' asthma	4180186
40615180	Tea-tasters' cough	4180186
40615180	Tea-tasters' disease (disorder)	4180186
40615199	Retired procedure (procedure)	4180186
40615201	Retired procedure (procedure)	4180186
40615209	Retired procedure (procedure)	4180186
40615223	Unspecified musculoskeletal disorder of the neck (disorder)	4180186
40615227	Niacin deficiency	4180186
40615227	Nicotinamide deficiency	4180186
40615227	Nicotinic acid deficiency	4180186
40615227	Pellagra (disorder)	4180186
40615227	Vitamin B3 deficiency	4180186
40615227	Vitamin PP deficiency	4180186
40615231	Cardiorrhaphy	4180186
40615231	Suture of heart (procedure)	4180186
40615302	Spondylolisthesis (disorder)	4180186
40615303	Heart block (disorder)	4180186
40615313	Retired procedure (procedure)	4180186
40615330	Retired procedure (procedure)	4180186
40615364	Salmonella III arizonae 17:z4,z23,z32:-- (organism)	4180186
40615388	Revision of arteriovenous shunt for renal dialysis (procedure)	4180186
40615409	Bone marrow depression	4180186
40615409	Hypoplasia of bone marrow (disorder)	4180186
40615409	Medullary hypoplasia	4180186
40615421	Retired procedure (procedure)	4180186
40615425	Multiple closed fractures of hand bones (disorder)	4180186
40615453	Retired procedure (procedure)	4180186
40615457	Salmonella 1,4,12,27;g,m,t;1,5	4180186
40615457	Salmonella bechuana	4180186
40615457	Salmonella II 1,4,12,27:g,[m],t:[1,5]	4180186
40615457	Salmonella II bechuana (organism)	4180186
40615460	Relapsing fever of Southwest United States AND/OR Mexico	4180186
40615460	Relapsing fever of Southwest United States AND/OR Mexico (disorder)	4180186
40615482	Retired procedure (procedure)	4180186
40615485	Diagnostic roentgenographic imaging procedure on pharynx	4180186
40615485	Diagnostic roentgenographic imaging procedure on pharynx (procedure)	4180186
40615485	Nasopharynx X-ray with water soluble contrast	4180186
40615517	Retired procedure (procedure)	4180186
40615521	Pasteurella hemolytica	4180186
40615521	Pasteurella haemolytica biovar A	4180186
40615521	Pasteurella haemolytica (organism)	4180186
40615523	Salmonella sakai	4180186
40615523	Salmonella saka (organism)	4180186
40615545	Retired procedure (procedure)	4180186
40615553	Retired procedure (procedure)	4180186
40615554	Retired procedure (procedure)	4180186
40615584	Poisoning by mephenesin (disorder)	4180186
40615596	Retired procedure (procedure)	4180186
40615617	Retired procedure (procedure)	4180186
40615621	Bacteroides oris (organism)	4180186
40615636	Corynebacterium liquefaciens (organism)	4180186
40615656	Diethylene triamine (substance)	4180186
40615681	Reinsertion of cardiac pacemaker battery (procedure)	4180186
40615685	Retired procedure (procedure)	4180186
40615700	Petroleum poisoning (disorder)	4180186
40615718	Salmonella III arizonae 56:z4,z23:-- (organism)	4180186
40615724	Colpoepisiorrhaphy (procedure)	4180186
40615724	Colpoperineoplasty	4180186
40615749	Guinea baboon (organism)	4180186
40615770	Secondary hyperoxaluria (disorder)	4180186
40615775	Epidural injection of neurolytic substance, caudal (procedure)	4180186
40615776	Retired procedure (procedure)	4180186
40615777	Operation on thoracic duct (procedure)	4180186
40615809	Cellulitis of foot, except toe (disorder)	4180186
40615825	Amyl alcohol (commercial)	4180186
40615825	Amyl alcohol (substance)	4180186
40615860	Retired procedure (procedure)	4180186
40615862	Drug cream, 0,1% (product)	4180186
40615871	Retired procedure (procedure)	4180186
40615872	Salmonella 51;l,z28;z6	4180186
40615872	Salmonella askraal	4180186
40615872	Salmonella II 51:l,z28:z6	4180186
40615872	Salmonella II askraal (organism)	4180186
40615877	Surgical construction of fistula (procedure)	4180186
40615883	Injury of ulnar blood vessel (disorder)	4180186
40615883	Ulnar blood vessel injury	4180186
40615899	Phocomelia of lower limb (disorder)	4180186
40615911	Other acquired deformity of knee, NEC (disorder)	4180186
40615938	Mucous membrane anti-infective (product)	4180186
40615977	Sprain of sacrum (disorder)	4180186
40616031	Retired procedure (procedure)	4180186
40616042	Retired procedure (procedure)	4180186
40616086	Barasingha (organism)	4180186
40616087	Retired procedure (procedure)	4180186
40616114	Suppression of menstruation (finding)	4180186
40616136	Xenorhabdus nematophilus ss. beddingii (organism)	4180186
40616138	Threatened abortion, delivered (disorder)	4180186
40616140	Retired procedure (procedure)	4180186
40616145	Excision of lesion of eyeball (procedure)	4180186
40616193	Fixation of duodenum (procedure)	4180186
40616196	Retired procedure (procedure)	4180186
40616252	Barium swallow (procedure)	4180186
40616253	Retired procedure (procedure)	4180186
40616258	Heteropagus (disorder)	4180186
40616263	Spongioblastoma (morphologic abnormality)	4180186
40616281	Retired procedure (procedure)	4180186
40616287	Retired procedure (procedure)	4180186
40616309	Actinomadura polychroma (organism)	4180186
40616355	Retired procedure (procedure)	4180186
40616356	Retired procedure (procedure)	4180186
40616358	Hirschsprung's disease (disorder)	4180186
40616359	Cheer pheasant (organism)	4180186
40616371	Cardiac end diastolic volume, function (observable entity)	4180186
40616390	Blacky lory (organism)	4180186
40616395	Retired procedure (procedure)	4180186
40616403	Erythromycin ophthalmic agent	4180186
40616403	Erythromycin ophthalmic agent (substance)	4180186
40616405	Recipient site (body structure)	4180186
40616410	Retired procedure (procedure)	4180186
40616415	Retired procedure (procedure)	4180186
40616424	Salmonella 3,15;y;z6	4180186
40616424	Salmonella tournai (organism)	4180186
40616439	Witkop's disease	4180186
40616439	Hereditary benign intraepithelial dyskeratosis (disorder)	4180186
40616439	Witkop-Brearley-Gentry syndrome	4180186
40616439	Witkop's syndrome	4180186
40616439	Witkop-Von Sallmann disease	4180186
40616439	Witkop-von Sallman syndrome	4180186
40616445	Removal of ligature of vas deferens (procedure)	4180186
40616452	Babirusa (organism)	4180186
40616464	Genotypic expression (substance)	4180186
40616502	Obstetrical laceration	4180186
40616502	Perineal laceration during delivery (disorder)	4180186
40616502	Perineal tear resulting from childbirth	4180186
40616502	Trauma to perineum during delivery	4180186
40616504	Retired procedure (procedure)	4180186
40616546	Ambulation and gait training (procedure)	4180186
40616567	Pulpy kidney disease (disorder)	4180186
40616580	Fishing owl (organism)	4180186
40616583	Retired procedure (procedure)	4180186
40616612	3-Methoxy-4,5- methylenedioxyamphetamine (substance)	4180186
40616612	MMDA	4180186
40616621	Retired procedure (procedure)	4180186
40616632	Wolinella curva (organism)	4180186
40616643	Excision of myoma of cervix (procedure)	4180186
40616710	Eutamias (organism)	4180186
40616710	Western American chipmunk	4180186
40616738	Modified radical mastectomy (procedure)	4180186
40616738	Patey total mastectomy	4180186
40616738	Total mastectomy and excision of pectoralis minor muscle	4180186
40616740	Refractory anaemia with excess of blasts with transformation	4180186
40616740	Refractory anemia with excess of blasts with transformation (morphologic abnormality)	4180186
40616774	Hearing transducer (physical object)	4180186
40616786	Acute lymphangitis of leg, except foot (disorder)	4180186
40616788	Increased body temperature (finding)	4180186
40616805	Retired procedure (procedure)	4180186
40616808	Incision of heart (procedure)	4180186
40616849	Chestnut-brown mannikin (organism)	4180186
40616855	Contrast radiography of brain (procedure)	4180186
40616859	Idiopathic diffuse ulcerative nongranulomatous enteritis (disorder)	4180186
40616867	Retired procedure (procedure)	4180186
40616878	Salmonella III arizonae (6),14:l,v:z35 (organism)	4180186
40616961	Ectopic thyroid tissue (disorder)	4180186
40616963	Retired procedure (procedure)	4180186
40617002	Retired procedure (procedure)	4180186
40617005	Finger stick (procedure)	4180186
40617008	Degeneration of skin	4180186
40617008	Degenerative skin disorder (disorder)	4180186
40617008	Senile dermatosis	4180186
40617015	Anastomosis of intestine (procedure)	4180186
40617018	Vitamin D intoxication (disorder)	4180186
40617064	Ileojejunal bypass (procedure)	4180186
40617088	Retired procedure (procedure)	4180186
40617112	Dizziness (finding)	4180186
40617112	Dizziness - giddy	4180186
40617112	Dizziness - light-headed	4180186
40617112	Dizzy	4180186
40617112	Feel I'm spinning round	4180186
40617112	Feels everything is spinning round	4180186
40617112	Feels light headed	4180186
40617112	Giddiness	4180186
40617112	Lightheadedness	4180186
40617112	Light-headedness	4180186
40617112	Rotation of self	4180186
40617112	Rotation of surroundings	4180186
40617112	Surroundings spinning round	4180186
40617112	Vertigo	4180186
40617112	Vertigo - giddiness	4180186
40617134	Blood group B>3<	4180186
40617134	Blood group B>3< (substance)	4180186
40617139	Closed traumatic dislocation of interphalangeal joint of hand (disorder)	4180186
40617185	Amputation of foredigit	4180186
40617185	Total phalangectomy (procedure)	4180186
40617193	Coital sexual orgasm (biological function) (observable entity)	4180186
40617205	Pseudomonas echinoides (organism)	4180186
40617232	Black-crowned night heron (organism)	4180186
40617269	Great white cockatoo (organism)	4180186
40617273	Retired procedure (procedure)	4180186
40617284	Salmonella III arizonae 43:l,v:z53 (organism)	4180186
40617288	Retired procedure (procedure)	4180186
40617318	Retired procedure (procedure)	4180186
40617324	Retired procedure (procedure)	4180186
40617326	Sorghum bicolor (living organism) (organism)	4180186
40617356	Retired procedure (procedure)	4180186
40617361	Retired procedure (procedure)	4180186
40617364	Removal of embedded foreign body from conjunctiva (procedure)	4180186
40617372	Amputation of arm through wrist (procedure)	4180186
40617372	Amputation of hand at wrist	4180186
40617372	Amputation of wrist	4180186
40617372	Disarticulation of wrist	4180186
40617382	Retired procedure (procedure)	4180186
40617389	Nonfatal effect of electric current (disorder)	4180186
40617410	Retired procedure (procedure)	4180186
40617420	Retired procedure (procedure)	4180186
40617428	Retired procedure (procedure)	4180186
40617456	Retired procedure (procedure)	4180186
40617477	Retired procedure (procedure)	4180186
40617490	Complete breech delivery (procedure)	4180186
40617498	Salmonella III arizonae, group 53 (organism)	4180186
40617529	Aplastic anaemia secondary to chronic systemic disease	4180186
40617529	Aplastic anemia secondary to chronic systemic disease (disorder)	4180186
40617537	Infection of bone, NEC (disorder)	4180186
40617539	Late effect of certain other external causes, NEC (finding)	4180186
40617560	Dik-dik	4180186
40617560	Madoqua (organism)	4180186
40617633	Cervical cryoconisation	4180186
40617633	Cervical cryoconization	4180186
40617633	Cold knife cone biopsy of cervix	4180186
40617633	Excision of cervix by cryoconisation	4180186
40617633	Excision of cervix by cryoconization (procedure)	4180186
40617633	Knife cone biopsy of cervix uteri	4180186
40617633	Sturmdorf conisation of cervix uteri	4180186
40617633	Sturmdorf conization of cervix uteri	4180186
40617640	Fetus or newborn affected by other specified abnormality of amnion, NEC (disorder)	4180186
40617647	Entellus	4180186
40617647	Hanuman langur	4180186
40617647	Presbytis entellus (organism)	4180186
40617659	Retired procedure (procedure)	4180186
40617663	Retired procedure (procedure)	4180186
40617695	Bromelin (substance)	4180186
40617716	Open fracture of lower epiphysis of femur (disorder)	4180186
40617739	Oleic acid (substance)	4180186
40617747	Retired procedure (procedure)	4180186
40617756	Retired procedure (procedure)	4180186
40617767	Moeller's glossitis (disorder)	4180186
40617785	Placenta bipartita (disorder)	4180186
40617805	Salmonella III arizonae 61:z10:z35 (organism)	4180186
40617821	Canine allergic bronchitis (disorder)	4180186
40617855	Peripheral T-cell lymphoma, pleomorphic medium and large cell (morphologic abnormality)	4180186
40617874	AIDS with abnormal weight loss (disorder)	4180186
40617882	Normal menstruation (finding)	4180186
40617884	Juvenile osteochondrosis (disorder)	4180186
40617898	Clostridium bryantii (organism)	4180186
40617901	Retired procedure (procedure)	4180186
40617903	Turkey (organism)	4180186
40617908	Retired procedure (procedure)	4180186
40617937	Salmonella III arizonae 65:l,v:z53 (organism)	4180186
40617938	Other acquired deformity of toe, NEC (disorder)	4180186
40617978	Ventral hernia (disorder)	4180186
40617985	Retired procedure (procedure)	4180186
40617988	Salmonella III arizonae 65:z10:e,n,x,z15 (organism)	4180186
40617995	Water rail (organism)	4180186
40617996	Erodium moschatum (living organism) (organism)	4180186
40618012	Electrocardiogram finding of infarction	4180186
40618012	Electrocardiogram finding of infarction (finding)	4180186
40618027	Astrovirus (organism)	4180186
40618038	Retired procedure (procedure)	4180186
40618068	Adjustment reaction of childhood (finding)	4180186
40618079	Retired procedure (procedure)	4180186
40618082	Retired procedure (procedure)	4180186
40618109	Retired procedure (procedure)	4180186
40618125	Eruption of tooth	4180186
40618125	Odontiasis	4180186
40618125	Teething	4180186
40618125	Teething syndrome	4180186
40618125	Tooth erupted (finding)	4180186
40618145	Sleep drunkenness (finding)	4180186
40618153	Retired procedure (procedure)	4180186
40618210	Streptococcus, group A (organism)	4180186
40618261	Poisoning by papain (disorder)	4180186
40618274	Salmonella 57;z29;z42	4180186
40618274	Salmonella II 57:z29:z42	4180186
40618274	Salmonella II locarno (organism)	4180186
40618274	Salmonella locarno	4180186
40618286	Interstitial radionuclide therapy (procedure)	4180186
40618303	Revision of stoma of small intestine (procedure)	4180186
40618326	Crystalline lens and capsule (body structure)	4180186
40618339	Retired procedure (procedure)	4180186
40618357	Salmonella III arizonae 35:k:z53 (organism)	4180186
40618362	Retired procedure (procedure)	4180186
40618387	Chronic osteomyelitis of shoulder region (disorder)	4180186
40618396	Salmonella III arizonae 1,13,23:g,z51:-- (organism)	4180186
40618408	Triamcinolone acetonide (product)	4180186
40618409	Retired procedure (procedure)	4180186
40618412	Salmonella IV, group F (organism)	4180186
40618415	Retired procedure (procedure)	4180186
40618423	Schirmer tear test (procedure)	4180186
40618430	Retired procedure (procedure)	4180186
40618434	Ability to sense pressure	4180186
40618434	Baraesthesia	4180186
40618434	Baresthesia, function (observable entity)	4180186
40618434	Pressure sense	4180186
40618434	Sensation of pressure	4180186
40618435	Boucard's train-bearer (organism)	4180186
40618466	Felis lynx (organism)	4180186
40618466	Lynx	4180186
40618489	Ulcerative balanoposthitis (disorder)	4180186
40618490	Umbilical hernia with obstruction but no gangrene (disorder)	4180186
40618495	Lactobacillus bavaricus (organism)	4180186
40618513	Washing of animal (procedure)	4180186
40618545	Retired procedure (procedure)	4180186
40618574	Subcutaneous tissue of anterior surface of leg	4180186
40618574	Subcutaneous tissue of anterior surface of lower leg	4180186
40618574	Subcutaneous tissue structure of anterior surface of lower leg (body structure)	4180186
40618582	Glossopharyngeal nerve lingual branch (body structure)	4180186
40618582	Ninth cranial nerve lingual branch	4180186
40618586	Drug cream, 0,25% (product)	4180186
40618596	Warbling vireo (organism)	4180186
40618606	Retired procedure (procedure)	4180186
40618625	Retired procedure (procedure)	4180186
40618629	Retired procedure (procedure)	4180186
40618651	Haemophilus avium	4180186
40618651	Hemophilus avium	4180186
40618651	Pasteurella avium (organism)	4180186
40618679	Retired procedure (procedure)	4180186
40618685	Incision of bone of vertebra (procedure)	4180186
40618708	Herpes zoster dermatitis of eyelids (disorder)	4180186
40618744	Salmonella III arizonae 60:k:z (organism)	4180186
40618775	Retired procedure (procedure)	4180186
40618808	Retired procedure (procedure)	4180186
40618812	Retired procedure (procedure)	4180186
40618814	Endocrine system disease (disorder)	4180186
40618815	Calliphora erythrocephala (organism)	4180186
40618826	Hot flashes	4180186
40618826	Hot flash (finding)	4180186
40618826	Hot flush	4180186
40618826	Hot flushes	4180186
40618857	Retired procedure (procedure)	4180186
40618869	Doll's eye sign (finding)	4180186
40618872	Retired procedure (procedure)	4180186
40618896	Gestation period, 24 weeks (finding)	4180186
40618896	Gestation period, 6 months	4180186
40618913	CPF pig (organism)	4180186
40618917	After-cataract obscuring vision (disorder)	4180186
40618941	Chipmunk (organism)	4180186
40618962	Retired procedure (procedure)	4180186
40618979	Antilean piculet (organism)	4180186
40618988	Postoperative drainage of thyroid	4180186
40618988	Postoperative examination of thyroid field	4180186
40618988	Postoperative exploration of thyroid	4180186
40618988	Postoperative thyroidotomy (procedure)	4180186
40618988	Reopening of thyroid field wound	4180186
40618993	Retired procedure (procedure)	4180186
40618994	Retired procedure (procedure)	4180186
40619038	Electrolyte and fluid disorder, NEC (disorder)	4180186
40619051	Retired procedure (procedure)	4180186
40619063	Colony-stimulating factor (substance)	4180186
40619065	Sedative withdrawal delirium (disorder)	4180186
40619075	Maxillary sinusectomy (procedure)	4180186
40619075	Maxillectomy without orbital exenteration	4180186
40619097	Vascular invasion by tumor (qualifier value)	4180186
40619097	Vascular invasion by tumour	4180186
40619135	Serofibrinous inflammation	4180186
40619135	Fibrinous inflammation (morphologic abnormality)	4180186
40619190	Surgical repair of small bowel (procedure)	4180186
40619196	Great gray owl (organism)	4180186
40619208	Retired procedure (procedure)	4180186
40619237	Osteochondrosis (disorder)	4180186
40619247	CD13 - Cluster of differentiation antigen 13	4180186
40619247	Cluster of differentiation antigen 13	4180186
40619247	Lymphocyte antigen CD13 (substance)	4180186
40619248	Atrophia unguium	4180186
40619248	Atrophy of nail (disorder)	4180186
40619248	Onychatrophia	4180186
40619261	Fetal position (finding)	4180186
40619282	Retired procedure (procedure)	4180186
40619302	Retired procedure (procedure)	4180186
40619308	Retired procedure (procedure)	4180186
40619403	Retired procedure (procedure)	4180186
40619412	Erwinia carnegieana (organism)	4180186
40619419	Poisoning by antidote or chelating agent, NEC (disorder)	4180186
40619422	EPH - Edema, proteinuria and hypertension of pregnancy	4180186
40619422	EPH - Oedema, proteinuria and hypertension of pregnancy	4180186
40619422	Gestosis	4180186
40619422	Hypertension with albuminuria	4180186
40619422	PE - Pre-eclampsia	4180186
40619422	PET - Pre-eclamptic toxaemia	4180186
40619422	PET - Pre-eclamptic toxemia	4180186
40619422	Pre-eclampsia (disorder)	4180186
40619422	Pre-eclamptic toxaemia	4180186
40619422	Pre-eclamptic toxemia	4180186
40619422	Proteinuric hypertension of pregnancy	4180186
40619425	Retired procedure (procedure)	4180186
40619448	Salmonella 11;z;z39	4180186
40619448	Salmonella II 11:z:z39	4180186
40619448	Salmonella II soutpan (organism)	4180186
40619448	Salmonella soutpan	4180186
40619469	Retired procedure (procedure)	4180186
40619522	European long-eared owl (organism)	4180186
40619555	Retired procedure (procedure)	4180186
40619557	Low pressure hydrocephalus (disorder)	4180186
40619559	Retired procedure (procedure)	4180186
40619560	Receptor site (substance)	4180186
40619560	Binding site	4180186
40619560	Cell membrane receptor site	4180186
40619560	Plasma membrane receptor site	4180186
40619560	Receptor protein	4180186
40619621	Anticoagulant agonist poisoning	4180186
40619621	Poisoning by anticoagulant antagonist (disorder)	4180186
40619638	Willow warbler (organism)	4180186
40619647	Goniosynechiae (disorder)	4180186
40619647	Peripheral anterior synechiae of iris	4180186
40619674	Retired procedure (procedure)	4180186
40619676	Sea snake (organism)	4180186
40619688	Retired procedure (procedure)	4180186
40619691	Salmonella 21;z4,z23;-	4180186
40619691	Salmonella baguida (organism)	4180186
40619691	Salmonella III arizonae 21:z4,z23:--	4180186
40619742	Gerbil (organism)	4180186
40619764	Elapid snake (organism)	4180186
40619782	Buphthalmos with macrocornea	4180186
40619782	Buphthalmos with megalocornea (disorder)	4180186
40619804	Retired procedure (procedure)	4180186
40619805	Retired procedure (procedure)	4180186
40619850	Retired procedure (procedure)	4180186
40619853	Albatross (organism)	4180186
40619867	Tetranitromethylaniline (substance)	4180186
40619867	Tetryl	4180186
40619914	Reconstruction of eyelid with skin flap (procedure)	4180186
40619927	Retired procedure (procedure)	4180186
40619932	Fracture of unspecified bone of lower limb (disorder)	4180186
40619958	Cavernous angioma	4180186
40619958	Cavernous angioma of skin	4180186
40619958	Cavernous haemangioma	4180186
40619958	Cavernous hemangioma	4180186
40619958	Cavernous naevus	4180186
40619958	Cavernous naevus of skin	4180186
40619958	Cavernous nevus	4180186
40619958	Cavernous nevus of skin	4180186
40619958	Naevus flammeus	4180186
40619958	Nevus flammeus	4180186
40619958	Port-wine birthmark	4180186
40619958	Port-wine naevus	4180186
40619958	Portwine naevus	4180186
40619958	Port-wine nevus	4180186
40619958	Portwine nevus	4180186
40619958	Port-wine stain	4180186
40619958	Port-wine stain of skin (disorder)	4180186
40619958	PWS - Port-wine stain	4180186
40620000	Fracture of lower leg (disorder)	4180186
40620000	Fracture of tibia and fibula	4180186
40620000	Fracture of tibia AND fibula	4180186
40620022	Hearing analyzer (physical object)	4180186
40620055	Retired procedure (procedure)	4180186
40620064	Retired procedure (procedure)	4180186
40620071	Meningococcal polysaccharide vaccine	4180186
40620071	Meningococcus vaccine (product)	4180186
40620083	Retired procedure (procedure)	4180186
40620105	Retired procedure (procedure)	4180186
40620115	Open fracture of malar AND/OR maxillary bones (disorder)	4180186
40620122	Retired procedure (procedure)	4180186
40620142	Cannot pass urine - retention	4180186
40620142	Not passing urine	4180186
40620142	Retention of urine	4180186
40620142	Unable to empty bladder	4180186
40620142	Unable to pass urine	4180186
40620142	Urinary retention (finding)	4180186
40620175	Egtved virus (organism)	4180186
40620201	Cord around neck with compression (disorder)	4180186
40620207	Retired procedure (procedure)	4180186
40620209	Disease of upper respiratory system (disorder)	4180186
40620219	Open biopsy of colon (procedure)	4180186
40620272	Salmonella III arizonae 17:l,v:z35 (organism)	4180186
40620274	Congenital myotonia (disorder)	4180186
40620282	Thrombosis of intracranial venous sinus (disorder)	4180186
40620284	Nitrate poisoning	4180186
40620284	Nitrite poisoning	4180186
40620284	Poisoning by nitrate (disorder)	4180186
40620285	Carbuncle of head, except face (disorder)	4180186
40620291	Play psychotherapy (procedure)	4180186
40620307	Retired procedure (procedure)	4180186
40620321	Decortication of brain (procedure)	4180186
40620332	Enzootic muscular dystrophy	4180186
40620332	Nutritional myopathy of lambs AND/OR calves (disorder)	4180186
40620332	Stiff lamb disease	4180186
40620332	White muscle disease	4180186
40620360	Retired procedure (procedure)	4180186
40620395	Bigeminal pulse	4180186
40620395	Coupled pulse	4180186
40620395	Pulsus bigeminus (finding)	4180186
40620401	Deep third degree burn of shoulder with loss of body part (disorder)	4180186
40620455	Secondary hypogonadism (disorder)	4180186
40620464	Diastolic arterial pressure (observable entity)	4180186
40620464	Diastolic blood pressure	4180186
40620470	Mollusk (organism)	4180186
40620488	Incision of perianal tissue (procedure)	4180186
40620573	Lymphosarcoma (morphologic abnormality)	4180186
40620577	Haemorrheologic agent-Retired-	4180186
40620577	Hemorrheologic agent-Retired- (substance)	4180186
40620599	Retired procedure (procedure)	4180186
40620601	Retired procedure (procedure)	4180186
40620610	Blood group antigen Rh^B^	4180186
40620610	Blood group antigen Rh^B^ (substance)	4180186
40620625	Himalayan tahr (organism)	4180186
40620640	T-zone lymphoma (morphologic abnormality)	4180186
40620649	Contusion of ankle AND/OR foot, excluding toes (disorder)	4180186
40620671	Subcutaneous tissue of leg and ankle (body structure)	4180186
40620696	Incomplete atrioventricular block (disorder)	4180186
40620696	Incomplete heart block	4180186
40620696	Partial atrioventricular block	4180186
40620696	Partial heart block	4180186
40620696	Second degree heart block	4180186
40620706	Senile degenerative atrophy (disorder)	4180186
40620718	Abscess of face (disorder)	4180186
40620756	Retired procedure (procedure)	4180186
40620762	Disease due to Uukuvirus (disorder)	4180186
40620796	Retired procedure (procedure)	4180186
40620803	Retired procedure (procedure)	4180186
40620809	Salmonella 16;l,w;z6	4180186
40620809	Salmonella II noordhoek (organism)	4180186
40620824	Episiorrhaphy (procedure)	4180186
40620846	Ara (organism)	4180186
40620846	Macaw	4180186
40620851	Deformity due to adhesions (morphologic abnormality)	4180186
40620867	Retired procedure (procedure)	4180186
40620872	Retired procedure (procedure)	4180186
40620887	Goldfinch (organism)	4180186
40620889	Mepacrine hydrochloride	4180186
40620889	Quinacrine hydrochloride (substance)	4180186
40620899	Suture of ulcer of duodenum (procedure)	4180186
40620906	Retired procedure (procedure)	4180186
40620911	Retired procedure (procedure)	4180186
40620922	Retired procedure (procedure)	4180186
40620973	Retired procedure (procedure)	4180186
40620989	Retired procedure (procedure)	4180186
40620990	Retired procedure (procedure)	4180186
40620998	Retired procedure (procedure)	4180186
40621013	Retired procedure (procedure)	4180186
40621032	Aggressive ex-smoker (life style)	4180186
40621033	Venous thrombosis imaging, unilateral (procedure)	4180186
40621036	Diet counseling (regime/therapy)	4180186
40621036	Diet counselling	4180186
40621036	Nutritional counseling	4180186
40621036	Nutritional counselling	4180186
40621051	Pilocytic astrocytoma (morphologic abnormality)	4180186
40621056	Listeria murrayi (organism)	4180186
40621079	Retired procedure (procedure)	4180186
40621081	Artificial menopause (qualifier value)	4180186
40621110	Salmonella III arizonae 60:i:e,n,x,z15 (organism)	4180186
40621116	Excisional biopsy of bone of humerus (procedure)	4180186
40621131	Retired procedure (procedure)	4180186
40621150	Infection by Phialophora gougerotii (disorder)	4180186
40621191	Chinese impeyan pheasant (organism)	4180186
40621192	Retired procedure (procedure)	4180186
40621196	Administration of therapeutic substance (procedure)	4180186
40621207	Retired procedure (procedure)	4180186
40621217	Abscess of pleural cavity	4180186
40621217	Abscess of thorax (disorder)	4180186
40621217	Pyothorax	4180186
40621250	Retired procedure (procedure)	4180186
40621277	Salmonella III arizonae 50:z4,z23,z32:-- (organism)	4180186
40621279	Salmonella III arizonae 61:k:1,5,(7) (organism)	4180186
40621305	Incontinent of faeces - finding	4180186
40621305	Incontinent of feces (finding)	4180186
40621319	Repair of tricuspid valve (procedure)	4180186
40621326	Satyr tragopan (organism)	4180186
40621333	Blood in faeces	4180186
40621333	Faeces: blood	4180186
40621333	Feces: blood	4180186
40621333	Haematochezia	4180186
40621333	Blood in feces	4180186
40621333	Blood in stool (disorder)	4180186
40621333	Passage of bloody stools	4180186
40621358	Haemoglobin S disease with crisis	4180186
40621358	Hemoglobin S disease with crisis (disorder)	4180186
40621358	Sickle cell crisis	4180186
40621378	Anxiolytic agent (product)	4180186
40621413	Malignant lymphoma, large cell, noncleaved, diffuse (morphologic abnormality)	4180186
40621436	Old disruption of posterior cruciate ligament (disorder)	4180186
40621445	Drug solution, 1,0% (product)	4180186
40621468	Retired procedure (procedure)	4180186
40621473	Thiamphenicol (substance)	4180186
40621473	Thiophenicol	4180186
40621476	Flavobacterium resinovorum (organism)	4180186
40621494	Mummified body (observable entity)	4180186
40621497	Fetus OR newborn affected by maternal condition (disorder)	4180186
40621497	Maternal condition affecting fetus OR newborn	4180186
40621507	Convergence insufficiency (disorder)	4180186
40621539	Deep third degree burn of scalp with loss of body part (disorder)	4180186
40621561	Salmonella II, group C3 (organism)	4180186
40621569	Vipera persica (organism)	4180186
40621572	Division of joint ligament (procedure)	4180186
40621574	Muntjac	4180186
40621574	Barking deer	4180186
40621574	Muntiacus (organism)	4180186
40621589	Retired procedure (procedure)	4180186
40621602	Accessory atrioventricular conduction (disorder)	4180186
40621647	Bone of arm	4180186
40621647	Bone structure of upper arm (body structure)	4180186
40621649	Retired procedure (procedure)	4180186
40621692	Placental lactogen level	4180186
40621692	Placental lactogen measurement (procedure)	4180186
40621692	Chorionic somatomammotropin measurement	4180186
40621692	HPL - Human placental lactogen level	4180186
40621692	Human chorionic somatomammotropin measurement	4180186
40621692	Human placental lactogen level	4180186
40621692	Human placental lactogen measurement	4180186
40621707	Salmonella 41;d;z6	4180186
40621707	Salmonella hennepin	4180186
40621707	Salmonella II 41:d:z6	4180186
40621707	Salmonella II hennipin (organism)	4180186
40621731	o-Phenylphenol (substance)	4180186
40621737	Retired procedure (procedure)	4180186
40621771	Unqualified visual loss of both eyes (disorder)	4180186
40621775	Retired procedure (procedure)	4180186
40621797	Eastern pipistrelle (organism)	4180186
40621837	Salmonella 3,15;l,z13;1,5	4180186
40621837	Salmonella kinshasa (organism)	4180186
40621864	Incision of ascending aorta (procedure)	4180186
40621885	Salmonella 9,12;z29;1,5	4180186
40621885	Salmonella II canastel (organism)	4180186
40621928	Retired procedure (procedure)	4180186
40621946	Reconstruction of scrotum with graft (procedure)	4180186
40621966	Secondary nephrogenic diabetes insipidus (disorder)	4180186
40621978	Retired procedure (procedure)	4180186
40622051	Excision of fistula in ano	4180186
40622051	Anal fissurectomy (procedure)	4180186
40622051	Excision of anal fissure	4180186
40622051	Excision of anal fistula	4180186
40622051	Excision of fissure of anus	4180186
40622100	Retired procedure (procedure)	4180186
40622111	Retired procedure (procedure)	4180186
40622117	Cut	4180186
40622117	Incised wound (morphologic abnormality)	4180186
40622144	Classical polyarteritis nodosa	4180186
40622144	Disseminated necrotising periarteritis	4180186
40622144	Disseminated necrotizing periarteritis	4180186
40622144	Necrotising angiitis	4180186
40622144	Necrotising arteritis	4180186
40622144	Necrotizing angiitis	4180186
40622144	Necrotizing arteritis	4180186
40622144	Panarteritis nodosa	4180186
40622144	PAN - Polyarteritis nodosa	4180186
40622144	Periarteritis nodosa	4180186
40622144	Polyarteritis nodosa (disorder)	4180186
40622144	Systemic periarteritis nodosa	4180186
40622178	Retired procedure (procedure)	4180186
40622186	Legionella micdadei (organism)	4180186
40622217	Retired procedure (procedure)	4180186
40622218	Pinta, mixed lesions (disorder)	4180186
40622223	Parathormone (substance)	4180186
40622238	Child abuse	4180186
40622238	Child deprivation syndrome	4180186
40622238	Child molesting	4180186
40622238	Non-accidental injury to child	4180186
40622238	Battered baby	4180186
40622238	Victim of child abuse (finding)	4180186
40622238	Victim of infant/child abuse	4180186
40622264	Retired procedure (procedure)	4180186
40622284	Enuresis (finding)	4180186
40622290	Arbovirus encephalitis (disorder)	4180186
40622311	Salmonella saintemarie (organism)	4180186
40622313	Repair of tendon of hand by transfer or transplantation (procedure)	4180186
40622320	Drug aerosol, 0,01% (product)	4180186
40622328	Adjustment reaction of adult life (finding)	4180186
40622359	Embryotomy (procedure)	4180186
40622370	Retired procedure (procedure)	4180186
40622397	Latrodectus mactans (living organism) (organism)	4180186
40622406	Elephant seal	4180186
40622406	Mirounga (organism)	4180186
40622419	Deficiency of N-acetylglucosamine-6-sulfatase (disorder)	4180186
40622419	Deficiency of N-acetylglucosamine-6-sulphatase	4180186
40622425	Other specified wound of ocular adnexa, NEC (disorder)	4180186
40622433	Retired procedure (procedure)	4180186
40622496	Retired procedure (procedure)	4180186
40622504	Bacteroides gracilis (organism)	4180186
40622506	3-Hydroxy-3-methylglutaryl-CoA lyase deficiency	4180186
40622506	HMG-CoA lyase deficiency	4180186
40622506	Hydroxymethylglutaricaciduria	4180186
40622506	Hydroxymethylglutaric aciduria	4180186
40622506	Hydroxymethylglutaryl-CoA lyase deficiency (disorder)	4180186
40622508	Complication of reattached hand (disorder)	4180186
40622508	Reattached hand complication	4180186
40622520	Chromomycosis (disorder)	4180186
40622524	Retired procedure (procedure)	4180186
40622584	Protein-energy malnutrition (disorder)	4180186
40622592	Retired procedure (procedure)	4180186
40622602	Paradoxical embolus (morphologic abnormality)	4180186
40622618	Aphthovirus SAT 1 (organism)	4180186
40622645	Salmonella III arizonae, group W (organism)	4180186
40622683	Fruit pigeon (organism)	4180186
40622721	Ventricular tachyarrhythmia (disorder)	4180186
40622762	Dimethyl sulfoxide (substance)	4180186
40622762	Dimethyl sulphoxide	4180186
40622762	DMSO	4180186
40622789	Roseola virus (organism)	4180186
40622852	Gray owlet-frogmouth (organism)	4180186
40622853	Phage-procoat-leader peptidase (substance)	4180186
40622858	AIDS with acquired haemolytic anaemia	4180186
40622858	AIDS with acquired hemolytic anemia (disorder)	4180186
40622878	Salmonella 59;k;(z)	4180186
40622878	Salmonella betioky	4180186
40622878	Salmonella II 59:k:(z)	4180186
40622878	Salmonella II betioky (organism)	4180186
40622902	Topical corticosteroid, group VI (product)	4180186
40622948	Zinc sulfate ophthalmic agent (substance)	4180186
40622948	Zinc sulphate ophthalmic preparation	4180186
40622962	Blood group antigen Allen S (substance)	4180186
40623006	Eastern Christianity (religion/philosophy)	4180186
40623020	Precocious sexual development and puberty, NEC (disorder)	4180186
40623076	Retired procedure (procedure)	4180186
40623082	delta-ALA	4180186
40623082	delta Aminolaevulinic acid	4180186
40623082	delta Aminolevulinic acid (substance)	4180186
40623102	Retired procedure (procedure)	4180186
40623104	Intertarsal joint (body structure)	4180186
40623133	Disease of teeth (disorder)	4180186
40623156	Sabin-Feldman syndrome (disorder)	4180186
40623165	Retired procedure (procedure)	4180186
40623176	Metal	4180186
40623176	Metal (element) (substance)	4180186
40623185	Retired procedure (procedure)	4180186
40623205	Retired procedure (procedure)	4180186
40623221	Salmonella III arizonae 41:z4,z23:-- (organism)	4180186
40623241	Retired procedure (procedure)	4180186
40623247	Retired procedure (procedure)	4180186
40623266	Abortion with laceration of uterus (finding)	4180186
40623266	Abortion with tear of uterus	4180186
40623266	Unspecified abortion with tear of uterus	4180186
40623302	Ergot preparation (product)	4180186
40623313	Retired procedure (procedure)	4180186
40623326	Retired procedure (procedure)	4180186
40623354	Retired procedure (procedure)	4180186
40623363	Retired procedure (procedure)	4180186
40623373	Coxiella burnetii antibody assay	4180186
40623373	Serologic test for Coxiella burnetii (procedure)	4180186
40623394	Retired procedure (procedure)	4180186
40623416	Local subdural haematoma as birth trauma	4180186
40623416	Local subdural hematoma as birth trauma (disorder)	4180186
40623469	Common iora (organism)	4180186
40623478	Dislocation of spine due to birth trauma (disorder)	4180186
40623492	Brown rat	4180186
40623492	Norway rat	4180186
40623492	Old World rat (organism)	4180186
40623492	Wild rat	4180186
40623541	Retired procedure (procedure)	4180186
40623583	Six-banded armadillo (organism)	4180186
40623605	Repair of cornea with conjunctival flap (procedure)	4180186
40623611	Salmonella III arizonae 59:z10:z53 (organism)	4180186
40623619	Retired procedure (procedure)	4180186
40623620	Retired procedure (procedure)	4180186
40623635	Retired procedure (procedure)	4180186
40623712	Salmonella stevenage	4180186
40623712	Salmonella 1,13,23;z42;1,5,7	4180186
40623712	Salmonella II 1,13,23:[z42]:1,[5],7	4180186
40623712	Salmonella II stevenage (organism)	4180186
40623721	Fructose 5-dehydrogenase (substance)	4180186
40623731	Vertebral artery compression syndrome (disorder)	4180186
40623746	Familial megaloblastic anemia (disorder)	4180186
40623746	Familial megaloblastic anaemia	4180186
40623765	Retired procedure (procedure)	4180186
40623801	Diabetes insipidus secondary to vasopressin deficiency	4180186
40623801	Vasopressin deficiency syndrome (disorder)	4180186
40623817	Retired procedure (procedure)	4180186
40623823	Hypesthesia	4180186
40623823	Hypoaesthesia	4180186
40623823	Impaired sensation	4180186
40623823	Limited sensation	4180186
40623823	Reduced sensation	4180186
40623823	Reduced sensation of skin (finding)	4180186
40623826	Depressed	4180186
40623826	Depressed mood (finding)	4180186
40623826	Feeling low	4180186
40623826	Feeling of sadness	4180186
40623826	Low mood	4180186
40623826	Melancholic	4180186
40623826	Miserable	4180186
40623826	Morose mood	4180186
40623826	Morosity	4180186
40623826	Sad	4180186
40623826	Sadness	4180186
40623828	Retired procedure (procedure)	4180186
40623836	Retired procedure (procedure)	4180186
40623862	Closed reduction of rib fracture with external fixation (procedure)	4180186
40623864	Prostaglandin PGF>2< alpha	4180186
40623864	Dinoprost	4180186
40623864	Prostaglandin PGF>2< alpha (substance)	4180186
40623871	Adiponecrosis e frigore	4180186
40623871	Cold panniculitis (disorder)	4180186
40623871	Haxthausen's disease	4180186
40623871	Haxthausen's syndrome	4180186
40623902	Coronary artery thrombosis (disorder)	4180186
40623902	Coronary thrombosis	4180186
40623902	CT - Coronary thrombosis	4180186
40623902	Heart attack	4180186
40623902	MI - Myocardial infarction	4180186
40623902	Myocardial infarct	4180186
40623902	Myocardial infarction	4180186
40623902	Thrombosis - coronary	4180186
40623941	Nonbacterial gastroenteritis (disorder)	4180186
40623991	Spinal tap (procedure)	4180186
40624016	Gummatous frambeside (disorder)	4180186
40624020	Poisoning by paramethadione (disorder)	4180186
40624051	Adrenal insufficiency	4180186
40624051	Primary hypoadrenalism	4180186
40624051	Adrenal cortical hypofunction (disorder)	4180186
40624051	Adrenocortical hypofunction	4180186
40624051	Corticoadrenal insufficiency	4180186
40624051	Hypoadrenocorticism	4180186
40624054	Retired procedure (procedure)	4180186
40624112	Amputation by disarticulation of hindfoot	4180186
40624112	Amputation of ankle	4180186
40624112	Amputation of leg through ankle joints	4180186
40624112	Ankle disarticulation (procedure)	4180186
40624112	Disarticulation of ankle	4180186
40624112	Disarticulation of foot	4180186
40624112	Disarticulation of the ankle	4180186
40624112	Guyon amputation	4180186
40624112	Through ankle amputation	4180186
40624128	Retired procedure (procedure)	4180186
40624161	Genus: Rotavirus	4180186
40624161	Genus Rotavirus (organism)	4180186
40624161	Rotavirus group A	4180186
40624163	Retired procedure (procedure)	4180186
40624203	Hyoscyamine hydrobromide (product)	4180186
40624205	Retired procedure (procedure)	4180186
40624227	Retired procedure (procedure)	4180186
40624235	Orbweaver spider (organism)	4180186
40624239	Sodium acid phosphate	4180186
40624239	Sodium biphosphate (product)	4180186
40624239	Sodium dihydrogen phosphate	4180186
40624239	Sodium phosphate monobasic	4180186
40624253	Retired procedure (procedure)	4180186
40624260	Retired procedure (procedure)	4180186
40624272	English ring-necked pheasant (organism)	4180186
40624273	Splenectomy (procedure)	4180186
40624279	Martinique white-breasted thrasher (organism)	4180186
40624280	Diffuse xanthoma (disorder)	4180186
40624282	Retired procedure (procedure)	4180186
40624283	Immunodeficiency (disorder)	4180186
40624286	Retired procedure (procedure)	4180186
40624329	AIDS with salivary gland disease (disorder)	4180186
40624331	Mephitis (organism)	4180186
40624331	Striped and hooded skunk	4180186
40624343	Retired procedure (procedure)	4180186
40624377	Other specified polyglandular dysfunction, NEC (disorder)	4180186
40624507	Syringing of lacrimal duct or sac (procedure)	4180186
40624532	Retired procedure (procedure)	4180186
40624536	Salmonella III arizonae 47:k:z (organism)	4180186
40624574	Peritoneal dialysis counseling (regime/therapy)	4180186
40624574	Peritoneal dialysis counselling	4180186
40624581	Retired procedure (procedure)	4180186
40624591	Acquired hunchback (disorder)	4180186
40624611	Oesophagospasm	4180186
40624611	Esophagospasm (disorder)	4180186
40624639	Tuberculosis of pleura (disorder)	4180186
40624643	Retired procedure (procedure)	4180186
40624651	Retired procedure (procedure)	4180186
40624652	Cervical spondylarthritis (disorder)	4180186
40624656	Retired procedure (procedure)	4180186
40624663	Drug ointment, 0,1% (product)	4180186
40624664	Hoffman's two-toed sloth (organism)	4180186
40624675	Atrophy of orbit (disorder)	4180186
40624675	Fat atrophy of orbit	4180186
40624675	Orbital atrophy	4180186
40624695	Biopsy of heart (procedure)	4180186
40624699	Salmonella ottershaw	4180186
40624699	Salmonella 40;d;-	4180186
40624699	Salmonella II 40:d:-	4180186
40624699	Salmonella II ottershaw (organism)	4180186
40624709	Thoracotomy for excision of emphysematous bleb of lung (procedure)	4180186
40624711	Retired procedure (procedure)	4180186
40624728	Salmonella 16;g,m,s,t;e,n,x	4180186
40624728	Salmonella II 16 g,[m],[s],t:[e,n,x]	4180186
40624728	Salmonella II mobeni (organism)	4180186
40624728	Salmonella mobeni	4180186
40624770	Touch	4180186
40624770	Ability to sense touch	4180186
40624770	Sense of touch	4180186
40624770	Tactile sensation	4180186
40624770	Tactile sense	4180186
40624770	Touch sensation, function (observable entity)	4180186
40624775	Chronic aggressive type A viral hepatitis (disorder)	4180186
40624780	Zinga fever	4180186
40624780	Enzootic hepatitis	4180186
40624780	Rift valley fever (disorder)	4180186
40624780	RVF - Rift valley fever	4180186
40624797	Decreased platelet count	4180186
40624797	Thrombocytopenia (disorder)	4180186
40624813	Retired procedure (procedure)	4180186
40624840	Retired procedure (procedure)	4180186
40624846	Salmonella II carletonville (organism)	4180186
40624846	Salmonella 38;d;1,5	4180186
40624846	Salmonella carletonville	4180186
40624846	Salmonella II 38:d:1,5	4180186
40624900	Anaemia	4180186
40624900	Anemia (disorder)	4180186
40624905	Excisional biopsy of bone of clavicle (procedure)	4180186
40624906	Common hutia (organism)	4180186
40624915	Retired procedure (procedure)	4180186
40624932	Salmonella III arizonae 47:r:z (organism)	4180186
40624951	Colposcopy	4180186
40624951	Colposcopy of vagina	4180186
40624951	Endoscopic exploration of vagina	4180186
40624951	Endoscopy of vagina (procedure)	4180186
40624951	Vaginoscopy	4180186
40624954	Hydroxy-etiocholanolone (substance)	4180186
40624955	Retired procedure (procedure)	4180186
40624962	Respiratory system drug (product)	4180186
40624986	Levirividae (Enterobacteriaceae, pseudomonas hosts)	4180186
40624986	Levivirus group (organism)	4180186
40624986	ssRNA phage virus	4180186
40624993	Drug gel, 0,1% (product)	4180186
40624997	Gluten free diet (finding)	4180186
40625000	Repair of hepatic duct (procedure)	4180186
40625010	Circumferential (modifier) (qualifier value)	4180186
40625016	Hypoglycaemia	4180186
40625016	Hypoglycemia (disorder)	4180186
40625021	Suture of duodenum (procedure)	4180186
40625027	Infection-associated haemophagocytic syndrome	4180186
40625027	Infection-associated hemophagocytic syndrome (disorder)	4180186
40625027	Infection-induced haemophagocytic histiocytosis	4180186
40625027	Infection-induced hemophagocytic histiocytosis	4180186
40625036	Flavobacterium breve (organism)	4180186
40625036	Flavobacterium brevis	4180186
40625042	Retired procedure (procedure)	4180186
40625056	Staple capsulorrhaphy of shoulder (procedure)	4180186
40625064	HLA-DR4 antigen (substance)	4180186
40625088	Burmese fairy bluebird (organism)	4180186
40625093	Bruises easily (finding)	4180186
40625093	Easy bruising	4180186
40625093	Increased tendency to bruise	4180186
40625125	Open dislocation of interphalangeal joint of thumb (disorder)	4180186
40625134	Dermatological operation	4180186
40625134	Operation on skin (procedure)	4180186
40625134	Skin operation	4180186
40625134	Skin procedure	4180186
40625136	Retired procedure (procedure)	4180186
40625156	Avian parvovirus (organism)	4180186
40625156	Goose parvovirus	4180186
40625161	Retired procedure (procedure)	4180186
40625166	Chronic active hepatitis (disorder)	4180186
40625181	Retired procedure (procedure)	4180186
40625191	Closed reduction of fracture of foot with internal fixation (procedure)	4180186
40625203	Diffuse ulcerations of jejunum AND/OR ileum (disorder)	4180186
40625211	Physical altercation (finding)	4180186
40625228	Other complication of labor and delivery, NEC (disorder)	4180186
40625228	Other complication of labour and delivery, NEC	4180186
40625243	Burkholderia solanacearum	4180186
40625243	Pseudomonas solanacearum (organism)	4180186
40625265	Falcivibrio (organism)	4180186
40625279	Retired procedure (procedure)	4180186
40625304	Leukorrhoea	4180186
40625304	Leukorrhea (finding)	4180186
40625316	Salmonella 47;a;1,5	4180186
40625316	Salmonella bilthoven	4180186
40625316	Salmonella II 47:a:1,5	4180186
40625316	Salmonella II bilthoven (organism)	4180186
40625330	Retired procedure (procedure)	4180186
40625347	Contracture of joint of lower leg (disorder)	4180186
40625351	Salmonella 47;z;z6	4180186
40625351	Salmonella chersina	4180186
40625351	Salmonella II 47:z:z6	4180186
40625351	Salmonella II chersina (organism)	4180186
40625357	Beta-glucuronidase test (procedure)	4180186
40625379	Nighthawk (organism)	4180186
40625413	Sulfamethoxpyridazine (substance)	4180186
40625413	Sulphamethoxpyridazine	4180186
40625419	Salmonella III arizonae 38:l,v:z35:(z54) (organism)	4180186
40625420	Meningomyelocele (disorder)	4180186
40625420	Myelocystocele	4180186
40625420	Myelomeningocele	4180186
40625420	Thoracic spinal hydromeningocele	4180186
40625434	Retired procedure (procedure)	4180186
40625455	Flamingo (organism)	4180186
40625463	Retired procedure (procedure)	4180186
40625475	Salmonella III arizonae 43:r:e,n,x,z15 (organism)	4180186
40625477	Mucor rennin	4180186
40625477	Aspergillopeptidase A	4180186
40625477	Baker's yeast proteinase A	4180186
40625477	Penicillopepsin	4180186
40625477	Peptidase A	4180186
40625477	Plasmodium aspartic proteinase (substance)	4180186
40625477	Trypsinogen kinase	4180186
40625481	Eubacterium timidum (organism)	4180186
40625534	Salmonella III arizonae 21:z65:e,n,x,z15 (organism)	4180186
40625553	Retired procedure (procedure)	4180186
40625563	Implantable lens, device (physical object)	4180186
40625587	Retired procedure (procedure)	4180186
40625624	Spread	4180186
40625624	Spreading (qualifier value)	4180186
40625631	Retired procedure (procedure)	4180186
40625662	Total carpectomy	4180186
40625662	Total ostectomy of carpals and metacarpals (procedure)	4180186
40625665	Retired procedure (procedure)	4180186
40625681	Excision of ulcer of duodenum (procedure)	4180186
40625683	Salmonella 1,9,12;d;e,n,x	4180186
40625683	Salmonella II rhodesiense (organism)	4180186
40625700	Photography of patient (procedure)	4180186
40625729	alpha-N-Acetylgalactosaminidase (substance)	4180186
40625760	Incision and exploration of hepatic ducts (procedure)	4180186
40625761	Closed traumatic dislocation of acromioclavicular joint (disorder)	4180186
40625781	Retired procedure (procedure)	4180186
40625800	Retired procedure (procedure)	4180186
40625802	Other specified endocrine disorder, NEC (disorder)	4180186
40625809	Haemodialysis counselling	4180186
40625809	Hemodialysis counseling (regime/therapy)	4180186
40625816	Lentigo (disorder)	4180186
40625816	Lentigo simplex	4180186
40625816	Naevus spilus	4180186
40625816	Nevus spilus	4180186
40625816	Speckled lentiginous naevus	4180186
40625816	Speckled lentiginous nevus	4180186
40625821	Retired procedure (procedure)	4180186
40625836	Acquired keratoderma palmaris et plantaris (disorder)	4180186
40625847	Retired procedure (procedure)	4180186
40625874	Sec-butyl alcohol (substance)	4180186
40625885	Retired procedure (procedure)	4180186
40625913	Retired procedure (procedure)	4180186
40625918	Status post (contextual qualifier) (qualifier value)	4180186
40625941	Retired procedure (procedure)	4180186
40625942	Antifreeze causing toxic effect	4180186
40625942	Anti-freeze poisoning	4180186
40625942	Ethylene glycol poisoning (disorder)	4180186
40625944	Seborrhea sicca (disorder)	4180186
40625944	Seborrhoea sicca	4180186
40625974	Retired procedure (procedure)	4180186
40625975	Retired procedure (procedure)	4180186
40626011	Retired procedure (procedure)	4180186
40626063	Retired procedure (procedure)	4180186
40626069	Refractory anaemia	4180186
40626069	Refractory anemia (morphologic abnormality)	4180186
40626115	Moving a patient in bed (procedure)	4180186
40626127	Effort function of larynx (biological function) (observable entity)	4180186
40626152	Anterior colporrhaphy for repair of cystocele (procedure)	4180186
40626172	Conjunctivitis in mucocutaneous disease (disorder)	4180186
40626180	Plasmin activator (substance)	4180186
40626201	Retired procedure (procedure)	4180186
40626225	Vireo (organism)	4180186
40626250	Salmonella III arizonae 35:g,z51:-- (organism)	4180186
40626253	Calomel (substance)	4180186
40626259	Acetyl carbromal (substance)	4180186
40626272	Acouchy (organism)	4180186
40626272	Tailed agouti	4180186
40626291	Retired procedure (procedure)	4180186
40626300	Retired procedure (procedure)	4180186
40626358	Cardiac external resuscitation by massage with open chest (procedure)	4180186
40626358	Cardiac massage with open chest	4180186
40626358	Cardioassist-method of circulatory assist, internal	4180186
40626358	Internal cardiac massage	4180186
40626358	Internal cardioassist	4180186
40626358	Open cardiac massage	4180186
40626358	Open chest massage of the heart	4180186
40626358	Open heart massage	4180186
40626383	Retired procedure (procedure)	4180186
40626408	Retired procedure (procedure)	4180186
40626428	Retired procedure (procedure)	4180186
40626429	Petroleum ether (substance)	4180186
40626440	Retired procedure (procedure)	4180186
40626444	Retired procedure (procedure)	4180186
40626454	Ability to sense vibration	4180186
40626454	Pallaesthesia	4180186
40626454	Pallesthesia	4180186
40626454	Vibration sense	4180186
40626454	Vibratory sensation	4180186
40626454	Vibratory sense, function (observable entity)	4180186
40626454	VS - Vibration sense	4180186
40626475	Retired procedure (procedure)	4180186
40626564	Disease of artery (disorder)	4180186
40626565	Lengthening of Achilles tendon (procedure)	4180186
40626572	Effusion of joint of lower leg (disorder)	4180186
40626613	Retired procedure (procedure)	4180186
40626656	Median nerve lateral root (body structure)	4180186
40626673	Goatsucker	4180186
40626673	Nightjar (organism)	4180186
40626676	Retired procedure (procedure)	4180186
40626689	Reconstruction of ankle (procedure)	4180186
40626692	Rhizopus cohnii (organism)	4180186
40626692	Rhizopus microsporus var rhizopodiformis	4180186
40626692	Rhizopus rhizopodiformis	4180186
40626692	Rhizopus rhizopodoformis	4180186
40626728	Retired procedure (procedure)	4180186
40626732	Weight maintenance consultation and regimen (procedure)	4180186
40626737	Retired procedure (procedure)	4180186
40626754	Threonine aldolase (substance)	4180186
40626766	Retired procedure (procedure)	4180186
40626794	Forceps application to aftercoming head (procedure)	4180186
40626795	Nonallopathic lesion of cervical region (finding)	4180186
40626811	Retired procedure (procedure)	4180186
40626828	Salmonella 3,10;z;e,n,x	4180186
40626828	Salmonella II finchley (organism)	4180186
40626834	Cervicitis (disorder)	4180186
40626847	Dromostanolone (substance)	4180186
40626847	Drostanolone	4180186
40626853	Opsoclonia	4180186
40626853	Opsoclonus (finding)	4180186
40626861	Retired procedure (procedure)	4180186
40626887	Fluoride	4180186
40626887	Fluoride salt (substance)	4180186
40626888	Secondary localised osteoarthrosis of forearm	4180186
40626888	Secondary localized osteoarthrosis of forearm (disorder)	4180186
40626894	Malignant lymphoma, centrocytic (morphologic abnormality)	4180186
40626903	Retired procedure (procedure)	4180186
40626922	Bat fly (organism)	4180186
40626939	Retired procedure (procedure)	4180186
40626975	Manifest (modifier) (qualifier value)	4180186
40626983	Acquired atrophy of fallopian tube (disorder)	4180186
40627008	Reduction mammoplasty, bilateral (procedure)	4180186
40627017	Retired procedure (procedure)	4180186
40627036	Urethrectomy (procedure)	4180186
40627071	Retired procedure (procedure)	4180186
40627081	Ethanoic acid (substance)	4180186
40627089	Hookworm (living organism) (organism)	4180186
40627119	Retired procedure (procedure)	4180186
40627128	Salmonella 1,6,14;m,t;1,5	4180186
40627128	Salmonella II 1,6,14:m,t:1,5	4180186
40627128	Salmonella II rooikrantz (organism)	4180186
40627128	Salmonella rooikrantz	4180186
40627173	Equine sensory ataxia	4180186
40627173	Cervical malformation - malarticulation (disorder)	4180186
40627173	Cervical stenotic myelopathy	4180186
40627173	Enzootic equine incoordination	4180186
40627173	Wobbler syndrome	4180186
40627177	Antibacterial drug poisoning	4180186
40627177	Antibiotic poisoning	4180186
40627177	Poisoning by antibiotic (disorder)	4180186
40627178	Morganella morganii (living organism) (organism)	4180186
40627187	Speech function	4180186
40627187	Speech, function (observable entity)	4180186
40627189	Postural proteinuria (disorder)	4180186
40627202	Retired procedure (procedure)	4180186
40627221	Graphaesthesia	4180186
40627221	Graphesthesia, function (observable entity)	4180186
40627234	Primary frambesia (disorder)	4180186
40627260	Malposition of fetus (disorder)	4180186
40627281	Retired procedure (procedure)	4180186
40627284	Hepatitis C virus measurement (procedure)	4180186
40627321	Retired procedure (procedure)	4180186
40627347	Cortex laceration with open intracranial wound AND no loss of consciousness (disorder)	4180186
40627353	Retired procedure (procedure)	4180186
40627374	Sloth (organism)	4180186
40627377	Oxpecker	4180186
40627377	Tickbird (organism)	4180186
40627383	Retired procedure (procedure)	4180186
40627411	Coagulation factor IV (substance)	4180186
40627422	Retired procedure (procedure)	4180186
40627423	Rheumatoid arteritis (disorder)	4180186
40627423	Rheumatoid vasculitis	4180186
40627438	Retired procedure (procedure)	4180186
40627443	Deer mouse (organism)	4180186
40627462	Retired procedure (procedure)	4180186
40627482	Suture of cervix (procedure)	4180186
40627482	Suture of laceration of cervix	4180186
40627482	Trachelorrhaphy	4180186
40627482	Trachelorrhaphy by vaginal approach	4180186
40627482	Trachelorrhaphy, Emmet type	4180186
40627485	Retired procedure (procedure)	4180186
40627496	Retired procedure (procedure)	4180186
40627516	Evacuation of haematoma of vagina	4180186
40627516	Evacuation of hematoma of vagina	4180186
40627516	Evacuation of vaginal haematoma	4180186
40627516	Evacuation of vaginal hematoma	4180186
40627516	Incision of haematoma of vagina	4180186
40627516	Incision of hematoma of vagina (procedure)	4180186
40627525	Ectopic atrial beats	4180186
40627525	Ectopic atrial pacemaker	4180186
40627525	Wandering pacemaker (disorder)	4180186
40627558	Acquired deformity of leg, NEC (disorder)	4180186
40627608	Chronic secretory otitis media (disorder)	4180186
40627617	Congenital anomaly of face (disorder)	4180186
40627617	Congenital deformity of face	4180186
40627617	Facial dysmorphism	4180186
40627617	Facial malformation	4180186
40627622	Retired procedure (procedure)	4180186
40627649	Infection due to Pasteurella haemolytica (disorder)	4180186
40627649	Infection due to Pasteurella hemolytica	4180186
40627651	Retired procedure (procedure)	4180186
40627660	Retired procedure (procedure)	4180186
40627683	Gout with other manifestation, NEC (disorder)	4180186
40627714	Toxic effect of isopropyl alcohol (disorder)	4180186
40627727	Retired procedure (procedure)	4180186
40627741	Acoustic radiations	4180186
40627741	Auditory pathway	4180186
40627741	Auditory pathway structure (body structure)	4180186
40627741	Auditory radiations	4180186
40627741	Geniculotemporal tract	4180186
40627766	Banksian black cockatoo (organism)	4180186
40627772	Breast operation	4180186
40627772	Breast procedure	4180186
40627772	Mammary gland operation	4180186
40627772	Mammary operation	4180186
40627772	Operation on breast (procedure)	4180186
40627776	Retired procedure (procedure)	4180186
40627791	Retired procedure (procedure)	4180186
40627804	Repair or plastic operation on humerus (procedure)	4180186
40627808	Actinobacillosis due to Actinobacillus equuli (disorder)	4180186
40627808	Perinatal actinobacillosis of foals	4180186
40627808	Pyosepticaemia neonatorum	4180186
40627808	Pyosepticemia neonatorum	4180186
40627808	Septicaemia of foals	4180186
40627808	Septicemia of foals	4180186
40627808	Sleepy foal disease	4180186
40627811	Tetanus antitoxin, human (product)	4180186
40627811	Tetanus immune globulin	4180186
40627811	TIG	4180186
40627819	Antibody constant region (substance)	4180186
40627819	Antibody C region	4180186
40627833	Icebox, device (physical object)	4180186
40627835	Retired procedure (procedure)	4180186
40627846	Salmonella 1,13,23;m,t;e,n,x	4180186
40627846	Salmonella II worcester (organism)	4180186
40627879	Respiratory depth, function (observable entity)	4180186
40627881	Retired procedure (procedure)	4180186
40627882	Black fly (organism)	4180186
40627899	Retired procedure (procedure)	4180186
40627904	Retired procedure (procedure)	4180186
40627910	Repair of elbow joint (procedure)	4180186
40627933	Cognitive decline	4180186
40627933	Cognitive disturbance	4180186
40627933	Cognitive dysfunction	4180186
40627933	Cognitive impairment	4180186
40627933	Impaired cognition (finding)	4180186
40627933	Mild cognitive disorder	4180186
40627939	Retired procedure (procedure)	4180186
40627972	Woodland jumping mouse (organism)	4180186
40627984	Transplantation of aberrant renal artery (procedure)	4180186
40627993	Retired procedure (procedure)	4180186
40627996	Salmonella arizonae 48:g,z51:-- (organism)	4180186
40628024	Crushing injury of shoulder AND upper arm (disorder)	4180186
40628034	Retired procedure (procedure)	4180186
40628036	Excision of axillary lymph nodes (procedure)	4180186
40628063	Streptococcus equi ss. zooepidemicus (organism)	4180186
40628083	Retired procedure (procedure)	4180186
40628103	Retired procedure (procedure)	4180186
40628107	Pyogenic arthritis of upper arm (disorder)	4180186
40628133	Gray fox	4180186
40628133	Urocyon (organism)	4180186
40628140	Polymyxin B sulfate otic agent	4180186
40628140	Polymyxin B sulfate otic agent (substance)	4180186
40628140	Polymyxin B sulphate otic preparation	4180186
40628143	Retired procedure (procedure)	4180186
40628158	Acid mantle	4180186
40628158	Skin pH, function (observable entity)	4180186
40628174	C/O - nausea	4180186
40628174	Feeling bilious	4180186
40628174	Feeling queasy	4180186
40628174	Feeling sick	4180186
40628174	Nausea (finding)	4180186
40628174	Nausea symptoms	4180186
40628174	Nauseated	4180186
40628174	Nauseous	4180186
40628174	Observation of nausea	4180186
40628184	Retired procedure (procedure)	4180186
40628211	Scrub typhus (disorder)	4180186
40628219	Infection by Leishmania tropica major (disorder)	4180186
40628241	Retired procedure (procedure)	4180186
40628256	Retired procedure (procedure)	4180186
40628267	3-Oxo-5alpha-steroid delta^4^-dehydrogenase	4180186
40628267	3-Oxo-5alpha-steroid delta^4^-dehydrogenase (substance)	4180186
40628304	Retired procedure (procedure)	4180186
40628320	Retired procedure (procedure)	4180186
40628328	Retired procedure (procedure)	4180186
40628330	Injury of seminal vesicle with open wound into abdominal cavity (disorder)	4180186
40628342	Retired procedure (procedure)	4180186
40628349	Retired procedure (procedure)	4180186
40628351	Repair of muscle of hand by suture (procedure)	4180186
40628357	Episode of (qualifier value)	4180186
40628376	Incomplete bilateral cleft palate with cleft lip (disorder)	4180186
40628386	Echinococcus granulosus (living organism) (organism)	4180186
40628387	LATS	4180186
40628387	LATS - Long-acting thyroid stimulator	4180186
40628387	Long-acting thyroid stimulator (substance)	4180186
40628387	Thyroid receptor antibody	4180186
40628387	Thyroid receptor immunoglobulin	4180186
40628387	Thyroid stimulating globulin	4180186
40628387	Thyroid stimulating hormone receptor antibody	4180186
40628387	TRI - Thyroid receptor immunoglobulin	4180186
40628387	TSI	4180186
40628398	Quinacrine (substance)	4180186
40628404	Amelia of upper limb (disorder)	4180186
40628406	Infection by Microsporea (disorder)	4180186
40628424	Retired procedure (procedure)	4180186
40628428	Sprain of radiocarpal joint AND/OR ligament (disorder)	4180186
40628432	Infestation by Acarina (disorder)	4180186
40628437	Salmonella II, 1,4,(5),12:f,g,t:z6,z42 (organism)	4180186
40628454	Pseudomonas glathei (organism)	4180186
40628461	Cast boot, device (physical object)	4180186
40628500	Gallinule (organism)	4180186
40628581	Falcivibrio grandis (organism)	4180186
40628582	Salmonella III arizonae 65:c:1,5,7 (organism)	4180186
40628586	Abortion with salpingo-oophoritis (finding)	4180186
40628595	Leishmania tropica complex (living organism) (organism)	4180186
40628602	Sodium tetradecyl (product)	4180186
40628632	Retired procedure (procedure)	4180186
40628642	Complement receptor 2 (substance)	4180186
40628653	Spinal cord anterior horn (body structure)	4180186
40628653	Spinal cord ventral horn	4180186
40628663	Rhodococcus terrae (organism)	4180186
40628665	Suture of ureter	4180186
40628665	Ureterorrhaphy (procedure)	4180186
40628718	Retired procedure (procedure)	4180186
40628726	Retired procedure (procedure)	4180186
40628729	Retired procedure (procedure)	4180186
40628798	Tendinosuture of hand	4180186
40628798	Suture of tendon of hand (procedure)	4180186
40628798	Tenorrhaphy of hand	4180186
40628798	Tenosuture of hand	4180186
40628831	Allergic drug reaction (disorder)	4180186
40628831	Allergic reaction to drug	4180186
40628831	Drug allergy	4180186
40628854	Excision of pelvic tissue (procedure)	4180186
40628856	Exostectomy	4180186
40628856	Excision of bony exostosis	4180186
40628856	Excision of exostosis	4180186
40628856	Excision of exostosis of bone (procedure)	4180186
40628856	Excision of osteochondroma	4180186
40628857	Retired procedure (procedure)	4180186
40628902	Salmonella III arizonae 47:z52:e,n,x,z15 (organism)	4180186
40628917	AIDS with retinal vascular changes (disorder)	4180186
40628947	Retired procedure (procedure)	4180186
40628961	Precirrhotic haemochromatosis	4180186
40628961	Precirrhotic hemochromatosis (disorder)	4180186
40629016	Flaccidity (finding)	4180186
40629016	Muscular flaccidity	4180186
40629062	Mycoplasmal pelvic inflammatory disease (disorder)	4180186
40629096	Osteogenesis imperfecta, perinatal lethal (disorder)	4180186
40629098	Retired procedure (procedure)	4180186
40629111	Other specified disorder of sweat gland, NEC (disorder)	4180186
40629130	Partial hip replacement by cup (procedure)	4180186
40629166	Retired procedure (procedure)	4180186
40629174	Retired procedure (procedure)	4180186
40629178	Retired procedure (procedure)	4180186
40629223	Mid abdomen	4180186
40629223	Mid abdomen (surface region)	4180186
40629223	Structure of mid abdomen (surface region) (body structure)	4180186
40629238	Transient paralysis of limb (finding)	4180186
40629248	Retired procedure (procedure)	4180186
40629262	Endolymphatic stromal myosis (morphologic abnormality)	4180186
40629266	Arthrotomy (procedure)	4180186
40629270	Forepaw apodia	4180186
40629270	Acheiria	4180186
40629270	Agenesis of forepaw	4180186
40629270	Agenesis of hand	4180186
40629270	Amelia of the hand	4180186
40629270	Congenital absence of hand (disorder)	4180186
40629270	Transverse deficiency of arm, wrist level	4180186
40629315	Retired procedure (procedure)	4180186
40629319	Cardioversion (procedure)	4180186
40629371	Human leucocyte antigen DRw53	4180186
40629371	Human leukocyte antigen DRw53	4180186
40629371	Human leukocyte antigen DRw53 (substance)	4180186
40629392	Chorioadenoma	4180186
40629392	Chorioadenoma destruens	4180186
40629392	IM - Invasive mole	4180186
40629392	Invasive hydatidiform mole	4180186
40629392	Invasive mole	4180186
40629392	Invasive mole - placenta	4180186
40629392	Malignant hydatidiform mole	4180186
40629392	Molar pregnancy with chorioadenoma	4180186
40629392	Molar pregnancy with chorioadenoma destruens	4180186
40629392	Molar pregnancy with invasive hydatidiform mole (disorder)	4180186
40629392	Molar pregnancy with invasive mole	4180186
40629392	Molar pregnancy with malignant hydatidiform mole	4180186
40629400	Retired procedure (procedure)	4180186
40629401	Retired procedure (procedure)	4180186
40629404	Bell magpie (organism)	4180186
40629404	Currawong	4180186
40629416	Anomalous congenital connection	4180186
40629416	Congenital abnormal communication (morphologic abnormality)	4180186
40629416	Congenital abnormal insertion	4180186
40629416	Congenital abnormal origin	4180186
40629429	Retired procedure (procedure)	4180186
40629435	Retired procedure (procedure)	4180186
40629438	Salmonella arizonae 45:g,z51:-- (organism)	4180186
40629440	Wild canary (living organism) (organism)	4180186
40629446	Retired procedure (procedure)	4180186
40629468	Implantation of inert material in scleral shell, reinsertion (procedure)	4180186
40629468	Implantation of inert material in Tenon's capsule, reinsertion	4180186
40629477	Blood group antigen Le^bL^	4180186
40629477	Blood group antigen Le^bL^ (substance)	4180186
40629514	Stillbirth (finding)	4180186
40629517	Retired procedure (procedure)	4180186
40629536	Retired procedure (procedure)	4180186
40629539	Retired procedure (procedure)	4180186
40629579	Retired procedure (procedure)	4180186
40629599	Otaria flavescens (organism)	4180186
40629599	Southern sea lion	4180186
40629624	Salmonella 9,46:z10:z6 (organism)	4180186
40629640	Caprine adenovirus (organism)	4180186
40629672	Cellulitis of leg, except foot (disorder)	4180186
40629673	Janitor (occupation)	4180186
40629674	Animal ear washing (procedure)	4180186
40629689	Retired procedure (procedure)	4180186
40629728	Retired procedure (procedure)	4180186
40629745	Retired procedure (procedure)	4180186
40629772	Operation on chest wall	4180186
40629772	Operation on thorax (procedure)	4180186
40629773	Hard exudates of retina (finding)	4180186
40629774	Malignant lymphoma, centroblastic, follicular (morphologic abnormality)	4180186
40629784	Superior pulmonary sulcus syndrome (disorder)	4180186
40629792	Platinosis (disorder)	4180186
40629792	Platinum asthma	4180186
40629799	Chimpanzee	4180186
40629799	Pan (organism)	4180186
40629852	Retired procedure (procedure)	4180186
40629864	Ethanolaminephosphotransferase (substance)	4180186
40629878	Retired procedure (procedure)	4180186
40629905	Common magpie (organism)	4180186
40629911	Retired procedure (procedure)	4180186
40629918	Retired procedure (procedure)	4180186
40629923	Mongoose lemur	4180186
40629923	Lemur mongoose (organism)	4180186
40629942	Salmonella 9,46;g,m,s,t;e,n,x	4180186
40629942	Salmonella II duivenhoks (organism)	4180186
40629955	Bromsulfalein (substance)	4180186
40629955	Bromsulphalein	4180186
40629959	Perch (organism)	4180186
40630003	Retired procedure (procedure)	4180186
40630012	Menopause praecox (qualifier value)	4180186
40630019	MM - Mucous membrane	4180186
40630019	Mucosa	4180186
40630019	Mucous membrane	4180186
40630019	Mucous membrane structure (body structure)	4180186
40630019	Tunica mucosa	4180186
40630022	Salmonella III arizonae 65:l,v:z35 (organism)	4180186
40630029	Hysterosalpingostomy	4180186
40630029	Repair of fallopian tube by reimplantation into uterus (procedure)	4180186
40630029	Salpingohysterostomy	4180186
40630029	Tubouterine implantation	4180186
40630029	Uterotubal implantation	4180186
40630046	Subacute myeloid leukaemia	4180186
40630046	Subacute myeloid leukemia (morphologic abnormality)	4180186
40630068	Closed fracture of condylar process of mandible (disorder)	4180186
40630071	Mycobacterium chelonae ss. chelonae (organism)	4180186
40630071	Mycobacterium chelonae subsp chelonae	4180186
40630071	Mycobacterium chelonae subsp. chelonae	4180186
40630071	Mycobacterium chelonae subspecies chelonae (organism)	4180186
40630071	Mycobacterium chelonae subspecies chelonae	4180186
40630079	Duodenal rupture (disorder)	4180186
40630092	Virchow's node (disorder)	4180186
40630114	Lennert lymphoma	4180186
40630114	Lennert's lymphoma	4180186
40630114	Lymphoepithelioid lymphoma (morphologic abnormality)	4180186
40630134	Vicia faba poisoning (disorder)	4180186
40630135	Retired procedure (procedure)	4180186
40630167	Open wound of supraclavicular region with complication (disorder)	4180186
40630176	Spontaneous tension pneumothorax (disorder)	4180186
40630220	Retired procedure (procedure)	4180186
40630235	Salmonella III arizonae 50:r:z (organism)	4180186
40630240	Generalised convulsion	4180186
40630240	Generalized convulsion (finding)	4180186
40630252	Retired procedure (procedure)	4180186
40630273	Least bittern (organism)	4180186
40630321	Retired procedure (procedure)	4180186
40630326	With laterality (attribute)	4180186
40630347	Contact dermatitis due to metal (disorder)	4180186
40630407	Salmonella 44;r;-	4180186
40630407	Salmonella camdeni	4180186
40630407	Salmonella V 44:r:-	4180186
40630407	Salmonella V camdeni (organism)	4180186
40630413	Retired procedure (procedure)	4180186
40630425	P-R interval, function (observable entity)	4180186
40630429	Injury of deep plantar blood vessels (disorder)	4180186
40630436	Salmonella 6,7;z42;1,7	4180186
40630436	Salmonella II sullivan (organism)	4180186
40630442	Homocarnosinase (substance)	4180186
40630444	Retired procedure (procedure)	4180186
40630468	Salmonella III arizonae 50:r:e,n,x,z15 (organism)	4180186
40630473	Normocalcaemic pseudohypoparathyroidism	4180186
40630473	Normocalcemic pseudohypoparathyroidism (disorder)	4180186
40630476	Degenerative arthritis	4180186
40630476	Degenerative arthropathy	4180186
40630476	Degenerative joint disease (disorder)	4180186
40630476	Degenerative polyarthritis	4180186
40630476	Hypertrophic arthritis	4180186
40630476	Hypertrophic polyarthritis	4180186
40630476	Osteoarthritis	4180186
40630476	Osteoarthrosis	4180186
40630476	Proliferative arthritis	4180186
40630486	Tenosynovitis of foot and ankle, NEC (disorder)	4180186
40630518	Ophthalmia neonatorum (disorder)	4180186
40630545	Repair of testis (procedure)	4180186
40630562	Japanese cormorant (organism)	4180186
40630578	Weight increase consultation and regimen (procedure)	4180186
40630595	Arthrodesis of interphalangeal joint of finger (procedure)	4180186
40630597	Pseudomonas gladioli (organism)	4180186
40630597	Pseudomonas marginata	4180186
40630609	Retired procedure (procedure)	4180186
40630613	Retired procedure (procedure)	4180186
40630624	Akathisia (finding)	4180186
40630624	Motor restlessness	4180186
40630650	Division of joint cartilage (procedure)	4180186
40630650	Joint chondrotomy	4180186
40630667	Retired procedure (procedure)	4180186
40630672	Trinidad vampire bat (organism)	4180186
40630701	Salmonella II, group P (organism)	4180186
40630714	Retired procedure (procedure)	4180186
40630725	Retired procedure (procedure)	4180186
40630735	Salmonella 1,6,14;z10;1,5	4180186
40630735	Salmonella II 1,6,14:z10:1,5	4180186
40630735	Salmonella II simonstown (organism)	4180186
40630735	Salmonella simonstown	4180186
40630808	Bacillus Calmette-Guerin vaccine	4180186
40630808	Bacillus Calmette-Guérin vaccine	4180186
40630808	BCG vaccine (product)	4180186
40630841	Retired procedure (procedure)	4180186
40630869	Thrombophlebitis of lateral venous sinus (disorder)	4180186
40630870	Retired procedure (procedure)	4180186
40630894	Derangement of meniscus, NEC (disorder)	4180186
40630910	Benign postural proteinuria (disorder)	4180186
40630968	Incision of muscle of hand (procedure)	4180186
40630997	Erotism, function (observable entity)	4180186
40631005	Retired procedure (procedure)	4180186
40631007	Phenformin agent (substance)	4180186
40631033	Ascitic fluid	4180186
40631033	Peritoneal fluid (substance)	4180186
40631035	Viral hepatitis, carrier state (finding)	4180186
40631048	Arthrotomy of knee for infection (procedure)	4180186
40631099	Retired procedure (procedure)	4180186
40631106	Role clarification by nurse (procedure)	4180186
40631112	Agammaglobulinaemia	4180186
40631112	Agammaglobulinemia (disorder)	4180186
40631127	Retired procedure (procedure)	4180186
40631139	Retired procedure (procedure)	4180186
40631147	Dermatitis infectiosa eczematoides (disorder)	4180186
40631150	Calcium, serum, ionised measurement	4180186
40631150	Calcium, serum, ionized measurement (procedure)	4180186
40631174	Vipera (organism)	4180186
40631184	von Willebrand disease, type IS/III (disorder)	4180186
40631190	Pel's fishing owl (organism)	4180186
40631198	Edema of penis (disorder)	4180186
40631198	Oedema of penis	4180186
40631217	Polydactyly (disorder)	4180186
40631226	Poisoning by vaccine AND/OR biological substance (navigational concept)	4180186
40631245	Shale (substance)	4180186
40631246	Folds in Descemet's membrane (disorder)	4180186
40631261	Retired procedure (procedure)	4180186
40631270	Salmonella III arizonae 43:z36:-- (organism)	4180186
40631277	Retired procedure (procedure)	4180186
40631283	Retired procedure (procedure)	4180186
40631297	Retired procedure (procedure)	4180186
40631308	Retired procedure (procedure)	4180186
40631324	AIDS with cachexia (disorder)	4180186
40631324	HIV disease resulting in wasting syndrome	4180186
40631324	HIV - Human immunodeficiency virus infection wasting syndrome	4180186
40631324	Human immunodeficiency virus infection wasting syndrome	4180186
40631324	Slim disease	4180186
40631336	Complication of transplanted heart (disorder)	4180186
40631345	Retired procedure (procedure)	4180186
40631361	Retired procedure (procedure)	4180186
40631362	GH - Growth hormone	4180186
40631362	Growth hormone	4180186
40631362	HGH	4180186
40631362	HGH - Growth hormone	4180186
40631362	Human growth hormone (substance)	4180186
40631362	Somatotrophin	4180186
40631362	Somatotropic hormone	4180186
40631362	Somatotropin	4180186
40631362	STH	4180186
40631366	Perinatal pulmonary hemorrhage	4180186
40631366	Neonatal pulmonary haemorrhage	4180186
40631366	Neonatal pulmonary hemorrhage	4180186
40631366	Perinatal pulmonary haemorrhage	4180186
40631366	Pulmonary haemorrhage in foetus OR newborn	4180186
40631366	Pulmonary hemorrhage in fetus OR newborn (disorder)	4180186
40631377	Cloud rat	4180186
40631377	Giant rat (organism)	4180186
40631378	Estradiol (substance)	4180186
40631378	Oestradiol	4180186
40631387	Retired procedure (procedure)	4180186
40631413	Salmonella 48;i;z	4180186
40631413	Salmonella III arizonae 48:i:z (organism)	4180186
40631413	Salmonella sydney	4180186
40631434	Pityriasis lichenoides chronica (disorder)	4180186
40631439	Retired procedure (procedure)	4180186
40631462	Salmonella III arizonae 53:g,z51:-- (organism)	4180186
40631478	Acetic acid solution (product)	4180186
40631489	Livedo reticularis without ulceration (disorder)	4180186
40631529	Deficiency of N-acetylgalactosamine-6-sulfatase (disorder)	4180186
40631529	Deficiency of N-acetylgalactosamine-6-sulphatase	4180186
40631546	Retired procedure (procedure)	4180186
40631557	Retired procedure (procedure)	4180186
40631581	Ostium secundum type atrial septal defect (disorder)	4180186
40631610	Drug cream, 0,02% (product)	4180186
40631616	Pruritus of skin (finding)	4180186
40631626	Poisoning by capillary-active drug (disorder)	4180186
40631651	Retired procedure (procedure)	4180186
40631669	Circinate choroidal dystrophy	4180186
40631669	Partial central dystrophy of choroid (disorder)	4180186
40631675	Retired procedure (procedure)	4180186
40631706	Flavimonas (organism)	4180186
40631738	Shrimp (organism)	4180186
40631755	Retired procedure (procedure)	4180186
40631778	Salmonella III arizonae 17:z10:e,n,x,z15:(z56) (organism)	4180186
40631790	Rhodococcus obuensis (organism)	4180186
40631808	Retired procedure (procedure)	4180186
40631815	Antiphlogistic agent (product)	4180186
40631818	Retired procedure (procedure)	4180186
40631836	Salmonella 47;d;z39	4180186
40631836	Salmonella II 47:d:z39	4180186
40631836	Salmonella II quimbamba (organism)	4180186
40631836	Salmonella quimbamba	4180186
40631838	Retired procedure (procedure)	4180186
40631841	Retired procedure (procedure)	4180186
40631845	Retired procedure (procedure)	4180186
40631847	Retired procedure (procedure)	4180186
40631864	Infiltrative tuberculosis of lung (disorder)	4180186
40631871	Congenital pectus excavatum	4180186
40631871	Acquired pectus excavatum	4180186
40631871	Cobbler's chest	4180186
40631871	Congenital funnel chest	4180186
40631871	Funnel chest	4180186
40631871	Pectus excavatum (disorder)	4180186
40631871	Pectus recurvatum	4180186
40631871	Trichterbrust	4180186
40631891	Retired procedure (procedure)	4180186
40631926	Retired procedure (procedure)	4180186
40631988	Fallopian tube operation	4180186
40631988	Operation on fallopian tube (procedure)	4180186
40631988	Procedure on fallopian tube	4180186
40631988	Tubal operations - fallopian	4180186
40631992	Junctional epidermolysis bullosa (disorder)	4180186
40631992	Epidermolysis bullosa letalis	4180186
40631992	Herlitz's disease	4180186
40631992	Herlitz syndrome	4180186
40631992	Junctional epidermolysis bullosa gravis of Herlitz	4180186
40631998	Blood group antigen Juneau (substance)	4180186
40632009	North Asian tick fever (disorder)	4180186
40632022	Urea 40-50% injection (product)	4180186
40632031	Benzyl hydroquinone	4180186
40632031	Monobenzone (substance)	4180186
40632031	Monobenzyl ether of hydroquinone	4180186
40632035	Eperythrozoon suis (organism)	4180186
40632041	Vampire bat (organism)	4180186
40632059	Retired procedure (procedure)	4180186
40632077	Allergic dermatitis due to poison vine	4180186
40632077	Allergic dermatitis due to Rhus radicans	4180186
40632077	Contact dermatitis due to poison vine (disorder)	4180186
40632077	Contact dermatitis due to Rhus radicans	4180186
40632093	Woodworking-machine operator (general) (occupation)	4180186
40632094	Congenital fistula of urachus (disorder)	4180186
40632101	Electrical fitter (general) (occupation)	4180186
40632120	Myelosclerosis (disorder)	4180186
40632121	Other specified birth trauma, NEC (disorder)	4180186
40632128	Chinchilla (living organism) (organism)	4180186
40632172	Late effect of burns of other specified sites, NEC (disorder)	4180186
40632246	Crab spider (organism)	4180186
40632279	Excision of aneurysm of sinus of Valsalva (procedure)	4180186
40632300	Deep third degree burn of abdominal wall with loss of body part (disorder)	4180186
40632328	Open biopsy of small intestine (procedure)	4180186
40632337	Retired procedure (procedure)	4180186
40632354	Retired procedure (procedure)	4180186
40632355	Marcus-Gunn pupillary sign (finding)	4180186
40632355	Swinging flashlight sign	4180186
40632360	Bacillus brevis (organism)	4180186
40632373	Salmonella III arizonae 40:l,v:z (organism)	4180186
40632420	Retired procedure (procedure)	4180186
40632421	Retired procedure (procedure)	4180186
40632459	Salmonella III arizonae 44:z4,z32:-- (organism)	4180186
40632475	Ocular trabeculectomy (procedure)	4180186
40632482	Analeptic poisoning	4180186
40632482	Poisoning by analeptic (disorder)	4180186
40632491	Retired procedure (procedure)	4180186
40632511	Fever 106 degrees F or over	4180186
40632511	Fever 41 degrees C or over	4180186
40632511	Hyperpyrexia (finding)	4180186
40632530	Excision of lesion of tongue (procedure)	4180186
40632542	Salmonella III arizonae 17:z4,z23:-- (organism)	4180186
40632563	Skeletal survey	4180186
40632563	Skeletal X-ray (procedure)	4180186
40632587	Lacrimal duct	4180186
40632587	Lacrimal ducts	4180186
40632587	Lacrimal duct structure (body structure)	4180186
40632587	Tear duct	4180186
40632682	Retired procedure (procedure)	4180186
40632702	Retired procedure (procedure)	4180186
40632718	Fetal extension (finding)	4180186
40632722	Retired procedure (procedure)	4180186
40632758	Salmonella 1,6,14,25;a;e,n,x	4180186
40632758	Salmonella ferlac (organism)	4180186
40632758	Salmonella VI 1,6,14,25:a:e,n,x	4180186
40632769	Anel operation	4180186
40632769	Dilation of lacrimal duct (procedure)	4180186
40632776	Retired procedure (procedure)	4180186
40632784	Osteotomy of innominate bone (procedure)	4180186
40632788	Injury of appendix with open wound into abdominal cavity (disorder)	4180186
40632800	Dysaesthesia	4180186
40632800	Dysesthesia (finding)	4180186
40632852	Retired procedure (procedure)	4180186
40632862	Retired procedure (procedure)	4180186
40632908	Rickettsia tsutsugamushi (organism)	4180186
40632918	Retired procedure (procedure)	4180186
40632921	Antimalarial drug prophylaxis	4180186
40632921	Anti-malarial prophylaxis	4180186
40632921	Malarial prophylaxis	4180186
40632921	Prescription of prophylactic anti-malarial (procedure)	4180186
40632923	Retired procedure (procedure)	4180186
40632952	Malignant lymphoma, lymphocytic, well differentiated, nodular (morphologic abnormality)	4180186
40632974	Thought deprivation (finding)	4180186
40632977	Mustela (organism)	4180186
40632977	Weasel	4180186
40632980	Salmonella 38;g,t;-	4180186
40632980	Salmonella foulpointe	4180186
40632980	Salmonella II 38:g,t:-	4180186
40632980	Salmonella II foulpointe (organism)	4180186
40633031	Galeated curassow (organism)	4180186
40633038	Pancreaticogastrostomy	4180186
40633038	Anastomosis of pancreatic duct to stomach	4180186
40633038	Pancreas to stomach anastomosis (procedure)	4180186
40633038	Pancreaticogastric anastomosis	4180186
40633059	Incisional hernia (disorder)	4180186
40633081	Retired procedure (procedure)	4180186
40633091	Removal of foreign body from vulva by incision (procedure)	4180186
40633099	LT	4180186
40633099	Lymphotoxin (substance)	4180186
40633107	Acute miliary tuberculosis (disorder)	4180186
40633112	Retired procedure (procedure)	4180186
40633114	Papovavirus infection subgroup A (disorder)	4180186
40633170	Salmonella IV, group H (organism)	4180186
40633177	Retired procedure (procedure)	4180186
40633188	Retired procedure (procedure)	4180186
40633199	Gastroparesis syndrome (disorder)	4180186
40633215	Retired procedure (procedure)	4180186
40633222	Cortex contusion with open intracranial wound AND prolonged loss of consciousness (more than 24 hours) AND return to pre-existing conscious level (disorder)	4180186
40633251	Retired procedure (procedure)	4180186
40633256	Automobile mechanic (occupation)	4180186
40633257	Implantation of hip joint, partial (procedure)	4180186
40633312	Closed fracture of angle of jaw (disorder)	4180186
40633312	Closed fracture of angle of mandible	4180186
40633326	Blood group antibody B>w<	4180186
40633326	Blood group antibody B>w< (substance)	4180186
40633334	Retired procedure (procedure)	4180186
40633340	Retired procedure (procedure)	4180186
40633365	Kea (organism)	4180186
40633407	Agenesis of lacrimal apparatus	4180186
40633407	Congenital absence of lacrimal apparatus (disorder)	4180186
40633423	Retired procedure (procedure)	4180186
40633425	Retired procedure (procedure)	4180186
40633432	Burkholderia pickettii	4180186
40633432	Pseudomonas pickettii (organism)	4180186
40633434	Retired procedure (procedure)	4180186
40633470	Acquired pes, NEC (disorder)	4180186
40633474	Structure of zygoma (body structure)	4180186
40633474	Zygoma	4180186
40633474	Zygomatic process of temporal bone	4180186
40633482	Transmissible virus dementia (disorder)	4180186
40633483	Bell's palsy (disorder)	4180186
40633484	Papillomavirus of rats (organism)	4180186
40633489	Retired procedure (procedure)	4180186
40633502	Intervertebral disc	4180186
40633502	Intervertebral disc structure (body structure)	4180186
40633502	Structure of intervertebral disc	4180186
40633511	Bacillus laterosporus (organism)	4180186
40633523	Human leucocyte antigen DRw52	4180186
40633523	Human leukocyte antigen DRw52	4180186
40633523	Human leukocyte antigen DRw52 (substance)	4180186
40633559	Retired procedure (procedure)	4180186
40633584	Neutropenia (disorder)	4180186
40633596	Retired procedure (procedure)	4180186
40633600	Dermatitic epidermal naevus	4180186
40633600	Dermatitic epidermal nevus	4180186
40633600	Epidermal naevus	4180186
40633600	Epidermal nevus	4180186
40633600	Epithelial naevus	4180186
40633600	Epithelial nevus	4180186
40633600	ILVEN - Inflammatory linear verrucous epidermal naevus	4180186
40633600	ILVEN - Inflammatory linear verrucous epidermal nevus	4180186
40633600	Inflammatory linear verrucous epidermal naevus	4180186
40633600	Inflammatory linear verrucous epidermal nevus	4180186
40633600	Linear epidermal naevus	4180186
40633600	Linear epidermal nevus	4180186
40633600	Linear naevus	4180186
40633600	Linear nevus	4180186
40633600	Naevus unius lateris	4180186
40633600	Naevus verrucosus	4180186
40633600	Nevus unius lateris (disorder)	4180186
40633600	Nevus verrucosus	4180186
40633600	Systematised epidermal naevus	4180186
40633600	Systematized epidermal nevus	4180186
40633600	Verrucous epidermal naevus	4180186
40633600	Verrucous epidermal nevus	4180186
40633600	Verrucous naevus	4180186
40633600	Verrucous nevus	4180186
40633620	Injury of cervical sympathetic nerves (disorder)	4180186
40633652	Repair of eyeball socket (procedure)	4180186
40633672	Child care training (regime/therapy)	4180186
40633673	Silver-haired bat (organism)	4180186
40633697	Atrophoderma maculatum (disorder)	4180186
40633723	Chills and fever (finding)	4180186
40633740	Dichorionic twins	4180186
40633740	Dizygotic twins (finding)	4180186
40633740	Fraternal twins	4180186
40633740	Polyovular twins	4180186
40633757	Abrasion AND/OR friction burn of forearm with infection (disorder)	4180186
40633759	Insertion of globe into eye socket (procedure)	4180186
40633763	Approximate relative activity of corticosteroids (product)	4180186
40633780	Retired procedure (procedure)	4180186
40633789	Salmonella 9,46;z;e,n,x	4180186
40633789	Salmonella II haarlem (organism)	4180186
40633792	Salmonella, Subgenus II (organism)	4180186
40633796	PV - Vaginal bleeding	4180186
40633796	Bleeding from vagina (disorder)	4180186
40633796	BVP - Vaginal bleeding	4180186
40633796	Haemorrhage of vagina	4180186
40633796	Hemorrhage of vagina	4180186
40633796	Non-menstrual vaginal bleeding	4180186
40633796	PV - Vaginal blood loss	4180186
40633796	Vaginal bleeding	4180186
40633796	Vaginal blood loss	4180186
40633824	Retired procedure (procedure)	4180186
40633884	Retired procedure (procedure)	4180186
40633901	Retired procedure (procedure)	4180186
40633933	Retired procedure (procedure)	4180186
40634007	Anti-nuclear antibody measurement (procedure)	4180186
40634034	Stanalone preparation (product)	4180186
40634109	Retired procedure (procedure)	4180186
40634126	Open atrial septectomy with inflow occlusion (procedure)	4180186
40634140	Scleredema (disorder)	4180186
40634147	Retired procedure (procedure)	4180186
40634170	Cerebrocardiac neurosis (disorder)	4180186
40634177	Unqualified visual loss of one eye (disorder)	4180186
40634190	Retired procedure (procedure)	4180186
40634204	Retired procedure (procedure)	4180186
40634224	CD46	4180186
40634224	CD46 - Cluster of differentiation antigen 46	4180186
40634224	Cluster of differentiation antigen 46	4180186
40634224	Gp45-70	4180186
40634224	MCP	4180186
40634224	MCP - Membrane cofactor protein	4180186
40634224	Membrane cofactor protein (substance)	4180186
40634224	TLX - Trophoblast leucocyte common antigen	4180186
40634224	TLX - Trophoblast leukocyte common antigen	4180186
40634224	Trophoblast leucocyte common antigen	4180186
40634224	Trophoblast leukocyte common antigen	4180186
40634226	Hollenhorst plaque (disorder)	4180186
40634229	Bacillus subtilis neutral proteinase (substance)	4180186
40634240	Kraurosis vulvae (disorder)	4180186
40634264	Salmonella III arizonae 62:z4,z23:-- (organism)	4180186
40634266	Retired procedure (procedure)	4180186
40634269	Puffin (organism)	4180186
40634279	Ehrlichia sennetsu (organism)	4180186
40634279	Rickettsia sennetsu	4180186
40634288	Excision of scar of pericardium (procedure)	4180186
40634291	Retired procedure (procedure)	4180186
40634311	EHV-1	4180186
40634311	Equid herpesvirus 1 (organism)	4180186
40634311	Equine abortion virus	4180186
40634311	Equine rhinopneumonitis virus	4180186
40634333	Bacteroides oulorum (organism)	4180186
40634333	Prevotella oulorum	4180186
40634340	Arthropathy associated with Reiter's disease (disorder)	4180186
40634340	Arthropathy in Reiter's disease	4180186
40634340	Post-genitourinary infection Reiter's disease	4180186
40634365	Retired procedure (procedure)	4180186
40634369	Retired procedure (procedure)	4180186
40634372	Retired procedure (procedure)	4180186
40634389	Black heron (organism)	4180186
40634410	Tayassu pecari (organism)	4180186
40634410	White-lipped peccary	4180186
40634418	Abbe operation for construction of vagina (procedure)	4180186
40634434	Radiologic examination of femur, anteroposterior and lateral views (procedure)	4180186
40634480	Retired procedure (procedure)	4180186
40634508	Salmonella 30;g,t;-	4180186
40634508	Salmonella II 30:g,t:-	4180186
40634508	Salmonella II slatograd (organism)	4180186
40634508	Salmonella slatograd	4180186
40634538	Retired procedure (procedure)	4180186
40634583	Retired procedure (procedure)	4180186
40634615	Retired procedure (procedure)	4180186
40634621	Retired procedure (procedure)	4180186
40634631	Retired procedure (procedure)	4180186
40634657	Isotype (substance)	4180186
40634660	Pulp gangrene (disorder)	4180186
40634666	Thrombocythaemia	4180186
40634666	Thrombocythemia (disorder)	4180186
40634666	Thrombocytosis	4180186
40634678	Radiopaque medium (product)	4180186
40634694	Salmonella III arizonae 59:(k):z (organism)	4180186
40634726	Retired procedure (procedure)	4180186
40634736	Long-tailed tree pangolin (organism)	4180186
40634738	Retired procedure (procedure)	4180186
40634761	Retired procedure (procedure)	4180186
40634800	Closed fracture of head of femur (disorder)	4180186
40634811	Injection of vein (procedure)	4180186
40634812	Retired procedure (procedure)	4180186
40634813	Retired procedure (procedure)	4180186
40634816	Infected (morphologic abnormality)	4180186
40634886	Deoxycortisone (substance)	4180186
40634899	Butane (substance)	4180186
40634901	Blood group antibody E^u^	4180186
40634901	Blood group antibody E^u^ (substance)	4180186
40634933	Drug cream, 1% (product)	4180186
40634936	Altitudinal hemianopsia (finding)	4180186
40634941	Dyssocial behaviour of child or adolescent	4180186
40634941	Behavior disorder of childhood in relationship with others	4180186
40634941	Behaviour disorder of childhood in relationship with others	4180186
40634941	Childhood or adolescent dyssocial behavior	4180186
40634941	Childhood or adolescent dyssocial behaviour	4180186
40634941	Dyssocial behavior of child or adolescent (finding)	4180186
40634954	Alcoholic cirrhosis of liver (disorder)	4180186
40634955	Alkaline phosphatase isoenzyme, placental fraction (substance)	4180186
40634964	Ulnar deviation of the fingers (finding)	4180186
40634965	Platelet production (biological function) (observable entity)	4180186
40634970	Retired procedure (procedure)	4180186
40634980	Salmonella 1,13,22;g,t;1,5	4180186
40634980	Salmonella II rotterdam (organism)	4180186
40635000	Phenothiazine (product)	4180186
40635000	Thiodiphenylamine	4180186
40635017	Retired procedure (procedure)	4180186
40635021	Retired procedure (procedure)	4180186
40635063	North Atlantic fulmar (organism)	4180186
40635064	History taking, complete (procedure)	4180186
40635076	Retired procedure (procedure)	4180186
40635128	Spirochaete	4180186
40635128	Spirochete (organism)	4180186
40635128	Treponemataceae	4180186
40635168	Salmonella III arizonae 50:i:1,5,7 (organism)	4180186
40635180	Agnosticism (religion/philosophy)	4180186
40635186	Injury of face AND/OR neck (disorder)	4180186
40635205	Closure of oromaxillary fistula	4180186
40635205	Closure of oromaxillary fistula (procedure)	4180186
40635211	Interval gout (disorder)	4180186
40635224	Retired procedure (procedure)	4180186
40635253	Retired procedure (procedure)	4180186
40635270	Alfalfa mosaic virus group (Plant hosts) (organism)	4180186
40635270	Genus Alfamovirus	4180186
40635287	Retired procedure (procedure)	4180186
40635288	Revision of esophagostomy (procedure)	4180186
40635288	Revision of oesophagostomy	4180186
40635299	Infection due to Diphtheroid bacteria other than diphtheriae (disorder)	4180186
40635302	Open medial dislocation of elbow (disorder)	4180186
40635304	Scopolamine hydrobromide	4180186
40635304	Scopolamine hydrobromide (product)	4180186
40635331	Third degree burn of multiple sites of trunk (disorder)	4180186
40635349	Retired procedure (procedure)	4180186
40635365	Beltsville pig (organism)	4180186
40635367	Reattachment of retina by photocoagulation (procedure)	4180186
40635372	Hypomagnesemia (disorder)	4180186
40635372	Hypomagnesaemia	4180186
40635375	Epidermal growth factor (substance)	4180186
40635387	Genus: Influenza virus C	4180186
40635387	Influenzavirus C (organism)	4180186
40635419	Retired procedure (procedure)	4180186
40635470	Retired procedure (procedure)	4180186
40635478	Subacute sclerosing panencephalitis (disorder)	4180186
40635511	Withdrawal bleeding (disorder)	4180186
40635525	Eyebrow	4180186
40635525	Eyebrow structure (body structure)	4180186
40635525	Hair of eyebrow	4180186
40635527	Transmetacarpal amputation (procedure)	4180186
40635536	Exposure to radiation (event)	4180186
40635544	Unilateral traumatic amputation below elbow with complication (disorder)	4180186
40635565	Impaired swallowing	4180186
40635565	Swallowing impairment	4180186
40635565	Swallowing problem (finding)	4180186
40635565	Uncompensated swallowing impairment	4180186
40635575	Retired procedure (procedure)	4180186
40635581	Heberden's node (disorder)	4180186
40635588	Retired procedure (procedure)	4180186
40635689	AIDS with candidiasis of lung (disorder)	4180186
40635705	Retired procedure (procedure)	4180186
40635710	Coronavirus (living organism) (organism)	4180186
40635721	Acute traumatic arthropathy (disorder)	4180186
40635736	Retired procedure (procedure)	4180186
40635740	Oesophagostomy operation	4180186
40635740	Artificial opening into esophagus	4180186
40635740	Artificial opening into oesophagus	4180186
40635740	Esophagostomy operation	4180186
40635740	Esophagostomy (procedure)	4180186
40635740	External fistulisation of oesophagus	4180186
40635740	External fistulization of esophagus	4180186
40635740	Oesophagostomy	4180186
40635761	Salmonella 4,12;l,w;e,n,x	4180186
40635761	Salmonella II kilwa (organism)	4180186
40635775	Retired procedure (procedure)	4180186
40635776	Salmonella II kommetje (organism)	4180186
40635776	Salmonella 43;b;z42	4180186
40635776	Salmonella II 43:b:z42	4180186
40635776	Salmonella kommetje	4180186
40635794	Reconstruction nail bed	4180186
40635794	Repair of ingrown toenail	4180186
40635794	Repair of nail bed (procedure)	4180186
40635803	Acquired hunchback	4180186
40635803	Acquired kyphosis	4180186
40635803	Angulation of spine	4180186
40635803	Congenital kyphosis	4180186
40635803	Gibbosity	4180186
40635803	Gibbus	4180186
40635803	Humpback	4180186
40635803	Hunchback	4180186
40635803	Kyphosis deformity of spine (disorder)	4180186
40635832	Black-necked screamer (organism)	4180186
40635853	Endotoxaemia	4180186
40635853	Endotoxemia	4180186
40635853	Endotoxic shock (disorder)	4180186
40635853	Gram-negative septic shock	4180186
40635853	Gram-negative shock	4180186
40635901	Drug cream, 0,05% (product)	4180186
40635943	Domestic Mallard duck (organism)	4180186
40635949	Hydroxymethylglutaryl-CoA lyase (substance)	4180186
40635995	American raven (organism)	4180186
40636010	Pseudomonas rubrilineans (organism)	4180186
40636013	Retired procedure (procedure)	4180186
40636049	Retired procedure (procedure)	4180186
40636057	Female infertility of pituitary-hypothalamic origin (disorder)	4180186
40636058	Moschowitz enterocele repair (procedure)	4180186
40636060	Sword-billed hummingbird (organism)	4180186
40636061	Retired procedure (procedure)	4180186
40636080	Other vomiting complicating pregnancy, NEC (disorder)	4180186
40636082	Salmonella III arizonae 53:r:z35 (organism)	4180186
40636087	Retired procedure (procedure)	4180186
40636102	AIDS with immunoblastic sarcoma (disorder)	4180186
40636117	Labourer (occupation)	4180186
40636121	Spondyloepiphyseal dysplasia congenita (disorder)	4180186
40636135	Retired procedure (procedure)	4180186
40636147	Retired procedure (procedure)	4180186
40636154	Salmonella III arizonae 38:z10:z (organism)	4180186
40636214	Serial scanning (procedure)	4180186
40636223	Disuse atrophy (disorder)	4180186
40636242	Salmonella III arizonae 47:l,v:e,n,x,z15 (organism)	4180186
40636288	Diabetic neuropathy (disorder)	4180186
40636291	Retired procedure (procedure)	4180186
40636306	Open reduction of coxofemoral joint dislocation (procedure)	4180186
40636309	Retired procedure (procedure)	4180186
40636316	Retired procedure (procedure)	4180186
40636325	Salmonella 40;z4,z24;z39	4180186
40636325	Salmonella degania	4180186
40636325	Salmonella II 40:z4,z24:z39	4180186
40636325	Salmonella II degania (organism)	4180186
40636350	Salmonella III arizonae 42:z4,z24:-- (organism)	4180186
40636404	Cone cells of inner nuclear layer (cell structure)	4180186
40636406	Avian dystocia (disorder)	4180186
40636406	Egg bound	4180186
40636407	Eunuchoidism (disorder)	4180186
40636417	Retired procedure (procedure)	4180186
40636421	Retired procedure (procedure)	4180186
40636455	Alternating intermittent esotropia (disorder)	4180186
40636455	Intermittent alternating esotropia	4180186
40636485	Salmonella arizonae 53:z4,z23:-- (organism)	4180186
40636497	Lactobacillus yamanashiensis (organism)	4180186
40636507	Salmonella III arizonae 65:z52:z53 (organism)	4180186
40636514	Poisoning by other psychotropic agent, NEC (disorder)	4180186
40636523	Salmonella 1,13,23;l,z28;z42	4180186
40636523	Salmonella II 1,13,23:l,z28:z42	4180186
40636523	Salmonella II vredelust (organism)	4180186
40636523	Salmonella vredelust	4180186
40636547	Ophthalmitis (disorder)	4180186
40636554	Closed fracture of neck of femur (disorder)	4180186
40636590	Other specified disorder of joint, NEC (disorder)	4180186
40636601	Retired procedure (procedure)	4180186
40636603	Retired procedure (procedure)	4180186
40636607	Air contrast barium enema (procedure)	4180186
40636624	Retired procedure (procedure)	4180186
40636635	Salmonella III arizonae 47:k:z53 (organism)	4180186
40636643	Retired procedure (procedure)	4180186
40636667	Reinsertion of ureterostomy tube (procedure)	4180186
40636678	White spot lesions of teeth (disorder)	4180186
40636717	Closed fracture of foot (disorder)	4180186
40636730	Retired procedure (procedure)	4180186
40636738	Retired procedure (procedure)	4180186
40636747	Retired procedure (procedure)	4180186
40636761	Retired procedure (procedure)	4180186
40636764	Salmonella III arizonae 52:k:z35 (organism)	4180186
40636776	Donor site (body structure)	4180186
40636777	Retired procedure (procedure)	4180186
40636779	Rieger eye malformation sequence (disorder)	4180186
40636781	Anterior packing of nose (procedure)	4180186
40636784	Endoscopic examination of esophagus and stomach	4180186
40636784	Endoscopic examination of oesophagus and stomach	4180186
40636784	Esophagogastroscopy (procedure)	4180186
40636784	Fiberoptic esophagogastroscopy	4180186
40636784	Fibreoptic oesophagogastroscopy	4180186
40636784	Oesophagogastroscopy	4180186
40636788	Sleep (biological function) (observable entity)	4180186
40636791	Persistent (modifier) (qualifier value)	4180186
40636794	Adrenal imaging (procedure)	4180186
40636794	Adrenal radioisotope scan	4180186
40636804	Drug suppository (product)	4180186
40636817	Ergometrine maleate preparation	4180186
40636817	Ergonovine maleate preparation (product)	4180186
40636831	Retired procedure (procedure)	4180186
40636875	Catbird (organism)	4180186
40636919	Retired procedure (procedure)	4180186
40636938	Palm civet (organism)	4180186
40636941	Salmonella 3,15;e,h;1,7	4180186
40636941	Salmonella selandia (organism)	4180186
40636956	Asian golden cat	4180186
40636956	Asiatic golden cat	4180186
40636956	Felis temmincki (organism)	4180186
40636993	Retired procedure (procedure)	4180186
40637034	Aneurysmectomy of sinus of Valsalva (procedure)	4180186
40637066	Pick tubular adenoma	4180186
40637066	Tubular androblastoma	4180186
40637066	Sertoli cell adenoma	4180186
40637066	Testicular adenoma	4180186
40637066	Sertoli cell tumor (morphologic abnormality)	4180186
40637066	Sertoli cell tumour	4180186
40637082	Injury of Fallopian tube with open wound into abdominal cavity (disorder)	4180186
40637108	Retired procedure (procedure)	4180186
40637151	Retired procedure (procedure)	4180186
40637160	Unlisted physical agent (qualifier value)	4180186
40637201	Retired procedure (procedure)	4180186
40637225	Chronic coronary insufficiency	4180186
40637225	Chronic ischaemic heart disease	4180186
40637225	Chronic ischemic heart disease (disorder)	4180186
40637225	Chronic myocardial ischaemia	4180186
40637225	Chronic myocardial ischemia	4180186
40637233	Retired procedure (procedure)	4180186
40637249	Arterial degeneration (disorder)	4180186
40637254	Topical corticosteroid, group I (product)	4180186
40637281	Pectinate muscles (body structure)	4180186
40637304	Cheilophagia (finding)	4180186
40637328	Excision of anal papilla (procedure)	4180186
40637331	Deep third degree burn of ear with loss of body part (disorder)	4180186
40637371	Encephalitis following chickenpox	4180186
40637371	Postchickenpox encephalitis	4180186
40637371	Postvaricella encephalitis (disorder)	4180186
40637371	Varicella encephalitis	4180186
40637372	Salmonella III arizonae 47:z10:z (organism)	4180186
40637377	Retired procedure (procedure)	4180186
40637430	Retired procedure (procedure)	4180186
40637439	Obstetric operation (procedure)	4180186
40637452	Subchronic catatonic schizophrenia with acute exacerbations (disorder)	4180186
40637464	Bovine papillomavirus group (organism)	4180186
40637469	5-Hydroxy-indoleacetic acid (substance)	4180186
40637471	Repair of total anomalous pulmonary venous connection, one-stage (procedure)	4180186
40637518	Pseudomonas lemoignei (organism)	4180186
40637536	Retired procedure (procedure)	4180186
40637580	LAV-II	4180186
40637580	Lymphadenopathy-associated virus, type II (LAV-II) (organism)	4180186
40637591	Glossopharyngeal nerve tonsillar branch (body structure)	4180186
40637591	Ninth cranial nerve tonsillar branch	4180186
40637599	Retired procedure (procedure)	4180186
40637602	Retired procedure (procedure)	4180186
40637611	Salmonella II 43:f,g,t:1,5 (organism)	4180186
40637614	Coagulation factor VIII (substance)	4180186
40637637	Retired procedure (procedure)	4180186
40637660	Fetus OR newborn affected by varices of umbilical cord (disorder)	4180186
40637662	Congenital night blindness (disorder)	4180186
40637665	Preauricular sinus (disorder)	4180186
40637693	Chlorpromazine hydrochloride (product)	4180186
40637742	Salmonella III arizonae, group 51 (organism)	4180186
40637744	Calculus of bile duct with acute cholecystitis (disorder)	4180186
40637749	Hypoplasia of thyroid (disorder)	4180186
40637750	Structure of tendon and tendon sheath of shoulder and upper extremity (body structure)	4180186
40637750	Tendon and tendon sheath of forelimb	4180186
40637750	Tendon and tendon sheath of shoulder and upper extremity	4180186
40637755	Retired procedure (procedure)	4180186
40637759	Retired procedure (procedure)	4180186
40637785	Total lobectomy of lung (procedure)	4180186
40637798	Clerambault's syndrome	4180186
40637798	Erotomania (finding)	4180186
40637801	Chloromethane (substance)	4180186
40637833	Retired procedure (procedure)	4180186
40637859	Salmonella II 13,22:(f),g,t:-- (organism)	4180186
40637869	Weak pulse (finding)	4180186
40637906	Complication peculiar to a certain specified procedure, NEC (disorder)	4180186
40637926	Retired procedure (procedure)	4180186
40637927	Retired procedure (procedure)	4180186
40637928	Oxtriphylline (substance)	4180186
40637931	Cold antibody (substance)	4180186
40637940	Mechanical complication of peripheral nerve graft (disorder)	4180186
40637959	Phocomelia of upper limb (disorder)	4180186
40637996	C5a complement receptor (substance)	4180186
40637998	HIV1 - Human immunodeficiency virus type 1	4180186
40637998	HTLV-3 - Human T-cell lymphotropic virus type 3	4180186
40637998	Human T-cell lymphotropic virus 3	4180186
40637998	T-lymphotropic virus (organism)	4180186
40638032	Retired procedure (procedure)	4180186
40638041	Retired procedure (procedure)	4180186
40638048	Downy woodpecker (organism)	4180186
40638058	Salmonella III arizonae 18:(k):z53 (organism)	4180186
40638094	Spinal cord lateral horn (body structure)	4180186
40638121	AIDS with herpes zoster (disorder)	4180186
40638123	Retired procedure (procedure)	4180186
40638131	Injury of transverse colon with open wound into abdominal cavity (disorder)	4180186
40638147	Salmonella III arizonae 47:l,v:z35 (organism)	4180186
40638154	Salmonella III arizonae 61:r:z35 (organism)	4180186
40638158	Proteinuria syndrome (disorder)	4180186
40638167	Benign bovine rickettsiosis	4180186
40638167	Bovine ehrlichiosis (disorder)	4180186
40638167	Mild disease of cattle	4180186
40638169	Retired procedure (procedure)	4180186
40638183	Retired procedure (procedure)	4180186
40638185	Hyaluronidase	4180186
40638185	Hyaluronoglucosaminidase (substance)	4180186
40638214	Retired procedure (procedure)	4180186
40638240	Clostridium durum (organism)	4180186
40638279	Retired procedure (procedure)	4180186
40638280	Retired procedure (procedure)	4180186
40638291	Right oviduct (body structure)	4180186
40638305	Repair of large omphalocele with prosthesis (procedure)	4180186
40638314	Posterior (modifier) (qualifier value)	4180186
40638321	Retired procedure (procedure)	4180186
40638336	Medical procedure on uterine ligament (procedure)	4180186
40638349	Atrophy of vulva (disorder)	4180186
40638361	Retired procedure (procedure)	4180186
40638362	Retired procedure (procedure)	4180186
40638365	DPA sodium	4180186
40638365	Sodium alpha-propylvalerate	4180186
40638365	Sodium dipropylacetate	4180186
40638365	Sodium valproate	4180186
40638365	Valproate sodium (product)	4180186
40638409	Arthrotomy with removal of foreign body of interphalangeal joint of toe (procedure)	4180186
40638410	Other ovarian hyperfunction, NEC (disorder)	4180186
40638426	Actinomycetoma	4180186
40638426	Actinomycotic madura foot (disorder)	4180186
40638426	Actinomycotic maduromycosis	4180186
40638426	Actinomycotic mycetoma	4180186
40638426	Actinomycotic schizomycetoma	4180186
40638438	Sprain of xiphoid cartilage (disorder)	4180186
40638447	Potato virus X group (Plants hosts)	4180186
40638447	Potexvirus group (organism)	4180186
40638449	Retired procedure (procedure)	4180186
40638450	Retired procedure (procedure)	4180186
40638464	Monogenetic fluke	4180186
40638464	Monogenetic trematode (organism)	4180186
40638491	Esophagojejunostomy with complete gastrectomy (procedure)	4180186
40638491	Oesophagojejunostomy with complete gastrectomy	4180186
40638498	Diaphyseal aclasis	4180186
40638498	Diaphyseal aclasis, external chondromatosis syndrome	4180186
40638498	Hereditary deforming chondrodysplasia	4180186
40638498	Multiple cartilaginous exostoses	4180186
40638498	Multiple exostoses syndrome (disorder)	4180186
40638498	Osteochondromatosis syndrome	4180186
40638531	Retired procedure (procedure)	4180186
40638603	Osteoplasty of ulna, shortening (procedure)	4180186
40638623	Flea (organism)	4180186
40638636	Lateral infarction by EKG (finding)	4180186
40638641	Salmonella III arizonae, group S (organism)	4180186
40638661	Blood group antibody A>X<	4180186
40638661	Blood group antibody A>X< (substance)	4180186
40638664	Purple grackle (organism)	4180186
40638674	Japanese encephalitis virus (organism)	4180186
40638674	Japanese enceph virus subgroup	4180186
40638684	Salmonella III arizonae 42:r:z (organism)	4180186
40638708	AIDS with CNS demyelinating disease (disorder)	4180186
40638738	Closure of fistula of cerebrospinal fluid (procedure)	4180186
40638765	Retired procedure (procedure)	4180186
40638773	Retired procedure (procedure)	4180186
40638783	BCVLV	4180186
40638783	Bovine calicivirus-like virus (organism)	4180186
40638823	Retired procedure (procedure)	4180186
40638834	Brown hyena	4180186
40638834	Hyaena brunnea (organism)	4180186
40638871	Torulopsis (organism)	4180186
40638880	Lyre-tailed nightjar (organism)	4180186
40638906	Clostridium thermoaceticum (organism)	4180186
40638914	Biopsy of joint structure (procedure)	4180186
40638922	Fracture of skull as birth trauma (disorder)	4180186
40638924	Retired procedure (procedure)	4180186
40638926	Nocardiopsis flava (organism)	4180186
40638927	Closed fracture of lower epiphysis of femur (disorder)	4180186
40638942	Infective abortion	4180186
40638942	Septic abortion (disorder)	4180186
40638946	Retired procedure (procedure)	4180186
40638962	Distal interphalangeal joint of fourth digit of forelimb	4180186
40638962	Distal interphalangeal joint of fourth finger	4180186
40638962	Distal interphalangeal joint of ring finger	4180186
40638962	Distal interphalangeal joint structure of fourth finger (body structure)	4180186
40638963	Enzootic balanoposthitis in sheep	4180186
40638963	Pizzle rot	4180186
40638963	Sheath-rot	4180186
40638963	Ulcerative posthitis AND/OR vulvitis (disorder)	4180186
40638964	Illegal abortion complicated by genital-pelvic infection (finding)	4180186
40638987	External cardioassist (procedure)	4180186
40639002	Congenital nonspherocytic haemolytic anaemia	4180186
40639002	Congenital nonspherocytic hemolytic anemia (disorder)	4180186
40639008	Retired procedure (procedure)	4180186
40639023	Methyl chloroform (substance)	4180186
40639026	Cerebrovascular accident (disorder)	4180186
40639031	Retired procedure (procedure)	4180186
40639058	Traumatic abnormality (morphologic abnormality)	4180186
40639070	Granuloma of lacrimal passages (disorder)	4180186
40639080	Congenital melanocytic naevus	4180186
40639080	Congenital melanocytic naevus of skin	4180186
40639080	Congenital melanocytic nevus (disorder)	4180186
40639080	Congenital melanocytic nevus of skin	4180186
40639080	Congenital pigmented naevus	4180186
40639080	Congenital pigmented naevus of skin	4180186
40639080	Congenital pigmented nevus	4180186
40639080	Congenital pigmented nevus of skin	4180186
40639096	Salmonella 1,4,12,27;z39;1,5,7	4180186
40639096	Salmonella II durbanville (organism)	4180186
40639100	Retired procedure (procedure)	4180186
40639107	Entomopoxvirus (organism)	4180186
40639107	Poxviruses of insects	4180186
40639107	Subfamily entomopoxvirinae	4180186
40639127	Echinoderm (organism)	4180186
40639139	Retired procedure (procedure)	4180186
40639148	Biopsy of tongue (procedure)	4180186
40639233	Colubrid snake (organism)	4180186
40639261	Retired procedure (procedure)	4180186
40639268	Nonfilarial chylocele (disorder)	4180186
40639270	Partial excision of turbinate (procedure)	4180186
40639270	Partial turbinectomy	4180186
40639270	TIT - Trimming of inferior turbinate	4180186
40639270	Trimming of nasal turbinate	4180186
40639270	Trimming of turbinate of nose	4180186
40639295	Closure of large intestine fistula (procedure)	4180186
40639295	Repair of fistula of large intestine	4180186
40639341	Persistent convolutions of aortic arch (disorder)	4180186
40639350	Retired procedure (procedure)	4180186
40639366	Retired procedure (procedure)	4180186
40639376	SNOMED RT to SNOMED CT simple map	4180186
40639376	SNOMED RT to SNOMED CT simple map (foundation metadata concept)	4180186
40639376	SNOMED RT identifier simple map	4180186
40639376	SNOMED RT identifier simple map (foundation metadata concept)	4180186
40639377	Scheme value (foundation metadata concept)	4180186
40639380	Map priority (foundation metadata concept)	4180186
40639381	Map rule (foundation metadata concept)	4180186
40639382	Map advice (foundation metadata concept)	4180186
40639386	Great Britain English language reference set	4180186
40639386	Great Britain English language reference set (foundation metadata concept)	4180186
40639392	Generated reference set (foundation metadata concept)	4180186
40639393	Query (foundation metadata concept)	4180186
40639394	Annotation type reference set (foundation metadata concept)	4180186
40639394	Annotation type reference set	4180186
40639395	Associated image reference set	4180186
40639395	Associated image reference set (foundation metadata concept)	4180186
40639396	Annotated component (foundation metadata concept)	4180186
40639399	Association type reference set (foundation metadata concept)	4180186
40639399	Association type reference set	4180186
40639400	Historical association reference set	4180186
40639400	Historical association reference set (foundation metadata concept)	4180186
40639401	POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)	4180186
40639402	MOVED TO association reference set (foundation metadata concept)	4180186
40639404	REPLACED BY association reference set (foundation metadata concept)	4180186
40639405	SAME AS association reference set (foundation metadata concept)	4180186
40639407	SIMILAR TO association reference set (foundation metadata concept)	4180186
40639408	ALTERNATIVE association reference set (foundation metadata concept)	4180186
40639411	Association target component (foundation metadata concept)	4180186
40639417	Description format (foundation metadata concept)	4180186
40639420	Extensible HyperText Markup Language (foundation metadata concept)	4180186
40639420	Extensible HyperText Markup Language	4180186
40639421	Darwin Information Typing Architecture (foundation metadata concept)	4180186
40639421	Darwin Information Typing Architecture	4180186
40639422	Description length (foundation metadata concept)	4180186
40639424	Inactive value (foundation metadata concept)	4180186
40639426	Preferred (foundation metadata concept)	4180186
40639427	Acceptable (foundation metadata concept)	4180186
40639428	Definition (core metadata concept)	4180186
40639448	Salmonella III arizonae 45:z4,z32:-- (organism)	4180186
40639455	Layer of fibers of optic nerve of retina (body structure)	4180186
40639455	Layer of fibres of optic nerve of retina	4180186
40639473	Disorder of facial nerve	4180186
40639473	Disorder of seventh cranial nerve	4180186
40639473	Disorders of the seventh nerve	4180186
40639473	Disorders of the VIIth cranial nerve	4180186
40639473	Facial nerve disorder (disorder)	4180186
40639473	Facial nerve palsy	4180186
40639473	Facial neuropathy	4180186
40639473	Facial palsy	4180186
40639473	Seventh nerve palsy	4180186
40639473	VII nerve palsy	4180186
40639522	Retired procedure (procedure)	4180186
40639527	Pathological dislocation of shoulder region (disorder)	4180186
40639529	Retired procedure (procedure)	4180186
40639532	Venous retinal engorgement (disorder)	4180186
40639541	Retired procedure (procedure)	4180186
40639555	Retired procedure (procedure)	4180186
40639578	Ovis (organism)	4180186
40639578	Wild sheep	4180186
40639597	Rhabdovirus group	4180186
40639597	Family: Bullet-shaped virus group	4180186
40639597	Rhabdoviridae	4180186
40639597	Rhabdovirus (organism)	4180186
40639630	Lymphatic of lower extremity (body structure)	4180186
40639636	Chronic rheumatoid nodular fibrosis (disorder)	4180186
40639651	Salmonella III arizonae 60:r:z35 (organism)	4180186
40639719	Repair of anal sphincter (procedure)	4180186
40639751	Retired procedure (procedure)	4180186
40639776	Intravascular bronchial alveolar tumor (morphologic abnormality)	4180186
40639776	Intravascular bronchial alveolar tumour	4180186
40639814	Retired procedure (procedure)	4180186
40639817	Retired procedure (procedure)	4180186
40639861	Salmonella III arizonae 21:z10:e,n,x,z15 (organism)	4180186
40639883	Retired procedure (procedure)	4180186
40639899	Steatocystoma	4180186
40639899	Keratinising cyst	4180186
40639899	Keratinizing cyst	4180186
40639899	Keratinous cyst	4180186
40639899	Pilar cyst	4180186
40639899	Sebaceous cyst (morphologic abnormality)	4180186
40639899	Steatoma	4180186
40639899	Trichilemmal cyst	4180186
40639899	Wen	4180186
40639912	pT category (tumor staging)	4180186
40639912	pT stage	4180186
40639947	Retired procedure (procedure)	4180186
40639948	Retired procedure (procedure)	4180186
40639950	Equine rhinovirus 2 (organism)	4180186
40639959	Paratetrafluoroethylene (substance)	4180186
40639959	Teflon	4180186
40639961	Chancroid (disorder)	4180186
40639968	Congenital fistula of salivary gland (disorder)	4180186
40639988	Topical corticosteroid, group IV (product)	4180186
40639992	Retired procedure (procedure)	4180186
40640002	Epidermal burn of multiple sites of lower limb (disorder)	4180186
40640002	Superficial burn of multiple sites of lower limb	4180186
40640002	Burn erythema of multiple sites of lower limb	4180186
40640002	First degree burn of multiple sites of lower limb	4180186
40640004	Subcutaneous tissue of leg and hip (body structure)	4180186
40640018	Retired procedure (procedure)	4180186
40640021	Himalayan impeyan pheasant (organism)	4180186
40640049	Drainage of abscess of peritonsillar tissues	4180186
40640049	Drainage of peritonsillar abscess	4180186
40640049	Drainage of quinsy	4180186
40640049	Incision and drainage of peritonsillar abscess (procedure)	4180186
40640062	Lactase (substance)	4180186
40640097	Drug solution, 0,1% (product)	4180186
40640102	Progressive myoclonic epilepsy (disorder)	4180186
40640115	Retired procedure (procedure)	4180186
40640171	Retired procedure (procedure)	4180186
40640202	Manipulation of lacrimal apparatus (procedure)	4180186
40640217	Bacteroides ruminicola ss. brevis (organism)	4180186
40640217	Bacteroides ruminicola subsp brevis	4180186
40640247	Implantation of joint prosthesis into knee joint (procedure)	4180186
40640247	Implantation of prosthesis or prosthetic device of knee, bioelectric or cineplastic	4180186
40640247	Implantation of prosthesis or prosthetic device of knee joint	4180186
40640247	Prosthetic arthroplasty of knee	4180186
40640259	Icosahedral cytoplasmic deoxyribovirus group	4180186
40640259	Iridovirus (organism)	4180186
40640259	Small iridescent insect virus group	4180186
40640277	Other Salmonella infection, NEC (disorder)	4180186
40640284	Retired procedure (procedure)	4180186
40640292	Salmonella III arizonae 59:z10:z57 (organism)	4180186
40640300	Partial breech delivery (procedure)	4180186
40640306	Leukaemic reticuloendotheliosis	4180186
40640306	Leukemic reticuloendotheliosis (morphologic abnormality)	4180186
40640317	Retired procedure (procedure)	4180186
40640336	Retired procedure (procedure)	4180186
40640341	Salmonella III arizonae 16:l,v:z:(z61) (organism)	4180186
40640405	Retired procedure (procedure)	4180186
40640406	Neutrophilic chemotactic factor (substance)	4180186
40640415	Shortening of extraocular muscle (procedure)	4180186
40640424	Retired procedure (procedure)	4180186
40640435	Salmonella 6,8;a;z52	4180186
40640435	Salmonella II tulear (organism)	4180186
40640437	Medical procedure on pituitary gland (procedure)	4180186
40640447	Retired procedure (procedure)	4180186
40640455	Retired procedure (procedure)	4180186
40640456	Retired procedure (procedure)	4180186
40640467	Argilla	4180186
40640467	Bolus alba	4180186
40640467	China clay	4180186
40640467	Kaolin	4180186
40640467	Native hydrated aluminium silicate	4180186
40640467	Native hydrated aluminum silicate (substance)	4180186
40640484	Salmonella 17;e,n,x,z15;1,6	4180186
40640484	Salmonella II verity (organism)	4180186
40640484	Salmonella verity	4180186
40640498	Achilles bursitis (disorder)	4180186
40640498	Calcaneal osteochondritis	4180186
40640500	Moholi galago (organism)	4180186
40640517	Cynocephalus (organism)	4180186
40640517	Flying lemur	4180186
40640539	Adhesive capsulitis of shoulder (disorder)	4180186
40640539	Duplay's periarthritis syndrome	4180186
40640539	Frozen shoulder	4180186
40640539	Periarthritis of shoulder	4180186
40640539	Pericapsulitis of shoulder	4180186
40640539	Scapulohumeral fibrositis	4180186
40640539	Scapulohumeral myofibrosis	4180186
40640547	Nape	4180186
40640547	Nuchal region	4180186
40640547	Posterior portion of neck	4180186
40640547	Structure of posterior portion of neck (body structure)	4180186
40640556	Retired procedure (procedure)	4180186
40640589	Retired procedure (procedure)	4180186
40640603	Retired procedure (procedure)	4180186
40640617	Emerald starling (organism)	4180186
40640619	Miscellaneous drug (navigational concept)	4180186
40640623	Northern elephant seal (organism)	4180186
40640645	Retired procedure (procedure)	4180186
40640666	Replacement of Gardner Wells tongs of skull (procedure)	4180186
40640701	Prostaglandin PGI>2< (substance)	4180186
40640701	PGI2 - Prostacyclin	4180186
40640701	Prostaglandin PGI>2<	4180186
40640706	Retired procedure (procedure)	4180186
40640721	Retired procedure (procedure)	4180186
40640734	Retired procedure (procedure)	4180186
40640757	Achromobacter xylosoxidans	4180186
40640757	Achromobacter xylosoxidans subsp xylosoxidans	4180186
40640757	Alcaligenes xylosoxidans (organism)	4180186
40640757	Alcaligenes xylosoxidans subsp xylosoxidans	4180186
40640757	CDC group IIIa	4180186
40640757	CDC group IIIb	4180186
40640773	Renal artery stenosis of unknown cause (disorder)	4180186
40640774	Abetalipoproteinaemia	4180186
40640774	Abetalipoproteinemia (disorder)	4180186
40640807	Aplastic anaemia secondary to infection	4180186
40640807	Aplastic anemia secondary to infection (disorder)	4180186
40640836	Salmonella III arizonae 53:z:1,5,(7) (organism)	4180186
40640852	Retired procedure (procedure)	4180186
40640853	Haemarthrosis of ankle AND/OR foot	4180186
40640853	Hemarthrosis of ankle AND/OR foot (disorder)	4180186
40640876	Retired procedure (procedure)	4180186
40640880	Shen-k'uei (disorder)	4180186
40640881	Non-invasive medical procedure (procedure)	4180186
40640884	Retired procedure (procedure)	4180186
40640908	Salmonella II, group G1 (organism)	4180186
40640913	Bimanual palpation (procedure)	4180186
40640924	Retired procedure (procedure)	4180186
40640927	Retired procedure (procedure)	4180186
40640929	Human transmitted infectious disease (disorder)	4180186
40640937	Retired procedure (procedure)	4180186
40640940	Retired procedure (procedure)	4180186
40640941	Retired procedure (procedure)	4180186
40640958	Retired procedure (procedure)	4180186
40640977	Retired procedure (procedure)	4180186
40640994	Closure of artificial opening of small intestine (procedure)	4180186
40641022	Great-billed touraco (organism)	4180186
40641029	Salmonella 1,44;z39;e,n,x,z15	4180186
40641029	Salmonella clovelly	4180186
40641029	Salmonella II 1,44:z39:e,n,x,z15	4180186
40641029	Salmonella II clovelly (organism)	4180186
40641056	Other specified diffuse disease of connective tissue, NEC (disorder)	4180186
40641059	Ability to be consciously aware of viscera	4180186
40641059	Visceral sensation, function (observable entity)	4180186
40641081	Retired procedure (procedure)	4180186
40641106	Organic dye (substance)	4180186
40641114	Graphosid spider (organism)	4180186
40641132	Mother's milk (substance)	4180186
40641134	Feline allergic bronchitis (disorder)	4180186
40641134	Feline asthma	4180186
40641181	Open dislocation of foot (disorder)	4180186
40641186	Retired procedure (procedure)	4180186
40641189	Haemobartonella muris (organism)	4180186
40641198	Operation on subcutaneous tissue (procedure)	4180186
40641217	Orbital region structure (body structure)	4180186
40641239	Retired procedure (procedure)	4180186
40641254	Retired procedure (procedure)	4180186
40641276	Eye, ear, nose AND/OR throat preparation (product)	4180186
40641310	Decubitus ulcer (finding)	4180186
40641334	Retired procedure (procedure)	4180186
40641340	Wisent	4180186
40641340	European bison	4180186
40641340	Bison bonasus (organism)	4180186
40641346	Salmonella 21;g,z51;-	4180186
40641346	Salmonella III arizonae 21:g,z51:-- (organism)	4180186
40641354	Retired procedure (procedure)	4180186
40641396	Radioallergosorbent test, in vitro testing for allergen-specific IGE, FAST type (procedure)	4180186
40641396	RAST test, FAST type	4180186
40641460	Spontaneous breech delivery (disorder)	4180186
40641473	Retired procedure (procedure)	4180186
40641521	Active immunization (procedure)	4180186
40641530	Juvenile osteochondrosis of capitellum of humerus (disorder)	4180186
40641533	Retired procedure (procedure)	4180186
40641537	Blepharorhytidectomy (procedure)	4180186
40641537	Excision of redundant skin of eyelid	4180186
40641537	Removal of redundant skin of eyelid	4180186
40641554	Retired procedure (procedure)	4180186
40641562	Repair of cornea (procedure)	4180186
40641582	Abnormal (modifier) (qualifier value)	4180186
40641609	Retired procedure (procedure)	4180186
40641614	Papillomavirus (living organism) (organism)	4180186
40641679	Blood group antigen Jc^a^	4180186
40641679	Blood group antigen Jc^a^ (substance)	4180186
40641709	Retired procedure (procedure)	4180186
40641716	Papio papio (organism)	4180186
40641716	Western baboon	4180186
40641730	Special nursing care in intensive care unit (procedure)	4180186
40641740	AIDS with pyrexia (disorder)	4180186
40641745	Retired procedure (procedure)	4180186
40641753	Retired procedure (procedure)	4180186
40641760	Red-bellied water snake (organism)	4180186
40641768	Retired procedure (procedure)	4180186
40641775	Rapid-acting insulin (substance)	4180186
40641777	Retired procedure (procedure)	4180186
40641787	Carolina parakeet (organism)	4180186
40641800	Tenth cranial nerve pharyngeal branch	4180186
40641800	Vagus nerve pharyngeal branch (body structure)	4180186
40641802	Motivation, function (observable entity)	4180186
40641815	Ascomycete (organism)	4180186
40641815	Ascospore forming fungus	4180186
40641815	Sac fungus	4180186
40641815	Subphylum Ascomycotina	4180186
40641815	Subphylum: Ascomycotina	4180186
40641828	Subcutaneous tissue of forearm and wrist (body structure)	4180186
40641876	Injury of digital blood vessels (disorder)	4180186
40641880	Retired procedure (procedure)	4180186
40641893	Bilateral repair of inguinal hernia (procedure)	4180186
40641900	Fine needle aspiration biopsy of pancreas	4180186
40641900	Fine needle aspiration of pancreas	4180186
40641900	Fine needle biopsy of pancreas (procedure)	4180186
40641900	FNA - Fine needle aspiration of pancreas	4180186
40641910	RE - Rectal examination	4180186
40641910	Digital examination of rectum	4180186
40641910	Digital palpation of rectum	4180186
40641910	DRE - Digital rectal examination	4180186
40641910	Rectal examination (procedure)	4180186
40641929	Repair of Wirsung's duct (procedure)	4180186
40641931	Drainage of sphenoid sinus	4180186
40641931	Exploration of sphenoid sinus	4180186
40641931	FESS - FSS sphenoidotomy	4180186
40641931	FESS - Sphenoidotomy	4180186
40641931	Puncture of sphenoid sinus	4180186
40641931	Sphenoidotomy	4180186
40641931	Sphenoid sinusotomy (procedure)	4180186
40641938	Retired procedure (procedure)	4180186
40641943	Other open anterior dislocation of hip, NEC (disorder)	4180186
40641949	Deprivation of water (disorder)	4180186
40641955	Cerebellar tuber (body structure)	4180186
40641988	Retired procedure (procedure)	4180186
40641990	Open fracture of distal end of femur	4180186
40641990	Open fracture of lower end of femur (disorder)	4180186
40642017	Banana spider (organism)	4180186
40642017	Phoneutria nigriventer	4180186
40642029	Anti-hyaluronidase (substance)	4180186
40642055	Influenza with involvement of gastrointestinal tract (disorder)	4180186
40642071	Retired procedure (procedure)	4180186
40642077	Retired procedure (procedure)	4180186
40642083	Retired procedure (procedure)	4180186
40642131	Retired procedure (procedure)	4180186
40642134	Lutra (organism)	4180186
40642134	River otter	4180186
40642162	Acquired methaemoglobinaemia	4180186
40642162	Acquired methemoglobinemia (disorder)	4180186
40642165	Ring-necked snake (organism)	4180186
40642176	Lagidum (organism)	4180186
40642176	Mountain viscacha	4180186
40642179	Retired procedure (procedure)	4180186
40642189	Other disorder of the pituitary gland, NEC (disorder)	4180186
40642196	Pituitary interstitial cell stimulating hormone (substance)	4180186
40642203	Retired procedure (procedure)	4180186
40642245	Retired procedure (procedure)	4180186
40642278	Complement factor B (substance)	4180186
40642301	Pigeon (living organism) (organism)	4180186
40642321	Booster vaccination (procedure)	4180186
40642327	Absence of hair - failure to grow	4180186
40642327	Cessation of hair growth	4180186
40642327	Failure of hair growth (finding)	4180186
40642327	Hair not growing properly	4180186
40642328	Retired procedure (procedure)	4180186
40642329	Other obstetrical injury to pelvic organ, NEC (disorder)	4180186
40642349	Retired procedure (procedure)	4180186
40642383	Retired procedure (procedure)	4180186
40642384	Hydroxyprogesterone caproate preparation (substance)	4180186
40642387	Rupture supraspinatus tendon	4180186
40642387	Supraspinatus rupture	4180186
40642387	Supraspinatus syndrome (disorder)	4180186
40642387	Supraspinatus tear	4180186
40642402	Retired procedure (procedure)	4180186
40642449	Malayan sun bear	4180186
40642449	Ursus malayanus (organism)	4180186
40642451	Other specified obstetrical trauma, NEC (disorder)	4180186
40642465	Retired procedure (procedure)	4180186
40642500	Retired procedure (procedure)	4180186
40642501	Retired procedure (procedure)	4180186
40642504	2-Butanone (substance)	4180186
40642528	Fully specified name (core metadata concept)	4180186
40642530	Not refinable (foundation metadata concept)	4180186
40642531	Stated relationship (core metadata concept)	4180186
40642532	Inferred relationship (core metadata concept)	4180186
40642533	SNOMED CT model component module	4180186
40642533	SNOMED CT model component module (core metadata concept)	4180186
40642537	Sufficiently defined by necessary conditions definition status (core metadata concept)	4180186
40642537	Sufficiently defined by necessary conditions definition status	4180186
40642538	Not sufficiently defined by necessary conditions definition status (core metadata concept)	4180186
40642538	Not sufficiently defined by necessary conditions definition status	4180186
40642540	Optional refinability (foundation metadata concept)	4180186
40642551	Description type (core metadata concept)	4180186
40642553	Entire term case insensitive	4180186
40642553	Entire term case insensitive (core metadata concept)	4180186
40642555	Modifier (core metadata concept)	4180186
40642556	Existential restriction modifier	4180186
40642556	Existential restriction modifier (core metadata concept)	4180186
40642557	Universal restriction modifier	4180186
40642557	Universal restriction modifier (core metadata concept)	4180186
40642558	Identifier scheme (core metadata concept)	4180186
40642559	Foundation metadata concept (foundation metadata concept)	4180186
40642560	Reference set (foundation metadata concept)	4180186
40642562	Reference set attribute (foundation metadata concept)	4180186
40642567	Description type component (foundation metadata concept)	4180186
40642569	Reference set member type component (foundation metadata concept)	4180186
40642571	Text (foundation metadata concept)	4180186
40642572	Single character (foundation metadata concept)	4180186
40642574	Uniform resource locator	4180186
40642574	Uniform resource locator (foundation metadata concept)	4180186
40642575	Hypertext Markup Language reference (foundation metadata concept)	4180186
40642575	Hypertext Markup Language reference	4180186
40642576	Image reference (foundation metadata concept)	4180186
40642580	Time (foundation metadata concept)	4180186
40642581	Integer (foundation metadata concept)	4180186
40642585	Attribute value type reference set	4180186
40642585	Attribute value type reference set (foundation metadata concept)	4180186
40642586	Concept inactivation value (foundation metadata concept)	4180186
40642592	Component moved elsewhere (foundation metadata concept)	4180186
40642592	Component moved elsewhere	4180186
40642593	Relationship refinability attribute value reference set	4180186
40642593	Relationship refinability attribute value reference set (foundation metadata concept)	4180186
40642596	Attribute value (foundation metadata concept)	4180186
40642598	Description inactivation value (foundation metadata concept)	4180186
40642615	Salmonella 1,13,23;m,t;1,5	4180186
40642615	Salmonella II katesgrove (organism)	4180186
40642640	Pygmy gerbil (organism)	4180186
40642684	Retired procedure (procedure)	4180186
40642704	Has time (qualifier value)	4180186
40642712	Sciurus (organism)	4180186
40642712	Tree squirrel	4180186
40642744	AIDS with aplastic anaemia	4180186
40642744	AIDS with aplastic anemia (disorder)	4180186
40642755	Central American woolly opossum (organism)	4180186
40642775	Retired procedure (procedure)	4180186
40642791	Cystic fibrosis (disorder)	4180186
40642828	Mucinous cystadenoma, borderline malignancy (morphologic abnormality)	4180186
40642829	Retired procedure (procedure)	4180186
40642837	Retired procedure (procedure)	4180186
40642840	Retired procedure (procedure)	4180186
40642896	Breathing exercise (regime/therapy)	4180186
40642925	Retired procedure (procedure)	4180186
40642958	Acute rheumatic heart disease (disorder)	4180186
40642963	Second degree burn of multiple sites of trunk (disorder)	4180186
40642975	Salmonella II 50:z10:z6:z42	4180186
40642975	Salmonella 50;z10;z6 : z42	4180186
40642975	Salmonella hooggraven	4180186
40642975	Salmonella II hooggraven (organism)	4180186
40642979	Retired procedure (procedure)	4180186
40643022	Disease of pituitary gland (disorder)	4180186
40643022	Disorder of hypothalamus	4180186
40643022	Disorder of pituitary	4180186
40643022	Disorder of pituitary gland	4180186
40643022	Disorder of pituitary gland and its hypothalamic control	4180186
40643022	Dyspituitarism	4180186
40643022	Hypothalamic disease	4180186
40643022	Hypothalamus disorder	4180186
40643022	Pituitary disease	4180186
40643027	Retired procedure (procedure)	4180186
40643039	Retired procedure (procedure)	4180186
40643043	CDC Enteric group 9	4180186
40643043	Enterobacter taylorae (organism)	4180186
40643049	Salmonella 1,40;z39;1,6	4180186
40643049	Salmonella grunty	4180186
40643049	Salmonella II 1,40:z39:1,6	4180186
40643049	Salmonella II grunty (organism)	4180186
40643053	AIDS with secondary thrombocytopenia (disorder)	4180186
40643063	Benzoyl peroxide (substance)	4180186
40643082	Retired procedure (procedure)	4180186
40643095	PTB - Pulmonary tuberculosis	4180186
40643095	Pulmonary tuberculosis	4180186
40643095	Respiratory tuberculosis (disorder)	4180186
40643095	RTB - Respiratory tuberculosis	4180186
40643095	TB - Pulmonary tuberculosis	4180186
40643103	Opsin kinase (substance)	4180186
40643112	Retired procedure (procedure)	4180186
40643142	Contusion of anterior neck (disorder)	4180186
40643161	Erythema annulare centrifugum (disorder)	4180186
40643161	Erythema figuratum	4180186
40643161	Erythema figuratum perstans	4180186
40643161	Erythema gyratum	4180186
40643161	Erythema gyratum perstans	4180186
40643161	Familial annular erythema	4180186
40643194	Rattlesnake (organism)	4180186
40643210	Ligation of supernumerary digit (procedure)	4180186
40643235	Retired procedure (procedure)	4180186
40643259	11-Deoxy, 17-hydroxycorticosterone (substance)	4180186
40643275	Retired procedure (procedure)	4180186
40643296	Retired procedure (procedure)	4180186
40643351	Monoarticular juvenile rheumatoid arthritis (disorder)	4180186
40643365	Salmonella III arizonae 47:c:z35 (organism)	4180186
40643366	Spotted sandpiper (organism)	4180186
40643390	Egg-laying mammal (organism)	4180186
40643396	Retired procedure (procedure)	4180186
40643450	Retired procedure (procedure)	4180186
40643484	Campylobacter laridis (organism)	4180186
40643524	Amino acid injection (product)	4180186
40643530	Retired procedure (procedure)	4180186
40643531	Salmonella III arizonae 35:i:z35 (organism)	4180186
40643539	Drainage of intracranial space, subarachnoid or subdural by incision or trephination (procedure)	4180186
40643550	Blood group antibody Le^s^	4180186
40643550	Blood group antibody Le^s^ (substance)	4180186
40643564	Bungarus candidus (living organism) (organism)	4180186
40643566	Indian fishing owl (organism)	4180186
40643572	Retired procedure (procedure)	4180186
40643578	FTLV	4180186
40643578	Feline T-lymphotropic virus (organism)	4180186
40643636	Chart review by physician and preparation of abstract or summary (procedure)	4180186
40643636	Preparation of discharge summary	4180186
40643648	Retired procedure (procedure)	4180186
40643714	Acquired hunchback	4180186
40643714	Acquired kyphosis (disorder)	4180186
40643739	Flat wart	4180186
40643739	Verruca plana (disorder)	4180186
40643745	Banner-tailed kangaroo rat (organism)	4180186
40643758	Angular cheilosis	4180186
40643758	Intertrigo labialis	4180186
40643758	Migrating cheilosis	4180186
40643758	Perlèche (disorder)	4180186
40643777	Retired procedure (procedure)	4180186
40643790	Removal and reapplication of therapeutic device	4180186
40643790	Removal and replacement of prosthetic device	4180186
40643790	Replacement of appliance	4180186
40643790	Replacement of device (procedure)	4180186
40643794	Vesicular stomatitis virus (organism)	4180186
40643803	Cutaneous anaphylaxis (disorder)	4180186
40643804	Subcutaneous tissue of arm and wrist (body structure)	4180186
40643885	Retired procedure (procedure)	4180186
40643888	Retired procedure (procedure)	4180186
40643899	Arthropathy associated with bacterial disease, NEC (disorder)	4180186
40643913	Human bone for identification (observable entity)	4180186
40643926	Reconstruction of trachea with graft (procedure)	4180186
40643939	Acanthocephalan infection	4180186
40643939	Infection by Acanthocephala (disorder)	4180186
40643956	Retired procedure (procedure)	4180186
40643965	Retired procedure (procedure)	4180186
40644049	Reattachment of upper extremity (procedure)	4180186
40644059	Retired procedure (procedure)	4180186
40644064	Polyarticular juvenile rheumatoid arthritis (disorder)	4180186
40644103	Retired procedure (procedure)	4180186
40644117	Retired procedure (procedure)	4180186
40644139	Retired procedure (procedure)	4180186
40644167	Retired procedure (procedure)	4180186
40644172	Disorder of the vertebral column (disorder)	4180186
40644172	Spinal disorder	4180186
40644172	Spondylopathy	4180186
40644172	Vertebral column disorder	4180186
40644174	Toucan (organism)	4180186
40644202	Retired procedure (procedure)	4180186
40644208	Narcissus pseudo-narcissus (living organism) (organism)	4180186
40644229	Bermuda petrel (organism)	4180186
40644229	Cahow	4180186
40644272	Musk shrew (organism)	4180186
40644296	Congenital absence of fallopian tube (disorder)	4180186
40644320	Arterial catheterisation	4180186
40644320	Arterial catheterization	4180186
40644320	Catheterisation of artery	4180186
40644320	Catheterization of artery	4180186
40644320	Insertion of catheter into artery (procedure)	4180186
40644328	Retired procedure (procedure)	4180186
40644331	Pseudomonas saccharophila (organism)	4180186
40644335	Retired procedure (procedure)	4180186
40644340	Pure tone audiometry, extended, sensitivity index (procedure)	4180186
40644348	Trigeminal rhizotomy (procedure)	4180186
40644365	Retired procedure (procedure)	4180186
40644367	Retired procedure (procedure)	4180186
40644375	Jird (organism)	4180186
40644388	Retired procedure (procedure)	4180186
40644396	Retired procedure (procedure)	4180186
40644426	Ability to detect odor	4180186
40644426	Ability to detect odour	4180186
40644426	Odor detection sense, function (observable entity)	4180186
40644426	Odour detection sense	4180186
40644439	Anaesthetic adjunct	4180186
40644439	Anesthetic adjunct (product)	4180186
40644446	Articulation disorder	4180186
40644446	Articulation impairment	4180186
40644446	Developmental articulation disorder (disorder)	4180186
40644446	Phonological disorder	4180186
40644446	Phonological impairment	4180186
40644446	Phonology impairment	4180186
40644446	Sound system impairment	4180186
40644448	Esophagomyotomy (procedure)	4180186
40644448	Oesophagomyotomy	4180186
40644453	Retired procedure (procedure)	4180186
40644459	Retired procedure (procedure)	4180186
40644484	Retired procedure (procedure)	4180186
40644487	Idiot savant (disorder)	4180186
40644507	Closure of intestinal fistula	4180186
40644507	Closure of intestinal fistula (procedure)	4180186
40644521	Clostridium barkeri (organism)	4180186
40644561	Burkholderia cepacia	4180186
40644561	Pseudomonas cepacia (organism)	4180186
40644561	Pseudomonas multivorans	4180186
40644594	Retired procedure (procedure)	4180186
40644652	Retired procedure (procedure)	4180186
40644653	Clinical psychologic mental status determination (procedure)	4180186
40644682	Retired procedure (procedure)	4180186
40644697	Sprain of coccyx (disorder)	4180186
40644706	Cooper's hawk (organism)	4180186
40644713	Porphyria (disorder)	4180186
40644713	Porphyrinopathy	4180186
40644717	Sarcobatus vermiculatus poisoning (disorder)	4180186
40644723	Wagtail (organism)	4180186
40644728	Salmonella III arizonae 21:i:1,5,7 (organism)	4180186
40644737	Cytotoxic cell	4180186
40644737	K cell	4180186
40644737	Killer cell	4180186
40644737	K lymphocyte (cell)	4180186
40644776	Retired procedure (procedure)	4180186
40644786	Felis planiceps (organism)	4180186
40644786	Flat-headed cat	4180186
40644849	Class reptilia	4180186
40644849	Reptile (organism)	4180186
40644871	Retired procedure (procedure)	4180186
40644877	Krebs cycle pathway (substance)	4180186
40644892	Erythema infectiosum virus (organism)	4180186
40644900	Salmonella woerden	4180186
40644900	Salmonella 17;c;z39	4180186
40644900	Salmonella II woerden (organism)	4180186
40644912	Retired procedure (procedure)	4180186
40644978	Clavulanate (substance)	4180186
40644988	Ampicillin with sulbactam (substance)	4180186
40644994	Piperacillin with tazobactam (product)	4180186
40645115	Retired procedure (procedure)	4180186
40645121	Secondary localised osteoarthrosis of lower leg	4180186
40645121	Secondary localized osteoarthrosis of lower leg (disorder)	4180186
40645168	Salmonella 40;z4,z32;-	4180186
40645168	Salmonella bern	4180186
40645168	Salmonella III arizonae 40:z4,z32:-	4180186
40645168	Salmonella IV 40:z4,z32:- (organism)	4180186
40645177	Retired procedure (procedure)	4180186
40645190	Little blue heron (organism)	4180186
40645212	Monteggia's dislocation (disorder)	4180186
40645267	Salmonella III arizonae 21:k:z (organism)	4180186
40645352	Carcinoma in situ of thoracic esophagus (disorder)	4180186
40645352	Carcinoma in situ of thoracic oesophagus	4180186
40645534	Doxepin metabolite (product)	4180186
40645541	Serotonin uptake inhibitor (product)	4180186
40645551	Clopenthixol (product)	4180186
40645551	Zuclopenthixol	4180186
40645605	Ecgonine (product)	4180186
40645608	Comamonas (organism)	4180186
40645614	Selenium supplement (product)	4180186
40645667	Balsam Peru oil (substance)	4180186
40645667	Honduras balsam	4180186
40645667	Peruvian balsam	4180186
40645667	Surinam balsam	4180186
40645669	Dexamethasone-21-isonicotinate (product)	4180186
40645710	Retired procedure (procedure)	4180186
40645724	Retired procedure (procedure)	4180186
40645747	Psychiatric drug therapy (procedure)	4180186
40645748	Immunoglobulin, Inv allotype (substance)	4180186
40645748	Inv marker	4180186
40645748	K>m< marker	4180186
40645748	Light chain marker	4180186
40645772	Acute intermittent porphyria (disorder)	4180186
40645802	Indentation tonometry	4180186
40645802	Tonography with medical evaluation, indentation tonometer method (procedure)	4180186
40645809	Retired procedure (procedure)	4180186
40645846	Chronic erythraemia in remission	4180186
40645846	Chronic erythremia in remission (disorder)	4180186
40645903	Salmonella III arizonae 43:k:z (organism)	4180186
40646016	Secondary malignant neoplasm of nasopharynx (disorder)	4180186
40646114	Nonionic iodinated contrast agent	4180186
40646114	Nonionic iodinated contrast media (product)	4180186
40646118	Removal of foreign body from upper limb, except hand (procedure)	4180186
40646118	Removal of foreign body of forelimb	4180186
40646118	Removal of foreign body without incision from upper limb, except hand	4180186
40646126	Retired procedure (procedure)	4180186
40646127	Retired procedure (procedure)	4180186
40646137	Retired procedure (procedure)	4180186
40646151	Strabismus in other neuromuscular disorder (disorder)	4180186
40646168	Smothering	4180186
40646168	Traumatic asphyxia	4180186
40646168	Traumatic asphyxial state	4180186
40646168	Traumatic asphyxiation (finding)	4180186
40646172	Cardene Capsules (substance)	4180186
40646174	Cardura Tablets (substance)	4180186
40646180	Retired procedure (procedure)	4180186
40646183	Retired procedure (procedure)	4180186
40646187	Retired procedure (procedure)	4180186
40646192	Retired procedure (procedure)	4180186
40646196	Retired procedure (procedure)	4180186
40646199	Transient ischaemic deafness	4180186
40646199	Transient ischemic deafness (finding)	4180186
40646203	Deep third degree burn of ankle with loss of body part (disorder)	4180186
40646204	Dalgan Injection (product)	4180186
40646205	Retired procedure (procedure)	4180186
40646222	Distal interphalangeal joint of middle finger	4180186
40646222	Distal interphalangeal joint of third digit of forelimb	4180186
40646222	Distal interphalangeal joint of third finger	4180186
40646222	Distal interphalangeal joint structure of third finger (body structure)	4180186
40646247	Retired procedure (procedure)	4180186
40646251	Retired procedure (procedure)	4180186
40646257	Salmonella III arizonae 42:z10:z (organism)	4180186
40646258	Hypoxanthine-guanine phosphoribosyltransferase deficiency (disorder)	4180186
40646314	Calcified structure	4180186
40646314	Calcium deposition	4180186
40646314	Calcified (qualifier value)	4180186
40646314	Calcification	4180186
40646325	Salmonella III arizonae 51:k:z35 (organism)	4180186
40646349	Unilateral congenital subluxation of hip (disorder)	4180186
40646366	Personal hygiene finding (procedure)	4180186
40646366	Personal hygiene observations	4180186
40646388	Retired procedure (procedure)	4180186
40646393	Salmonella II, group C2 (organism)	4180186
40646395	Retired procedure (procedure)	4180186
40646509	Congenital anomaly of oviduct (disorder)	4180186
40646637	Emcyt Capsules (product)	4180186
40646640	Acquired megacolon in children (disorder)	4180186
40646643	Olefin (substance)	4180186
40646669	Haemorrhagic septicaemia due to Pasteurella multocida	4180186
40646669	Hemorrhagic septicemia due to Pasteurella multocida (disorder)	4180186
40646673	alpha>2< Globulin	4180186
40646673	alpha>2< Globulin (substance)	4180186
40646680	Idamycin for Injection (product)	4180186
40646692	Retired procedure (procedure)	4180186
40646709	Retired procedure (procedure)	4180186
40646712	Grahamella talpae (organism)	4180186
40646715	Mag-Ox 400 (product)	4180186
40646725	Recurrent ventral hernia with obstruction (disorder)	4180186
40646726	Diabetes with peripheral circulatory disorders (disorder)	4180186
40646737	Retired procedure (procedure)	4180186
40646750	Retired procedure (procedure)	4180186
40646762	Retired procedure (procedure)	4180186
40646774	Effects of high altitude on sinuses (disorder)	4180186
40646778	Anatomic pathology procedure or service (procedure)	4180186
40646780	Electric shock	4180186
40646780	Electric shock effect	4180186
40646780	Electrocution and non-fatal electrical shock	4180186
40646780	Shock from electric current (disorder)	4180186
40646797	Pulmonary eosinophilia (disorder)	4180186
40646799	Menstrual molimen (disorder)	4180186
40646826	Retired procedure (procedure)	4180186
40646834	Camel (organism)	4180186
40646856	Arthrobacter flavescens (organism)	4180186
40646862	Retired procedure (procedure)	4180186
40646886	Tropicbird (organism)	4180186
40646896	Retired procedure (procedure)	4180186
40646906	Actinomadura spiralis (organism)	4180186
40646927	HLA-DR7 antigen (substance)	4180186
40646963	Congenital camptodactyly (disorder)	4180186
40647027	Haematoma of testis as birth trauma	4180186
40647027	Hematoma of testis as birth trauma (disorder)	4180186
40647137	Salmonella III arizonae 47:z52:1,5,7 (organism)	4180186
40647160	Salmonella 48;z4,z23;-	4180186
40647160	Salmonella III arizonae 48:z4,z23:-- (organism)	4180186
40647160	Salmonella IV 48:z4,z23:-	4180186
40647195	Corneal hypoaesthesia	4180186
40647195	Corneal hypoesthesia (disorder)	4180186
40647197	Retired procedure (procedure)	4180186
40647204	Campylobacter concisus (organism)	4180186
40647206	Retired procedure (procedure)	4180186
40647213	Drug lotion, 2,5% (product)	4180186
40647230	Staphage Lysate (SPL) (product)	4180186
40647236	Pudu (organism)	4180186
40647240	Synarel Nasal Solution (product)	4180186
40647242	Comovirus group (organism)	4180186
40647242	Cowpea mosaic virus group (Plant hosts)	4180186
40647278	Fearful mood (finding)	4180186
40647284	Retired procedure (procedure)	4180186
40647286	Drug ointment, 0,025% (product)	4180186
40647303	Deoxycortisol (substance)	4180186
40647367	Central serous retinopathy (disorder)	4180186
40647367	CSR - Central serous retinopathy	4180186
40647367	Serous macular detachment	4180186
40647369	Cyriax's syndrome (disorder)	4180186
40647393	Congenital rectourethral fistula (disorder)	4180186
40647430	Retired procedure (procedure)	4180186
40647451	Bastard sibling	4180186
40647451	Illegitimate sibling (person)	4180186
40647457	Retired procedure (procedure)	4180186
40647533	Lymphosarcoma of intra-abdominal lymph nodes (disorder)	4180186
40647535	Lymphosarcoma of intrathoracic lymph nodes (disorder)	4180186
40647537	Lymphosarcoma of lymph nodes of head, face AND/OR neck (disorder)	4180186
40647539	Lymphosarcoma of lymph nodes of multiple sites (disorder)	4180186
40647630	Mixed cell type lymphosarcoma of spleen (disorder)	4180186
40647631	Mixed cell type lymphosarcoma of extranodal AND/OR solid organ site (disorder)	4180186
40647633	Monocytic leukaemia in remission	4180186
40647633	Monocytic leukemia in remission (disorder)	4180186
40647634	Monocytic leukaemia	4180186
40647634	Monocytic leukemia (disorder)	4180186
40647657	Myeloid leukaemia	4180186
40647657	Myeloid leukemia, disease (disorder)	4180186
40647697	Neoplasm of uncertain behavior of biliary tract (disorder)	4180186
40647697	Neoplasm of uncertain behaviour of biliary tract	4180186
40647757	Retired procedure (procedure)	4180186
40647759	Other specified bullous dermatosis, NEC (disorder)	4180186
40647760	Retired procedure (procedure)	4180186
40647786	Prescription of drug from outside authority list (procedure)	4180186
40647787	Salmonella III arizonae 61:l,v:z35 (organism)	4180186
40647795	Implantation of cochlear prosthetic device (procedure)	4180186
40647798	Rock ptarmigan (organism)	4180186
40647809	Evacuation of thrombosed hemorrhoid	4180186
40647809	Evacuation of thrombosed haemorrhoids	4180186
40647809	Evacuation of thrombosed hemorrhoids	4180186
40647809	Evacuation of thrombosed haemorrhoid	4180186
40647809	Incision of thrombosed haemorrhoid	4180186
40647809	Incision of thrombosed hemorrhoid (procedure)	4180186
40647836	Retired procedure (procedure)	4180186
40647840	Alcaligenes eutrophus (organism)	4180186
40647851	Retired procedure (procedure)	4180186
40647852	Schmorl's nodes of other region, NEC (disorder)	4180186
40647884	Retired procedure (procedure)	4180186
40647924	Congenital hypoplasia of renal papilla (disorder)	4180186
40647971	Lymphosarcoma cell leukaemia	4180186
40647971	Lymphosarcoma cell leukemia (morphologic abnormality)	4180186
40648095	Neoplasm of uncertain behavior of gum (disorder)	4180186
40648095	Neoplasm of uncertain behaviour of gum	4180186
40648133	Flavimonas oryzihabitans (living organism) (organism)	4180186
40648134	Retired procedure (procedure)	4180186
40648153	Congenital diverticulum of esophagus (disorder)	4180186
40648153	Congenital diverticulum of oesophagus	4180186
40648158	Chlamydia psitacci infection (disorder)	4180186
40648158	Chlamydiosis	4180186
40648173	Retired procedure (procedure)	4180186
40648180	Closed fracture of multiple sites of mandible (disorder)	4180186
40648214	Retired procedure (procedure)	4180186
40648235	Asphyxiation by environmental gas exposure (disorder)	4180186
40648237	Grade 2	4180186
40648237	Grade II	4180186
40648237	Intermediate differentiation	4180186
40648237	Moderately differentiated (grade) (qualifier value)	4180186
40648237	Moderately well differentiated	4180186
40648269	Infantile GM>1< gangliosidosis	4180186
40648269	Deficiency of beta-galactosidase isoenzymes A, B AND C	4180186
40648269	Generalised gangliosidosis	4180186
40648269	Generalized gangliosidosis	4180186
40648269	GM>1< gangliosidosis, type 1	4180186
40648269	Infantile gangliosidosis with bony involvement	4180186
40648269	Infantile GM>1< gangliosidosis (disorder)	4180186
40648341	Drug allergy (disorder)	4180186
40648388	Haemangioma of unspecified site	4180186
40648388	Hemangioma of unspecified site (disorder)	4180186
40648400	Hodgkin's disease, lymphocytic depletion of intrapelvic lymph nodes (disorder)	4180186
40648413	Neoplasm of uncertain behavior of lacrimal duct (disorder)	4180186
40648413	Neoplasm of uncertain behaviour of lacrimal duct	4180186
40648423	Retired procedure (procedure)	4180186
40648609	Fitting of prosthesis or prosthetic device of arm (procedure)	4180186
40648733	Retired procedure (procedure)	4180186
40648809	Polycythaemia neonatorum	4180186
40648809	Polycythemia neonatorum (disorder)	4180186
40648829	Organ component (body structure)	4180186
40648860	Hodgkin's disease, lymphocytic depletion of spleen (disorder)	4180186
40648868	Hodgkin's disease, lymphocytic-histiocytic predominance of lymph nodes of multiple sites (disorder)	4180186
40648873	Hodgkin's disease, mixed cellularity of intra-abdominal lymph nodes (disorder)	4180186
40648874	Hodgkin's disease, mixed cellularity of intrapelvic lymph nodes (disorder)	4180186
40648883	Hodgkin's disease, nodular sclerosis of intra-abdominal lymph nodes (disorder)	4180186
40648885	Hodgkin's disease, nodular sclerosis of intrathoracic lymph nodes (disorder)	4180186
40648893	Retired procedure (procedure)	4180186
40648902	Hodgkin's granuloma of intra-abdominal lymph nodes (disorder)	4180186
40648909	Hodgkin's granuloma of lymph nodes of multiple sites (disorder)	4180186
40648912	Hodgkin's paragranuloma of intra-abdominal lymph nodes (disorder)	4180186
40648913	Hodgkin's paragranuloma of intrapelvic lymph nodes (disorder)	4180186
40648937	Hypoglycaemic product	4180186
40648937	Hypoglycemic product (product)	4180186
40649020	Retired procedure (procedure)	4180186
40649076	Retired procedure (procedure)	4180186
40649164	Vaginal outlet (body structure)	4180186
40649166	Hog-nosed skunk	4180186
40649166	Conepatus (organism)	4180186
40649179	Acute erythraemia in remission	4180186
40649179	Acute erythremia in remission (disorder)	4180186
40649180	Acute erythraemia	4180186
40649180	Acute erythremia (disorder)	4180186
40649186	M5b - Acute monocytic leukaemia	4180186
40649186	M5b - Acute monocytic leukemia	4180186
40649186	Acute monocytic leukaemia	4180186
40649186	Acute monocytic leukaemia, FAB M5	4180186
40649186	Acute monocytic leukemia	4180186
40649186	Acute monocytic leukemia, FAB M5 (disorder)	4180186
40649203	Reduced ossification of ischium	4180186
40649203	Incomplete ossification of ischium (disorder)	4180186
40649215	Incomplete ossification of pubis (disorder)	4180186
40649215	Reduced ossification of pubis	4180186
40649279	Malignant neoplasm of abdominal esophagus	4180186
40649279	Malignant neoplasm of abdominal oesophagus	4180186
40649279	Primary malignant neoplasm of abdominal esophagus (disorder)	4180186
40649279	Primary malignant neoplasm of abdominal oesophagus	4180186
40649288	Malignant tumor of adrenal cortex	4180186
40649288	Malignant tumour of adrenal cortex	4180186
40649288	Primary malignant neoplasm of adrenal cortex (disorder)	4180186
40649295	Salmonella III arizonae 17:z4,z32:-- (organism)	4180186
40649298	Malignant tumor of anterior two-thirds of tongue	4180186
40649298	Malignant tumor of mobile part of tongue	4180186
40649298	Malignant tumour of anterior two-thirds of tongue	4180186
40649298	Malignant tumour of mobile part of tongue	4180186
40649298	Primary malignant neoplasm of anterior two-thirds of tongue (disorder)	4180186
40649370	Retired procedure (procedure)	4180186
40649381	Briquet's disorder (finding)	4180186
40649381	Briquet's syndrome	4180186
40649381	Multiple somatic complaints	4180186
40649381	Polysomatising disorder	4180186
40649381	Polysomatizing disorder	4180186
40649540	Benign neoplasm of anterior portion of floor of mouth (disorder)	4180186
40649569	Retired procedure (procedure)	4180186
40649591	Malignant neoplasm of bone and articular cartilage (disorder)	4180186
40649610	Malignant neoplasm of caecum	4180186
40649610	Malignant neoplasm of cecum	4180186
40649610	Primary malignant neoplasm of caecum	4180186
40649610	Primary malignant neoplasm of cecum (disorder)	4180186
40649628	Ca cervix	4180186
40649628	Cancer of cervix	4180186
40649628	Malignant neoplasm of cervix	4180186
40649628	Malignant neoplasm of cervix uteri	4180186
40649628	Malignant tumor of cervix	4180186
40649628	Malignant tumour of cervix	4180186
40649628	Primary malignant neoplasm of uterine cervix (disorder)	4180186
40649634	Clitoral Ca	4180186
40649634	Primary malignant neoplasm of clitoris (disorder)	4180186
40649637	Retired procedure (procedure)	4180186
40649642	Malignant neoplasm of connective and other soft tissues	4180186
40649642	Primary malignant neoplasm of soft tissues (disorder)	4180186
40649652	Malignant neoplasm of dorsal vertebral column	4180186
40649652	Primary malignant neoplasm of thoracic vertebral column (disorder)	4180186
40649682	Nodular lymphoma of lymph nodes of axilla and upper limb (disorder)	4180186
40649684	Nodular lymphoma of lymph nodes of head, face, and neck (disorder)	4180186
40649685	Nodular lymphoma of lymph nodes of inguinal region and lower limb (disorder)	4180186
40649727	Reticulosarcoma of lymph nodes of inguinal region and lower limb (disorder)	4180186
40649757	Sézary's disease of intra-abdominal lymph nodes (disorder)	4180186
40649758	Sézary's disease of intrapelvic lymph nodes (disorder)	4180186
40649760	Sézary's disease of lymph nodes of axilla AND/OR upper limb (disorder)	4180186
40649764	Sézary's disease of lymph nodes of multiple sites (disorder)	4180186
40649776	Subacute lymphoid leukaemia in remission	4180186
40649776	Subacute lymphoid leukemia in remission (disorder)	4180186
40649777	Subacute lymphoid leukaemia	4180186
40649777	Subacute lymphoid leukemia (disorder)	4180186
40649778	Subacute monocytic leukaemia in remission	4180186
40649778	Subacute monocytic leukemia in remission (disorder)	4180186
40649861	Benign neoplasm of blood vessel of arm (disorder)	4180186
40649874	Benign neoplasm of blood vessel of leg (disorder)	4180186
40649894	Benign neoplasm of bone of face (disorder)	4180186
40649914	Benign neoplasm of calcaneus (disorder)	4180186
40649990	Extrahepatic bile duct carcinoma	4180186
40649990	Malignant tumor of extrahepatic bile duct	4180186
40649990	Malignant tumour of extrahepatic bile duct	4180186
40649990	Primary malignant neoplasm of extrahepatic bile ducts (disorder)	4180186
40649995	Fallopian tube Ca	4180186
40649995	Malignant tumor of fallopian tube	4180186
40649995	Malignant tumour of fallopian tube	4180186
40649995	Primary malignant neoplasm of fallopian tube (disorder)	4180186
40650015	Malignant neoplasm of gastrointestinal tract (disorder)	4180186
40650023	CA - Cancer of gum	4180186
40650023	Cancer of gum	4180186
40650023	Malignant tumor of alveolar mucosa	4180186
40650023	Malignant tumor of gingiva	4180186
40650023	Malignant tumor of gum	4180186
40650023	Malignant tumour of alveolar mucosa	4180186
40650023	Malignant tumour of gingiva	4180186
40650023	Malignant tumour of gum	4180186
40650023	Primary malignant neoplasm of gum (disorder)	4180186
40650027	Malignant tumor of hard palate	4180186
40650027	Malignant tumour of hard palate	4180186
40650027	Primary malignant neoplasm of hard palate (disorder)	4180186
40650028	Carcinoma of head of pancreas	4180186
40650028	Malignant tumor of head of pancreas	4180186
40650028	Malignant tumour of head of pancreas	4180186
40650028	Primary malignant neoplasm of head of pancreas (disorder)	4180186
40650063	Malignant neoplasm of laryngeal aspect of interarytenoid fold	4180186
40650063	Malignant tumor of aryepiglottic fold - laryngeal aspect	4180186
40650063	Malignant tumour of aryepiglottic fold - laryngeal aspect	4180186
40650063	Primary malignant neoplasm of laryngeal aspect of aryepiglottic fold (disorder)	4180186
40650072	Primary malignant neoplasm of lateral wall of urinary bladder (disorder)	4180186
40650078	CA - Cancer of lip	4180186
40650078	Cancer of lip	4180186
40650078	Malignant tumor of lip	4180186
40650078	Malignant tumour of lip	4180186
40650078	Primary malignant neoplasm of lip (disorder)	4180186
40650087	Malignant neoplasm of lower third of esophagus	4180186
40650087	Malignant neoplasm of lower third of oesophagus	4180186
40650087	Primary malignant neoplasm of lower third of esophagus (disorder)	4180186
40650087	Primary malignant neoplasm of lower third of oesophagus	4180186
40650112	Retired procedure (procedure)	4180186
40650121	Unilateral acheiria (disorder)	4180186
40650121	Unilateral agenesis of hand	4180186
40650121	Unilateral congenital absence of hand	4180186
40650121	Unilateral forepaw apodia	4180186
40650123	Retired procedure (procedure)	4180186
40650255	Benign neoplasm of first cuneiform bone of foot (disorder)	4180186
40650277	Benign neoplasm of hamate bone (disorder)	4180186
40650298	Benign neoplasm of inner aspect of lip (disorder)	4180186
40650352	Benign neoplasm of lunate bone (disorder)	4180186
40650394	Malignant tumour of minor salivary gland	4180186
40650394	Malignant tumor of minor salivary gland	4180186
40650394	Primary malignant neoplasm of minor salivary gland (disorder)	4180186
40650395	CA - Mouth cancer	4180186
40650395	Cancer of oral cavity	4180186
40650395	Malignant tumor of mouth	4180186
40650395	Malignant tumor of oral cavity	4180186
40650395	Malignant tumour of mouth	4180186
40650395	Malignant tumour of oral cavity	4180186
40650395	Mouth cancer	4180186
40650395	Primary malignant neoplasm of mouth (disorder)	4180186
40650423	Malignant neoplasm of navicular bone of hand	4180186
40650423	Primary malignant neoplasm of scaphoid bone (disorder)	4180186
40650438	CA - Cancer of palate	4180186
40650438	Cancer of palate	4180186
40650438	Malignant neoplasm of roof of mouth	4180186
40650438	Malignant tumor of palate	4180186
40650438	Malignant tumor of roof of mouth	4180186
40650438	Malignant tumour of palate	4180186
40650438	Malignant tumour of roof of mouth	4180186
40650438	Primary malignant neoplasm of palate (disorder)	4180186
40650440	CA - Cancer of tonsil	4180186
40650440	Cancer of tonsil	4180186
40650440	Malignant neoplasm of palatine tonsil	4180186
40650440	Malignant tumor of faucial tonsil	4180186
40650440	Malignant tumor of palatine tonsil	4180186
40650440	Malignant tumor of tonsil	4180186
40650440	Malignant tumour of faucial tonsil	4180186
40650440	Malignant tumour of palatine tonsil	4180186
40650440	Malignant tumour of tonsil	4180186
40650440	Primary malignant neoplasm of tonsil (disorder)	4180186
40650453	CA - Cancer of parotid gland	4180186
40650453	Cancer of parotid gland	4180186
40650453	Malignant tumor of parotid gland	4180186
40650453	Malignant tumour of parotid gland	4180186
40650453	Primary malignant neoplasm of parotid gland (disorder)	4180186
40650523	Pituitary dependent hypercortisolism (disorder)	4180186
40650626	Diverticula of jejunum	4180186
40650626	Diverticulum of jejunum (disorder)	4180186
40650671	Benign neoplasm of nasopharynx (disorder)	4180186
40650672	Benign neoplasm of navicular bone of foot (disorder)	4180186
40650673	Benign neoplasm of navicular bone of hand	4180186
40650673	Benign neoplasm of scaphoid bone (disorder)	4180186
40650733	Retired procedure (procedure)	4180186
40650780	Benign neoplasm of short bone of lower limb (disorder)	4180186
40650783	Malignant neoplasm of retrocaecal tissue	4180186
40650783	Malignant neoplasm of retrocecal tissue	4180186
40650783	Primary malignant neoplasm of retrocaecal tissue	4180186
40650783	Primary malignant neoplasm of retrocecal tissue (disorder)	4180186
40650798	Pyosalpingitis (disorder)	4180186
40650868	Malignant tumor of soft tissue of arm	4180186
40650868	Malignant tumor of soft tissue of upper limb	4180186
40650868	Malignant tumour of soft tissue of arm	4180186
40650868	Malignant tumour of soft tissue of upper limb	4180186
40650868	Primary malignant neoplasm of soft tissues of upper limb (disorder)	4180186
40650869	Spermatic cord Ca	4180186
40650869	Malignant tumor of spermatic cord	4180186
40650869	Malignant tumour of spermatic cord	4180186
40650869	Primary malignant neoplasm of spermatic cord (disorder)	4180186
40650894	Malignant neoplasm of mesentery	4180186
40650894	Primary malignant neoplasm of the mesentery (disorder)	4180186
40650973	Benign congenital hypotonia (disorder)	4180186
40650980	Central nervous system deficit (finding)	4180186
40650990	Neurologic myelopathy-retired (disorder)	4180186
40651048	Retired procedure (procedure)	4180186
40651053	Retinal atrophy	4180186
40651053	Peripheral retinal degeneration	4180186
40651053	Retina atrophic (disorder)	4180186
40651059	Retired procedure (procedure)	4180186
40651072	Application of traction (procedure)	4180186
40651091	Follicle stimulating hormone preparation (product)	4180186
40651091	Follitropin preparation	4180186
40651091	FSH preparation	4180186
40651091	Human follicle stimulating hormone	4180186
40651136	Correction of tricuspid atresia (procedure)	4180186
40651142	Retired procedure (procedure)	4180186
40651168	Open posterior dislocation of hip (disorder)	4180186
40651176	Sodium dihydrogen phosphate (product)	4180186
40651305	Benign neoplasm of the mesocolon (disorder)	4180186
40651317	Retired procedure (procedure)	4180186
40651327	Benign neoplasm of trapezoid bone (disorder)	4180186
40651355	Malignant neoplasm of tip AND/OR lateral border of tongue	4180186
40651355	Primary malignant neoplasm of border of tongue (disorder)	4180186
40651363	Malignant neoplasm of trapezial bone	4180186
40651363	Primary malignant neoplasm of trapezium (disorder)	4180186
40651372	Malignant tumor of upper gingiva	4180186
40651372	Malignant tumor of upper gum	4180186
40651372	Malignant tumour of upper gingiva	4180186
40651372	Malignant tumour of upper gum	4180186
40651372	Primary malignant neoplasm of upper gum (disorder)	4180186
40651389	Cancer of vagina	4180186
40651389	Malignant tumor of vagina	4180186
40651389	Malignant tumour of vagina	4180186
40651389	Primary malignant neoplasm of vagina (disorder)	4180186
40651402	CA - Cancer of vocal cord	4180186
40651402	Cancer of vocal cord	4180186
40651402	Carcinoma of vocal cord	4180186
40651402	Malignant tumor of vocal cord	4180186
40651402	Malignant tumor of vocal fold	4180186
40651402	Malignant tumour of vocal cord	4180186
40651402	Malignant tumour of vocal fold	4180186
40651402	Primary malignant neoplasm of vocal cord (disorder)	4180186
40651438	Secondary malignant neoplasm of apex of urinary bladder (disorder)	4180186
40651470	Dislocation of lens (disorder)	4180186
40651470	Luxation of lens	4180186
40651495	Anterior membrane corneal dystrophy	4180186
40651495	Basement membrane corneal dystrophy	4180186
40651495	Epithelial corneal dystrophy	4180186
40651495	Epithelial stromal corneal dystrophy (disorder)	4180186
40651507	Hordeolum internum	4180186
40651507	Infected chalazion	4180186
40651507	Infected cyst of Meibomian gland (disorder)	4180186
40651507	Infected meibomian cyst	4180186
40651507	Infection of meibomian gland	4180186
40651507	Meibomian adenitis	4180186
40651525	Obstruction of lacrimal canaliculi	4180186
40651525	Obstruction of lacrimal ducts (disorder)	4180186
40651618	Retired procedure (procedure)	4180186
40651621	Dermoid cyst of mouth (disorder)	4180186
40651628	Retired procedure (procedure)	4180186
40651648	Salmonella III arizonae 35:z36:-- (organism)	4180186
40651656	Endoscopic biopsy of trachea (procedure)	4180186
40651659	Frigatebird (organism)	4180186
40651662	Diagnostic procedure on eye (procedure)	4180186
40651704	Retired procedure (procedure)	4180186
40651727	Retired procedure (procedure)	4180186
40651742	Pseudomonas iners (organism)	4180186
40651757	Disease due to Hantavirus (disorder)	4180186
40651792	Retired procedure (procedure)	4180186
40651808	Bilateral agenesis of feet	4180186
40651808	Bilateral congenital absence of feet (disorder)	4180186
40651808	Bilateral hindpaw apodia	4180186
40651840	Carcinoma in situ of anterior portion of floor of mouth (disorder)	4180186
40651899	Antiparasite drug (product)	4180186
40651899	Drug for parasites	4180186
40651924	Secondary malignant neoplasm of lateral axillary lymph nodes (disorder)	4180186
40651932	Retired procedure (procedure)	4180186
40651955	Metastatic malignant neoplasm to cervix uteri	4180186
40651955	Metastatic malignant neoplasm to uterine cervix	4180186
40651955	Secondary malignant neoplasm of cervix uteri	4180186
40651955	Secondary malignant neoplasm of uterine cervix (disorder)	4180186
40652022	Retired procedure (procedure)	4180186
40652044	Difficulty walking (finding)	4180186
40652049	Candidiasis of the genitals (disorder)	4180186
40652176	Retired procedure (procedure)	4180186
40652182	Human globulin preparation (product)	4180186
40652188	Erwinia rubrifaciens (organism)	4180186
40652224	Retired procedure (procedure)	4180186
40652281	Closed reduction of fracture of carpals and metacarpals with internal fixation (procedure)	4180186
40652284	Bang's disease	4180186
40652284	Bovine brucellosis (disorder)	4180186
40652284	Contagious abortion	4180186
40652284	Infection due to Brucella abortus	4180186
40652293	Retired procedure (procedure)	4180186
40652383	Carcinoma in situ of lateral portion of floor of mouth (disorder)	4180186
40652418	Carcinoma in situ of orbit (disorder)	4180186
40652421	"This parent group contains a single group for LOINC radiology terms that have ""Head"" as the region imaged. It allows users to find all radiology studies that image the head, regardless of the imaging focus or method (modality). Note that terms with multiple regions imaged will be included in the individual group for each region."	4180186
40652422	This parent group contains individual groups by analyte for terms in the Drug/Tox class that have been tagged as potentially being drugs of abuse in the LOINC database. Marking these terms as such is a work in progress, so there may be terms that should be included that are not, as well as those that are included that should not be. Each individual group contains terms with the same Component regardless of Property, Time aspect, System, Scale, and Method, in order to help identify patients who have been tested for a particular substance regardless of the specific testing done. Feedback is welcome.	4180186
40652423	"This parent group contains a single group for LOINC radiology terms that have ""Chest"" as the region imaged. It allows users to find all radiology studies that image the chest, regardless of the imaging focus or method (modality). Note that terms with multiple regions imaged will be included in the individual group for each region."	4180186
40652424	"This parent group contains a single group for LOINC radiology terms that have ""Upper extremity"" as the region imaged. It allows users to find all radiology studies that image the upper extremity, regardless of the imaging focus or method (modality). Note that terms with multiple regions imaged will be included in the individual group for each region."	4180186
40652425	"This parent group contains a single group for LOINC radiology terms that have ""Neck"" as the region imaged. It allows users to find all radiology studies that image the neck, regardless of the imaging focus or method (modality). Note that terms with multiple regions imaged will be included in the individual group for each region."	4180186
40652427	This parent group contains individual groups for each Type of Service+Kind of Note combination in the Document Ontology, regardless of Subject Matter Domain, Role, and Setting.	4180186
40652428	This parent group contains separate groups for individual viruses that are considered reportable by the Centers for Disease Control and Prevention (CDC). A given group contains all of the terms that represent testing for a specific virus, regardless of the Method or type of result.	4180186
40652429	"This parent group contains a single group for LOINC radiology terms that have ""Lower extremity"" as the region imaged. It allows users to find all radiology studies that image the lower extremity, regardless of the imaging focus or method (modality). Note that terms with multiple regions imaged will be included in the individual group for each region."	4180186
40652430	"This parent group contains individual groups for non-fetal body weight, body height and head circumference, where each group contains terms that represent the more routine measurements for each parameter. Each group is defined as ""routine"" based on the following: 1) they do not include terms with a Method of 'Estimated'; 2) body weight terms only include the challenges 'usual','used for drug calculation','with clothes','without clothes' and do not include any of the 'pre-' or 'post-' measurements; 3) body height terms only include the challenges 'lying' and 'standing' and do not include any 'pre-' and 'post-' measurements."	4180186
40652433	This parent group contains groups for terms in any of the following classes: CHEM, DRUG/TOX, CHAL, SERO, and ALLERGY. Each group contains terms with the same Component, Property, and Time aspect. The terms in a given group also have the same System, except when the System is in the intravascular or urine category, in which case terms that have any of the Systems in that category are rolled up. For example, a group for a given analyte in CSF only has terms with the System 'CSF', but a group for an analyte in an intravascular specimen contains terms with a variety of Systems, including 'Bld', 'Ser/Plas', 'BldV', etc. Some intravascular Systems are purposely excluded from this rollup, including cord blood ('BldCo') and dried blood spots (DBS).	4180186
40652434	"This parent group contains a single group for LOINC radiology terms that have ""Whole body"" as the region imaged, regardless of the imaging focus or method (modality)."	4180186
40652436	This parent group contains a single group of LOINC radiology terms that do not specify the region imaged. Such terms are for general concepts such as ultrasound guidance during surgery, or for studies where the imaging focus exists in multiple parts of the body but only one specific instance is being imaged, such as a blood vessel or bone.	4180186
40652437	This parent group contains groups for microalbumin terms that have the same Component and Property regardless of the Time aspect or Method.	4180186
40652438	"This parent group contains a single group for LOINC radiology terms that have ""Extremity"" as the region imaged, regardless of the imaging focus or method (modality). It does not include terms that specify either the lower or upper extremity."	4180186
40652442	"This parent group contains a single group for concepts related to Social determinants of health (SDOH). SDOH are defined as ""the structural determinants and conditions in which people are born, grow, live, work, and age"" and are divided into several categories, including socioeconomic status, education, physical environment, employment, social support network, and access to health care. Examples of social conditions affecting health In the United States include the direct correlation between level of education and life expectancy and the inverse correlation between level of education and the likelihood of smoking. Attempts to improve the health of people in United States have historically focused primarily on the healthcare system itself, but studies have shown that increasing access to quality healthcare does not translate into better health outcomes. To truly improve the health of all sectors of society a much broader approach must be developed that includes SDOH. [https://www.kf..."	4180186
40652443	This parent group contains individual groups for breast imaging terms that have the same method (modality) and component, regardless of laterality.	4180186
40652445	This parent group contains individual groups for urine terms that have the same Component and Property regardless of the Time aspect or Method. Note that Microalbumin terms are excluded from this parent group due to the way these terms are modeled in LOINC (based on a combination of the Component and Method), but there is a separate parent group for microalbumin.	4180186
40652446	This parent group contains specific groups for each type of cell in a cell differential. Each individual group contains terms with the same cell type, Property (e.g., number concentration), Time aspect, and System, regardless of the Method. These groups mostly combine methodless terms with those that specify automated or manual counts.	4180186
40652453	This parent group contains groups for terms with the same Component, System of either 'Urine' or 'Urine sed', and any Property, Time aspect, or Method.	4180186
40757160	Abd; Abdo; Abdomen+; Abdominal; c; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kidney; Kidney-R; Nephric; Nephrology; Nephrostogram; NT; Point in time; R; Rad; RADIOLOGY; Random; Renal; RT; View; VWS; W contr via NT; WC	4180186
40757160	RF Kidney-R Views W contr via NT	4180186
40757160	多重视图^采用经肾脏造瘘管给予对比剂:发现:时间点:腹部>肾脏.右侧:文档型:放射荧光透视法	4182948
40757161	CARE Survey; Point in time; Random; Survey	4180186
40757164	Account #; Admin; ADMIN.PATIENT; ADMIN.PATIENT.ID; Ident; Identifier; Intradermal; No; Nominal; Num; Patient ID # or Provider Acct #; Point in time; Random	4180186
40757164	Patient ID # or Provider Acct #	4180186
40757164	患者身份标识编号或服务提供者账号:标识符:时间点:^患者:名义型	4182948
40757166	CARE Survey; Drugs; Point in time; Random; Survey	4180186
40757169	CARE Survey; Point in time; Random; Survey	4180186
40757171	2 days; 48 hours; CARE Survey; Survey	4180186
40757172	CARE Survey; Point in time; Random; Survey; Sx	4180186
40757173	CARE Survey; Point in time; Random; Survey	4180186
40757174	CARE Survey; Continuity assessment record and evaluation; II; Patient Health Questionnaire; PHQ; PHQ 2; PHQ2; Point in time; Random; Survey	4180186
40757175	CARE Survey; Point in time; Random; Survey	4180186
40757177	CARE Survey; Disch; Point in time; Random; Survey	4180186
40757184	Before; CARE Survey; Point in time; Random; Survey	4180186
40757185	CARE Survey; Hx; Patient Hx; Patient Hx Prior to this Current Illness, Exacerbation, or Injury; Point in time; Random; Survey; Ulcer	4180186
40757186	CARE Survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Tx	4180186
40757188	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757193	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757195	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757198	History; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
40757200	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Primary language; Random; Survey	4180186
40757202	CARE Survey; Continuity assessment record and evaluation; Nominal; Othr; Point in time; Random; Survey; Typ	4180186
40757203	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Major Txs; Major Txs admitted/discharged with; Nominal; Point in time; Random; Survey; Transferred; Tx; Txs	4180186
40757204	CARE Survey; Continuity assessment record and evaluation; Drugs; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757206	BIMS; BIMS attempted; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757207	BIMS; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Reason BIMS was not attempted; Screen; Survey	4180186
40757210	2 days; 48 hours; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Sx	4180186
40757212	2 days; 48 hours; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; Sx	4180186
40757213	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757215	CARE Survey; Continuity assessment record and evaluation; Deglutition; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757217	CARE Survey; Continuity assessment record and evaluation; Disch; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757219	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757221	CARE Survey; Continuity assessment record and evaluation; Disch; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757224	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757225	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Medical procedures/Txs assistance needed; Nominal; Point in time; Random; Survey; Tx; Txs	4180186
40757226	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757228	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757229	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757235	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; OP; OP services considered appropriate; Point in time; Random; Survey	4180186
40757236	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Hosp; Nominal; Point in time; Random; Survey	4180186
40757237	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757238	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Personal hygiene; Point in time; Random; Survey	4180186
40757241	Add; CARE Survey; Continuity assessment record and evaluation; Discharged with referral for addl services; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757244	CARE Survey; Disch; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757245	CARE Survey; Disch; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757246	CARE Survey; Continuity assessment record and evaluation; Disch; Finding; Findings; Nominal; Othr; Point in time; Random; Survey	4180186
40757247	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757249	Admin; CARE Survey; Continuity assessment record and evaluation; Nominal; Othr; Point in time; Random; Survey; Transferred; Typ	4180186
40757252	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Housing; Living Arrangement; Living Arrangements; Nominal; Point in time; Random; Survey	4180186
40757257	Brief Interview for Mental Status; CARE Survey; Finding; Findings; O.BIMS; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757258	Brief Interview for Mental Status; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757259	Brief Interview for Mental Status; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757261	2 days; 48 hours; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
40757262	2 days; 48 hours; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
40757266	After; Assessment; CARE; CARE Survey; CARE tool - PAC admission; Continuity Assessment Record and Evaluation (CARE) Pnl; Eval; H&P; History and physical; Pan; Panel; Panl; Pnl; Point in time; PST; Random; Survey	4180186
40757269	CARE Survey; Continuity Assessment Record and Evaluation (CARE) Pnl; Major Txs; Major Txs admitted with; Major Txs admitted with panel; Pan; Panl; Pnl; Point in time; Random; Survey; Transferred; Tx; Txs	4180186
40757270	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Major Txs; Major Txs admitted with; Nominal; Point in time; Random; Survey; Transferred; Tx; Txs	4180186
40757272	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Major Txs; Major Txs discharged with; Nominal; Point in time; Random; Survey; Tx; Txs	4180186
40757275	Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; T vaginalis; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
40757275	T vaginalis DNA Vag Ql Probe+sig amp	4180186
40757275	阴道毛滴虫 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.信号	4182948
40757276	Amplif; Amplification; Amplified; Bact; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Random; UniversalLabOrders; Vag fld; Vag fluid; Vagina; Vaginal fluid; Vaginal pathogens; Vaginosis/itis DNA Pnl	4180186
40757276	Vaginosis/itis DNA Pnl Vag Probe+sig amp	4180186
40757276	细菌性阴道病与阴道炎 DNA 组套:-:时间点:阴道:-:探针法.基因扩增.信号	4182948
40757278	ACIF; Anticomplement Immunofluorescence; Auto Ab; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Rat liv+stom+kid; Report; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40757278	Auto Ab Ser Rat liv+stom+kid-Imp	4180186
40757278	自身抗体:印象:时间点:血清:叙述型:免疫荧光 - 大鼠肝脏+胃+肾脏底物法	4182948
40757279	ACIF; Anticomplement Immunofluorescence; Auto Ab; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40757279	Auto Ab Ser HEp2 subst-Imp	4180186
40757279	自身抗体:印象:时间点:血清:叙述型:免疫荧光 - Hep2 底物法	4182948
40757284	NuMA Ab Titr Ser IF	4180186
40757284	有丝分裂器 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40757284	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MSA NuMA; MSA-1; Nuc; NuMA; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40757285	细胞核抗体模式.细胞间桥型:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40757285	ACIF; ANA; ANA intercell bridge; ANA Pat; ANF; Anticomplement Immunofluorescence; Antinuclear antibody; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Midbody; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stem body; Time Resolved Fluorescence; TRF	4180186
40757285	ANA intercell bridge Ser Ql IF	4180186
40757289	Pan CK Ab Ser Ql IF	4180186
40757289	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Pan CK; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40757289	广谱细胞角蛋白 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40757290	Pan CK Ab Titr Ser IF	4180186
40757290	广谱细胞角蛋白 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40757290	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Pan CK; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40757293	CA Pat PL-7+PL-12 Titr Ser IF	4180186
40757293	细胞浆抗体模式.PL-7+PL-12:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40757293	ACIF; Anticomplement Immunofluorescence; CA Pat; CA Pat PL-7+PL-12; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; PL12; PL7; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40757294	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; CMV; Cnt; Count; Count/volume; CT; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA DL=200; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn; Viral load	4180186
40757294	CMV DNA # Ur NAA DL=200	4180186
40757294	巨细胞病毒 DNA:计数型浓度:时间点:尿液:定量型:探针法.基因扩增.靶向 检测极限 = 200 拷贝/毫升	4182948
40757295	Antigen; Antigens; Blood; CMV; CMV IE; Cytomegalo virus; Cytomgal; EA; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40757295	CMV IE Ag Bld Ql	4180186
40757295	巨细胞病毒即刻-早期 抗原:存在情况或阈值:时间点:全血:序数型	4182948
40757297	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefobid; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757297	Cefoperazone+Sulbac Susc Islt	4180186
40757297	头孢哌酮+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40757298	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefobid; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757298	Cefoperazone+Sulbac Islt MIC	4180186
40757298	头孢哌酮+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40757308	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757308	Clotrimazole Islt KB	4180186
40757308	克霉唑:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757314	Ansamycin; ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Mycobutin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757314	Rifabutin Islt KB	4180186
40757314	利福布汀:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757315	Amithiozone; ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Thioacetazone	4180186
40757315	Thiacetazone Islt KB	4180186
40757315	氨硫脲:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757316	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757316	Caspofungin Islt Grad strip	4180186
40757316	卡泊芬净:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40757317	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Noxafil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757317	Posaconazole Islt Grad strip	4180186
40757317	泊沙康唑:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40757320	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Noxafil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757320	Posaconazole Islt KB	4180186
40757320	泊沙康唑:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757326	ANTIBIOTIC SUSCEPTIBILITIES; AST; Baypen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Mezlin; Minimum inhibitory concentration; Optocillin; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757326	Mezlocillin+Sulbac Islt MIC	4180186
40757326	美洛西林+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40757327	ANTIBIOTIC SUSCEPTIBILITIES; AST; Baypen; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Mezlin; Optocillin; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757327	Mezlocillin+Sulbac Islt KB	4180186
40757327	美洛西林+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757328	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Piper; PIPJ; Pipracil; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757328	Piperacillin+Sulbac Susc Islt	4180186
40757328	氧哌嗪青霉素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40757329	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Piper; PIPJ; Pipracil; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757329	Piperacillin+Sulbac Islt MIC	4180186
40757329	氧哌嗪青霉素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40757331	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757331	Griseofulvin Susc Islt	4180186
40757331	灰黄霉素:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40757333	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757333	Griseofulvin Islt KB	4180186
40757333	灰黄霉素:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757334	ANTIBIOTIC SUSCEPTIBILITIES; AST; Bestcall; Cefmax; Cefmenoxim; Cemix; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tacef	4180186
40757334	Cefmenoxime Islt MIC	4180186
40757334	头孢甲肟:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40757337	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
40757337	CMV DNA SerPl NAA+probe-Log#	4180186
40757337	巨细胞病毒 DNA:对数型数量或计数浓度:时间点:血清/血浆:定量型:探针法.基因扩增.靶向	4182948
40757342	17-Hydroxycorticosterone; 24h p DEX; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hydrocortisone; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757342	Cortis 24h p DEX SerPl-sCnc	4180186
40757342	皮质醇^在给予剂量地塞米松之后24小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757345	17-Hydroxycorticosterone; 5D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hydrocortisone; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757345	Cortis 5D p Dex SerPl-sCnc	4180186
40757345	皮质醇^在给予剂量地塞米松之后5天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757349	Blood; CD3 Cells; CD3+CD4+ Cells; CD3+CD8+ Cells; CD3-CD4+; CD4+ T cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Helper T cells; Inducer T cells; L3T4; Leu2; Leu-2; Leu3; Leu-3; Leu4; Leu-4; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T4; T-4; T4 helper/inducer cells; T8; T-8; T8 suppressor cells; Tsuppressor; W3/25; WB; Whole blood	4180186
40757349	CD3+CD4+ Cells/CD3+CD8+ Cells Bld	4180186
40757349	细胞.CD3+CD4+/细胞.CD3+CD8+:计数型比率:时间点:全血:定量型	4182948
40757350	Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; i; imm 1:4 NP; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; TCT; Throm; Thrombin clotting time; Thrombin time; Tilt tube; TT	4180186
40757350	TT imm 1:4 NP PPP	4180186
40757350	凝血酶诱导型凝血过程.因子替换^紧接着在添加1:4正常血浆之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40757351	CELL MARKERS; Imm; Impression; Impression/interpretation of study; Impressions; Imun; Imune; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
40757351	Immune response markers Spec-Imp	4180186
40757351	免疫应答标志物:印象:时间点:XXX:叙述型	4182948
40757354	Lymphoma - CLL screen markers Spec-Imp	4180186
40757354	CELL MARKERS; Chronic lymphocytic leukemia; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Scn; Scr; Scrn; Spec; To be specified in another part of the message; Unspecified	4180186
40757354	淋巴瘤 - 慢性淋巴细胞白血病筛查标志物:印象:时间点:XXX:叙述型	4182948
40757355	Lymphoma - T-cell markers Spec-Imp	4180186
40757355	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; T cell; T prime; To be specified in another part of the message; UCHL-1; Unspecified	4180186
40757355	淋巴瘤 - T-细胞标志物:印象:时间点:XXX:叙述型	4182948
40757356	CELL MARKERS; Dynamic; FC; Imm; Immune response Pnl; Imun; Imune; Misc; Miscellaneous; Other; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40757356	Immune response Pnl Spec FC	4180186
40757356	免疫应答组套:-:时间点:XXX:-:流式细胞测量术	4182948
40757357	CELL MARKERS; Dynamic; FC; Lymphoma Pnl; Misc; Miscellaneous; Other; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified	4180186
40757357	Lymphoma Pnl Spec FC	4180186
40757357	淋巴瘤组套:-:时间点:XXX:-:流式细胞测量术	4182948
40757361	Cell cnt & Diff Pnl with Glu & Prot CSF	4180186
40757361	Cell cnt & Diff Pnl with Glu & Prot; Cell Cnt + Diff Pnl; Cerebral spinal fluid; Cerebrospinal Fl; Diff; Diff Pnl; Differl; Differn; Glu; Gluc; Glucoseur; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40757361	带有葡萄糖和蛋白质测定项目的细胞计数与分类组套:-:时间点:脑脊液:定量型	4182948
40757363	Metab Pnl.large animal SerPl	4180186
40757363	Chemistry; Metab Pnl.large animal; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40757363	代谢组套.大型动物:-:时间点:血清/血浆:定量型	4182948
40757364	Chemistry; Metab Pnl.small animal; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40757364	Metab Pnl.small animal SerPl	4180186
40757364	代谢组套.小型动物:-:时间点:血清/血浆:定量型	4182948
40757366	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortis chal Pnl; F; hydrocortisone; Oral fluid; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; Random; Sal	4180186
40757366	Cortis chal Pnl Sal	4180186
40757366	皮质醇刺激组套:-:时间点:唾液:-	4182948
40757367	Cortis 9 AM day 2 SerPl-mCnc	4180186
40757367	17-Hydroxycorticosterone; 9 AM day 2; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR	4180186
40757367	皮质醇^第2天上午9点标本:质量浓度:时间点:血清/血浆:定量型	4182948
40757369	Arbitrary concentration; Chemistry; oxLDL; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40757369	LDL.oxidized SerPl-aCnc	4180186
40757369	低密度脂蛋白.氧化型:任意型浓度:时间点:血清/血浆:定量型	4182948
40757370	CPE; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40757370	Cytopathic effect Spec Ql	4180186
40757370	细胞病变效应:存在情况或阈值:时间点:XXX:序数型	4182948
40757371	Antigen; Antigens; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40757371	FLUV Ag Spec Ql	4180186
40757371	流感病毒 抗原:存在情况或阈值:时间点:XXX:序数型	4182948
40757373	FLUV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Islt; Isol; Isolated; Microbiology; Nominal; Point in time; Random	4180186
40757373	FLUV Islt	4180186
40757373	流感病毒 已鉴定的:存在与否或特征标识:时间点:分离株:名义型	4182948
40757375	FLUV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Isolated; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40757375	FLUV Spec	4180186
40757375	流感病毒 已鉴定的:存在与否或特征标识:时间点:XXX:名义型	4182948
40757376	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; ID; Identity or presence; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Resp virus; RV; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified	4180186
40757376	Resp virus Ag Spec IF	4180186
40757376	呼吸道病毒 抗原:存在与否或特征标识:时间点:XXX:名义型:免疫荧光法	4182948
40757378	cmmt; cmnt; Com; Comm; Comments; Commt; DRUG/TOXICOLOGY; Drugs; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Remarks; Scn; Scr; Scrn; UA; UR; Urn	4180186
40757378	Drug screen comment Ur-Imp	4180186
40757378	药物筛查注释:印象:时间点:尿液:名义型	4182948
40757381	15M pre Gc; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757381	Glucose 15M pre Gc SerPl-sCnc	4180186
40757381	葡萄糖^在给予剂量胰高血糖素之前15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757388	Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Ins IV; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40757388	Glucose pre Ins IV SerPl-sCnc	4180186
40757388	葡萄糖^在静脉注射剂量胰岛素之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757389	120 min; 120 minutes; 120min; 2 hours; 2h p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40757389	Glucose 2h p Ins IV SerPl-sCnc	4180186
40757389	葡萄糖^在静脉注射剂量胰岛素之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757391	15M p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40757391	Glucose 15M p Ins IV SerPl-sCnc	4180186
40757391	葡萄糖^在静脉注射剂量胰岛素之后15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757392	15M pre Ins IV; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Ins IV; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40757392	Glucose 15M pre Ins IV SerPl-sCnc	4180186
40757392	葡萄糖^在静脉注射剂量胰岛素之前15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757394	30M p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40757394	Glucose 30M p Ins IV SerPl-sCnc	4180186
40757394	葡萄糖^在静脉注射剂量胰岛素之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757397	1.3h p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40757397	Glucose 1.3h p Ins IV SerPl-sCnc	4180186
40757397	葡萄糖^在静脉注射剂量胰岛素之后1.3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757398	1 1/2 hours; 1 1/2 HR; 1.5h p Ins IV; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40757398	Glucose 1.5h p Ins IV SerPl-sCnc	4180186
40757398	葡萄糖^在静脉注射剂量胰岛素之后1.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757400	120 min; 120 minutes; 120min; 2 hours; 2h p OKG; 2h p Orn; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757400	Glucose 2h p OKG SerPl-sCnc	4180186
40757400	葡萄糖^在给予剂量鸟氨酸 alpha-酮戊二酸之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757401	2.5h p OKG; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757401	Glucose 2.5h p OKG SerPl-sCnc	4180186
40757401	葡萄糖^在给予剂量鸟氨酸 alpha-酮戊二酸之后2.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757402	15M p OKG; 15M p Orn; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757402	Glucose 15M p OKG SerPl-sCnc	4180186
40757402	葡萄糖^在给予剂量鸟氨酸 alpha-酮戊二酸之后15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757404	2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; 3h p OKG; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757404	Glucose 3h p OKG SerPl-sCnc	4180186
40757404	葡萄糖^在给予剂量鸟氨酸 alpha-酮戊二酸之后3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757405	2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; 30M p OKG; 30M p Orn; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757405	Glucose 30M p OKG SerPl-sCnc	4180186
40757405	葡萄糖^在给予剂量鸟氨酸 alpha-酮戊二酸之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757407	1 hour; 1.0Hr; 1h p OKG; 1h p Orn; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; 60 min; 60 minutes; 60M; 60min; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757407	Glucose 1h p OKG SerPl-sCnc	4180186
40757407	葡萄糖^在给予剂量鸟氨酸 alpha-酮戊二酸之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757408	1 1/2 hours; 1 1/2 HR; 1.5h p OKG; 1.5h p Orn; 1.5Hr; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; 90 min; 90 minutes; 90M; 90min; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757408	Glucose 1.5h p OKG SerPl-sCnc	4180186
40757408	葡萄糖^在给予剂量鸟氨酸 alpha-酮戊二酸之后1.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757409	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Glutaric acid; Level; Pentanedioiate; Pentanedioic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757409	Glutarate CSF-sCnc	4180186
40757409	戊二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
40757411	Glutarylcarn CSF-sCnc	4180186
40757411	C5DC; C5-DC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757411	戊二酰肉碱 (C5-DC):物质的量浓度:时间点:脑脊液:定量型	4182948
40757412	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C5DC; C5-DC; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757412	Glutarylcarn Amn-sCnc	4180186
40757412	戊二酰肉碱 (C5-DC):物质的量浓度:时间点:羊水:定量型	4182948
40757413	C5DC; C5-DC; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757413	Glutarylcarn Ur-sCnc	4180186
40757413	戊二酰肉碱 (C5-DC):物质的量浓度:时间点:尿液:定量型	4182948
40757415	Glycerol Fld-sCnc	4180186
40757415	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757415	甘油:物质的量浓度:时间点:体液:定量型	4182948
40757418	Guanidinoacetate CSF-sCnc	4180186
40757418	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; GAA; glycocyamine; guanidinoacetic acid; guanidoacetic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757418	胍基乙酸:物质的量浓度:时间点:脑脊液:定量型	4182948
40757419	Guanidinoacetate Amn-sCnc	4180186
40757419	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; GAA; glycocyamine; guanidinoacetic acid; guanidoacetic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757419	胍基乙酸:物质的量浓度:时间点:羊水:定量型	4182948
40757420	Hgb Bld BPU-mCnc	4180186
40757420	Blood; Blood product unit; Blood Product Unit (Pack); Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40757420	血红蛋白:质量浓度:时间点:全血^血液制品单位:定量型	4182948
40757421	C7; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757421	Heptanoylcarn/Creat Ur-sRto	4180186
40757421	庚酰肉碱 (C7)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757422	C7; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757422	Heptanoylcarn CSF-sCnc	4180186
40757422	庚酰肉碱 (C7):物质的量浓度:时间点:脑脊液:定量型	4182948
40757424	Heptanoylcarn Ur-sCnc	4180186
40757424	C7; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757424	庚酰肉碱 (C7):物质的量浓度:时间点:尿液:定量型	4182948
40757426	C6; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757426	Hexanoylcarn/Creat Ur-sRto	4180186
40757426	己酰肉碱 (C6)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757427	Hexanoylcarn CSF-sCnc	4180186
40757427	C6; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757427	己酰肉碱 (C6):物质的量浓度:时间点:脑脊液:定量型	4182948
40757428	Hexanoylcarn Amn-sCnc	4180186
40757428	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C6; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757428	己酰肉碱 (C6):物质的量浓度:时间点:羊水:定量型	4182948
40757433	(Hcys)2; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Homocyst(e)ine; Homocystin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40757433	(Hcys)2 DBS-sCnc	4180186
40757433	同型胱氨酸:物质的量浓度:时间点:全血.斑点:定量型	4182948
40757434	OH-Lysine DBS-sCnc	4180186
40757434	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Hydroxy lysine; Hydroxyl; Level; OH-Lysine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40757434	羟基赖氨酸:物质的量浓度:时间点:全血.斑点:定量型	4182948
40757435	Isobutyrylgly Ur-sCnc	4180186
40757435	Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757435	异丁酰甘氨酸:物质的量浓度:时间点:尿液:定量型	4182948
40757438	C5; Chemistry; Isovaleryl+MeButyrylcarn; Isovaleryl-2-Methylbutyrylcarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757438	Isovaleryl+MeButyrylcarn Ur-sCnc	4180186
40757438	异戊酰肉碱+甲基丁酰肉碱 (C5):物质的量浓度:时间点:尿液:定量型	4182948
40757441	Linoleoylcarn/Creat Ur-sRto	4180186
40757441	C18:2; Chemistry; CR; Crea; Creat; II; Linoleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757441	亚油酰肉碱 (C18:2)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757443	Linoleoylcarn Amn-sCnc	4180186
40757443	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C18:2; Chemistry; II; Level; Linoleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757443	亚油酰肉碱 (C18:2):物质的量浓度:时间点:羊水:定量型	4182948
40757445	Malonylcarn/Creat Ur-sRto	4180186
40757445	C3DC; C3-DC; Chemistry; CR; Crea; Creat; Dicarboxylic carnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757445	丙二酰肉碱 (C3-DC)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757447	C4DC; C4-DC; C4-DCC; Chemistry; CR; Crea; Creat; Dicarboxylic carnitine; Me-malonylcarn; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757447	Me-malonylcarn/Creat Ur-sRto	4180186
40757447	甲基丙二酰肉碱 (C4-DC)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757448	Me-malonylcarn CSF-sCnc	4180186
40757448	C4DC; C4-DC; C4-DCC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dicarboxylic carnitine; Level; Me-malonylcarn; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757448	甲基丙二酰肉碱 (C4-DC):物质的量浓度:时间点:脑脊液:定量型	4182948
40757449	Me-malonylcarn Amn-sCnc	4180186
40757449	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C4DC; C4-DC; C4-DCC; Chemistry; Dicarboxylic carnitine; Level; Me-malonylcarn; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757449	甲基丙二酰肉碱 (C4-DC):物质的量浓度:时间点:羊水:定量型	4182948
40757450	C4DC; C4-DC; C4-DCC; Chemistry; Dicarboxylic carnitine; Level; Me-malonylcarn; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757450	Me-malonylcarn Ur-sCnc	4180186
40757450	甲基丙二酰肉碱 (C4-DC):物质的量浓度:时间点:尿液:定量型	4182948
40757451	Octanoylcarn/Creat Ur-sRto	4180186
40757451	C8; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757451	辛酰肉碱 (C8)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757453	Octanoylcarn Amn-sCnc	4180186
40757453	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C8; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757453	辛酰肉碱 (C8):物质的量浓度:时间点:羊水:定量型	4182948
40757454	C16; Chemistry; CR; Crea; Creat; Hexadecanoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757454	Palmitoylcarn/Creat Ur-sRto	4180186
40757454	棕榈酰肉碱 (C16)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757456	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C16; Chemistry; Hexadecanoylcarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757456	Palmitoylcarn Amn-sCnc	4180186
40757456	棕榈酰肉碱 (C16):物质的量浓度:时间点:羊水:定量型	4182948
40757457	PETN DBS-sCnc	4180186
40757457	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; PEA; PETN; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40757457	磷酸乙醇胺:物质的量浓度:时间点:全血.斑点:定量型	4182948
40757461	C3; C3-carntitine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757461	Propionylcarn CSF-sCnc	4180186
40757461	丙酰肉碱 (C3):物质的量浓度:时间点:脑脊液:定量型	4182948
40757465	Stearoylcarn CSF-sCnc	4180186
40757465	C18; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Steroylcarnitine; Substance concentration	4180186
40757465	硬脂酰肉碱 (C18):物质的量浓度:时间点:脑脊液:定量型	4182948
40757466	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C18; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Steroylcarnitine; Substance concentration	4180186
40757466	Stearoylcarn Amn-sCnc	4180186
40757466	硬脂酰肉碱 (C18):物质的量浓度:时间点:羊水:定量型	4182948
40757467	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Cys(SO3H); Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757467	Sulfocysteine CSF-sCnc	4180186
40757467	磺酰半胱氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
40757468	Sulfocysteine DBS-sCnc	4180186
40757468	Blood; Chemistry; Cys(SO3H); DBS; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40757468	磺酰半胱氨酸:物质的量浓度:时间点:全血.斑点:定量型	4182948
40757469	C14; Chemistry; CR; Crea; Creat; Myristoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Tdecanoylcarn; UA; UCr; UR; Urn	4180186
40757469	Tdecanoylcarn/Creat Ur-sRto	4180186
40757469	十四烷酰肉碱 (C14)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757470	C14; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Myristoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Tdecanoylcarn	4180186
40757470	Tdecanoylcarn CSF-sCnc	4180186
40757470	十四烷酰肉碱 (C14):物质的量浓度:时间点:脑脊液:定量型	4182948
40757471	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C14; Chemistry; Level; Myristoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tdecanoylcarn	4180186
40757471	Tdecanoylcarn Amn-sCnc	4180186
40757471	十四烷酰肉碱 (C14):物质的量浓度:时间点:羊水:定量型	4182948
40757472	C14:1; Chemistry; cis-9-tetradecenoate; cis-9-tetradecenoic acid; CR; Crea; Creat; Myristoleic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757472	Myristoleate/Creat Ur-sRto	4180186
40757472	肉豆寇烯酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757476	C2; Chemistry; Ejaculate; Genitourinary; GU; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Substance concentration; URO; Urology	4180186
40757476	Acetylcarn Smn-sCnc	4180186
40757476	乙酰肉碱 (C2):物质的量浓度:时间点:精液:定量型	4182948
40757480	Amm; Ammon; Amon; Chemistry; Diaf; Dialysate; Dialysis fluid; Kidney; Level; Mass concentration; Nephrology; NH3; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40757480	Ammonia Dial fld-mCnc	4180186
40757480	氨:质量浓度:时间点:透析液:定量型	4182948
40757482	Ascorbic acid; c702; Chemistry; DHA; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vit C; Vit C+DHA; Vitamin C	4180186
40757482	Vit C+DHA SerPl-mCnc	4180186
40757482	抗坏血酸+脱氢抗坏血酸:质量浓度:时间点:血清/血浆:定量型	4182948
40757483	N2 Ur-mCnc	4180186
40757483	Chemistry; Level; Mass concentration; N; N2; Nit; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40757483	氮:质量浓度:时间点:尿液:定量型	4182948
40757484	B; B1 globulin; Beta1 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40757484	Beta1 Glob Ur Elph-mCnc	4180186
40757484	Beta 1 球蛋白:质量浓度:时间点:尿液:定量型:电泳	4182948
40757486	B; B2 Microglob; B2 Microglob CSF; b2-M; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hematology; Heme; II; Microglob; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Ser; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR	4180186
40757486	B2 Microglob CSF/Ser	4180186
40757486	Beta-2-微球蛋白.脑脊液/Beta-2-微球蛋白.血清:相对比率:时间点:血清+脑脊液:定量型	4182948
40757490	HCO3 p dialysis Plas-sCnc	4180186
40757490	After; BIC; bicar; Bicarb; Chemistry; Dialy; HCO3; Level; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757490	碳酸氢盐^在透析之后:物质的量浓度:时间点:血浆:定量型	4182948
40757493	Bili; Bilirubins; Billirubin; Chemistry; Diaf; Dialysate; Dialysis fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TBIL	4180186
40757493	Bilirub Dial fld-sCnc	4180186
40757493	胆红素:物质的量浓度:时间点:透析液:定量型	4182948
40757496	Blood - (umbilical) cord; Ca; Cal; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757496	Calcium BldCo-sCnc	4180186
40757496	钙:物质的量浓度:时间点:脐带全血:定量型	4182948
40757497	Ca-I adj pH7.4 BldCo-sCnc	4180186
40757497	adj; adj pH7.4; Blood - (umbilical) cord; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; Cord (umbilical) blood; Cord bld; Cord blood; ICA; Ion; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757497	钙.离子型^^调整至pH 7.4的:物质的量浓度:时间点:脐带全血:定量型	4182948
40757498	Ca-I BldCo-sCnc	4180186
40757498	Blood - (umbilical) cord; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; Cord (umbilical) blood; Cord bld; Cord blood; ICA; Ion; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757498	钙.离子型:物质的量浓度:时间点:脐带全血:定量型	4182948
40757499	Catalytic Concentration; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40757499	Catalase Plas-cCnc	4180186
40757499	过氧化氢酶:催化浓度:时间点:血浆:定量型	4182948
40757501	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Cl; Cl-; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40757501	Chloride Fld-mCnc	4180186
40757501	氯:质量浓度:时间点:体液:定量型	4182948
40757502	Cholest Prt-sCnc	4180186
40757502	Ascites; Ascitic fluid; Ascitis; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Level; Lipid; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757502	胆固醇:物质的量浓度:时间点:腹膜液:定量型	4182948
40757505	1 day; 24 hours; 24HR; Bdy weight; bod; Bodies; BW; Chemistry; CR; Crea; Creat; Kidney; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UR; Urn; Wt	4180186
40757505	Creat/BW 24h Ur-RelSRat	4180186
40757505	肌酐/体重:相对物质的量速率:24小时:尿液:定量型	4182948
40757507	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C721; Cbl; Cobalamin; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Vit B12; Vitamin B12	4180186
40757507	Vit B12 Fld-sCnc	4180186
40757507	钴胺素类:物质的量浓度:时间点:体液:定量型	4182948
40757508	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C721; Cbl; Cobalamin; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vit B12; Vitamin B12	4180186
40757508	Vit B12 Fld-mCnc	4180186
40757508	钴胺素类:质量浓度:时间点:体液:定量型	4182948
40757511	Cystatin C 24h Ur-mCnc	4180186
40757511	1 day; 24 hours; 24HR; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40757511	半胱氨酸蛋白酶抑制剂 C:质量浓度:24小时:尿液:定量型	4182948
40757513	AF; Amn; Amn fl; Amnc; Amnio; Amniotic flu; Amniotic fluid; Amniotic fluid cells; Catalytic Content; Chemistry; COX; CyC Oxidase; cyt; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40757513	CyC Oxidase Amnc-cCnt	4180186
40757513	细胞色素 C 氧化酶:催化含量:时间点:羊水细胞:定量型	4182948
40757514	Catalytic Content; Chemistry; COX; CyC Oxidase; cyt; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40757514	CyC Oxidase Fib-cCnt	4180186
40757514	细胞色素 C 氧化酶:催化含量:时间点:成纤维细胞:定量型	4182948
40757515	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Catalytic Content; Chemistry; COX; CyC Oxidase; cyt; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40757515	CyC Oxidase Amn-cCnt	4180186
40757515	细胞色素 C 氧化酶:催化含量:时间点:羊水:定量型	4182948
40757518	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; DHCA; Dihydroxycholestanoic acid; Di-OH-cholestanoate; Fl; Fld; FLU; Fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757518	Di-OH-cholestanoate Fld-sCnc	4180186
40757518	二羟基胆固酸:物质的量浓度:时间点:体液:定量型	4182948
40757519	Di-OH-cholestanoate Ur-sCnc	4180186
40757519	Chemistry; DHCA; Dihydroxycholestanoic acid; Di-OH-cholestanoate; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757519	二羟基胆固酸:物质的量浓度:时间点:尿液:定量型	4182948
40757521	FGF-23.intact SerPl-mCnc	4180186
40757521	Autosomal dominant hypophosphatemic rickets; Chemistry; Fac; Fact; Familial tumoral calcinosis with hyperphosphatemia; FGF 23; FGF23; FGF-23; FGF-23.intact; iFGF23; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40757521	成纤维细胞生长因子 23.完整型:质量浓度:时间点:血清/血浆:定量型	4182948
40757525	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp11; sp11 p chal; Spec; SR; Substance concentration	4180186
40757525	Glucose sp11 p chal SerPl-sCnc	4180186
40757525	葡萄糖^在XXX刺激之后的第11个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757527	After; CHEMISTRY.CHALLENGE TESTING; Convalescent; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p chal; Spec; SR; Substance concentration	4180186
40757527	Glucose sp2 p chal SerPl-sCnc	4180186
40757527	葡萄糖^在XXX刺激之后的第2个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757529	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p chal; Spec; SR; Substance concentration	4180186
40757529	Glucose sp4 p chal SerPl-sCnc	4180186
40757529	葡萄糖^在XXX刺激之后的第4个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757533	4OH-midazolam SerPl-mCnc	4180186
40757533	4-Hydroxy midazolam; 4OH-midazolam; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Midazolam metabolite; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40757533	4-羟基咪达唑仑:质量浓度:时间点:血清/血浆:定量型	4182948
40757535	Pooled Platelet Conc Gvn BPU	4180186
40757535	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnc; Cnt; Conc; Count; Gvn; Number; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte; Thrombocytes	4180186
40757535	混合浓缩血小板单位 给予的:数量(计数):时间点:^血液制品单位:定量型	4182948
40757536	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Cryo; Cryoppt; Cryoprec; Hematology; Heme; Num units trans pooled cryoppt; Number; Point in time; Pooled Cryoppt; QNT; Quan; Quant; Quantitative; Random	4180186
40757536	Num units trans pooled cryoppt	4180186
40757536	输注混合冷沉淀单位:数量(计数):时间点:^血液制品单位:定量型	4182948
40757537	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Cryo; Cryoppt; Cryoprec; Gvn; Hematology; Heme; Number; Point in time; Pooled Cryoppt; QNT; Quan; Quant; Quantitative; Random	4180186
40757537	Pooled Cryoppt Gvn BPU	4180186
40757537	混合冷沉淀单位 给予的:数量(计数):时间点:^血液制品单位:定量型	4182948
40757538	Num units trans pooled FFP	4180186
40757538	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; FFP; Froz; Frozn; Num units trans pooled FFP; Number; Point in time; Pooled FFP; QNT; Quan; Quant; Quantitative; Random	4180186
40757538	输注混合新鲜冷冻血浆单位:数量(计数):时间点:^血液制品单位:定量型	4182948
40757539	Pooled FFP Gvn BPU	4180186
40757539	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; FFP; Froz; Frozn; Gvn; Number; Point in time; Pooled FFP; QNT; Quan; Quant; Quantitative; Random	4180186
40757539	混合新鲜冷冻血浆单位 给予的:数量(计数):时间点:^血液制品单位:定量型	4182948
40757541	Antiglob; Beta 1 C-globulin; BLOOD BANK; Comp; Complmt; DAGT; DAT; DAT C3-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; Spec	4180186
40757541	DAT C3-Sp Reag RBC Ql	4180186
40757541	直接抗球蛋白试验.补体 C3 特异性试剂:存在情况或阈值:时间点:红细胞:序数型	4182948
40757542	Rh Ig Gvn Ql	4180186
40757542	BLOOD BANK; D phenotyping; D typing; Finding; Findings; GLB; Glob; Glob%; Globul; Globulins; Gvn; Imm; Imun; Imune; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rh Ig; Rh phenotyping; Rh typing; RHIG; RhoGAM; Screen	4180186
40757542	Rh 血型免疫球蛋白 给予的:发现:时间点:^患者:序数型	4182948
40757544	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Leuc; Leuk; Leukocytes; Leukodepleted; Leukoreduced; Lkcs; LP; LP Platpheresis; Num units trans WBC-poor platpheresis; Number; pheresis; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
40757544	Num units trans WBC-poor platpheresis	4180186
40757544	输注贫白细胞机采血小板单位:数量(计数):时间点:^血液制品单位:定量型	4182948
40757545	LP Platpheresis Gvn BPU	4180186
40757545	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Gvn; Leuc; Leuk; Leukocytes; Leukodepleted; Leukoreduced; Lkcs; LP; LP Platpheresis; Number; pheresis; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
40757545	贫白细胞机采血小板单位 给予的:数量(计数):时间点:^血液制品单位:定量型	4182948
40757547	Blood; BLOOD BANK; D phenotyping; D typing; Fetal; Gyn; Gynecology; Hematology; Heme; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood	4180186
40757547	Rh Bld Fetus	4180186
40757547	Rh:类型:时间点:全血^胎儿:名义型	4182948
40757551	Frozen RBC NB Gvn BPU	4180186
40757551	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Discocytes; Erthrocyte; Erythrocyte; Froz; Frozen RBC; Frozen RBC NB; Frozn; Gvn; New born; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
40757551	冰冻红细胞新生儿单位 给予的:数量(计数):时间点:^血液制品单位:定量型	4182948
40757553	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Discocytes; Erthrocyte; Erythrocyte; Froz; Frozen RBC; Frozen RBC ped; Frozn; Gvn; Number; PEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
40757553	Frozen RBC ped Gvn BPU	4180186
40757553	冰冻红细胞儿科单位 给予的:数量(计数):时间点:^血液制品单位:定量型	4182948
40757554	Num 1/2 units trans platpheresis	4180186
40757554	1/2 Platpheresis; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Num 1/2 units trans platpheresis; Number; pheresis; Point in time; QNT; Quan; Quant; Quantitative; Random; Trans Platpheresis	4180186
40757554	输注采血小板半量单位:数量(计数):时间点:^血液制品单位:定量型	4182948
40757556	弱 D 抗原:存在情况或阈值:时间点:红细胞^胎儿:序数型	4182948
40757556	Antigen; Antigens; BLOOD BANK; Dextro; Erythrocytes; Fetal; Gyn; Gynecology; Hematology; Heme; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rhesus; Screen	4180186
40757556	Weak D Ag RBC Fetus Ql	4180186
40757557	FFP ped Gvn BPU	4180186
40757557	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; FFP; FFP ped; Froz; Frozn; Gvn; Number; PEDS; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40757557	新鲜冰冻血浆儿科单位 给予的:数量(计数):时间点:^血液制品单位:定量型	4182948
40757558	Trans NB units frozen RBC Vol Patient	4180186
40757558	BLOOD BANK; Discocytes; Erthrocyte; Erythrocyte; Froz; Frozen RBC; Frozen RBC NB; Frozn; New born; Num NB units trans frozen RBC; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Volume	4180186
40757558	输注冰冻红细胞新生儿单位:体积型属性:时间点:^患者:定量型	4182948
40757559	Frozen packed RBC Gvn Vol	4180186
40757559	BLOOD BANK; Discocytes; Erthrocyte; Erythrocyte; Froz; Frozen packed RBC; Frozn; Gvn; Packed RBC; Point in time; PRBC; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Volume	4180186
40757559	冰冻浓缩红细胞 给予的:体积型属性:时间点:^患者:定量型	4182948
40757560	5% PPF Gvn Vol	4180186
40757560	5% PPF; BLOOD BANK; Frac; Fract; Fractionation; Fractions; Gvn; Point in time; PPF; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
40757560	5% 血浆蛋白质成分 给予的:体积型属性:时间点:^患者:定量型	4182948
40757561	BLOOD BANK; Gvn; Platelet; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes; Volume	4180186
40757561	Pooled platelets Gvn Vol	4180186
40757561	混合血小板 给予的:体积型属性:时间点:^患者:定量型	4182948
40757562	BLOOD BANK; Cryo; Cryoppt; Cryoprec; Gvn; Hematology; Heme; Point in time; Pooled Cryoppt; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
40757562	Pooled Cryoppt Gvn Vol	4180186
40757562	混合冷沉淀 给予的:体积型属性:时间点:^患者:定量型	4182948
40757563	BLOOD BANK; FFP; Froz; Frozn; Gvn; Point in time; Pooled FFP; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
40757563	Pooled FFP Gvn Vol	4180186
40757563	混合新鲜冷冻血浆 给予的:体积型属性:时间点:^患者:定量型	4182948
40757565	LDL SerPl-sCnc	4180186
40757565	B; Chemistry; LDL; LDL particle concentration; LDL particle number; Level; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757565	脂蛋白.Beta.亚微颗粒:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757567	Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; Kidney; Mass Fraction; Nephrology; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Stn; Stone; Stones; Tot; Totl; UA; Urates; Uric acid	4180186
40757567	Urate dihyd MFr Stone	4180186
40757567	尿酸盐二水合物/总计:质量分数:时间点:结石:定量型	4182948
40757568	Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; Infared spectoscopy; IR; Kidney; Mass Fraction; Monosodium Urate; Na; Na Urate; Na+; NaU; Nephrology; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Stn; Stone; Stones; Tot; Totl; UA; Urates; Uric acid	4180186
40757568	Na Urate MFr Stone IR	4180186
40757568	尿酸钠/总计:质量分数:时间点:结石:定量型:红外光谱分析法	4182948
40757570	Ca; Ca Bilirub; Cal; Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; Kidney; Mass Fraction; Nephrology; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Stn; Stone; Stones; Tot; Totl	4180186
40757570	Ca Bilirub MFr Stone	4180186
40757570	胆红素钙/总计:质量分数:时间点:结石:定量型	4182948
40757571	Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; Kidney; Mass fraction; Nephrology; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Stn; Stone; Stones; Tot; Totl	4180186
40757571	Newberyite MFr Stone	4180186
40757571	镁磷石/总计:质量分数:时间点:结石:定量型	4182948
40757572	Chemistry; Finding; Findings; Lip; Lipoprot; Lipoproteins; LP; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40757572	脂蛋白目标:发现:时间点:^患者:序数型	4182948
40757573	Carn esters/C0 Ur-sRto	4180186
40757573	C0; Carn esters; Carnitine Free; Carnitine.total; Chemistry; Ester; FC; FR; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UR; Urn	4180186
40757573	肉碱酯类/肉碱.游离型 (C0):物质的量比率:时间点:尿液:定量型	4182948
40757574	ECV2 Ab Titr Ser	4180186
40757574	艾柯病毒 2 型 抗体:滴定度:时间点:血清:定量型	4182948
40757574	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; ECV; ECV2; EV; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40757575	ECV8 Ab Titr Ser	4180186
40757575	艾柯病毒 8 型 抗体:滴定度:时间点:血清:定量型	4182948
40757575	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; ECV; ECV8; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40757583	Ferning Cerv mucus Ql	4180186
40757583	Cerv mucus; Cervical mucus; FERTILITY TESTING; Genital tract; Ordinal; Pattern of crystallization; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40757583	蕨样结晶:存在情况或阈值:时间点:子宫颈粘液:序数型	4182948
40757585	Arsenic fractions Pnl; AS; DRUG/TOXICOLOGY; Drugs; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn	4180186
40757585	Arsenic fractions Pnl Ur	4180186
40757585	砷类成分组套:-:时间点:尿液:定量型	4182948
40757586	Antigen; Antigens; Arbitrary concentration; B dermat; B dermatitidis; B/F; BF; Blasto; Blastomycosis; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40757586	B dermat Ag Fld-aCnc	4180186
40757586	皮炎芽生菌 抗原:任意型浓度:时间点:体液:定量型	4182948
40757587	Urea reduction ratio SerPl	4180186
40757587	Chemistry; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; URR	4180186
40757587	尿素降低比率:物质的量分数:时间点:血清/血浆:定量型	4182948
40757588	Catalytic Concentration; Chemistry; Contrl; Control; norm cont; Normal; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPl^normal control; SerPlas; Serum; Serum or plasma; SR	4180186
40757588	Biotinidase SerPl Norm cont-cCnc	4180186
40757588	生物素化物酶:催化浓度:时间点:血清/血浆^正常对照:定量型	4182948
40757593	Blood; C3DC; C3-DC; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40757593	Malonylcarn DBS-sCnc	4180186
40757593	丙二酰肉碱 (C3-DC):物质的量浓度:时间点:全血.斑点:定量型	4182948
40757594	C3DC; C3-DC; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757594	Malonylcarn Ur-sCnc	4180186
40757594	丙二酰肉碱 (C3-DC):物质的量浓度:时间点:尿液:定量型	4182948
40757595	Alb; Albumin fraction; Albumin%; Chemistry; Diaf; Dialysate; Dialysis fluid; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Mass fraction; Percent; Point in time; PR; Prot; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP	4180186
40757595	Albumin MFr Dial fld Elph	4180186
40757595	白蛋白/蛋白质.总计:质量分数:时间点:透析液:定量型:电泳	4182948
40757599	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; HDLc; HDL-C; HDLc 2b; Heart Disease; High density lipoprotein cholesterols; Lipid; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCHHDL; Tot; Totl	4180186
40757599	HDLc 2b MFr SerPl Elph	4180186
40757599	胆固醇.HDL 2b 之中的/胆固醇.HDL 之中的.总计:质量分数:时间点:血清/血浆:定量型:电泳	4182948
40757606	Pimeloylcarn DBS-sCnc	4180186
40757606	Blood; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40757606	庚二酰肉碱 (C7-DC):物质的量浓度:时间点:全血.斑点:定量型	4182948
40757607	Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757607	Pimeloylcarn Ur-sCnc	4180186
40757607	庚二酰肉碱 (C7-DC):物质的量浓度:时间点:尿液:定量型	4182948
40757608	C16DC; C16-DC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hexadecanediolycarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; thapsoyl carnitine	4180186
40757608	Dicarboxypalmitoylcarn CSF-sCnc	4180186
40757608	二羧基棕榈酰肉碱 (C16-DC):物质的量浓度:时间点:脑脊液:定量型	4182948
40757612	C18DC; C18-DC; Chemistry; CR; Crea; Creat; Dicarboxy stearoyl carnitine; Dicarboxy stearoylcarnitine; Dicarboxylic carnitine; octadecanedioyl carnitine; octadecanedioylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757612	Dicarboxystearoylcarn/Creat Ur-sRto	4180186
40757612	二羧基硬脂酰肉碱 (C18-DC)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757614	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C18DC; C18-DC; Chemistry; Dicarboxy stearoyl carnitine; Dicarboxy stearoylcarnitine; Dicarboxylic carnitine; Level; octadecanedioyl carnitine; octadecanedioylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757614	Dicarboxystearoylcarn Amn-sCnc	4180186
40757614	二羧基硬脂酰肉碱 (C18-DC):物质的量浓度:时间点:羊水:定量型	4182948
40757615	Deprecated Dicarboxystearoylcarn Bld.Dot	4180186
40757615	Blood; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40757619	Chemistry; CR; Crea; Creat; Dicarboxylic carnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757619	Pimeloylcarn/Creat Ur-sRto	4180186
40757619	庚二酰肉碱 (C7-DC)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757620	Phosphoserine DBS-sCnc	4180186
40757620	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Point in time; PS; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40757620	磷酸丝氨酸:物质的量浓度:时间点:全血.斑点:定量型	4182948
40757624	Allantoine 24h Ur Elph-sRate	4180186
40757624	1 day; 24 hours; 24HR; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; QNT; Quan; Quant; Quantitative; sRate; Substance rate; UA; UR; Urn	4180186
40757624	尿囊素:物质的量速率:24小时:尿液:定量型:电泳	4182948
40757629	^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR; Substance concentration	4180186
40757629	Glucose sp7 p chal SerPl-sCnc	4180186
40757629	葡萄糖^在XXX刺激之后的第7个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757630	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR; Substance concentration	4180186
40757630	Glucose sp8 p chal SerPl-sCnc	4180186
40757630	葡萄糖^在XXX刺激之后的第8个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757633	Assessment/tracking type; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757634	Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757635	Point in time; Random; Survey; SURVEY.MDS	4180186
40757642	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757643	Pan; Panel; Panl; Past; Pnl; Survey; SURVEY.MDS	4180186
40757645	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey; Sx	4180186
40757646	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
40757647	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
40757648	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
40757653	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757657	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757659	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757664	Heart/circulation; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757666	GU; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757672	Pan; Panel; Panl; Pnl; Point in time; Psychiatric/mood disorder; Random; Survey; SURVEY.MDS	4180186
40757673	Pan; Panel; Panl; Pnl; Point in time; Pulm; Random; Survey; SURVEY.MDS	4180186
40757674	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757675	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757676	Add; Addl diagnoses; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757677	Add; Addl ICD Dx 1 in last 7D; Dx; i; Identity or presence; International Classification of Diseases; Nominal; Past; Survey; SURVEY.MDS	4180186
40757679	Add; Addl ICD Dx 3 in last 7D; Dx; Identity or presence; III; International Classification of Diseases; Nominal; Past; Survey; SURVEY.MDS	4180186
40757681	Add; Addl ICD Dx 5 in last 7D; Dx; Identity or presence; International Classification of Diseases; Nominal; Past; Survey; SURVEY.MDS	4180186
40757683	Add; Addl ICD Dx 7 in last 7D; Dx; Identity or presence; International Classification of Diseases; Nominal; Past; Survey; SURVEY.MDS	4180186
40757686	Add; Addl ICD Dx 10 in last 7D; Dx; Identity or presence; International Classification of Diseases; Nominal; Past; Survey; SURVEY.MDS	4180186
40757687	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757689	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
40757696	Deglutition; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS; Swallowing/nutritional status	4180186
40757699	Centers for Medicare and Medicaid Assessment; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757700	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757703	Integument; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757707	II; Pan; Panel; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; SURVEY.MDS	4180186
40757709	Pan; Panel; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; SURVEY.MDS	4180186
40757710	Pan; Panel; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; SURVEY.MDS	4180186
40757712	Facility provider #s	4180186
40757712	ADMIN; Facility provider #s; Pan; Panel; PANEL.ADMIN; Panl; Pnl; Point in time; Random	4180186
40757712	设施提供方编号:-:时间点:设施:-	4182948
40757713	MDS version 3; Nominal; Point in time; Random; Survey; SURVEY.MDS; Typ	4180186
40757715	Centers for Medicare and Medicaid Assessment; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Typ	4180186
40757718	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757719	ADMIN; ADMIN.PATIENT; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Translator	4180186
40757719	需要口译员:发现:时间点:^患者:序数型	4182948
40757720	Asympt; Asymptomatic; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Scn; Screen; Survey	4180186
40757721	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
40757722	Admin; MDS version 3; Nominal; Point in time; Random; Survey; SURVEY.MDS; Transferred; Typ	4180186
40757723	Centers for Medicare and Medicaid Assessment; Correctn; Point in time; Prev; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40757724	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40757726	Centers for Medicare and Medicaid Assessment; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Survey	4180186
40757727	Centers for Medicare and Medicaid Assessment; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40757728	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757730	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757731	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757733	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757735	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757736	BIMS; BIMS should be conducted; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757737	3; Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757738	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757740	Brief Interview for Mental Status; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757743	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757744	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757745	BIMS summary score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey	4180186
40757746	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Staff assessment for mental status should be conducted; Survey	4180186
40757749	MDS version 3; Memory/recall ability; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757752	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757754	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757755	Centers for Medicare and Medicaid Assessment; Decision-making; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757757	MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757764	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757766	14 days; 2 weeks; Mental health; MentalHealth; Pan; Panel; PANEL.SURVEY.CMS; Panl; Patient Health Questionnaire; PHQ9; Pnl; Psych; Psychiatry; Survey	4180186
40757767	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757768	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757769	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757771	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757772	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; Trouble falling or staying asleep, or sleeping too much.frequency	4180186
40757776	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757777	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757778	14 days; 2 weeks; Feeling bad about yourself - or that you are a failure or have let yourself or your family down.frequency; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757779	14 days; 2 weeks; Arterial Stenosis; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757781	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Othr; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757784	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757786	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757793	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757795	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757796	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757798	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757799	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; S prime; Screen; Survey	4180186
40757800	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; S prime; Screen; Survey	4180186
40757801	14 days; 2 weeks; Arterial Stenosis; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757802	14 days; 2 weeks; Arterial Stenosis; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757805	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; T prime	4180186
40757807	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757811	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757813	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey; Sx	4180186
40757814	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey; Sx	4180186
40757816	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; Sx	4180186
40757818	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
40757819	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
40757822	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757824	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757826	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757828	Activ; Actvty; Centers for Medicare and Medicaid Assessment; Finding; Findings; Movements; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757829	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757831	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757833	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757835	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757836	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757841	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757842	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757843	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757844	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757845	Activ; Actvty; Centers for Medicare and Medicaid Assessment; Finding; Findings; Movements; Nominal; Point in time; Random; Survey	4180186
40757846	Activ; Actvty; Centers for Medicare and Medicaid Assessment; Finding; Findings; Movements; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757847	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757848	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757850	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757851	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757853	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757854	Finding; Findings; Last; MDS version 3; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757855	Finding; Findings; MDS version 3; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757856	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757857	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757859	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757860	Arterial Stenosis; Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757861	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757862	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757863	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757868	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757871	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757872	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757876	bod; Bodies; Finding; Findings; Low; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757877	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757879	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757880	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757881	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757883	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757884	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Surf; Survey	4180186
40757885	Arm; Centers for Medicare and Medicaid Assessment; EXT; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rnge; Screen; Survey; UE; Up	4180186
40757886	Centers for Medicare and Medicaid Assessment; EXT; Finding; Findings; LE; Leg; Low; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rnge; Screen; Survey	4180186
40757889	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757890	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757893	Cath; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757895	Cath; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757900	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757902	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757906	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757907	Finding; Findings; MDS version 3; Ordinal; Othr; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757908	CAD; Dis; Diseases; Dz; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757909	DVT/pulmonary or pulmonary thrombo-embolism in last 7D; Finding; Findings; MDS version 3; Ordinal; Past; PE; PTE; Pulm; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757910	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757911	Finding; Findings; HTN; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757915	Dis; Diseases; Dz; Finding; Findings; Gastroesophageal reflux disease/ulcer in last 7D; GE; GERD; MDS version 3; Ordinal; Past; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; Ulcer	4180186
40757916	Dis; Diseases; Dz; Finding; Findings; IBD; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.MDS; Ulcerative colitis/Crohn's disease/inflammatory bowel disease in last 7D	4180186
40757917	BPH; Finding; Findings; MDS version 3; Ordinal; Past; Prost; Prostate; Prostati; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757918	Dis; Diseases; Dz; Finding; Findings; Kidney; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Renal insufficiency or renal failure/end-stage renal disease in last D; Screen; Survey; SURVEY.MDS	4180186
40757919	AIDS; Finding; Findings; Human immunodeficiency virus; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757920	c162; Celbenin; Dimethoxypenicillin; Finding; Findings; MDS version 3; Metacillin; Metin; MRSA; MRSA/VRE/C diff infections/colonization in last 30D; o71; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; S aureus; Screen; Staficyn; Staph; Staphicillin; Survey; SURVEY.MDS; VANC; Vancocin; Vancor; VRE; VRE screen	4180186
40757921	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757923	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; TB	4180186
40757926	DM; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757927	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757928	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757932	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757934	Finding; Findings; MDS version 3; Ordinal; Othr; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757935	Dis; Diseases; Dz; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.MDS	4180186
40757936	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757940	Finding; Findings; Hemiplegia/hemiparesis in last 7D; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757942	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757943	Finding; Findings; MDS version 3; MS; Mult; Multi; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757944	Dis; Diseases; Dz; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.MDS	4180186
40757946	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; TBI; Ulcer	4180186
40757947	Cal; Calories; Finding; Findings; MDS version 3; Ordinal; Past; PR; Prot; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757949	Finding; Findings; MDS version 3; Ordinal; Othr; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757950	Bipolar disease; Finding; Findings; MDS version 3; Ordinal; Othr; Past; QL; Qual; Qualitative; Screen; SCZ; Survey; SURVEY.MDS	4180186
40757955	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757956	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757957	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757958	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Received non-med pain intervention; Screen; Survey; SURVEY.MDS	4180186
40757959	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757960	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757961	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757962	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757964	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757966	5 days; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757968	5 days; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757973	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Resting; Screen; Survey; SURVEY.MDS	4180186
40757975	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; Sx	4180186
40757977	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757978	MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757985	# falls since admission or prior assessment; Centers for Medicare and Medicaid Assessment; No; Num; Num of falls; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
40757986	# falls since admission or prior assessment; # falls since admission or prior assessment - no injury; Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Num of falls; Number; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; Ulcer	4180186
40757987	# falls since admission or prior assessment; # falls since admission or prior assessment - injury except major; Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Num of falls; Number; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; Ulcer	4180186
40757989	Finding; Findings; Loss of liquids/solids from mouth when eating or drinking in last 7D; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757990	Finding; Findings; Holding food in mouth/cheeks or residual food in mouth after meals in last 7D; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757994	Centers for Medicare and Medicaid Assessment; Finding; Findings; month; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; Weight loss of 5% or more in the last month or loss of 10% or more in last 6 months; Wt	4180186
40757997	Exchange; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Replace; Screen; Survey; SURVEY.MDS	4180186
40758000	Fld; Flow; MDS version 3; QNT; Quan; Quant; Quantitative; Survey; SURVEY.MDS; Volume rate; vRate	4180186
40758001	Able to perform dent exam; Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758002	Broken or loosely fitting full or partial dtr in last 7D; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758008	Dent status - none of the above in last 7D; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758009	Finding; Findings; i; MDS version 3; Ordinal; Past; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; Ulcer	4180186
40758016	Finding; Findings; II; Injury; MDS version 3; Ordinal; Point in time; Pressure injuries; pressure injury; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.MDS	4180186
40758019	III; MDS version 3; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS	4180186
40758020	Date and time; III; MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS; Time stamp; Timestamp	4180186
40758021	Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758024	Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758025	Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758026	MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758027	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758032	Ascites; Ascitic fluid; Ascitis; Chemistry; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random	4180186
40758032	IgG Prt-mCnc	4180186
40758032	IgG:质量浓度:时间点:腹膜液:定量型	4182948
40758034	14 days; 2 weeks; Finding; Findings; Ordinal; Othr; Past; Patient Health Questionnaire; PHQ9; QL; Qual; Qualitative; S prime; Screen; Survey	4180186
40758035	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Norovirus 1; Norovirus G1; Norovirus GI; Norwalk virus; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40758035	Norovirus GI RNA Stl Ql NAA+probe	4180186
40758035	诺如病毒基因群 I RNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
40758036	2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Norovirus 2; Norovirus G2; Norovirus GII; Norwalk virus; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40758036	Norovirus GII RNA Stl Ql NAA+probe	4180186
40758036	诺如病毒基因群 II RNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
40758038	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758038	Cefminox Susc Islt	4180186
40758038	头孢米诺:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758039	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Culex mosquito; Immune globulin E; Immunoglobulin E; Mosquito; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758039	Culex mosquito IgE Qn	4180186
40758039	尖音库蚊 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758040	dsDNA Ab Ser IF-aCnc	4180186
40758040	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Arbitrary concentration; Autoantibodies; Autoantibody; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Native DNA; N-DNA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Stranded; Strnd; Time Resolved Fluorescence; TRF	4180186
40758040	双链 DNA 抗体:任意型浓度:时间点:血清:定量型:免疫荧光法	4182948
40758042	Fosfomycin IgE Qn	4180186
40758042	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c375; Fosfomycine; Fosomin; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758042	磷霉素 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758044	Antigen; Antigens; Arbitrary concentration; EIA; ELFA; ELISA; Enzyme immunoassay; HCV; HCV core; HCV core Ag; Hep; Hep C; Hepatis; Hepatit; Hepatology; IAA; ID; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
40758044	HCV core Ag Ser IA-aCnc	4180186
40758044	丙型肝炎病毒核心 抗原:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40758045	Iroko IgE Qn	4180186
40758045	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Iroko; Milicia excelsa; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758045	大绿柄桑 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758047	Chemistry; k208; Level; Lysozymes; Mass concentration; Muramidase; N-Acetylmuramide Glycanhydrolase; nGal d 4 Lysozyme, Egg; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Rk208; thoracentesis fluid	4180186
40758047	Lysozyme Plr-mCnc	4180186
40758047	溶菌酶:质量浓度:时间点:胸膜液:定量型	4182948
40758048	Ma+Ta Ab Ser IA-aCnc	4180186
40758048	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MA1; MA-1; Ma2; MATA; MEIA; Paraneoplastic Ag Ma 1; Paraneoplastic syndrome; PNMA1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40758048	Ma+Ta 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40758050	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hopper ant; Immune globulin E; Immunoglobulin E; Jack jumper ant; Jumper ant; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758050	Jumper ant IgE Qn	4180186
40758050	多毛蜜蚁 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758051	ABS; Aby; ANNA 2; ANNA-2; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Hu; Hu2; IAA; II; MEIA; Neuro; Neurology; Neuronal nuclear type II; Nuc; Paraneoplastic syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; RI; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40758051	Hu2 Ab CSF IA-aCnc	4180186
40758051	神经元细胞核 2 型 抗体:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40758053	Propyphenazone IgE Qn	4180186
40758053	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Budiro; C58; Causyth; Cibalgina; Eufibron; Immune globulin E; Immunoglobulin E; Isoprochin; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758053	异丙安替比林 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758054	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Neuro; Neurology; Paraneoplastic syndrome; PCA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Yo autoantibody	4180186
40758054	Purkinje Cells Ab CSF IA-aCnc	4180186
40758054	浦肯雅细胞 抗体:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40758055	DRUG/TOXICOLOGY; Drugs; Ejaculate; Genitourinary; GU; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SE; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
40758055	Selenium Smn-mCnc	4180186
40758055	硒:质量浓度:时间点:精液:定量型	4182948
40758058	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tindamax	4180186
40758058	Tinidazole Susc Islt	4180186
40758058	替硝唑:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758060	Fava bean IgE Qn	4180186
40758060	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bell bean; Broad bean; Fava bean; Field bean; Horse bean; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tic bean	4180186
40758060	蚕豆 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758061	Isovaleryl+MeButyrylcarn/Creat Ur-sRto	4180186
40758061	C5; Chemistry; CR; Crea; Creat; Isovaleryl+MeButyrylcarn; Isovaleryl-2-Methylbutyrylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40758061	异戊酰肉碱+甲基丁酰肉碱 (C5)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40758063	Abrine Ur-mCnc	4180186
40758063	Abrin; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758063	相思豆碱:质量浓度:时间点:尿液:定量型	4182948
40758064	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758064	Ricinine Ur-mCnc	4180186
40758064	蓖麻碱:质量浓度:时间点:尿液:定量型	4182948
40758066	CCl4; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tetrachloromethane	4180186
40758066	Carbon Tet SerPl-mCnc	4180186
40758066	四氯化碳:质量浓度:时间点:血清/血浆:定量型	4182948
40758070	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758070	Styrene SerPl-mCnc	4180186
40758070	苯乙烯:质量浓度:时间点:血清/血浆:定量型	4182948
40758071	Tungsten Ur-mCnc	4180186
40758071	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; W	4180186
40758071	钨:质量浓度:时间点:尿液:定量型	4182948
40758073	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MDEA; Methyl diethanolamine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758073	N-methyldiethanolamine Ur-mCnc	4180186
40758073	N-甲基二乙醇胺:质量浓度:时间点:尿液:定量型	4182948
40758075	Monochloroacetate Ur-mCnc	4180186
40758075	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Monochloroacetic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758075	氯乙酸:质量浓度:时间点:尿液:定量型	4182948
40758077	Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758088	Centers for Medicare and Medicaid Assessment; Cnt; Count; II; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758090	Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758094	Finding; Findings; Low; Lower extremity; MDS version 3; Ordinal; Othr; Past; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.MDS	4180186
40758097	Finding; Findings; MDS version 3; Ordinal; Othr; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.MDS	4180186
40758099	Finding; Findings; Integument; MDS version 3; Ordinal; Other ulcers, wounds and skin problems; Othr; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758100	# venous and arterial ulcers in last 7D; Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
40758101	Integument; Pan; Panel; Panl; Past; Pnl; pressure injury; Pressure ulcer; Pressure Ulcers; Skin and ulcer Txs in last 7D; Survey; SURVEY.MDS; Tx; Txs; Ulcer	4180186
40758102	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Reduc; Screen; Survey; SURVEY.MDS	4180186
40758103	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Reduc; Screen; Survey; SURVEY.MDS	4180186
40758104	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; Turning/repositioning provided in last 7D	4180186
40758105	Finding; Findings; Integument; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758107	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Surg; Survey; SURVEY.MDS	4180186
40758108	Application of nonsurgical dressings (with or W/O topical medications) other than to feet provided in last 7D; Finding; Findings; MDS version 3; Ordinal; Othr; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758109	Applications of ointments/medications other than to feet provided in last 7D; Finding; Findings; MDS version 3; Ordinal; Othr; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758110	Application of dressings to feet (with or W/O topical medications) provided in last 7D; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758111	Finding; Findings; Integument; MDS version 3; Ordinal; Past; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Screen; Skin and ulcer Txs - none of above provided in last 7D; Survey; SURVEY.MDS; Tx; Txs; Ulcer	4180186
40758112	# days injectable medications received in last 7D or since admission/reentry if less than 7D; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
40758113	Medications received in last 7D or since admission/reentry if less than 7D; Pan; Panel; Panl; Past; Pnl; Survey; SURVEY.MDS	4180186
40758116	Antidepressant received in last 7D or since admission/reentry if less than 7D; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758118	Anticoag; Anticoagulant received in last 7D or since admission/reentry if less than 7D; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758120	Pan; Panel; Panl; Pnl; Point in time; Random; Special Txs and procedures; Survey; SURVEY.MDS; Tx; Txs	4180186
40758123	Chemo; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758124	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758125	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758126	Finding; Findings; MDS version 3; O2; O2 therapy; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; tO2	4180186
40758128	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758131	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758132	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758133	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758134	BIPAP/CPAP machine in last 14D - while not a resident; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758136	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758138	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758140	Dialy; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758144	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758148	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758149	Centers for Medicare and Medicaid Assessment; Finding; Findings; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40758150	Centers for Medicare and Medicaid Assessment; Finding; Findings; FLUV; Influ; Nominal; Point in time; Random; Survey	4180186
40758154	Pan; Panel; Panl; Past; Pnl; Survey; SURVEY.MDS	4180186
40758155	Centers for Medicare and Medicaid Assessment; Path; Point in time; QNT; Quan; Quant; Quantitative; Random; Speech-language pathology and audiology services; Started; Survey	4180186
40758156	Centers for Medicare and Medicaid Assessment; Path; Point in time; QNT; Quan; Quant; Quantitative; Random; Speech-language pathology and audiology services; Survey	4180186
40758157	Centers for Medicare and Medicaid Assessment; OT; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Survey	4180186
40758160	Centers for Medicare and Medicaid Assessment; Point in time; PT; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758161	MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Survey; SURVEY.MDS	4180186
40758163	Date and time; Emotional stability; MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Survey; SURVEY.MDS; Time stamp; Timestamp	4180186
40758164	Date and time; Emotional stability; MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS; Time stamp; Timestamp	4180186
40758165	Centers for Medicare and Medicaid Assessment; Past; QNT; Quan; Quant; Quantitative; Survey; Tot; Totl	4180186
40758168	Date and time; MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS; Time stamp; Timestamp	4180186
40758170	# days physician examined the patient in last 14D; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
40758171	# days physician orders changed in last 14D; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
40758172	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758173	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758176	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758183	Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40758185	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758186	Centers for Medicare and Medicaid Assessment; Pan; Panel; Panl; Pnl; Point in time; Random; S prime; Survey; SURVEY.MDS	4180186
40758188	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; S prime; Source of info; Srce; Survey; Typ	4180186
40758190	Point in time; Random; Survey; SURVEY.MDS	4180186
40758192	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Therapy evals completed	4180186
40758193	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758194	Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40758198	Nominal; Point in time; Random; Resource Utilization Groups; Survey; Typ	4180186
40758201	Nominal; Point in time; Random; Resource Utilization Groups; Survey; Typ	4180186
40758202	Nominal; Point in time; Random; Resource Utilization Groups; Survey; Typ	4180186
40758203	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; Typ; Ulcer	4180186
40758205	Ident; Identifier; Nominal; Point in time; Random; Survey; SURVEY.MDS	4180186
40758206	MDS version 3; Nominal; Point in time; Random; Survey; SURVEY.MDS; Typ	4180186
40758208	Ident; Identifier; Intradermal; Nominal; Point in time; Random; Survey; SURVEY.MDS	4180186
40758210	Ident; Identifier; Nominal; Point in time; Random; Survey; SURVEY.MDS	4180186
40758212	MDS version 3; Nominal; Point in time; Random; Survey; SURVEY.MDS; Typ	4180186
40758213	Nominal; Point in time; Random; Survey; SURVEY.MDS; Typ	4180186
40758214	Other special Txs and programs in last 14D; Othr; Pan; Panel; Panl; Past; Pnl; Point in time; Random; Special Txs and programs in last 14D; Survey; SURVEY.MDS; Tx; Txs	4180186
40758215	Pan; Panel; Panl; Past; Pnl; Point in time; Random; Respiratory Txs in last 14D; Survey; SURVEY.MDS; Tx; Txs	4180186
40758216	Cancer Txs in last 14D; Pan; Panel; Panl; Past; Pnl; Point in time; Random; Survey; SURVEY.MDS; Tx; Txs	4180186
40758217	No; Num; Pan; Panel; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; SURVEY.MDS	4180186
40758218	Pan; Panel; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; SURVEY.MDS; Ulcer	4180186
40758220	CD3-CD56+ Cells NFr Bld	4180186
40758220	Blood; CD3 Cells; CD3+CD56+ Cells; CD3-CD56+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; Leu19; Leu-19; Leu4; Leu-4; Natural killer cells; NCAM; Neural cell adhesion molecule; NKH1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood	4180186
40758220	细胞.CD3-CD56+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40758224	MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758227	C&S; Cult; Cultures; HPIV; HPIV1; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PI1; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40758227	HPIV1 Spec Ql Cult	4180186
40758227	副流感病毒 1 型:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
40758229	C&S; Cult; Cultures; HPIV; HPIV3; Human respirovirus 3; ID; III; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PI3; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40758229	HPIV3 Spec Ql Cult	4180186
40758229	副流感病毒 3 型:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
40758230	C&S; Cult; Cultures; HRSV; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; RSV; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40758230	RSV Spec Ql Cult	4180186
40758230	呼吸道合胞病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
40758231	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Lung; Microbiology; Misc; Miscellaneous; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Pulmonary; Pulmonology; Random; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory path Pnl; Respiratory virus panel; Respiratory viruses panel; RVP; Spec; To be specified in another part of the message; Unspecified	4180186
40758231	Respiratory path Pnl Spec Cult	4180186
40758231	呼吸道病原体类组套:-:时间点:XXX:-:微生物特异性培养	4182948
40758234	Operative note planned procedure	4180186
40758234	Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H+P; H+P.SURGICAL PROCEDURES; Narrative; notes; Operative note; Operative note planned procedure; P prime; Point in time; Random; Report; Surg; Visit note	4180186
40758234	外科手术记录 计划内操作:发现:时间点:^患者:叙述型	4182948
40758239	Complications Doc	4180186
40758239	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40758239	并发症:发现:时间点:^患者:文档型	4182948
40758240	Conclusions Imp Doc	4180186
40758240	DOC.MISC; Document; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MISC; Point in time; Random	4180186
40758240	结论:印象:时间点:^患者:文档型	4182948
40758241	Current imaging proc desc Doc	4180186
40758241	Current imaging proc desc; Description; DOC.MISC; Document; MISC; Point in time; Random	4180186
40758241	当前成像操作描述:描述:时间点:^患者:文档型	4182948
40758245	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40758245	Requested imaging studies info Doc	4180186
40758245	已申请成像检查信息:发现:时间点:^患者:文档型	4182948
40758248	CEH trace metals Pnl Ur-mCnc	4180186
40758248	CEH trace metals Pnl; Centers for Environmental Health; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Metal; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn	4180186
40758248	CEH 痕量金属元素组套:质量浓度:时间点:尿液:-	4182948
40758249	CEH N2 mustard metab Pnl Ur-mCnc	4180186
40758249	Brassica/Sinapis spp; CEH N2 mustard metab Pnl; Centers for Environmental Health; DRUG/TOXICOLOGY; Drugs; f089; f89; Level; Mass concentration; Metab; Metabolites; Metb; N; N2; Nit; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn	4180186
40758249	CEH 氮芥代谢产物组套:质量浓度:时间点:尿液:-	4182948
40758252	DOC.MISC; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; MISC; Narrative; notes; Operative note; Operative note implants; Point in time; Random; Report; Surg; Visit note	4180186
40758252	Operative note implants	4180186
40758252	外科手术记录 植入物:发现:时间点:^患者:叙述型	4182948
40758254	Centers for Medicare and Medicaid Assessment; Cnt; Count; II; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758256	Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758257	# unhealed stage 2 ulcers known to be present for more than 1 month; Cnt; Count; i; II; MDS version 3; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS	4180186
40758259	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758260	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758262	# days of rehabilitative or restorative training and skill practice; Dextro; No; Num; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758264	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV NA; FLUV; Fowl plague; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NA; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40758264	FLUAV NA RNA Islt NAA+probe	4180186
40758264	流感病毒 A 型神经氨酸酶 RNA:存在与否或特征标识:时间点:分离株:名义型:探针法.基因扩增.靶向	4182948
40758265	ABL; ALL; BCR/ABL1 kinase domain; BCR1; Blood; Breakpoint cluster region; Chronic myeloid leukemia; CML; D22S11; D22S662; Genetics; Hematology; Heme; Heredity; Heritable; Identity or presence; Inherited; JTK7; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; p150; PCR; PHL; Point in time; Random; Tissue; Tissue, unspecified; v-abl Abelson murine leukemia viral oncogene homolog 1; WB; Whole blood; Whole blood or Tissue	4180186
40758265	BCR/ABL1 kinase domain Mut Anl Bld/T	4180186
40758265	BCR-ABL1 激酶结构域 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40758266	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; PCN; Pen; Penicillin Parenteral; Penicilloyl; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Wycillin	4180186
40758266	Penicillin Parenteral Islt MIC	4180186
40758266	青霉素.胃肠外:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758268	17-Hydroxycorticosterone; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hydrocortisone; Level; Mass concentration; p Dex; p Dex overnight; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758268	Cortis p Dex overnight SerPl-mCnc	4180186
40758268	皮质醇^在剂量地塞米松口服过夜之后:质量浓度:时间点:血清/血浆:定量型	4182948
40758270	AE; Pan; PANEL.VACCIN; Panl; Pnl; Point in time; Random; VAERS Pnl	4180186
40758270	VAERS Pnl	4180186
40758270	疫苗不良事件报告系统:-:时间点:^患者:-	4182948
40758271	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chronic Urticaria Index; CU Index; Fc epsilon R1; Fce; FceRI; High affinity IgE receptor; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
40758271	Fc epsilon RI + RII Ab Ser-aCnc	4180186
40758271	Fc Epsilon 受体 I 型 + II 型 抗体:任意型浓度:时间点:血清:定量型	4182948
40758273	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CA; Calif; CSGV; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40758273	CSGV RNA Spec Ql NAA+probe	4180186
40758273	加利福尼亚血清群病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40758274	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; POWV; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40758274	POWV RNA Spec Ql NAA+probe	4180186
40758274	Powassan 病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40758276	Blood; Document; Familial LQTS; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40758276	Familial LQTS Mut Anl Bld/T	4180186
40758276	家族性长QT间期综合征基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40758278	ABL; ALL; Arbitrary; BCR1; Blood; Breakpoint cluster region; Chronic myeloid leukemia; CML; D22S11; D22S662; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; JTK7; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Ordinal; p150; PCR; PHL; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; Tissue; Tissue, unspecified; translocation; v-abl Abelson murine leukemia viral oncogene homolog 1; WB; Whole blood; Whole blood or Tissue	4180186
40758278	Deprecated Bld/T Ql	4180186
40758280	嗜吞噬球无形体抗体.IgG 与 IgM 组套:-:时间点:血清:序数型	4182948
40758280	A phagocytoph IgG+IgM Pnl; E equi; E phagocytophila; Ehrlichia equi; Ehrlichia phagocytophila; HGE; Human granulocytic ehrlichiosis; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40758280	A phagocytoph IgG+IgM Pnl Ser	4180186
40758281	Activ; Actvty; Aldosterone + RA + ARR Pnl; Angiotensin forming enzyme; Angiotensinogenase; Chemistry; Endocrine; Endocrinology; Movements; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders	4180186
40758281	Aldosterone + RA + ARR Pnl Plas	4180186
40758281	醛固酮与肾素活性组套:-:时间点:血浆:定量型	4182948
40758284	AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c301; Etambol; Ethamb; ID; Inagen; Infectious Disease; InfectiousDisease; Islt; Isol; Myambutol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mycobutol; Olbutam; Point in time; Random; RIF; Rifadin; Rifampicin; Rimactane; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40758284	Ethambutol+rifAMPin Islt SlowMyco	4180186
40758284	乙胺丁醇+利福平:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40758287	9-Hydroxy risperidone; 9-Hydroxy-risperidone; 9-OH-Risperidone; 9OH-risperidone; DRUG/TOXICOLOGY; Drugs; Invega; Paliperidone; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Risperidal; Risperidone metabolite; risperiDONE+9OH-Ris; risperiDONE+9OH-Ris Pnl; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758287	risperiDONE+9OH-Ris Pnl SerPl	4180186
40758287	利培酮与9-羟基利培酮组套:-:时间点:血清/血浆:定量型	4182948
40758288	AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis; Tygacil; Tygecycline	4180186
40758288	Tigecycline Islt SlowMyco	4180186
40758288	替加环素:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40758289	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UDC; UDCA; Ursodeoxycholic acid; Ursodiol	4180186
40758289	Ursodeoxycholate SerPl-sCnc	4180186
40758289	熊去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758291	B pert; B pert IgA+IgG Pnl; B pertussis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pertussis; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; Whooping cough	4180186
40758291	B pert IgA+IgG Pnl Ser IA	4180186
40758291	百日咳博德特菌抗体.IgA 与 IgG 组套:-:时间点:血清:定量型:免疫测定法	4182948
40758292	HTLV I+II 抗体组套:-:时间点:血清:-	4182948
40758292	2; HTLV I+II Ab Pnl; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; ID; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR	4180186
40758292	HTLV I+II Ab Pnl Ser	4180186
40758295	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Echinococcosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; p2; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR	4180186
40758295	Echinococcus IgG4 Ser Ql	4180186
40758295	棘球属单个未知种 抗体.IgG4:存在情况或阈值:时间点:血清:序数型	4182948
40758296	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hep; Hep G; Hepatis; Hepatit; HGV; HGV E2; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40758296	HGV E2 Ab Ser Ql	4180186
40758296	庚型肝炎病毒 E2 抗体:存在情况或阈值:时间点:血清:序数型	4182948
40758299	DEEDS 1.0	4180186
40758299	DEEDS; DEEDS 1.0; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
40758299	急诊科系统数据元 发布版本 1.0:-:时间点:^患者:-	4182948
40758303	Data Elements for Emergency Department Systems; DEEDS; Dx; ED dispo & Dx data; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
40758303	ED dispo & Dx data DEEDS	4180186
40758303	急诊科处置与诊断数据:-:时间点:^患者:集合型:DEEDS	4182948
40758305	Data Elements for Emergency Department Systems; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Facility & Practitioner ID data; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
40758305	Facility & Practitioner ID data DEEDS	4180186
40758305	设施与执业人员标识数据:-:时间点:^患者:集合型:DEEDS	4182948
40758308	Ca; Ca Phos; Ca Phos Cry; Cal; CAP; Crys; Cryst; Crystal; i Phos; Inorganic phosphate; LM; Micro; Micros; Microscopic; Misc; Miscellaneous; Ordinal; Other; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; URINALYSIS	4180186
40758308	Ca Phos Cry Spec Ql Micro	4180186
40758308	磷酸钙结晶:存在情况或阈值:时间点:XXX:序数型:显微镜检查.光学	4182948
40758309	Crys; Cryst; Crystal; LM; Micro; Micros; Microscopic; Misc; Miscellaneous; Monosodium Urate; Na; Na Urate; Na Urate Cry; Na+; NaU; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; UA; Unspecified; Urates; Uric acid; URINALYSIS	4180186
40758309	Na Urate Cry Spec Ql Micro	4180186
40758309	尿酸钠结晶:存在情况或阈值:时间点:XXX:序数型:显微镜检查.光学	4182948
40758310	Chemistry; Endometrial cancer; Gyn; Gynecology; HE4; Level; OB; ObGyn; Obstetrics; Ovarian cancer; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker; UniversalLabOrders; WAP four-disulfide core domain protein 2	4180186
40758310	HE4 SerPl-sCnc	4180186
40758310	人附睾蛋白 4:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758311	Misc; Miscellaneous; Other; Pan; PANEL.SURVEY.QRDA; Panl; Pnl; Point in time; QRDA; QRDA Pnl; Random; Spec; Survey; SURVEY.QRDA; To be specified in another part of the message; Unspecified	4180186
40758314	Document; Finding; Findings; Point in time; QRDA; QRDA calculated summary; Random; Survey; SURVEY.QRDA	4180186
40758315	Document; Finding; Findings; Misc; Miscellaneous; Other; Point in time; Random; Spec; Survey; SURVEY.QRDA; To be specified in another part of the message; Unspecified	4180186
40758316	Document; Finding; Findings; Misc; Miscellaneous; Other; Point in time; Random; Spec; Survey; SURVEY.QRDA; To be specified in another part of the message; Unspecified	4180186
40758318	Document; Finding; Findings; Misc; Miscellaneous; Other; Point in time; Random; Spec; Survey; SURVEY.QRDA; To be specified in another part of the message; Unspecified	4180186
40758319	ANTIBIOTIC SUSCEPTIBILITIES; AST; Claforan; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Islt.mening; Isol; KB; Kirby-bauer; Mening; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758319	Cefotaxime Islt.mening KB	4180186
40758319	头孢噻肟:抗生素敏感性:时间点:分离株.脑膜炎:定量型或序数型:琼脂扩散法	4182948
40758320	ANTIBIOTIC SUSCEPTIBILITIES; AST; c9; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Islt.mening; Isol; KB; Kirby-bauer; Mening; Point in time; Random; Rocephin; ROCJ; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758320	cefTRIAXone Islt.mening KB	4180186
40758320	头孢三嗪:抗生素敏感性:时间点:分离株.脑膜炎:定量型或序数型:琼脂扩散法	4182948
40758326	BLOOD BANK; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tx	4180186
40758326	Transfusion status Patient Ql	4180186
40758326	输血状态:发现:时间点:^患者:序数型	4182948
40758327	接合性:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40758327	Blood; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; Multiple Births; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; Twin zygosity; WB; Whole blood; Whole blood or Tissue	4180186
40758327	Zygosity Bld/T	4180186
40758328	Blood; Cell; Cellularity; Cnt; Count; Molecular pathology; MOLPATH; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Tot; Totl; WB; Whole blood; Whole blood or Tissue	4180186
40758328	Cells karyotyped.total Bld/T	4180186
40758328	已分析核型的细胞.总计:数量(计数):时间点:全血/组织:定量型	4182948
40758329	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Carnitine.total; Chemistry; Fl; Fld; FLU; Fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40758329	Carnitine Fld-sCnc	4180186
40758329	肉碱:物质的量浓度:时间点:体液:定量型	4182948
40758332	5M p NP; Activated partial thromboplastin time; After; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Contrl; Control; Fac; Fact; Hematology; Heme; Little(A)PTT; Mixing studies; Normal; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
40758332	aPTT 5M p NP Cont PPP	4180186
40758332	表面诱导型凝血过程.因子替换^在添加正常血浆后孵育之后5分钟:时间:时间点:贫血小板血浆^对照:定量型:凝血功能分析	4182948
40758335	Blood; HEMATOLOGY/CELL COUNTS; Percent; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte; Thrombocytes; Volfr; Volume fraction; WB; Whole blood	4180186
40758335	Deprecated Platelet mass VFr Bld	4180186
40758336	Blood; Genetic; Genetic analysis discrete result Pnl; Genetics; Genomic; Heredity; Heritable; HL7.GENETICS; Inherited; Molecular genetics; MOLPATH.GENERAL; Pan; PANEL.HL7.GENETICS; Panl; PCR; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40758336	Genetic analysis discrete result Pnl	4180186
40758336	遗传分析离散结果组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
40758338	Date and time of most recent arrival US	4180186
40758338	Date and time; Date and time of most recent arrival US; Date+time; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; S prime; Time stamp; Timestamp	4180186
40758338	最近到达美国的日期和时间:时间戳:时间点:^患者:定量型	4182948
40758344	Cnt; Count; No; Num; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Tot; Total # of lifetime sex partners; Totl	4180186
40758344	Total # of lifetime sex partners	4180186
40758344	一生性伴侣总数:数量(计数):时间点:^患者:定量型	4182948
40758345	Assault involving Bld or semen; Finding; Findings; Nominal; Persons; Point in time; Public Health; PUBLICHEALTH; Random	4180186
40758345	Assault involving Bld or semen	4180186
40758345	涉及到血液或精液的对于暴露人员的身体伤害:发现:时间点:^患者:名义型	4182948
40758346	Finding; Findings; NDL; Nominal; Othr; Point in time; Public Health; PUBLICHEALTH; Random; Stick/puncture w Bld contam object	4180186
40758346	Stick/puncture w Bld contam object	4180186
40758346	采用污染有血液的针或其他的物体捅或者刺:发现:时间点:^患者:名义型	4182948
40758348	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758348	Antioxidants SerPl-sCnc	4180186
40758348	抗氧化剂:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758350	Carbohydrates Stl Ql	4180186
40758350	Bowel movement; Carbohydrate; Chemistry; Faecal; Faeces; Fecal; Feces; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal	4180186
40758350	碳水化合物:存在情况或阈值:时间点:大便:序数型	4182948
40758351	AFB stain; Aspirate; Auramine stain; Auramine-Rhodamine stain; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Rhodamine-auramine Stn; St; Stains; Stn	4180186
40758351	Rhodamine-auramine Stn Aspirate	4180186
40758351	显微镜观察:存在与否或特征标识:时间点:吸出物:名义型:罗丹明-金胺荧光色素染色法	4182948
40758352	ABS; Aby; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; M tb; M tb A60; M tuberculosis; MEIA; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; TB; Tuberculosis	4180186
40758352	M tb A60 IgM Ser Ql IA	4180186
40758352	结核分枝杆菌 A60 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40758353	ABS; Aby; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; M tb; M tb A60; M tuberculosis; MEIA; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; TB; Tuberculosis	4180186
40758353	M tb A60 Ab Ser Ql IA	4180186
40758353	结核分枝杆菌 A60 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40758356	Sapeli IgE Qn	4180186
40758356	Aboudikro; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Sapele; Sapeli; Sapely; Serum; SR	4180186
40758356	筒状非洲楝木 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758359	免疫表型分型检查:发现:时间点:全血/组织:文档型:免疫表现型分型	4182948
40758359	Blood; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Study report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40758360	Blood; Chemistry; Elect; Electr; Electrolyte; Lytes; Lytes Pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood	4180186
40758360	Lytes Pnl Bld	4180186
40758360	电解质组套:-:时间点:全血:定量型	4182948
40758362	Blood; Genetic; Genetic analysis master Pnl; Genetics; Genomic; Heredity; Heritable; HL7.GENETICS; Inherited; Molecular genetics; MOLPATH.GENERAL; Pan; PANEL.HL7.GENETICS; Panl; PCR; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40758362	Genetic analysis master Pnl	4180186
40758362	遗传分析主组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
40758363	Alfa; Alpha thalassemia gene Pnl; Blood; Molecular genetics; Molecular pathology; MOLPATH; Pan; Panel.molpath; Panl; PCR; Pnl; Point in time; Random; WB; Whole blood	4180186
40758363	Alpha thalassemia gene Pnl Bld	4180186
40758363	Alpha 地中海贫血基因组套:-:时间点:全血:-:分子遗传学类实验室方法	4182948
40758368	Beta globulin gene; Beta thalessemia; beta-globin; Blood; CD113t-C; Genetics; HB Tak; HBB c.441_442insAC; Hemoglobin beta chain; Hemoglobin S gene; hemoglobin, beta; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sickle cell anemia; WB; Whole blood	4180186
40758368	HBB c.441_442insAC Bld Ql	4180186
40758368	HBB 基因.c.441_442insAC:存在情况或阈值:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758370	Beta globulin gene; Beta thalessemia; beta-globin; Blood; c.G19A; CD113t-C; Genetics; Glu7Lys; HB C; HBB c.19G&gt;A; Hemoglobin beta chain; Hemoglobin S gene; hemoglobin, beta; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs33930165; Screen; Sickle cell anemia; WB; Whole blood	4180186
40758370	HBB c.19G>A Bld Ql	4180186
40758370	HBB 基因.c.19G>A:存在情况或阈值:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758371	A20T; Beta globulin gene; Beta thalessemia; beta-globin; Blood; CD113t-C; Genetics; Glu7Val; HB S; HBB c.20A&gt;T; Hemoglobin beta chain; Hemoglobin S gene; hemoglobin, beta; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs77121243; Screen; Sickle cell anemia; T prime; WB; Whole blood	4180186
40758371	HBB c.20A>T Bld Ql	4180186
40758371	HBB 基因.c.20A>T:存在情况或阈值:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758372	Beta globulin gene; Beta thalessemia; beta-globin; Blood; c.G364C; CD113t-C; Genetics; Glu122Lys; HB D Punjab; HB D-Chicago; HB D-North Carolina; HB D-Portugal; HB Oak Ridge; HBB c.364G&gt;C; Hemoglobin beta chain; Hemoglobin S gene; hemoglobin, beta; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs33946267; Screen; Sickle cell anemia; WB; Whole blood	4180186
40758372	HBB c.364G>C Bld Ql	4180186
40758372	HBB 基因.c.364G>C:存在情况或阈值:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758374	Asp74Tyr; Beta globulin gene; Beta thalessemia; beta-globin; Blood; c.G220A; CD113t-C; Genetics; HB G-Accra; HB Korle-Bu; HBB c.220G&gt;A; Hemoglobin beta chain; Hemoglobin S gene; hemoglobin, beta; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs33945705; Screen; Sickle cell anemia; WB; Whole blood	4180186
40758374	HBB c.220G>A Bld Ql	4180186
40758374	HBB 基因.c.220G>A:存在情况或阈值:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758377	BETA E THALASSEMIA; Beta globulin gene; Beta thalessemia; beta-globin; BETA-PLUS-THALASSEMIA; Blood; CD113t-C; G79A; Genetics; Glu27Lys; HB E; HBB c.79G&gt;A; Hemoglobin beta chain; Hemoglobin S gene; hemoglobin, beta; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs33950507; Screen; Sickle cell anemia; WB; Whole blood	4180186
40758377	HBB c.79G>A Bld Ql	4180186
40758377	HBB 基因.c.79G>A:存在情况或阈值:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758378	HBA2 SEA Del Bld Ql	4180186
40758378	Alpha thal; Alpha thal 1; Alpha thal 1 (--SEA deletion type); Alpha thalassemia; alpha-2 globin; Arbitrary; Blood; Del; Deletions; HBA2 SEA; HBA-T2; HBH; Hemoglobin, alpha 2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40758378	HBA2 基因 SEA 缺失:任意型:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758379	Alfa; Alpha thal; Alpha thal 1; Alpha thal 1 (--THAI, --FIL, MED, alpha 20.5 deletions); Alpha thalassemia; alpha-2 globin; Arbitrary; Blood; Del; Deletions; HBA2 THAI+FIL+MED+alpha 20.5; HBA-T2; HBH; Hemoglobin, alpha 2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40758379	HBA2 THAI+FIL+MED+alpha 20.5 Del Bld Ql	4180186
40758379	HBA2 基因 THAI+FIL+MED+alpha 20.5 缺失:任意型:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758381	Methoxsalen 0.02 mg/mL Gvn Vol	4180186
40758381	8-Methoxypsoralen; 8-MOP; DRUG DOSES; Gvn; Methoxsalen 0.02 mg/mL; Oxsoralen; Point in time; QNT; Quan; Quant; Quantitative; Random; Uvadex; Volume	4180186
40758381	甲氧补骨脂素 0.02 毫克/毫升 给予的:体积型属性:时间点:^患者:定量型	4182948
40758385	ED payment data DEEDS	4180186
40758385	Data Elements for Emergency Department Systems; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
40758385	急诊科支付数据:-:时间点:^患者:集合型:DEEDS	4182948
40758386	Date last C tetani immunization	4180186
40758386	C tetani; Date last C tetani immunization; H+P; H+P.HX; Immunization status; P prime; Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Tet; Tetanus; Vaccination; Vaccinations; Vaccine	4180186
40758386	末次破伤风梭菌疫苗接种日期:日期:时间点:^患者:定量型	4182948
40758388	Date and time; H+P; H+P.HX; P prime; Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40758388	最后进食固体食物的时间:时间戳:时间点:^患者:定量型	4182948
40758389	Consumed; Date and time; Drink; H+P; H+P.HX; Liquids; P prime; Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40758389	最后饮用液体的时间:时间戳:时间点:^患者:定量型	4182948
40758391	FLUV; FLUV immunization status; H+P; H+P.HX; History; ID; Immunization status; Infectious Disease; InfectiousDisease; Influ; Nominal; P prime; Point in time; Random; Vaccination; Vaccinations; Vaccine	4180186
40758391	FLUV immunization status	4180186
40758391	流感病毒疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758393	H+P; H+P.HX; HAV; HAV immunization status; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; Hepatology; History; ID; Immunization status; Infectious Disease; InfectiousDisease; Liver; Nominal; P prime; Point in time; Random; Vaccination; Vaccinations; Vaccine	4180186
40758393	HAV immunization status	4180186
40758393	甲型肝炎病毒疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758394	H+P; H+P.HX; History; ID; Infectious Disease; InfectiousDisease; MeV; MeV status; Msls; Nominal; P prime; Point in time; Random; Rubeola	4180186
40758394	MeV status	4180186
40758394	麻疹病毒状态:历史记录:时间点:^患者:名义型	4182948
40758398	N men immunization status	4180186
40758398	H+P; H+P.HX; History; Immunization status; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; N men; N men immunization status; N menigitidis; N meningitidis; Nominal; P prime; Point in time; Random; Vaccination; Vaccinations; Vaccine	4180186
40758398	脑膜炎奈瑟菌疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758402	H+P; H+P.HX; History; ID; Immunization status; Infectious Disease; InfectiousDisease; Nominal; P prime; Point in time; Poliovirus; PV; PV immunization status; Random; Vaccination; Vaccinations; Vaccine	4180186
40758402	PV immunization status	4180186
40758402	脊髓灰质炎病毒疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758403	Chicken pox; Chicken pox virus; Chickenpox; H+P; H+P.HX; Herpes zoster; HHV-3; History; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; Nominal; P prime; Point in time; Random; Shingles; VZ; VZV; VZV status; Zoster	4180186
40758403	VZV status	4180186
40758403	水痘带状疱疹病毒状态:历史记录:时间点:^患者:名义型	4182948
40758404	H+P; H+P.HX; HBV; HBV status; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; History; ID; Infectious Disease; InfectiousDisease; Liver; Nominal; P prime; Point in time; Random	4180186
40758404	HBV status	4180186
40758404	乙型肝炎病毒状态:历史记录:时间点:^患者:名义型	4182948
40758408	CMV; CMV status; Cytomegalo virus; Cytomgal; H+P; H+P.HX; HHV-5; History; Human Herpesvirus-5; Nominal; P prime; Point in time; Random	4180186
40758408	CMV status	4180186
40758408	巨细胞病毒状态:历史记录:时间点:^患者:名义型	4182948
40758409	Military service	4180186
40758409	Finding; Findings; H+P; H+P.HX; Narrative; P prime; Point in time; Random; Report	4180186
40758409	兵役:发现:时间点:^患者:叙述型	4182948
40758411	Date symptoms of pregnancy 1st noted	4180186
40758411	Date symptoms of pregnancy 1st noted; Gestation; Gestations; Gravida; H+P; H+P.HX; P prime; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random; Sx	4180186
40758411	妊娠症状首次记录日期:日期:时间点:^患者:定量型	4182948
40758414	FCN; Func; Funct; Function; GCS special circumstances; Neuro; Neurology; Nominal; Point in time; Random; Typ	4180186
40758414	GCS special circumstances	4180186
40758414	格拉斯哥昏迷分值特殊情况:类型:时间点:^患者:名义型	4182948
40758415	bod; Bodies; H+P; H+P.HX; P prime; PEA; Physical exam by body areas; Point in time; Random	4180186
40758415	按身体区域的体格检查:-:时间点:^患者:集合型	4182948
40758416	Date and time; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40758416	死亡时间:时间戳:时间点:^患者:定量型	4182948
40758422	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; NXL 103; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; XRP 2868	4180186
40758422	Linopristin+Flopristin Islt MIC	4180186
40758422	利诺普丁+氟洛普丁:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758423	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; NXL 103; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; XRP 2868	4180186
40758423	Linopristin+Flopristin Islt KB	4180186
40758423	利诺普丁+氟洛普丁:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758427	Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HC; HPA; HPV; HPV Low Risk; HPV6; HPV6+11; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Papilloma virus low risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; Urth	4180186
40758427	HPV Low Risk DNA Urth Ql Probe+sig amp	4180186
40758427	人乳头瘤病毒 6+11+42+43+44 型 DNA:存在情况或阈值:时间点:尿道:序数型:探针法.基因扩增.信号	4182948
40758428	Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HC; HPA; HPV; HPV Low Risk; HPV6; HPV6+11; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Papilloma virus low risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40758428	HPV Low Risk DNA Spec Ql Probe+sig amp	4180186
40758428	人乳头瘤病毒 6+11+42+43+44 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.信号	4182948
40758429	Blood; Document; Erythrocytosis; Finding; Findings; Genetics; Heredity; Heritable; Inherited; JAK2 exon 12; Janus kinase 2; Janus kinase 2 gene; JTK10; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Polycythemia vera; PV; Random; THCYT3; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40758429	JAK2 exon 12 Mut Anl Bld/T	4180186
40758429	JAK2 基因外显子 12 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40758430	Blood; Document; Erythrocytosis; Finding; Findings; Genetics; Heredity; Heritable; Inherited; JAK2 exon 13; Janus kinase 2; Janus kinase 2 gene; JTK10; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Polycythemia vera; PV; Random; THCYT3; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40758430	JAK2 exon 13 Mut Anl Bld/T	4180186
40758430	JAK2 基因外显子 12 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40758433	Fung; Fungal; Fungi; ID; Infectious Disease; InfectiousDisease; Lower respiratory; Lung; Microbiology; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Spt; Sputum	4180186
40758433	Fungus Spt Ql KOH Prep	4180186
40758433	真菌:存在情况或阈值:时间点:痰液:序数型:氢氧化钾制片法	4182948
40758437	ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Yeast pseudohyphae	4180186
40758437	Yeast pseudohyphae Spec Ql KOH Prep	4180186
40758437	酵母菌.假菌丝:存在情况或阈值:时间点:XXX:序数型:氢氧化钾制片法	4182948
40758438	ID; Infectious Disease; InfectiousDisease; Lower respiratory; Lung; Microbiology; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Spt; Sputum; Yeast pseudohyphae	4180186
40758438	Yeast pseudohyphae Spt Ql KOH Prep	4180186
40758438	酵母菌.假菌丝:存在情况或阈值:时间点:痰液:序数型:氢氧化钾制片法	4182948
40758440	Dermatologic; Epidermis; ID; Infectious Disease; InfectiousDisease; Integument; Microbiology; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Skn; Yeast pseudohyphae	4180186
40758440	Yeast pseudohyphae Skin Ql KOH Prep	4180186
40758440	酵母菌.假菌丝:存在情况或阈值:时间点:皮肤:序数型:氢氧化钾制片法	4182948
40758441	Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid; Yeast pseudohyphae	4180186
40758441	Yeast pseudohyphae Vag Ql KOH Prep	4180186
40758441	酵母菌.假菌丝:存在情况或阈值:时间点:阴道:序数型:氢氧化钾制片法	4182948
40758444	ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40758444	Yeast Spec Ql KOH Prep	4180186
40758444	酵母:存在情况或阈值:时间点:XXX:序数型:氢氧化钾制片法	4182948
40758445	ID; Infectious Disease; InfectiousDisease; Lower respiratory; Lung; Microbiology; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Spt; Sputum	4180186
40758445	Yeast Spt Ql KOH Prep	4180186
40758445	酵母:存在情况或阈值:时间点:痰液:序数型:氢氧化钾制片法	4182948
40758446	Dermatologic; Epidermis; ID; Infectious Disease; InfectiousDisease; Integument; Microbiology; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Skn	4180186
40758446	Yeast Skin Ql KOH Prep	4180186
40758446	酵母:存在情况或阈值:时间点:皮肤:序数型:氢氧化钾制片法	4182948
40758447	Bro; Fung; Fungal; Fungi; ID; Infectious Disease; InfectiousDisease; Lung; Microbiology; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
40758447	Fungus Bronch Ql KOH Prep	4180186
40758447	真菌:存在情况或阈值:时间点:支气管来源的标本:序数型:氢氧化钾制片法	4182948
40758448	Bro; ID; Infectious Disease; InfectiousDisease; Lung; Microbiology; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Yeast pseudohyphae	4180186
40758448	Yeast pseudohyphae Bronch Ql KOH Prep	4180186
40758448	酵母菌.假菌丝:存在情况或阈值:时间点:支气管来源的标本:序数型:氢氧化钾制片法	4182948
40758449	Bro; ID; Infectious Disease; InfectiousDisease; Lung; Microbiology; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
40758449	Yeast Bronch Ql KOH Prep	4180186
40758449	酵母:存在情况或阈值:时间点:支气管来源的标本:序数型:氢氧化钾制片法	4182948
40758453	Jk sup(b) Ab Titr SerPl	4180186
40758453	Jk^b 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758453	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); J (little k) (little b); Jk sup(b); Jk^b; k; Kell Blood Group System; Kidd Blood Group System; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758457	Le sup(a) Ab Titr SerPl	4180186
40758457	Le^a 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758457	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); e; L (little e); L (little e) (little a); Le; Le sup(a); Le^a; Left; Levo; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758458	Le sup(b) Ab Titr SerPl	4180186
40758458	Le^b 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758458	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); e; L (little e); L (little e) (little b); Le; Le sup(b); Le^b; Left; Levo; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758459	Lu sup(a) Ab Titr SerPl	4180186
40758459	Lu^a 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758459	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); L (little u) (little a); Left; Levo; Lu sup(a); Lu^a; Lutheran Blood Group System; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758463	little k Ab Titr SerPl	4180186
40758463	k 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758463	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); k; Kell Blood Group System; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758464	little s Ab Titr SerPl	4180186
40758464	s 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758464	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); MNSs Blood Group System; Pl; Plasma; Plsm; Point in time; Random; s; S prime; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758465	N Ab Titr SerPl	4180186
40758465	N 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758465	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); MNSs Blood Group System; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758468	Sd sup(a) Ab Titr SerPl	4180186
40758468	Sd^a 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758468	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dextro; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; S prime; Sd sup(a); Sd^e; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758471	Antigen; Antigens; BLOOD BANK; Dextro; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; S prime; Screen; Sd sup(a); Sd^e	4180186
40758471	Sd sup(a) Ag RBC Ql	4180186
40758471	Sd^a 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40758473	Agg; Aggr; COAGULATION; Hematology; Heme; mcg; PA; PA Rist; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; RlACnc; Thrombocyte; Thrombocytes	4180186
40758473	PA Rist 1000 ug/mL PRP	4180186
40758473	血小板聚集.瑞斯托菌素诱导型^1000 微克/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
40758474	Arbitrary; Bowel movement; ColoSure; CTRCT30; DNA methylation; Faecal; Faeces; Fecal; Feces; HEL113; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; vimentin	4180186
40758474	VIM gene methylation Stl Ql	4180186
40758474	VIM 基因甲基化:任意型:时间点:大便:序数型:分子遗传学类实验室方法	4182948
40758475	cloBAZam+Norclobazam SerPl-sCnc	4180186
40758475	Clarmyl; Clobazam metabolite; Clopax; Desmeth; Desmethylclobazam; DRUG/TOXICOLOGY; Drugs; Frisium; Level; N-desmethylclobazam; Noiafren; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Urbadan; Urbanol; Urbanyl	4180186
40758475	氯巴詹+去甲基氯巴詹:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758478	Ethyl glucuronide Ur Ql	4180186
40758478	DRUG/TOXICOLOGY; Drugs; EtG; Ethanol metabolite; Gluc; Glucouronide; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40758478	乙基葡糖苷酸:存在情况或阈值:时间点:尿液:序数型	4182948
40758479	Fenfluramine Ur Ql	4180186
40758479	Dima-fen; DRUG/TOXICOLOGY; Drugs; Fentrate; Fenured; Ordinal; Pesos; Point in time; Ponderal; Ponderax; Pondimin; Ponflurol; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40758479	芬氟拉明:存在情况或阈值:时间点:尿液:序数型	4182948
40758480	1 1/2 hours; 1 1/2 HR; 1.5h p 75 g Glc PO; 1.5Hr; 75Gm; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758480	Glucose 1.5h p 75 g Glc PO SerPl-sCnc	4180186
40758480	葡萄糖^在口服75 g葡萄糖之后1.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758481	45M p 75 g Glc PO; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758481	Glucose 45M p 75 g Glc PO SerPl-sCnc	4180186
40758481	葡萄糖^在口服75 g葡萄糖之后45分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758482	Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Level; Mass concentration; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758482	Hirudin PPP Chro-mCnc	4180186
40758482	水蛭素:质量浓度:时间点:贫血小板血浆:定量型:凝血因子酶学测定法	4182948
40758485	Osmolality p 5h FFST Ur	4180186
40758485	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 5h FFST; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758485	渗透压^在液体型禁食之后5小时:渗透压:时间点:尿液:定量型	4182948
40758486	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 3h FFST; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758486	Osmolality p 3h FFST Ur	4180186
40758486	渗透压^在液体型禁食之后3小时:渗透压:时间点:尿液:定量型	4182948
40758491	Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH	4180186
40758491	TSH pre chal SerPl-aCnc	4180186
40758491	促甲状腺激素^在 XXX 刺激之前:任意型浓度:时间点:血清/血浆:定量型	4182948
40758492	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758492	Argatroban PPP-mCnc	4180186
40758492	阿加曲班:质量浓度:时间点:贫血小板血浆:定量型	4182948
40758493	CD5+CD19+CD38+ Cells NFr Bld	4180186
40758493	ADP-ribosyl cyclase; B4; B-4; Blood; CD5 Cells; CD5+CD19+ Cells; CD5+CD19+CD38+ Cells; Cell; CELL MARKERS; Cellularity; Cyclic ADP-ribose hydrolase; Gated cells; HD-37; Leu1; Leu-1; Leu12; Leu-12; Leu17; Leu-17; Ly-1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T1; T10; Tp67; WB; Whole blood	4180186
40758493	细胞.CD5+CD19+CD38+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40758501	Hgb CSp MFr Bld	4180186
40758501	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hemoglobin constant sprint; Hgb; Hgb CSp; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
40758501	血红蛋白 Constant Spring/血红蛋白.总计:质量分数:时间点:全血:定量型	4182948
40758503	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb N+I; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
40758503	Hgb N+I MFr Bld	4180186
40758503	血红蛋白 N+I/血红蛋白.总计:质量分数:时间点:全血:定量型	4182948
40758504	Megaloblasts # Bld Manual	4180186
40758504	#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40758504	巨成红细胞:计数型浓度:时间点:全血:定量型:手工计数方法	4182948
40758505	100WBC; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
40758505	Megaloblasts/leuk NFr Bld Manual	4180186
40758505	巨成红细胞/100 个白细胞:计数型分数:时间点:全血:定量型:手工计数方法	4182948
40758506	100WBC; Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Imm; Immat; Immature mononuc; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mononuc; Mononuc Cells; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
40758506	Immature mononuc/leuk NFr Bld Manual	4180186
40758506	单个核细胞.不成熟/100 个白细胞:计数型分数:时间点:全血:定量型:手工计数方法	4182948
40758511	5M p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758511	Insulin 5M p chal SerPl-sCnc	4180186
40758511	胰岛素^在XXX刺激之后5分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758512	Insulin 10M p chal SerPl-sCnc	4180186
40758512	10M p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758512	胰岛素^在XXX刺激之后10分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758515	2M p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758515	Insulin 2M p chal SerPl-sCnc	4180186
40758515	胰岛素^在XXX刺激之后2分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758516	45M p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758516	Insulin 45M p chal SerPl-sCnc	4180186
40758516	胰岛素^在XXX刺激之后45分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758517	4h p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758517	Insulin 4h p chal SerPl-sCnc	4180186
40758517	胰岛素^在XXX刺激之后4小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758518	5h p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758518	Insulin 5h p chal SerPl-sCnc	4180186
40758518	胰岛素^在XXX刺激之后5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758519	6h p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758519	Insulin 6h p chal SerPl-sCnc	4180186
40758519	胰岛素^在XXX刺激之后6小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758522	DRUG/TOXICOLOGY; Drugs; Nails; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content; Ungal nail	4180186
40758522	Lead Nail-sCnt	4180186
40758522	铅:物质的量含量:时间点:甲:定量型	4182948
40758523	Prot + Glucose Pnl CSF	4180186
40758523	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Glu; Gluc; Glucoseur; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PR; Prot; Prot + Glucose Pnl; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40758523	蛋白质与葡萄糖组套:-:时间点:脑脊液:定量型	4182948
40758524	Antiphospholipid; aPA; APL; COAGULATION; Hematology; Heme; Immune globulin A; Immune globulin G; Immune globulin M; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lipid; Pan; PANEL.COAGULATION; Panl; Phoslpd; Phospholipid IgA+IgG+IgM Pnl; Phospholipids; Pl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758524	Phospholipid IgA+IgG+IgM Pnl Ser	4180186
40758524	磷脂抗体.IgA 与 IgG 与 IgM 组套:-:时间点:血清:定量型	4182948
40758527	COAGULATION; D Dimer; D dimer FEU; Dextro; Fragment D-dimer; Pan; PANEL.COAGULATION; Panl; Plas; Platelet poor plasma; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Short Fibrin D-dimer FEU & DDU Pnl	4180186
40758527	Short Fibrin D-dimer FEU & DDU Pnl PPP	4180186
40758527	简版纤维蛋白 D-二聚体 FEU 与 DDU 组套:-:时间点:贫血小板血浆:定量型	4182948
40758534	Heart failure tracking Pnl; Pan; Panl; PHR panels; Pnl; Point in time; Random	4180186
40758534	Heart failure tracking Pnl	4180186
40758534	心力衰竭跟踪组套:-:时间点:^患者:-	4182948
40758535	Cardiac; Cardiac EF method; Cardio; Cardiology; EF; Frac; Fract; Fractionation; Fractions; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; L; LT; LV; LVEF; Meth; Method of; Nominal; Point in time; Random; Typ; Ventricular	4180186
40758535	LV Cardiac EF method	4180186
40758535	心脏射血分数方法:类型:时间点:心脏.心室.左侧:名义型	4182948
40758542	Pedometer tracking Pnl	4180186
40758542	Pan; Panl; Pedometer tracking Pnl; PHR panels; Pnl; Point in time; Random	4180186
40758542	计步器跟踪组套:-:时间点:^患者:-	4182948
40758545	Lung; Nominal; Point in time; PULMONARY; Pulmonology; Random; Respiratory; Typ	4180186
40758545	血氧测量 特殊情况:类型:时间点:^患者:名义型	4182948
40758546	Short BP Pnl	4180186
40758546	BP; BP Pnl; Pan; Panl; PHR panels; Pnl; Point in time; Random; Short BP Pnl	4180186
40758546	简版血压组套:-:时间点:^患者:-	4182948
40758551	Art sys; Count/time; Encounter; Heart beat; HEART RATE.MOLEC; Maximum; nRate; Number rate; Number Rate = Count/Time; Pulse; QNT; Quan; Quant; Quantitative	4180186
40758551	Heart rate Enctr Max	4180186
40758551	心率:计数型速率:就医过程持续时间^最大值:动脉系统:定量型	4182948
40758553	?Tm; CLIN; Energy/time; Power; QNT; Quan; Quant; Quantitative	4180186
40758553	Calories burned ?Tm Pedometer	4180186
40758553	已消耗的热量:功率:XXX:^患者:定量型:计步器	4182948
40758555	Heart rate ?Tm Max Pedometer	4180186
40758555	?Tm; Art sys; Count/time; Heart beat; HEART RATE.MOLEC; Maximum; nRate; Number rate; Number Rate = Count/Time; Pulse; QNT; Quan; Quant; Quantitative	4180186
40758555	心率:计数型速率:XXX^最大值:动脉系统:定量型:计步器	4182948
40758557	Drug test kit name Ur	4180186
40758557	DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; UA; UR; Urn	4180186
40758557	药物试剂盒名称:存在与否或特征标识:时间点:尿液:名义型	4182948
40758559	?Tm; Activity; CLIN; Exercise; Length; QNT; Quan; Quant; Quantitative; Walk distance	4180186
40758559	Walk distance ?Tm Pedometer	4180186
40758559	行走距离:长度:XXX:^患者:定量型:计步器	4182948
40758561	Immature cells # Bld	4180186
40758561	#; ABS; absolute; absolutes; Blood; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Imm; Immat; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40758561	不成熟细胞:计数型浓度:时间点:全血:定量型	4182948
40758562	Immature cells/leuk NFr Bld	4180186
40758562	100WBC; Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Imm; Immat; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
40758562	不成熟细胞/100 个白细胞:计数型分数:时间点:全血:定量型	4182948
40758563	Insulin 20M p chal SerPl-sCnc	4180186
40758563	20M p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758563	胰岛素^在XXX刺激之后20分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758567	登革热病毒 抗体.中和:滴定度:时间点:血清:定量型:中和试验	4182948
40758567	DENV NAb Titr Ser Nt	4180186
40758567	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Conventional virus neutralization test; cVNT; Denv; Dilution factor; Dilution Factor (Titer); Flavivirus; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT	4180186
40758572	ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; Hematology; Heme; Lab orders; LimitedUseLabOrders; Point in time; Random; Serum; SR	4180186
40758572	Deprecated Cardiolipin Ab Ser	4180186
40758575	ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; Hematology; Heme; Immune globulin G; Immunoglobulin G; Lab orders; LimitedUseLabOrders; Point in time; Random; Serum; SR	4180186
40758575	Deprecated Cardiolipin IgG Ser	4180186
40758578	D Dimer; Dextro; Fragment D-dimer; Lab orders; LimitedUseLabOrders; Plas; Platelet poor plasma; Point in time; Random	4180186
40758578	Deprecated D Dimer PPP	4180186
40758579	Coagulation factor I; FDP; FgDP; FGN; Fibrin degradation products; Fibrin split products; Fibrinogen degradation products; Fibrinogen Frg; Fibrinogen related antigens; Frag; Fragment; FSP; Lab orders; LimitedUseLabOrders; Point in time; Random; Serum; SR; TDP	4180186
40758579	Deprecated FSP Ser	4180186
40758585	Blood; Haemoglobin; Hb; HBs; Hgb; Hgb S; Lab orders; LimitedUseLabOrders; Point in time; Random; S prime; Sickle cell; Sickle cells; WB; Whole blood	4180186
40758585	Deprecated Hgb S Bld	4180186
40758586	FR; Haemoglobin; Hb; Hgb; Hgb Free; Lab orders; LimitedUseLabOrders; Non-protein bound; Pl; Plasma; Plsm; Point in time; Random	4180186
40758586	Deprecated Hgb Free Plas	4180186
40758587	Alfa; IFN; IFN-A; Lab orders; LimitedUseLabOrders; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758587	Deprecated IFN-A SerPl	4180186
40758588	Fletcher factor; Lab orders; LimitedUseLabOrders; PK; Plas; Platelet poor plasma; Point in time; Prokallikrein; Prokinogenase; Random	4180186
40758588	Deprecated PK PPP	4180186
40758590	Autoprothrombin II-a; Lab orders; LimitedUseLabOrders; PC; Plas; Platelet poor plasma; Point in time; PR; Prot; Prot C; Random	4180186
40758590	Deprecated Prot C PPP	4180186
40758591	Lab orders; LimitedUseLabOrders; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH	4180186
40758591	Deprecated TSH SerPl	4180186
40758592	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV swine; FLUV; Fowl plague; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Pig; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40758592	FLUAV swine RNA Spec NAA+probe	4180186
40758592	流感病毒 A 型猪源性 RNA:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
40758595	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUAV H1 2009 pand; FLUAV H1 2009 pand RNA pnl; FLUV; Fowl plague; H1N1; H1N1v; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza virus A hemagglutinin H1 swine origin; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; S-OIV; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40758595	FLUAV H1 2009 pan RNA pnl Spec NAA+probe	4180186
40758595	流感病毒 A 型血凝素 H1 型 2009 大流行 RNA 组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
40758599	1 hour; 1.0Hr; 17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 1h p ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40758599	17OHP 1h p ACTH SerPl-sCnc	4180186
40758599	17-羟孕酮^在给予剂量促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758600	1 hour; 1.0Hr; 1h p ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Endocrine; Endocrinology; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40758600	Aldost 1h p ACTH SerPl-sCnc	4180186
40758600	醛固酮^在给予剂量促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758602	Cortis 3h p chal SerPl-sCnc	4180186
40758602	17-Hydroxycorticosterone; 3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758602	皮质醇^在XXX刺激之后3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758603	DHEA BS SerPl-sCnc	4180186
40758603	BS; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Pl; Plasma; Plsm; Point in time; Prasterone; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758603	脱氢表雄酮^基线:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758604	1 hour; 1.0Hr; 1h p ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; DHEA; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40758604	DHEA 1h p ACTH SerPl-sCnc	4180186
40758604	脱氢表雄酮^在给予剂量促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758606	17-beta estradiol; 4h p chal; After; CHEMISTRY.CHALLENGE TESTING; E2; Level; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758606	Estradiol 4h p chal SerPl-sCnc	4180186
40758606	雌二醇^在XXX刺激之后4小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758607	FSH 4h p chal SerPl-aCnc	4180186
40758607	4h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758607	促卵泡激素^在XXX刺激之后4小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40758608	Insulin 7M p Glc IV SerPl-sCnc	4180186
40758608	7M p Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758608	胰岛素^在静脉注射剂量葡萄糖之后7分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758609	Insulin 5M pre Glc SerPl-sCnc	4180186
40758609	5M pre Glc; Before; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Glc; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758609	胰岛素^在给予剂量葡萄糖之前5分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758613	Insulin 10M p Glc IV SerPl-sCnc	4180186
40758613	10M p Glc; 10M p Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758613	胰岛素^在静脉注射剂量葡萄糖之后10分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758617	Insulin 1h p Gc SerPl-sCnc	4180186
40758617	1 hour; 1.0Hr; 1h p Gc; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; HGF; HUM; Humulin; Hyperglycemic factor; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758617	胰岛素^在给予剂量胰高血糖素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758618	Insulin 1.5h p Gc SerPl-sCnc	4180186
40758618	1 1/2 hours; 1 1/2 HR; 1.5h p Gc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; HGF; HUM; Humulin; Hyperglycemic factor; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758618	胰岛素^在给予剂量胰高血糖素之后1.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758620	120 min; 120 minutes; 120min; 2 hours; 2h p Gc; After; CHEMISTRY.CHALLENGE TESTING; HGF; HUM; Humulin; Hyperglycemic factor; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758620	Insulin 2h p Gc SerPl-sCnc	4180186
40758620	胰岛素^在给予剂量胰高血糖素之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758621	30M p Glc; 30M p Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758621	Insulin 30M p Glc IV SerPl-sCnc	4180186
40758621	胰岛素^在静脉注射剂量葡萄糖之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758625	120 min; 120 minutes; 120min; 2 hours; 2h p Glc; 2h p Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758625	Insulin 2h p Glc IV SerPl-sCnc	4180186
40758625	胰岛素^在静脉注射剂量葡萄糖之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758626	Insulin 3M p Glc IV SerPl-sCnc	4180186
40758626	3M p Glc; 3M p Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758626	胰岛素^在静脉注射剂量葡萄糖之后3分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758627	Insulin 7M pre Glc SerPl-sCnc	4180186
40758627	7M pre Glc; Before; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Glc; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758627	胰岛素^在给予剂量葡萄糖之前7分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758629	Insulin 30M p Gc SerPl-sCnc	4180186
40758629	30M p Gc; After; CHEMISTRY.CHALLENGE TESTING; HGF; HUM; Humulin; Hyperglycemic factor; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758629	胰岛素^在给予剂量胰高血糖素之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758630	4h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758630	LH 4h p chal SerPl-aCnc	4180186
40758630	促黄体素^在XXX刺激之后4小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40758631	Prolactin 20M pTRH IV SerPl-mCnc	4180186
40758631	20M p TRH; 20M pTRH IV; After; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; Mass concentration; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758631	催乳素^在静脉注射剂量TRH之前20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40758633	120 min; 120 minutes; 120min; 2 hours; 2h p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGF; HGH; Human growth hormone; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758633	GH 2h p Gc SerPl-mCnc	4180186
40758633	生长激素^在给予剂量胰高血糖素之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
40758634	30M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758634	GH 30M p Glc SerPl-mCnc	4180186
40758634	生长激素^在剂量葡萄糖之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40758635	10M p Exc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; EXCZ; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p Exc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758635	GH 10M p Exc SerPl-mCnc	4180186
40758635	生长激素^在运动之后10分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40758637	1 hour; 1.0Hr; 1h p Glc; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758637	GH 1h p Glc SerPl-mCnc	4180186
40758637	生长激素^在剂量葡萄糖之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40758640	3h p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGF; HGH; Human growth hormone; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758640	GH 3h p Gc SerPl-mCnc	4180186
40758640	生长激素^在给予剂量胰高血糖素之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
40758641	30M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGF; HGH; Human growth hormone; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758641	GH 30M p Gc SerPl-mCnc	4180186
40758641	生长激素^在给予剂量胰高血糖素之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40758642	30M p CLN; After; Catapres; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758642	GH 30M p CLN SerPl-mCnc	4180186
40758642	生长激素^在剂量可乐定之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40758644	2.5h p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGF; HGH; Human growth hormone; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758644	GH 2.5h p Gc SerPl-mCnc	4180186
40758644	生长激素^在给予剂量胰高血糖素之后2.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40758646	1 hour; 1.0Hr; 1h p Gc; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGF; HGH; Human growth hormone; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758646	GH 1h p Gc SerPl-mCnc	4180186
40758646	生长激素^在给予剂量胰高血糖素之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40758648	Testost BS SerPl-sCnc	4180186
40758648	BS; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Testo; Testos; Testost	4180186
40758648	睾酮^基线:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758650	Acebutolol Spec-sCnc	4180186
40758650	Acecor; ALOL; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Monitan; Neptal; Other; Point in time; Prent; QNT; Quan; Quant; Quantitative; Random; Rhotral; Sectral; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40758650	醋丁洛尔:物质的量浓度:时间点:XXX:定量型	4182948
40758651	Acetadiazol; Acetazolam; AK-Zol; Diamox; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758651	acetaZOLAMIDE SerPl-sCnc	4180186
40758651	乙酰唑胺:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758653	Atropine SerPl-sCnc	4180186
40758653	DRUG/TOXICOLOGY; Drugs; Enlon; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758653	阿托品:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758657	Chloral Hydrate SerPl-sCnc	4180186
40758657	Chloraldurat; Chloralix; Dormel; DRUG/TOXICOLOGY; Drugs; Elix-node; Level; Medianox; Noctec; Pediatric chloral elixir; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Trichloroethanol; Trichloroethyl alcohol; Trichloroethylalcohol; Welldorm	4180186
40758657	水合氯醛:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758660	Cyclobenzaprine SerPl-sCnc	4180186
40758660	Amrix; DRUG/TOXICOLOGY; Drugs; Flexaril; Flexeril; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758660	环苯扎林:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758662	Cardizem; Cartia; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tiamate; Tiazac	4180186
40758662	dilTIAZem SerPl-sCnc	4180186
40758662	硫氮卓酮:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758666	Actiq; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; Illicit; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sublimaze; Substance concentration	4180186
40758666	fentaNYL SerPl-sCnc	4180186
40758666	芬太尼:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758668	Flurbiprofen SerPl-sCnc	4180186
40758668	DRUG/TOXICOLOGY; Drugs; Flubiprofen; Level; Ocufen; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758668	氟联苯丙酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758670	HTCZ SerPl-sCnc	4180186
40758670	Aldactizide; c381; DRUG/TOXICOLOGY; Drugs; Esidrix; HCTZ; HTCZ; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758670	氢氯噻嗪:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758671	6-hydroxybupropion; Bupropion metabolite; BW 306U; DRUG/TOXICOLOGY; Drugs; Level; OH-bupropion; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758671	OH-bupropion SerPl-sCnc	4180186
40758671	羟基丁氨苯丙酮:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758673	Atarax; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vistaril	4180186
40758673	hydrOXYzine SerPl-sCnc	4180186
40758673	羟嗪:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758676	Labetalol SerPl-sCnc	4180186
40758676	Abetol; Alfabetal; Amipress; Betadren; DRUG/TOXICOLOGY; Drugs; Ibidomide; Ipolab; Labrocol; Level; Lolum; Mitalolo; Normodyne; Pl; Plasma; Plsm; Point in time; Presolol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Trandate	4180186
40758676	拉贝洛尔:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758677	DRUG/TOXICOLOGY; Drugs; Glucophage; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758677	metFORMIN SerPl-sCnc	4180186
40758677	二甲双胍:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758680	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; MDA; Methylenedioxymethamphetamine metabolite; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758680	MDA SerPl-sCnc	4180186
40758680	亚甲基二氧苯丙胺:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758681	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Me-phenidate; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Ritalin; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758681	Me-phenidate SerPl-sCnc	4180186
40758681	哌甲酯:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758682	Metoprolol SerPl-sCnc	4180186
40758682	DRUG/TOXICOLOGY; Drugs; Level; LO; Lopressor; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758682	美多洛尔:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758689	Banflex; Biorphen; Brocasipal; Disipal; Dolan; DRUG/TOXICOLOGY; Drugs; Flexon; Level; Mephenamine; Myophen; Myotrol; Norflex; Norgesic; OrfenAce; Orphenadin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758689	Orphenadrine SerPl-sCnc	4180186
40758689	邻甲基苯海拉明:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758691	Oxyphenbutazone SerPl-sCnc	4180186
40758691	Californit; DRUG/TOXICOLOGY; Drugs; Hydroxyphenylbutazone; Level; Otone; Oxybutazone; Phenylbutazone metabolite; Phlogont; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tanderil chlorampenicol	4180186
40758691	羟基保泰松:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758693	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Talwin	4180186
40758693	Pentazocine SerPl-sCnc	4180186
40758693	戊唑星:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758697	DRUG/TOXICOLOGY; Drugs; Level; Phenolthalein; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758697	Phenolphthalein SerPl-sCnc	4180186
40758697	酚酞:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758698	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ionamin; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758698	Phentermine SerPl-sCnc	4180186
40758698	芬特明:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758699	C254; Cortan; Deltasone; DRUG/TOXICOLOGY; Drugs; Level; Liquid Pred; Meticorten; Orasone; Panasol-S; Pl; Plasma; Plsm; Point in time; Prednicen-M; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758699	predniSONE SerPl-sCnc	4180186
40758699	泼尼松:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758700	c234; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758700	Prilocaine SerPl-sCnc	4180186
40758700	丙胺卡因:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758702	Atosil; Avomine; DRUG/TOXICOLOGY; Drugs; Fargan; Farganesse; Lergigan; Level; Phenergan; Pl; Plasma; Plsm; Point in time; Promethegan; Prothiazine; QNT; Quan; Quant; Quantitative; Random; Receptozine; Romergan; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sominex; SR; Substance concentration	4180186
40758702	Promethazine SerPl-sCnc	4180186
40758702	异丙嗪:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758703	Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Level; Napsalgesic; n-desmethylproproxyphene; Norpropoxyp; Pl; Plasma; Plsm; Point in time; Propoxyph+Nor; Propoxyphene metabolite; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758703	Propoxyph+Nor SerPl-sCnc	4180186
40758703	丙氧氨酚+去甲基丙氧氨酚:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758704	Cenafed; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; Pseudoephed; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Sudafed	4180186
40758704	Pseudoephedrine SerPl-sCnc	4180186
40758704	伪麻黄碱:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758705	QUEtiapine SerPl-sCnc	4180186
40758705	DRUG/TOXICOLOGY; Drugs; Ketipinor; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Seroquel; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Xeroquel	4180186
40758705	喹硫平:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758706	Salicylamide SerPl-sCnc	4180186
40758706	DRUG/TOXICOLOGY; Drugs; Level; Lobac; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Salicylamid; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinedol; SR; Substance concentration; Triaprin-DC; Utrosal	4180186
40758706	水杨酰胺:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758710	Accucol; Asulfidine; Azopyrin; Azulfidine; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rorasul; Salazopyrin; Salazosulfapyridine; Salicylazosulfapyridine; SASP; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SSZ; Substance concentration; Sulcolon	4180186
40758710	sulfaSALAzine SerPl-sCnc	4180186
40758710	柳氮磺胺吡啶:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758712	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Parnate; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758712	Tranylcypromine SerPl-sCnc	4180186
40758712	反苯环丙胺:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758713	c202; c242; C62; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; Polytrim; Primsol; Proloprim; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TMP; Trimeth; Trimpex	4180186
40758713	Trimethoprim SerPl-sCnc	4180186
40758713	三甲氧苄二氨嘧啶:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758714	Tripelennamine SerPl-sCnc	4180186
40758714	DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; Pyribenzamine; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758714	苄吡二胺:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758715	Verapamil SerPl-sCnc	4180186
40758715	APO-TRIMIP; Calan; DRUG/TOXICOLOGY; Drugs; Isoptin; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758715	维拉帕米:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758716	Addiction; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Methamphet; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40758716	Methamphet Ur-sCnc	4180186
40758716	甲基苯丙胺:物质的量浓度:时间点:尿液:定量型	4182948
40758717	10,11-dihydro-10-hydroxycarbamazepine; 10-Hydroxy carbazepine; 10-hydroxycarbamazepine; 10-Monohydroxyoxcarbazepine; 10-OH-carbazepine; 10OH-Carbazepine; DRUG/TOXICOLOGY; Drugs; Level; Licarbazepine; OXC; Oxcarbazepine metabolite; OXcarbazepine+OH-carbazepine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Trileptal	4180186
40758717	OXcarbazepine+OH-carbazepine SerPl-sCnc	4180186
40758717	奥卡西平+10-羟基奥卡西平:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758720	Chicken Feather IgE Ql	4180186
40758720	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e085; e85; f083; f83; Feathers; Gallus spp; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40758720	鸡羽毛 抗体.IgE:存在情况或阈值:时间点:血清:序数型	4182948
40758721	Cockatiel Feather IgE Ql	4180186
40758721	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Feathers; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40758721	孔雀羽毛 抗体.IgE:存在情况或阈值:时间点:血清:序数型	4182948
40758722	?Tm; Chemistry; CR; Crea; Creat; Kidney; Level; Nephrology; QNT; Quan; Quant; Quantitative; Renal; Substance Concentration; UA; UCr; UR; Urn	4180186
40758722	Creat ?Tm Ur-sCnc	4180186
40758722	肌酐:物质的量浓度:XXX:尿液:定量型	4182948
40758723	Duck Feather IgE Ql	4180186
40758723	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e086; e86; Feathers; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40758723	鸭羽毛 抗体.IgE:存在情况或阈值:时间点:血清:序数型	4182948
40758726	Js sup(b) Ab Titr SerPl	4180186
40758726	Js^b 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758726	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); J (little s) (little b); Js sup(b); Js^b; Kell Blood Group System; Pl; Plasma; Plsm; Point in time; Random; s; S prime; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758727	100WBC; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBC.disintegrated; WBCs; White blood cell; White blood cells	4180186
40758727	WBC.disintegrated/leuk NFr Fld Manual	4180186
40758727	白细胞.碎裂/100 个白细胞:计数型分数:时间点:体液:定量型:手工计数方法	4182948
40758728	WBC.disintegrated/leuk NFr CSF Manual	4180186
40758728	100WBC; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBC.disintegrated; WBCs; White blood cell; White blood cells	4180186
40758728	白细胞.碎裂/100 个白细胞:计数型分数:时间点:脑脊液:定量型:手工计数方法	4182948
40758729	Cyto Prt	4180186
40758729	Ascites; Ascitic fluid; Ascitis; CYTOLOGY; Cytology stain; Cytostain; Identity or presence; Nominal; Pap Smear; Pap Stain; Papanicolaou smear; Peritoneal fluid; Point in time; Prt; Random; St; Stains; Stn	4180186
40758729	显微镜观察:存在与否或特征标识:时间点:腹膜液:名义型:细胞学染色法	4182948
40758735	Parrot Feather IgE Ql	4180186
40758735	ABS; Aby; African Gray Parrot; African Grey Parrot; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e213; e91; Feathers; Immune globulin E; Immunoglobulin E; Macaw; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40758735	鹦鹉羽毛 抗体.IgE:存在情况或阈值:时间点:血清:序数型	4182948
40758736	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; Heart Disease; High density lipoprotein cholesterols; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio; TCHHDL; Tg; Trig; Trigly; Triglycerides; Triglycrides	4180186
40758736	Trigl/HDLc SerPl-sRto	4180186
40758736	甘油三酯/胆固醇.HDL 之中的:物质的量比率:时间点:血清/血浆:定量型	4182948
40758737	Turkey Feather IgE Ql	4180186
40758737	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e89; Feathers; Immune globulin E; Immunoglobulin E; Meleagis gallopavo; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40758737	吐绶鸡羽毛 抗体.IgE:存在情况或阈值:时间点:血清:序数型	4182948
40758740	FSH sp1 p chal SerPl-aCnc	4180186
40758740	Acute specimen; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; First; Follicle stimulating hormone; FSH; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR	4180186
40758740	促卵泡激素^在XXX刺激之后的第1个标本:任意型浓度:时间点:血清/血浆:定量型	4182948
40758741	^7th spec pst XXX chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR	4180186
40758741	FSH sp7 p chal SerPl-aCnc	4180186
40758741	促卵泡激素^在XXX刺激之后的第7个标本:任意型浓度:时间点:血清/血浆:定量型	4182948
40758745	Amox; Amoxicilloyl; Amoxil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bristamox; c204; c6; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Larotid; Moxalin; Point in time; Polymox; Random; Sulb; Sulbact; Sumox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Trimox; Wymox	4180186
40758745	Amoxicillin+Sulbactam Islt KB	4180186
40758745	羟氨苄青霉素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758747	ANTIBIOTIC SUSCEPTIBILITIES; AST; Atavaquone; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Lung; Mepron; Minimum inhibitory concentration; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758747	Atovaquone Islt MIC	4180186
40758747	阿托伐醌:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758749	Albaxin; Ambacamp; Ambaxin; Amplibac; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bacacil; Bacampicin; Bacocil; Carampicillin; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Penglobe; Point in time; Random; Sprectrobid; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Velbacampin	4180186
40758749	Bacampicillin Islt Grad strip	4180186
40758749	氨下青霉素甲戊酯:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758750	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Flavomycin; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758750	Bambermycins Islt Grad strip	4180186
40758750	班贝霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758751	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758751	Butirosin Islt Grad strip	4180186
40758751	丁酰苷菌素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758752	ANTIBIOTIC SUSCEPTIBILITIES; AST; CAPASTAT; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Ogostal; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758752	Capreomycin Islt Grad strip	4180186
40758752	卷曲霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758753	ANTIBIOTIC SUSCEPTIBILITIES; AST; cephacetrile; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758753	Cefacetrile Islt MIC	4180186
40758753	头孢乙腈:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758754	ANTIBIOTIC SUSCEPTIBILITIES; AST; cephacetrile; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758754	Cefacetrile Susc Islt	4180186
40758754	头孢乙腈:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758757	ANTIBIOTIC SUSCEPTIBILITIES; AST; Bidocef; Cefadril; Cefadrox; Cefamox; Cefroxil; Cehpos; Ceoxil; Crenodyn; Droxicef; Duracef; Duricef; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758757	Cefadroxil Islt Grad strip	4180186
40758757	头孢羟氨苄:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758758	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758758	Cephaloglycin Islt Grad strip	4180186
40758758	头孢甘酸:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758759	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefalotin; Cephalotin; Ceporacin; Cepovenin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Keflin; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758759	Cephalothin+Sulbactam Islt MIC	4180186
40758759	头孢金素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758761	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefalotin; Cephalotin; Ceporacin; Cepovenin; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Keflin; Kirby-bauer; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758761	Cephalothin+Sulbactam Islt KB	4180186
40758761	头孢金素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758762	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefalotin; Cephalotin; Ceporacin; Cepovenin; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Keflin; MIC; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758762	Cephalothin+Sulbactam Islt Grad strip	4180186
40758762	头孢金素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758763	ANTIBIOTIC SUSCEPTIBILITIES; AST; C31; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kefadol; Mandol; MANJ; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758763	Cefamandole+Sulbactam Islt MIC	4180186
40758763	头孢羟唑+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758765	ANTIBIOTIC SUSCEPTIBILITIES; AST; C31; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kefadol; Kirby-bauer; Mandol; MANJ; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758765	Cefamandole+Sulbactam Islt KB	4180186
40758765	头孢羟唑+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758767	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefadyl; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758767	Cephapirin Islt Grad strip	4180186
40758767	头孢吡硫:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758769	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758769	Cefetamet Islt Grad strip	4180186
40758769	头孢他美:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758770	ANTIBIOTIC SUSCEPTIBILITIES; AST; Bestcall; Cefmax; Cefmenoxim; Cemix; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tacef	4180186
40758770	Cefmenoxime Islt Grad strip	4180186
40758770	头孢甲肟:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758771	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefonocid; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Monocid; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758771	Cefonocid Islt Grad strip	4180186
40758771	头孢尼西:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758773	ANTIBIOTIC SUSCEPTIBILITIES; AST; Claforan; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758773	Cefotaxime+Sulbac Islt Grad strip	4180186
40758773	头孢噻肟+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758774	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Spizef; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758774	Cefotiam Islt Grad strip	4180186
40758774	头孢替安:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758775	Anspor; ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefamid; Cefrabiotic; Cefradine; Cefral; Cefrasol; Cefril; Celex; Cesporan; Citicef; Ecosporina; Epsilometer; Eskacef; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kelsef; Lenzacef; Lisacef; Maxisporin; MIC; Minimum inhibitory concentration; Point in time; Random; Samedrin; Sefril; Septacef; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Velocef; Velosef	4180186
40758775	Cephradine Islt Grad strip	4180186
40758775	头孢拉定:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758777	ANTIBIOTIC SUSCEPTIBILITIES; AST; Ceftaz; Forj; Fortaz; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj	4180186
40758777	cefTAZidime+Sulbactam Islt MIC	4180186
40758777	头孢他啶+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758778	ANTIBIOTIC SUSCEPTIBILITIES; AST; Ceftaz; Forj; Fortaz; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj	4180186
40758778	cefTAZidime+Sulbactam Susc Islt	4180186
40758778	头孢他啶+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758779	ANTIBIOTIC SUSCEPTIBILITIES; AST; Ceftaz; Disk diffusion; Forj; Fortaz; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj	4180186
40758779	cefTAZidime+Sulbactam Islt KB	4180186
40758779	头孢他啶+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758782	ANTIBIOTIC SUSCEPTIBILITIES; AST; c308; C33; Ceftin; Cefuroxime Axetil; Cefuroxime Oral; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zinacef	4180186
40758782	Cefuroxime Oral Islt Grad strip	4180186
40758782	头孢呋辛.口服型:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758783	ANTIBIOTIC SUSCEPTIBILITIES; AST; c308; C33; Ceftin; Cefuroxime Axetil; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zinacef	4180186
40758783	Cefuroxime Islt Grad strip	4180186
40758783	头孢呋辛:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758784	ANTIBIOTIC SUSCEPTIBILITIES; AST; Aureomycin; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758784	Chlortetracycline Islt Grad strip	4180186
40758784	氯四环素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758786	ANTIBIOTIC SUSCEPTIBILITIES; AST; c306; Cleocin; CLIJ; Dalacin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sobelin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Synergistic; Synergy; Topical	4180186
40758786	Clindamycin.high potency Susc Islt	4180186
40758786	氯洁霉素.高效:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758788	ANTIBIOTIC SUSCEPTIBILITIES; AST; c306; Cleocin; CLIJ; Dalacin; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sobelin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Synergistic; Synergy; Topical	4180186
40758788	Clindamycin.high potency Islt KB	4180186
40758788	氯洁霉素.高效:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758791	ANTIBIOTIC SUSCEPTIBILITIES; AST; Clofazamine; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758791	Clofazamine Islt Grad strip	4180186
40758791	氯法齐明:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758793	Alclox; Ampiclox; Amplium; ANTIBIOTIC SUSCEPTIBILITIES; APO-CLOXI; AST; Austrastaph; Clocillin; Cloxin; Ekvacillin; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Novo-cloxi; Nu-cloxi; Orbenin; Penstapho n; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tegopen	4180186
40758793	Cloxacillin Islt Grad strip	4180186
40758793	邻氯青霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758796	ANTIBIOTIC SUSCEPTIBILITIES; AST; Closina; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Oxamycin; Point in time; Random; Seromycine; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758796	cycloSERINE Islt Grad strip	4180186
40758796	环丝氨酸:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758801	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758801	Dibekacin Islt Grad strip	4180186
40758801	地贝卡星:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758804	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758804	Flumequine Islt MIC	4180186
40758804	氟甲喹:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758806	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758806	Flumequine Islt KB	4180186
40758806	氟甲喹:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758808	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Framitulle; Framybiotal; Framygen; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isofra; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Soframycin; Soframycine; Sofra-tulle; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tuttomycin	4180186
40758808	Framycetin Islt Grad strip	4180186
40758808	新霉素 B:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758809	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Isepacine; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758809	Isepamicin Islt Grad strip	4180186
40758809	异帕米星:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758813	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758813	Isoconazole Islt Grad strip	4180186
40758813	异康唑:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758816	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Macroral; MIC; Midecamycin; Minimum inhibitory concentration; Miocamen; Miokacin; Miokamycin; Momicine; Myoxam; Normicina; Point in time; Ponsinomycin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758816	Miocamycin Islt Grad strip	4180186
40758816	美欧卡霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758818	ANTIBIOTIC SUSCEPTIBILITIES; AST; c216; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758818	Nystatin Islt Grad strip	4180186
40758818	制真菌素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758822	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758822	Ornidazole Islt KB	4180186
40758822	奥硝唑:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758823	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758823	Ornidazole Islt MIC	4180186
40758823	奥硝唑:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758824	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Oxolinic acid; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758824	Oxolinate Islt MIC	4180186
40758824	噁喹酸:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758827	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Oxolinic acid; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758827	Oxolinate Islt Grad strip	4180186
40758827	噁喹酸:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758828	ANTIBIOTIC SUSCEPTIBILITIES; AST; Berkmycen; Clinimycin; Epsilometer; Estrip; E-strip; Glomicin; Grad strip; Hydroxytetracycline; ID; Imperacon; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Oxymicin; Oxytetramix; Point in time; Random; Riomitsin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Terramicina; Terramycin; Terramycine; Terravenos	4180186
40758828	Oxytetracycline Islt Grad strip	4180186
40758828	羟四环素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758835	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Piromidic acid; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758835	Piromidate Susc Islt	4180186
40758835	吡咯酸:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758836	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Piromidic acid; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758836	Piromidate Islt KB	4180186
40758836	吡咯酸:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758840	200 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; PZA; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40758840	PZA 200 ug/mL Islt SlowMyco	4180186
40758840	吡嗪酰胺 200.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40758841	40 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c301; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; RIF; Rifadin; Rifampicin; Rimactane; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40758841	rifAMPin 40 ug/mL Islt SlowMyco	4180186
40758841	利福平 40.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40758842	Acrosoxacin; ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Eracine; Eradacil; Eradacin; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Rosacin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Winuron	4180186
40758842	Rosoxacin Islt Grad strip	4180186
40758842	罗索沙星:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758844	ANTIBIOTIC SUSCEPTIBILITIES; AST; Bykomycetin; c436; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Leucomycin; MIC; Minimum inhibitory concentration; Point in time; Provamicina; Random; Rovamicina; Rovamycin; Rovamycine; Selectomycin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758844	Spiramycin Islt Grad strip	4180186
40758844	螺旋霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758845	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Ticar; Timentin; TIMJ	4180186
40758845	Ticarcillin+Sulbactam Islt MIC	4180186
40758845	羧噻吩青霉素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758846	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Ticar; Timentin; TIMJ	4180186
40758846	Ticarcillin+Sulbactam Susc Islt	4180186
40758846	羧噻吩青霉素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758847	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Ticar; Timentin; TIMJ	4180186
40758847	Ticarcillin+Sulbactam Islt KB	4180186
40758847	羧噻吩青霉素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758851	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tindamax	4180186
40758851	Tinidazole Islt Grad strip	4180186
40758851	替硝唑:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758852	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Stafac; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758852	Virginiamycin Islt Grad strip	4180186
40758852	维及尼霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758853	2; APO; Apo A; Apo A-I; ApoA1; Apol A-I+A-II+B+C Pnl; Apolipo; Apolipoprot; Apolipoprotein A1; Apolipoproteins; Cardio; Cardiology; Chemistry; Heart Disease; Level; Mass concentration; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders	4180186
40758853	Apol A-I+A-II+B+C Pnl SerPl-mCnc	4180186
40758853	载脂蛋白 A-I 与 A-II 与 B 与 C 组套:质量浓度:时间点:血清/血浆:定量型	4182948
40758854	Arylsulfatase A+ B Pnl SerPl-cCnc	4180186
40758854	Aryl sulfatase A; Aryl sulfatase B; Arylsulfatase A; Arylsulfatase A+ B Pnl; Arylsulfatase A+B; Arylsulfatase B; Catalytic Concentration; Chemistry; GalNAc6S sulfatase; Maroteaux-Lamy disease; Metachromatic leucodystrophy; MPS VI; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; rh4S; rhASB; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758854	脑苷脂硫酸酯酶与N-乙酰半乳糖胺-4-硫酸酯酶组套:催化浓度:时间点:血清/血浆:定量型	4182948
40758856	Celiac disease; Fibrin stabilizing factor; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Protein-glutamine gamma glutamyltransferase; Random; Serology; Serum; SR; TG2; tTG; tTG IgA+IgG Pnl; UniversalLabOrders	4180186
40758856	tTG IgA+IgG Pnl Ser	4180186
40758856	组织谷氨酰胺转移酶抗体.IgA 与 IgG 组套:-:时间点:血清:-	4182948
40758857	ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; species; spp; SR; Yersinia sp IgG+IgM Pnl	4180186
40758857	Yersinia sp IgG+IgM Pnl Ser	4180186
40758857	耶尔森氏菌属抗体.IgG 与 IgM 组套:-:时间点:血清:-	4182948
40758858	Fetal RBC/100 RBC Bld FC-Rto	4180186
40758858	100 RBC; Blood; Discocytes; Dynamic; Erthrocyte; Erythrocyte; FC; Fetal cells; Fetal RBC; HEMATOLOGY/CELL COUNTS; Hemoglobin F-loaded erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Rto; WB; Whole blood	4180186
40758858	红细胞.胎儿/100 个红细胞:比率:时间点:全血:定量型:流式细胞测量术	4182948
40758860	Inject Rh Ig Dose Qn	4180186
40758860	BLOOD BANK; D phenotyping; D typing; Dose med or substance; GLB; Glob; Glob%; Globul; Globulins; Imm; Imun; Imune; Inject Rh Ig; Point in time; QNT; Quan; Quant; Quantitative; Random; Rh Ig; Rh phenotyping; Rh typing; RHIG; RhoGAM	4180186
40758860	注射 Rh 血型免疫球蛋白:质量:时间点:剂量药物或剂量物质:定量型	4182948
40758867	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
40758868	Finding; Findings; LMTED; LTD; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
40758869	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Req help from others; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
40758871	Patient safety report Doc	4180186
40758871	Document; Finding; Findings; Point in time; Random	4180186
40758871	患者安全报告:发现:时间点:^事件:文档型	4182948
40758872	Public health Case rprt	4180186
40758872	Case rprt; DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
40758872	案例报告:发现:时间点:{环境}:文档型:公共卫生	4182948
40758878	II; Pan; Panel; PANEL.SURVEY.PHQ; Panl; Patient Health Questionnaire; PHQ; PHQ 2; PHQ2; PHQ-2; Pnl; Point in time; Random; Survey; SURVEY.PHQ	4180186
40758881	CARE Survey; Continuity assessment record and evaluation; Nominal; Othr; Point in time; Random; Survey; Typ	4180186
40758884	#unhealed pressure ulcers at each stage - at assessment; CARE Survey; No; Num; Point in time; Random; Survey	4180186
40758885	Arbitrary; Blood; Del; Deletions; EGFR exon 19; epidermal growth factor receptor; Epidermal growth factor receptor gene; ERBB; ERBB1; Genetics; HER1; Heredity; Heritable; Inherited; mENA; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NISBD2; Oncogene ERBB; Oncology; Ordinal; PCR; PIG61; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; V-ERB-B avian erythroblastic leukemia viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
40758885	EGFR exon 19 Del Bld/T Ql	4180186
40758885	EGFR 基因外显子 19 缺失:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40758889	Blood; EGFR c.2303G&gt;T; epidermal growth factor receptor; Epidermal growth factor receptor gene; ERBB; ERBB1; G2303T; Genetics; HER1; Heredity; Heritable; Inherited; mENA; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NISBD2; Oncogene ERBB; Oncology; Ordinal; PCR; PIG61; Point in time; PR; QL; Qual; Qualitative; Random; S768I; Screen; T prime; Tissue; Tissue, unspecified; V-ERB-B avian erythroblastic leukemia viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
40758889	EGFR c.2303G>T Bld/T Ql	4180186
40758889	EGFR 基因.c.2303G>T:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40758891	Arbitrary; Blood; EGFR exon 20; EGFR exon 20 Ins; epidermal growth factor receptor; Epidermal growth factor receptor gene; ERBB; ERBB1; Genetics; HER1; Heredity; Heritable; Inherited; insertions; mENA; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NISBD2; Oncogene ERBB; Oncology; Ordinal; PCR; PIG61; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; V-ERB-B avian erythroblastic leukemia viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
40758891	EGFR exon 20 Ins Bld/T Ql	4180186
40758891	EGFR 基因外显子 20 插入:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40758892	Baso; Basophil; Basos; Bph; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; HEMATOLOGY/CELL COUNTS; Manl; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40758892	Basophils CSF Manual	4180186
40758892	嗜碱性粒细胞:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
40758893	ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; COAGULATION; Hematology; Heme; Immune globulin G; Immunoglobulin G; MoM; Multiple of the median; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758893	Cardiolipin IgG MoM Ser	4180186
40758893	心磷脂 抗体.IgG:中位数的倍数:时间点:血清:定量型	4182948
40758894	ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; COAGULATION; Hematology; Heme; Immune globulin M; Immunoglobulin M; MoM; Multiple of the median; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758894	Cardiolipin IgM MoM Ser	4180186
40758894	心磷脂 抗体.IgM:中位数的倍数:时间点:血清:定量型	4182948
40758895	Antiglob; BLOOD BANK; Comp; Complmt; DAGT; DAT; DAT C3d-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; Spec	4180186
40758895	DAT C3d-Sp Reag RBC Ql	4180186
40758895	直接抗球蛋白试验.补体 C3d 特异性试剂:存在情况或阈值:时间点:红细胞:序数型	4182948
40758899	Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Manl; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40758899	Eosinophil CSF Manual	4180186
40758899	嗜酸性粒细胞:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
40758903	Blood; Cardio; Cardiology; Haemoglobin; Hb; Heart Disease; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40758903	Hgb Bld Oximetry-mCnc	4180186
40758903	血红蛋白:质量浓度:时间点:全血:定量型:血氧定量法	4182948
40758907	Anticoag; Anti-phospholipid antibody; Clot; Clottable; COAGULATION; Coagulation assay; Coagulation inhibiting antibody; dRVVT; Fac; Fact; Hematology; Heme; i; II; imm 1:2 Plat lysate; LA; LA Nt HPL; LAC; Lipid; Lupus inhibitor; Neut; Neutr; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte; Thrombocytes; Tilt tube	4180186
40758907	LA Nt HPL imm 1:2 Plat lysate PPP	4180186
40758907	狼疮抗凝物质中和作用.高磷脂.因子替换^紧接着在添加1:2血小板溶解产物之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40758908	Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; HEMATOLOGY/CELL COUNTS; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Neuro; Neurology; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40758908	Lymphocytes CSF Manual	4180186
40758908	淋巴细胞:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
40758909	Mononuc Cells # Mar	4180186
40758909	#; ABS; absolute; absolutes; BM; BON; Bone marrow; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Mononuc; Mononuc Cells; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758909	单个核细胞:计数型浓度:时间点:骨髓:定量型	4182948
40758910	Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; HEMATOLOGY/CELL COUNTS; Manl; Myel; Myelo; Myelocyte; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40758910	Myelocytes CSF Manual	4180186
40758910	中幼粒细胞:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
40758911	Bands; bnd; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; HEMATOLOGY/CELL COUNTS; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40758911	Neuts Band CSF Manual	4180186
40758911	嗜中性粒细胞.带状核:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
40758912	Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; HEMATOLOGY/CELL COUNTS; Manl; Neuro; Neurology; Neut; Neutr; Neutrophil; Number; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40758912	Neutrophils CSF Manual	4180186
40758912	嗜中性粒细胞:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
40758913	#; ABS; absolute; absolutes; BM; BON; Bone marrow; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758913	Nuc cell # Mar	4180186
40758913	有核细胞类:计数型浓度:时间点:骨髓:定量型	4182948
40758914	Nuc cell # Fld	4180186
40758914	#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758914	有核细胞类:计数型浓度:时间点:体液:定量型	4182948
40758915	Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; HEMATOLOGY/CELL COUNTS; Manl; Number; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40758915	Other cells CSF Manual	4180186
40758915	其他细胞:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
40758917	ABS; Aby; Antby; Anti; Antibodies; Antibody; aPS; Autoantibodies; Autoantibody; COAGULATION; Hematology; Heme; Immune globulin M; Immunoglobulin M; MoM; Multiple of the median; Phosphatidyl serine; Point in time; PS; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758917	PS IgM MoM Ser	4180186
40758917	磷脂酰丝氨酸 抗体.IgM:中位数的倍数:时间点:血清:定量型	4182948
40758919	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; Ordinal; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; Pl; Platelet rich plasma; Platelets; Platelt; Plavix response assay; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrombocyte; Thrombocytes	4180186
40758919	PA ADP 5 umol/L PRP Ql	4180186
40758919	血小板聚集.二磷酸腺苷诱导型^5 微摩尔/升:存在情况或阈值:时间点:富血小板血浆:序数型	4182948
40758920	Agg; Aggr; COAGULATION; Hematology; Heme; Left; Levo; Ordinal; PA; PA Rist; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; RIPA; Screen; Thrombocyte; Thrombocytes	4180186
40758920	PA Rist 1125 mg/L PRP Ql	4180186
40758920	血小板聚集.瑞斯托菌素诱导型^1125 毫克/升:存在情况或阈值:时间点:富血小板血浆:序数型	4182948
40758921	Agg; Aggr; COAGULATION; Hematology; Heme; Left; Levo; Ordinal; PA; PA Rist; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; RIPA; Screen; Thrombocyte; Thrombocytes	4180186
40758921	PA Rist 1000 mg/L PRP Ql	4180186
40758921	血小板聚集.瑞斯托菌素诱导型^1000 毫克/升:存在情况或阈值:时间点:富血小板血浆:序数型	4182948
40758922	Agg; Aggr; COAGULATION; Hematology; Heme; Left; Levo; Ordinal; PA; PA Rist; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; RIPA; Screen; Thrombocyte; Thrombocytes	4180186
40758922	PA Rist 500 mg/L PRP Ql	4180186
40758922	血小板聚集.瑞斯托菌素诱导型^500 毫克/升:存在情况或阈值:时间点:富血小板血浆:序数型	4182948
40758923	Platelet # BldCo Est	4180186
40758923	#; ABS; absolute; absolutes; Blood - (umbilical) cord; Cnt; Cord (umbilical) blood; Cord bld; Cord blood; Count; Count/volume; CT; estimation; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Platelet; Platelet count; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes	4180186
40758923	血小板:计数型浓度:时间点:脐带全血:定量型:估计法	4182948
40758925	HEMATOLOGY/CELL COUNTS; LAP; Leuc; Leuk; Leukocyte alkaline phosphatase; Leukocytes; Lkcs; NAT; Neutrophil alkaline phosphatase; Ordinal; Phos; Phosphtase; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WBC; WBCs; White blood cell; White blood cells	4180186
40758925	LAP WBC Ql	4180186
40758925	磷酸酶.白细胞:存在情况或阈值:时间点:白细胞:序数型	4182948
40758927	Cellcept; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MMF; MPA; Mycophenolate mofetil; Mycophenolic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758927	Mycophenolate SerPl LC/MS/MS-mCnc	4180186
40758927	吗替麦考酚酯:质量浓度:时间点:血清/血浆:定量型:LC/MS/MS	4182948
40758928	Mycophenolate-G SerPl LC/MS/MS-mCnc	4180186
40758928	Cellcept; DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; Level; Mass concentration; MMF; MPA; MPAG; MPA-G; Mycophenolate mofetil; Mycophenolate-G; Mycophenolic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758928	葡糖苷酸吗替麦考酚酯:质量浓度:时间点:血清/血浆:定量型:LC/MS/MS	4182948
40758930	11DC Amn-mCnc	4180186
40758930	11DC; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758930	11-脱氧皮质醇:质量浓度:时间点:羊水:定量型	4182948
40758931	18OH-Cortis; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758931	18OH-Cortis SerPl-sCnc	4180186
40758931	18-羟基皮质醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758933	18OH-Cortis 24h Ur-sCnc	4180186
40758933	1 day; 18OH-Cortis; 24 hours; 24HR; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
40758933	18-羟基皮质醇:物质的量浓度:24小时:尿液:定量型	4182948
40758936	1 day; 24 hours; 24HR; Chemistry; DHEA; Endocrine; Endocrinology; Level; Mass concentration; Prasterone; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40758936	DHEA 24h Ur-mCnc	4180186
40758936	脱氢表雄酮:质量浓度:24小时:尿液:定量型	4182948
40758938	Amino acids Hair-sCnt	4180186
40758938	AA; Acd; Acid; Amino acid; Amino acids.total; Chemistry; Har; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40758938	氨基酸类:物质的量含量:时间点:毛发:定量型	4182948
40758940	Adiponectin.HMW SerPl-mCnc	4180186
40758940	Adiponectin.HMW; Chemistry; HMW; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Wt	4180186
40758940	脂联素.高分子量:质量浓度:时间点:血清/血浆:定量型	4182948
40758941	Allo-pregnanediol 24h Ur-mRate	4180186
40758941	1 day; 24 hours; 24HR; 5alpha-pregnane-3alpha-20alpha-diol; Chemistry; Mass Rate; mRate; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40758941	别-孕二醇:质量速率:24小时:尿液:定量型	4182948
40758942	1 day; 24 hours; 24HR; 5alpha-pregnane-3alpha-20alpha-diol; Chemistry; Level; Mass concentration; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40758942	Allo-pregnanediol 24h Ur-mCnc	4180186
40758942	别-孕二醇:质量浓度:24小时:尿液:定量型	4182948
40758944	1 day; 24 hours; 24HR; Allo TH-DC; Allo-TH-DC; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; tetrahydro-11-deoxycortisol; TH-DC; UA; UR; Urn	4180186
40758944	Allo-TH-DC 24h Ur-mCnc	4180186
40758944	别-四氢脱氧皮质醇:质量浓度:24小时:尿液:定量型	4182948
40758945	Allo-THB 24h Ur-mRate	4180186
40758945	1 day; 24 hours; 24HR; 5-alpha tetrahydrocorticosterone; 5a-tetrahydrocorticosterone; Allo-THB; Chemistry; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; THB; UA; UR; Urn	4180186
40758945	别-四氢皮质酮:质量速率:24小时:尿液:定量型	4182948
40758946	1 day; 24 hours; 24HR; 5-alpha tetrahydrocorticosterone; 5a-tetrahydrocorticosterone; Allo-THB; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; THB; UA; UR; Urn	4180186
40758946	Allo-THB 24h Ur-mCnc	4180186
40758946	别-四氢皮质酮:质量浓度:24小时:尿液:定量型	4182948
40758947	1 day; 24 hours; 24HR; Allo THC; Allo-THF; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; THC; THF; UA; UR; Urn	4180186
40758947	Allo-THF 24h Ur-mCnc	4180186
40758947	别-四氢皮质醇:质量浓度:24小时:尿液:定量型	4182948
40758948	Acd; Acid A-Glucosidase; Acid maltase; Acids; Alfa; Alpha galactosidase; Alpha-1,4-glucosidase; Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; GAA; Glucoinvertase; Glucosidosucrase; Maltase; Maltase-glucoamylase; Point in time; Pompe disease; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40758948	Acid A-Glucosidase DBS-cCnc	4180186
40758948	Alpha 葡糖苷酶:催化浓度:时间点:全血.斑点:定量型	4182948
40758950	Catalytic Content; Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40758950	Catalase Tiss-cCnt	4180186
40758950	过氧化氢酶:催化含量:时间点:组织与涂片:定量型	4182948
40758951	Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Epinephrine+norepinephrine+dopamine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40758951	Catechols CSF-sCnc	4180186
40758951	儿茶酚胺类:物质的量浓度:时间点:脑脊液:定量型	4182948
40758953	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758953	Cathepsin K SerPl-sCnc	4180186
40758953	组织蛋白酶 K:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758954	Cathepsin L SerPl-mCnc	4180186
40758954	Chemistry; Left; Level; Levo; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758954	组织蛋白酶 L:质量浓度:时间点:血清/血浆:定量型	4182948
40758958	1 day; 24 hours; 24HR; Bowel movement; Chemistry; Cl; Cl-; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Level; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal; Substance Concentration	4180186
40758958	Chloride 24h Stl-sCnc	4180186
40758958	氯:物质的量浓度:24小时:大便:定量型	4182948
40758961	Chemistry; Chol; Choles; Cholest; Cholest Ester; Cholesterol total; Cholesterols; Ester; Level; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758961	Cholest Ester SerPl-sCnc	4180186
40758961	胆固醇酯类:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758962	1 day; 24 hours; 24HR; B; Chemistry; Compound B; Cort; Corticoster; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40758962	Corticoster 24h Ur-mCnc	4180186
40758962	皮质酮:质量浓度:24小时:尿液:定量型	4182948
40758964	Corticoster 24h Ur-sCnc	4180186
40758964	1 day; 24 hours; 24HR; B; Chemistry; Compound B; Cort; Corticoster; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
40758964	皮质酮:物质的量浓度:24小时:尿液:定量型	4182948
40758965	1 day; 17-Hydroxycorticosterone; 24 hours; 24HR; Chemistry; Compound F; Coritsol; Cort; Cortis F; F; FR; hydrocortisone; Mass rate; mRate; Non-protein bound; QNT; Quan; Quant; Quantitative; RADIOIMMUNOASSAY; UA; UR; Urn	4180186
40758965	Cortis F 24h Ur RIA-mRate	4180186
40758965	皮质醇.游离型:质量速率:24小时:尿液:定量型:放射免疫分析法	4182948
40758967	Cryo; Cryoglob IgA; Cryoglob IgA moncl; Cryoglobulins; Cryoprecipitate; Immune globulin A; Immunoglobulin A; M-IgA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
40758967	Cryoglob IgA moncl Ser Ql	4180186
40758967	冷球蛋白.IgA.单克隆型:存在情况或阈值:时间点:血清:序数型	4182948
40758972	Chemistry; gamma-5-Androstenodiol; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758972	Androstenediol SerPl-sCnc	4180186
40758972	雄烯二醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758974	C12DC; C12-DC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40758974	Dicarboxydodecanoylcarn CSF-sCnc	4180186
40758974	二羧基十二烷酰肉碱 (C12-DC):物质的量浓度:时间点:脑脊液:定量型	4182948
40758976	C12DC; C12-DC; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758976	Dicarboxydodecanoylcarn SerPl-sCnc	4180186
40758976	二羧基十二烷酰肉碱 (C12-DC):物质的量浓度:时间点:血清/血浆:定量型	4182948
40758978	Estradiol Fld-mCnc	4180186
40758978	17-beta estradiol; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; E2; Fl; Fld; FLU; Fluid; Level; Mass concentration; Oestradiol; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758978	雌二醇:质量浓度:时间点:体液:定量型	4182948
40758979	Estradiol Fld-sCnc	4180186
40758979	17-beta estradiol; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; E2; Fl; Fld; FLU; Fluid; Level; Oestradiol; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40758979	雌二醇:物质的量浓度:时间点:体液:定量型	4182948
40758980	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Folat; Folic acid; Level; Mass concentration; Point in time; Pteroylglutamate; Pteroylglutamic acid; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Vit M; Vitamin M	4180186
40758980	Folate CSF-mCnc	4180186
40758980	叶酸:质量浓度:时间点:脑脊液:定量型	4182948
40758981	Glucose 24h Stl-mRate	4180186
40758981	1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Glu; Gluc; Glucoseur; Mass rate; mRate; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
40758981	葡萄糖:质量速率:24小时:大便:定量型	4182948
40758985	Glycolate Fld-sCnc	4180186
40758985	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Glycolic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40758985	羟乙酸:物质的量浓度:时间点:体液:定量型	4182948
40758988	B-HCG Free Fld-mCnc	4180186
40758988	B; B HCG; B/F; Beta HCG; Beta human chorionic gonadotropin; BF; B-HCG; B-HCG Free; bod; Bodies; Body fluid; Body fluid, unsp; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; Fl; Fld; FLU; Fluid; FR; HCG; Human chorionic gonadotropin; Level; Mass concentration; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Tumor marker	4180186
40758988	绒毛膜促性腺激素.Beta 亚单位.游离型:质量浓度:时间点:体液:定量型	4182948
40758990	B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
40758990	B-HCG SerPl-mCnc	4180186
40758990	绒毛膜促性腺激素.Beta 亚单位:质量浓度:时间点:血清/血浆:定量型	4182948
40758993	Dicarboxypalmitoylcarn SerPl-sCnc	4180186
40758993	C16DC; C16-DC; Chemistry; Hexadecanediolycarnitine; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; thapsoyl carnitine	4180186
40758993	二羧基棕榈酰肉碱 (C16-DC):物质的量浓度:时间点:血清/血浆:定量型	4182948
40758995	Histidine Hair-sCnt	4180186
40758995	Chemistry; Formiminoglutamic Acidemia; Har; His; Histidinemia; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40758995	组氨酸:物质的量含量:时间点:毛发:定量型	4182948
40758999	1 day; 24 hours; 24HR; Cardio; Cardiology; Chemistry; HCY; Hcys; Hcyst; Heart Disease; Homocyst(e)ine; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
40758999	Hcys 24h Ur-sCnc	4180186
40758999	同型半胱氨酸:物质的量浓度:24小时:尿液:定量型	4182948
40759003	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Hydroxycobalamin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Vit B12b; Vitamin B12; Vitamin B12b	4180186
40759003	Vit B12b Fld-sCnc	4180186
40759003	羟钴胺素:物质的量浓度:时间点:体液:定量型	4182948
40759006	Chemistry; Hydroxycobalamin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Vit B12b; Vitamin B12; Vitamin B12b	4180186
40759006	Vit B12b Ur-mCnc	4180186
40759006	羟钴胺素:质量浓度:时间点:尿液:定量型	4182948
40759008	3OH-anthranilate SerPl-sCnc	4180186
40759008	3-Hydroxy anthranilate; 3-Hydroxyanthranilic acid; 3OH-anthranilate; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759008	3-羟邻氨苯甲酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759009	3OH-anthranilate 24h Ur-sRate	4180186
40759009	1 day; 24 hours; 24HR; 3-Hydroxy anthranilate; 3-Hydroxyanthranilic acid; 3OH-anthranilate; Chemistry; III; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40759009	3-羟邻氨苯甲酸:物质的量速率:24小时:尿液:定量型	4182948
40759012	OH-Lysine Hair-sCnt	4180186
40759012	Chemistry; Har; Hydroxy lysine; Hydroxyl; OH-Lysine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40759012	羟基赖氨酸:物质的量含量:时间点:毛发:定量型	4182948
40759015	HPRT/APRT Placenta-cRto	4180186
40759015	Adenine transaminase; APRT; B4 Hemosan; Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Enzymatic activity ratio; HGPRT; HPRT; hypoxanthine-guanine phosphoribosyltransferase; Leuco-4; Placent; Placental; Point in time; QNT; Quan; Quant; Quantitative; Random; Vit B4; Vitamin B4	4180186
40759015	次黄嘌呤-鸟嘌呤磷酸核糖转移酶/腺嘌呤磷酸核糖转移酶:催化比率:时间点:胎盘:定量型	4182948
40759019	Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; FLC; FR; Hematology; Heme; IFE; Ifix; Immune globulin; Immuno; Immunofixation electrophoresis; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Non-protein bound; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40759019	BJ Protein Free Ser Ql IFE	4180186
40759019	免疫球蛋白轻链.游离型:存在情况或阈值:时间点:血清:序数型:免疫固定电泳分析法	4182948
40759020	Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; FLC; FR; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Non-protein bound; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40759020	BJ Protein Free Ur Ql Elph	4180186
40759020	免疫球蛋白轻链.游离型:存在情况或阈值:时间点:尿液:序数型:电泳	4182948
40759021	Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; FLC; FR; Hematology; Heme; IFE; Ifix; Immune globulin; Immuno; Immunofixation electrophoresis; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Non-protein bound; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40759021	BJ Protein Free Ur Ql IFE	4180186
40759021	免疫球蛋白轻链.游离型:存在情况或阈值:时间点:尿液:序数型:免疫固定电泳分析法	4182948
40759022	M-IgA Ser Ql IEP	4180186
40759022	Chemistry; IEP; Imm elect; Immune globulin A; Immunoelect; Immunoglobulin A; M-IgA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SIE; SIEP; SR	4180186
40759022	IgA.单克隆型:存在情况或阈值:时间点:血清:序数型:免疫电泳	4182948
40759023	Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Immune globulin A; Immunoglobulin A; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759023	IgA Ser Elph-mCnc	4180186
40759023	IgA:质量浓度:时间点:血清:定量型:电泳	4182948
40759024	M-IgD Ser Ql IEP	4180186
40759024	Chemistry; IEP; Imm elect; Immune globulin D; Immunoelect; Immunoglobulin D; M-IgD; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SIE; SIEP; SR	4180186
40759024	IgD.单克隆型:存在情况或阈值:时间点:血清:序数型:免疫电泳	4182948
40759025	Chemistry; IEP; Imm elect; Immune globulin E; Immunoelect; Immunoglobulin E; M-IgE; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SIE; SIEP; SR	4180186
40759025	M-IgE Ser Ql IEP	4180186
40759025	IgE.单克隆型:存在情况或阈值:时间点:血清:序数型:免疫电泳	4182948
40759027	1 day; 24 hours; 24HR; A-cortolone; Alfa; Chemistry; Cortisol metabolite; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40759027	A-cortolone 24h Ur-mRate	4180186
40759027	Alpha-皮酮四醇:质量速率:24小时:尿液:定量型	4182948
40759028	A-cortolone 24h Ur-mCnc	4180186
40759028	1 day; 24 hours; 24HR; A-cortolone; Alfa; Chemistry; Cortisol metabolite; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40759028	Alpha-皮酮四醇:质量浓度:24小时:尿液:定量型	4182948
40759030	A-L-Iduronidase DBS-cCnc	4180186
40759030	Alfa; Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Hurler disease; Left; Levo; Point in time; QNT; Quan; Quant; Quantitative; Random; Scheie disease; WB; Whole blood	4180186
40759030	Alpha-L-艾杜糖苷酶:催化浓度:时间点:全血.斑点:定量型	4182948
40759033	Arylsulfatase DBS-cCnc	4180186
40759033	Arylsulfatase.total; Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40759033	芳基硫酸酯酶:催化浓度:时间点:全血.斑点:定量型	4182948
40759035	Beta1 Glob CSF Elph-mCnc	4180186
40759035	B; B1 globulin; Beta1 Glob; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40759035	Beta 1 球蛋白:质量浓度:时间点:脑脊液:定量型:电泳	4182948
40759037	B; B-Galactosidase; Blood; Catalytic Concentration; Chemistry; DBS; Disaccharidase; Dried blood spot; Filter paper; FP; GM 1-gangliosidosis; Lactase; Morquio disease type B; MPS IV B; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40759037	B-Galactosidase DBS-cCnc	4180186
40759037	Beta 半乳糖苷酶:催化浓度:时间点:全血.斑点:定量型	4182948
40759038	Glucosylceramidase DBS-cCnc	4180186
40759038	Acid beta Glucosidase; Beta glucocerebrosidase; Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40759038	葡糖神经酰胺酶:催化浓度:时间点:全血.斑点:定量型	4182948
40759039	After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759039	C peptide p meal SerPl-mCnc	4180186
40759039	C 肽^在进餐之后:质量浓度:时间点:血清/血浆:定量型	4182948
40759040	C peptide p meal SerPl-sCnc	4180186
40759040	After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759040	C 肽^在进餐之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759045	M-IgM Ser Ql IEP	4180186
40759045	Chemistry; IEP; Imm elect; Immune globulin M; Immunoelect; Immunoglobulin M; M-IgM; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SIE; SIEP; SR	4180186
40759045	IgM.单克隆型:存在情况或阈值:时间点:血清:序数型:免疫电泳	4182948
40759047	Alfa; CG Antigen-Specific Helper Factor; Chains; Chemistry; Chn; Epidermal Cell Derived Thymocyte-Activating Factor; ETAF; i; IL; IL1; IL-1; Il2RecepA; Level; Lymphocyte-Activating Factor; Lymphocyte-Stimulating Hormone; Macrophage Cell Factor; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T Helper Factor	4180186
40759047	Il2RecepA SerPl-mCnc	4180186
40759047	白细胞介素 1 受体 alpha 链:质量浓度:时间点:血清/血浆:定量型	4182948
40759049	Iodine/Creat Ur	4180186
40759049	c616; Chemistry; CR; Crea; Creat; i; I-; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40759049	碘/肌酐:质量比率:时间点:尿液:定量型	4182948
40759050	Chemistry; Har; Ile; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40759050	Isoleucine Hair-sCnt	4180186
40759050	异亮氨酸:物质的量含量:时间点:毛发:定量型	4182948
40759053	Lactate BldCo-sCnc	4180186
40759053	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Lact; Lactic acid; Level; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40759053	乳酸:物质的量浓度:时间点:脐带全血:定量型	4182948
40759056	Lysine Hair-sCnt	4180186
40759056	2,6-diaminohexanoic acid; Chemistry; Har; Lys; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40759056	赖氨酸:物质的量含量:时间点:毛发:定量型	4182948
40759061	C3DC; C3-DC; Chemistry; Dicarboxylic carnitine; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759061	Malonylcarn SerPl-sCnc	4180186
40759061	丙二酰肉碱 (C3-DC):物质的量浓度:时间点:血清/血浆:定量型	4182948
40759062	Mannitol Ur-mCnc	4180186
40759062	Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40759062	甘露醇:质量浓度:时间点:尿液:定量型	4182948
40759063	Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Haemoglobin; Hb; Hemiglobin; Hgb; Hi; Mass fraction; Methaemoglobin; MetHb; Methgb; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
40759063	MetHgb MFr BldCo	4180186
40759063	高铁血红蛋白/血红蛋白.总计:质量分数:时间点:脐带全血:定量型	4182948
40759069	Chemistry; Level; NO2; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759069	Nitrite SerPl-sCnc	4180186
40759069	亚硝酸盐:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759070	Dicarboxystearoylcarn SerPl-sCnc	4180186
40759070	C18DC; C18-DC; Chemistry; Dicarboxy stearoyl carnitine; Dicarboxy stearoylcarnitine; Dicarboxylic carnitine; Level; octadecanedioyl carnitine; octadecanedioylcarnitine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759070	二羧基硬脂酰肉碱 (C18-DC):物质的量浓度:时间点:血清/血浆:定量型	4182948
40759071	Octanoylcarn Ur-sCnc	4180186
40759071	C8; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40759071	辛酰肉碱 (C8):物质的量浓度:时间点:尿液:定量型	4182948
40759078	Oleoylcarn Amn-sCnc	4180186
40759078	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C18:1; Chemistry; i; Level; Octadecenoyl carnitine; Octadecenoylcarnitine; Oleoyl carnitine; Oleyl carnitine; Oleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40759078	油酰肉碱 (C18:1):物质的量浓度:时间点:羊水:定量型	4182948
40759080	AA; Acd; Acid; Amino acid; Amino acids.total; Chemistry; Orn; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Tot; Totl	4180186
40759080	Ornithine SFr SerPl	4180186
40759080	鸟氨酸/氨基酸类.总计:物质的量分数:时间点:血清/血浆:定量型	4182948
40759081	Osmolality Dial fld	4180186
40759081	Chemistry; Diaf; Dialysate; Dialysis fluid; Osmo; Osmol; Osmolality; osmolarity; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759081	渗透压:渗透压:时间点:透析液:定量型	4182948
40759082	Chemistry; Ethanedioate; Ethanedioic acid; Level; Oxal; Oxalic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Wat	4180186
40759082	Oxalate Wat-sCnc	4180186
40759082	草酸:物质的量浓度:时间点:水:定量型	4182948
40759084	C16:1; Chemistry; CR; Crea; Creat; Hexadecenoylcarnitine; i; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40759084	Palmitoleylcarn/Creat Ur-sRto	4180186
40759084	棕榈烯酰肉碱 (C16:1)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40759085	Palmitoleylcarn CSF-sCnc	4180186
40759085	C16:1; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hexadecenoylcarnitine; i; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40759085	棕榈烯酰肉碱 (C16:1):物质的量浓度:时间点:脑脊液:定量型	4182948
40759086	Palmitoleylcarn Amn-sCnc	4180186
40759086	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C16:1; Chemistry; Hexadecenoylcarnitine; i; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40759086	棕榈烯酰肉碱 (C16:1):物质的量浓度:时间点:羊水:定量型	4182948
40759087	Palmitoleylcarn Ur-sCnc	4180186
40759087	C16:1; Chemistry; Hexadecenoylcarnitine; i; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40759087	棕榈烯酰肉碱 (C16:1):物质的量浓度:时间点:尿液:定量型	4182948
40759091	Chemistry; Har; Phe; Point in time; PPA; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40759091	Phe Hair-sCnt	4180186
40759091	苯丙氨酸:物质的量含量:时间点:毛发:定量型	4182948
40759094	Ascites; Ascitic fluid; Ascitis; Chemistry; i Phos; Inorganic phosphate; Level; Peritoneal fluid; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40759094	Phosphate Prt-sCnc	4180186
40759094	磷酸盐:物质的量浓度:时间点:腹膜液:定量型	4182948
40759095	Chemistry; ID; Imm; Immune globulin G; Immunodiff; Immunodiffusion; Immunoglobulin G; Imun; Imune; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759095	IgG Ser ID-mCnc	4180186
40759095	IgG:质量浓度:时间点:血清:定量型:免疫扩散法	4182948
40759098	by LM; Corr lens; Distance; EYE; EYE.GLASSES; Focimeter; Inverse Length; L; L corr lens; Lensometer; LM; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759098	L corr lens Sphere far by LM	4180186
40759098	球面距离:长度倒数:时间点:矫正镜片.左侧:定量型:透镜屈光度计法	4182948
40759099	by LM; Corr lens; EYE; EYE.GLASSES; Focimeter; L; L corr lens; Length Ratio; Lensometer; LM; LT; Near VA; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA	4180186
40759099	L corr lens Near VA by LM	4180186
40759099	视力.近距:长度比率:时间点:矫正镜片.左侧:定量型:透镜屈光度计法	4182948
40759100	by LM; Corr lens; Distance; EYE; EYE.GLASSES; Far VA; Focimeter; Length Ratio; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; Refraction; RT; VA	4180186
40759100	R corr lens Far VA by LM	4180186
40759100	视力.远距:长度比率:时间点:矫正镜片.右侧:定量型:透镜屈光度计法	4182948
40759102	by LM; Corr lens; Distance; EYE; EYE.GLASSES; Far VA; Focimeter; L; L corr lens; Length Ratio; Lensometer; LM; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; SBM VA far; VA	4180186
40759102	L corr lens SBM VA far by LM	4180186
40759102	SBM 视力.远距:长度比率:时间点:矫正镜片.左侧:定量型:透镜屈光度计法	4182948
40759103	棱镜基准方向:角度:时间点:矫正镜片.右侧:定量型:透镜屈光度计法	4182948
40759103	R corr lens Prism base dir by LM	4180186
40759103	by LM; Corr lens; EYE; EYE.GLASSES; Focimeter; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; RT	4180186
40759104	by LM; Corr lens; EYE; EYE.GLASSES; Focimeter; Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Oral; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; RT	4180186
40759104	R corr lens N PO by LM	4180186
40759104	N 口服:长度:时间点:矫正镜片.右侧:定量型:透镜屈光度计法	4182948
40759105	EYE; EYE.GLASSES; Glasses Rx; i; Inverse Length; L; L glasses Rx; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Rx; Sphere N 1	4180186
40759105	L glasses Rx Sphere N 1	4180186
40759105	近视球镜度 1:长度倒数:时间点:眼镜处方.镜片.左侧:定量型	4182948
40759106	瞳距.单眼近用:长度:时间点:眼镜处方.镜片.左侧:定量型	4182948
40759106	EYE; EYE.GLASSES; Glasses Rx; L; L glasses Rx; Length; LT; Ophthalmology; Ophtho; Ophthy; PD; PD monoc; PD monoc near; Point in time; QNT; Quan; Quant; Quantitative; Random; Rx	4180186
40759106	L glasses Rx PD monoc near	4180186
40759107	EYE; EYE.GLASSES; Glasses Rx; Length; Ophthalmology; Ophtho; Ophthy; Oral; Point in time; QNT; Quan; Quant; Quantitative; R; R glasses Rx; Random; RT; Rx	4180186
40759107	R glasses Rx N PO	4180186
40759107	N 口服:长度:时间点:眼镜处方.镜片.右侧:定量型	4182948
40759108	L eye Near VA by Phoropter	4180186
40759108	by Phoropter; Eye; EYE.REFRACTION; Eyeball; L; L eye; Length Ratio; LT; Near VA; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
40759108	视力.近距:长度比率:时间点:眼睛.左侧:定量型:综合屈光检查仪	4182948
40759113	Cont lens; EYE; EYE.CONTACT_LENS; Identity or presence; L; L cont lens Rx; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Rx	4180186
40759113	L cont lens Rx Lens fitting	4180186
40759113	镜片安装:存在与否或特征标识:时间点:隐形眼镜处方.左侧:名义型	4182948
40759116	Cont lens; DIA; Diam; EYE; EYE.CONTACT_LENS; L; L cont lens; Length; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759116	L cont lens Diam	4180186
40759116	直径:长度:时间点:隐形眼镜.左侧:定量型	4182948
40759117	Cont lens; EYE; EYE.CONTACT_LENS; Length; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cont lens; Random; RT; Upper extremity	4180186
40759117	R cont lens Radius	4180186
40759117	半径:长度:时间点:隐形眼镜.右侧:定量型	4182948
40759118	Cont lens; EYE; EYE.CONTACT_LENS; Inverse Length; Ophthalmology; Ophtho; Ophthy; OR sphere; Point in time; QNT; Quan; Quant; Quantitative; R; R cont lens; Random; RT	4180186
40759118	R cont lens OR sphere	4180186
40759118	重叠屈光球面:长度倒数:时间点:隐形眼镜.右侧:定量型	4182948
40759119	Cont lens; CYL; EYE; EYE.CONTACT_LENS; Inverse Length; Ophthalmology; Ophtho; Ophthy; OR cylinder; Point in time; QNT; Quan; Quant; Quantitative; R; R cont lens; Random; RT	4180186
40759119	R cont lens OR cylinder	4180186
40759119	重叠屈光柱面:长度倒数:时间点:隐形眼镜.右侧:定量型	4182948
40759120	Cont lens; EYE; EYE.CONTACT_LENS; Ophthalmology; Ophtho; Ophthy; OR axis; Point in time; QNT; Quan; Quant; Quantitative; R; R cont lens; Random; RT	4180186
40759120	R cont lens OR axis	4180186
40759120	重叠屈光轴:角度:时间点:隐形眼镜.右侧:定量型	4182948
40759121	Cont lens; EYE; EYE.CONTACT_LENS; Ident; Identifier; Narrative; Ophthalmology; Ophtho; Ophthy; Point in time; R; R cont lens; Random; Report; RT	4180186
40759121	R cont lens Manufacturer name	4180186
40759121	制造商名称:标识符:时间点:隐形眼镜.右侧:叙述型	4182948
40759122	Arbitrary; Cont lens; EYE; EYE.CONTACT_LENS; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; R; R cont lens; Random; RT; Screen	4180186
40759122	R cont lens Lenticulation	4180186
40759122	透镜光栅:任意型:时间点:隐形眼镜.右侧:序数型	4182948
40759124	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Blood; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; Ordinal; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; PA ADP ATP secr; Pl; Platelets; Platelt; Plavix response assay; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759124	PA ADP ATP secr 10 umol/L Bld Ql	4180186
40759124	血小板聚集.二磷酸腺苷诱导型 ATP 分泌^10 微摩尔/升:存在情况或阈值:时间点:全血:序数型	4182948
40759126	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Blood; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; Pl; Platelets; Platelt; Plavix response assay; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759126	PA ADP 5 umol/L Bld	4180186
40759126	血小板聚集.二磷酸腺苷诱导型^5 微摩尔/升:相对任意型浓度:时间点:全血:定量型	4182948
40759128	5,8,11,14 Eicosatetraenoic acid; AA; Agg; Aggr; Arachidonic acid; Arch acid; Aspirin Assay; Blood; C20:4w6; COAGULATION; Eicosatetraenoate; Hematology; Heme; Left; Levo; PA; PA AA; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759128	PA AA 500 umol/L Bld	4180186
40759128	血小板聚集.花生四烯酸诱导型^500 微摩尔/升:相对任意型浓度:时间点:全血:定量型	4182948
40759131	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; mcg; PA; PA Rist; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759131	PA Rist 250 ug/mL Bld	4180186
40759131	血小板聚集.瑞斯托菌素诱导型^250.0 微克/毫升:相对任意型浓度:时间点:全血:定量型	4182948
40759133	5,8,11,14 Eicosatetraenoic acid; AA; Agg; Aggr; Arachidonic acid; Arch acid; Aspirin Assay; Blood; C20:4w6; COAGULATION; Eicosatetraenoate; Hematology; Heme; Left; Levo; Ordinal; PA; PA AA; PA AA ATP secr; Pl; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759133	PA AA ATP secr 500 umol/L Bld Ql	4180186
40759133	血小板聚集.花生四烯酸诱导型 ATP 分泌^500 微摩尔/升:存在情况或阈值:时间点:全血:序数型	4182948
40759140	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; i; PA; PA Thromb ATP secr; PA Thrombin; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Throm; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759140	PA Thromb ATP secr 1 U/mL Bld	4180186
40759140	血小板聚集.凝血酶诱导型 ATP 分泌^1 单位/毫升:相对任意型浓度:时间点:全血:定量型	4182948
40759141	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; PA; PA Thromb ATP secr; PA Thrombin; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Throm; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759141	PA Thromb ATP secr 5 U/mL Bld	4180186
40759141	血小板聚集.凝血酶诱导型 ATP 分泌^5 单位/毫升:相对任意型浓度:时间点:全血:定量型	4182948
40759144	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aphthovirus; Arbitrary concentration; Dis; Diseases; DNA NUCLEIC ACID PROBE; DNA probe; Dz; FMDV; Foot and mouth disease; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lower extremity; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Picornavirus; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
40759144	FMDV RNA Spec NAA+probe-aCnc	4180186
40759144	口蹄疫病毒 RNA:任意型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
40759145	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV N1; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load	4180186
40759145	FLUAV N1 RNA Spec NAA+probe-aCnc	4180186
40759145	流感病毒 A 型神经氨酸酶 N1 型 RNA:任意型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
40759146	8 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Etambol; Ethamb; ID; Inagen; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myambutol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mycobutol; Olbutam; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40759146	Ethambutol 8 ug/mL Islt SlowMyco	4180186
40759146	乙胺丁醇 8.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40759150	CD3-CD56+ Cells NFr Fld	4180186
40759150	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD3 Cells; CD3+CD56+ Cells; CD3-CD56+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Leu19; Leu-19; Leu4; Leu-4; Natural killer cells; NCAM; Neural cell adhesion molecule; NKH1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3	4180186
40759150	细胞.CD3-CD56+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40759151	Bladder cell cancer; Chromosome analysis; Fluorescent in situ hybridization; Genetics; Genotype; Heredity; Heritable; Identity or presence; Inherited; Karyogram; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; UA; UR; Urn	4180186
40759151	Karyotyp Ur FISH	4180186
40759151	核型:存在与否或特征标识:时间点:尿液:叙述型:FISH	4182948
40759154	1 day; 24 hours; 24HR; Chemistry; gamma-5-Androstenodiol; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40759154	Androstenediol 24h Ur-mRate	4180186
40759154	雄烯二醇:质量速率:24小时:尿液:定量型	4182948
40759155	OH-Lysine Fld-sCnc	4180186
40759155	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Hydroxy lysine; Hydroxyl; Level; OH-Lysine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40759155	羟基赖氨酸:物质的量浓度:时间点:体液:定量型	4182948
40759157	APO; Apo B; ApoB; Apolipo; Apolipoprot; Apolipoproteins; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; LDLc; LDL-C; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759157	Apo B/LDLc SerPl	4180186
40759157	载脂蛋白 B/胆固醇.LDL 之中的:质量比率:时间点:血清/血浆:定量型	4182948
40759160	Lysozyme Ur-aCnc	4180186
40759160	Arbitrary concentration; Chemistry; k208; Lysozymes; Muramidase; N-Acetylmuramide Glycanhydrolase; nGal d 4 Lysozyme, Egg; Point in time; QNT; Quan; Quant; Quantitative; Random; Rk208; UA; UR; Urn	4180186
40759160	溶菌酶:任意型浓度:时间点:尿液:定量型	4182948
40759164	Adduction PROM; H+P; H+P.PX; Horizontal adduction PROM; MSK; Musculoskeletal; Ortho; Orthopedics; P prime; Point in time; PROM; QNT; Quan; Quant; Quantitative; R; Random; Rnge; RT; Should-R; Upper extremity joint	4180186
40759164	Should-R Horizontal adduction PROM Qn	4180186
40759164	水平内收.被动运动范围:角度:时间点:肩关节.右侧:定量型	4182948
40759166	Adduction PROM; H+P; H+P.PX; Horizontal adduction PROM; L; LT; MSK; Musculoskeletal; Ortho; Orthopedics; P prime; Point in time; PROM; QNT; Quan; Quant; Quantitative; Random; Rnge; Should-L; Upper extremity joint	4180186
40759166	Should-L Horizontal adduction PROM Qn	4180186
40759166	水平内收.被动运动范围:角度:时间点:肩关节.左侧:定量型	4182948
40759167	Adduction PROM; H+P; H+P.PX; Horizontal adduction PROM; MSK; Musculoskeletal; Ortho; Orthopedics; P prime; Point in time; PROM; QNT; Quan; Quant; Quantitative; Random; Rnge; Upper extremity joint	4180186
40759167	Should Horizontal adduction PROM Qn	4180186
40759167	水平内收.被动运动范围:角度:时间点:肩关节:定量型	4182948
40759168	Adduction AROM; AROM; H+P; H+P.PX; Horizontal adduction AROM; MSK; Musculoskeletal; Ortho; Orthopedics; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnge; Upper extremity joint	4180186
40759168	Should Horizontal adduction AROM Qn	4180186
40759168	水平内收.主动运动范围:角度:时间点:肩关节:定量型	4182948
40759169	Adduction AROM; AROM; H+P; H+P.PX; Horizontal adduction AROM; L; LT; MSK; Musculoskeletal; Ortho; Orthopedics; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnge; Should-L; Upper extremity joint	4180186
40759169	Should-L Horizontal adduction AROM Qn	4180186
40759169	水平内收.主动运动范围:角度:时间点:肩关节.左侧:定量型	4182948
40759170	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40759172	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40759172	西班牙裔或拉丁裔:发现:时间点:^患者:序数型	4182948
40759175	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Upper extremity	4180186
40759177	Birth weight Reported	4180186
40759177	@ birth; Bdy weight; bod; Bodies; BODY WEIGHT.MOLEC; New born; Newborn; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
40759177	体重^出生时:质量:时间点:^患者:定量型:报告法	4182948
40759181	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40759183	Girth; Lower extremity joint; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40759184	Circumf of gluteus muscles Pelvis	4180186
40759184	Circumf of gluteus muscles; Girth; Length; Pelvic; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759184	周长.臀肌最突出部位:长度:时间点:盆腔:定量型	4182948
40759185	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40759186	Pan; Panel; PANEL.PHENX; Panl; PhenX; Pnl; Point in time; Random	4180186
40759186	自我报告的最大成年身高:-:时间点:^患者:-	4182948
40759187	Axial length; bod; Bodies; Body length; Length; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759187	Body height at age 25 Stated	4180186
40759187	身高^在25岁时:长度:时间点:^患者:定量型:声称法	4182948
40759188	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Wt	4180186
40759192	Girth; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Up; Upper extremity	4180186
40759195	Girth; Length; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759195	Circumf Neck	4180186
40759195	周长:长度:时间点:颈部:定量型	4182948
40759197	Gestation; Gestations; Gravida; Pan; Panel; PANEL.PHENX; Panl; PhenX; Pnl; Point in time; Pregnancies; Random; Wt; Wt gain	4180186
40759197	妊娠期体重增加.当前:-:时间点:^患者:-	4182948
40759198	Bdy weight; Before; bod; Bodies; Gestation; Gestations; Gravida; PhenX; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
40759198	Weight pre current pregnancy	4180186
40759198	体重^在当前妊娠之前:质量:时间点:^患者:定量型	4182948
40759199	Wt gain during current pregnancy	4180186
40759199	Gestation; Gestations; Gravida; PhenX; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random; Wt; Wt gain	4180186
40759199	体重增加^在当前妊娠过程中:质量:时间点:^患者:定量型	4182948
40759200	Weight pre most recent pregnancy	4180186
40759200	Bdy weight; Before; bod; Bodies; Gestation; Gestations; Gravida; PhenX; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
40759200	体重^在最近妊娠之前:质量:时间点:^患者:定量型	4182948
40759202	Fetal; GA; GA (weeks); Gest; Gestation; Gyn; Gynecology; OB; ObGyn; Obstetrics; PhenX; Point in time; Prenatal; QNT; Quan; Quant; Quantitative; Random	4180186
40759202	GA (weeks)--at most recent delivery	4180186
40759202	以星期为单位的孕龄^最近分娩时:时间:时间点:^胎儿:定量型	4182948
40759204	Weight XXX time ago	4180186
40759204	Bdy weight; bod; Bodies; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
40759204	体重^XXX 时间以前:质量:时间点:^患者:定量型	4182948
40759205	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Wt	4180186
40759206	Girth; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40759207	Girth; Pan; Panel; PANEL.PHENX; Panl; PhenX; Pnl; Point in time; Random	4180186
40759207	Adult Waist Circumf	4180186
40759207	成年人腰围方案:-:时间点:^患者:-	4182948
40759209	Pan; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40759212	Race PhenX	4180186
40759212	Ethnicity; Nominal; Point in time; Random; Typ	4180186
40759212	种族:类型:时间点:^患者:名义型:PhenX	4182948
40759214	@ birth; Bdy weight; bod; Bodies; BODY WEIGHT.MOLEC; New born; Newborn; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
40759214	体重^出生时:质量:时间点:^患者:定量型:正常变异矮小身材	4182948
40759217	Hand dom- 42Mo proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Upper extremity	4180186
40759217	Hand dom- 42Mo proto ALSPAC	4180186
40759217	PhenX - 手部优势 - 42 个月及其以上方案 020601:-:时间点:^患者:-:ALSPAC	4182948
40759219	Hand dom- throwing a ball ALSPAC	4180186
40759219	Finding; Findings; Hand dom- throwing a ball; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759219	手部优势 - 投球:发现:时间点:^患者:名义型:ALSPAC	4182948
40759220	Finding; Findings; Hand dom- coloring; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759220	Hand dom- coloring ALSPAC	4180186
40759220	手部优势 - 涂颜色:发现:时间点:^患者:名义型:ALSPAC	4182948
40759221	Hand dom- holding a toothbrush ALSPAC	4180186
40759221	Finding; Findings; Hand dom- holding a toothbrush; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759221	手部优势 - 手持牙刷:发现:时间点:^患者:名义型:ALSPAC	4182948
40759232	Hand dom- thread a needle EHI	4180186
40759232	Finding; Findings; Hand dom- thread a needle; NDL; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759232	手部优势 - 穿针引线:发现:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759235	Circumf by NHANES	4180186
40759235	Abd; Abdo; Abdomen+; Abdominal; BODY CIRCUMFERENCE.MOLEC; Girth; Length; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759235	周长:长度:时间点:腹部.中部:定量型:NHANES	4182948
40759236	Circumf by NCFS	4180186
40759236	Abd; Abdo; Abdomen+; Abdominal; BODY CIRCUMFERENCE.MOLEC; Girth; Length; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759236	周长:长度:时间点:腹部.中部:定量型:全国儿童食品调查	4182948
40759238	Circumf by WHI	4180186
40759238	Abd; Abdo; Abdomen+; Abdominal; BODY CIRCUMFERENCE.MOLEC; Girth; Length; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759238	周长:长度:时间点:腹部.中部:定量型:腰臀指数测定法	4182948
40759242	Chemistry; Immune globulin A; Immunoglobulin A; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40759242	IgA Ur-mCnc	4180186
40759242	IgA:质量浓度:时间点:尿液:定量型	4182948
40759243	Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759243	IgG BldCo-mCnc	4180186
40759243	IgG:质量浓度:时间点:脐带全血:定量型	4182948
40759244	IgM Ur-mCnc	4180186
40759244	Chemistry; Immune globulin M; Immunoglobulin M; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40759244	IgM:质量浓度:时间点:尿液:定量型	4182948
40759245	1 hour; 1.0Hr; 1h p meal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p meal; PC; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40759245	Glucose 1h p meal Ur-mCnc	4180186
40759245	葡萄糖^在进餐之后1小时:质量浓度:时间点:尿液:定量型	4182948
40759246	Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; FLC; FR; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Non-protein bound; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40759246	BJ Protein Free Ser Ql	4180186
40759246	免疫球蛋白轻链.游离型:存在情况或阈值:时间点:血清:序数型	4182948
40759249	CHIKV IgG Titr SerPl IF	4180186
40759249	基孔肯亚病毒 抗体.IgG:滴定度:时间点:血清/血浆:定量型:免疫荧光法	4182948
40759249	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CHIKV; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759252	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CHIKV; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF	4180186
40759252	CHIKV IgM SerPl Ql IF	4180186
40759252	基孔肯亚病毒 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
40759253	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; HDLc 2a; Heart Disease; High density lipoprotein cholesterols; Level; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TCHHDL	4180186
40759253	HDLc 2a SerPl-sCnc	4180186
40759253	胆固醇.HDL 2a 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759257	Cardio; Cardiology; Chemistry; Heart Disease; i; LDL1; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759257	LDL1 SerPl-sCnc	4180186
40759257	胆固醇.LDL 1 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759258	Cardio; Cardiology; Chemistry; Heart Disease; II; LDL2; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759258	LDL2 SerPl-sCnc	4180186
40759258	胆固醇.LDL 2 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759259	Cardio; Cardiology; Chemistry; Heart Disease; III; LDL3; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759259	LDL3 SerPl-sCnc	4180186
40759259	胆固醇.LDL 3 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759260	Cardio; Cardiology; Chemistry; Heart Disease; LDL4; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759260	LDL4 SerPl-sCnc	4180186
40759260	胆固醇.LDL 4 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759261	Amplif; Amplification; Amplified; Anus; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HC; HPA; HPV; HPV I/H Risk 1; HPV IHR; HPV16; HPV16 and 18; HPV16+18; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Papilloma virus high risk; Papilloma virus intermediate/high risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Rectal specimen; Screen	4180186
40759261	HPV I/H Risk 1 DNA Anal Ql Probe+sig amp	4180186
40759261	人乳头瘤病毒 16+18+31+33+35+39+45+51+52+56+58+59+68 型 DNA:存在情况或阈值:时间点:肛门:序数型:探针法.基因扩增.信号	4182948
40759262	1073G&gt;A; Blood; CD110; C-MPL; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MPL p.S505N; MPL proto-oncogene, thrombopoietin receptor; MPLV; MYELOPROLIFERATIVE LEUKEMIA VIRUS ONCOGENE; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Ser505Asn; THCYT2; thrombopoietin receptor mutations; Tissue; Tissue, unspecified; TPOR; WB; Whole blood; Whole blood or Tissue	4180186
40759262	MPL p.S505N Bld/T Ql	4180186
40759262	MPL 基因.p.S505N:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40759264	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; k; K+; Kidney; Nephrology; Potass; QNT; Quan; Quant; Quantitative; Renal; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40759264	Potassium/Creat 24h Ur-sRto	4180186
40759264	钾/肌酐:物质的量比率:24小时:尿液:定量型	4182948
40759265	Blood; BRX-like translocated in leukemia; BTL; Cysteine-rich hydrophobic domain 2; Cystein-rich hydrophobic domain 2; Del; Deletions; Document; Finding; Findings; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; MGC21173; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40759265	CHIC2 gene 4q12 Del Bld/T FISH	4180186
40759265	CHIC2 基因 4q12 缺失:发现:时间点:全血/组织:文档型:FISH	4182948
40759266	CD55+CD59 def RBC+Gran Bld-Imp	4180186
40759266	1F-5Ag; Blood; CD55 Granulocytes; CD55+CD59 def RBC+Gran; CD59.deficient; CELL MARKERS; DAF; Decay accelerating factor; Discocytes; Erthrocyte; Erythrocyte; Gran; Grans; Granulocyte; Granulocytes; H19; HRF20; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MACIF; Membrane Inhibitor of Reactive Lysis; MIRL; Narrative; P-18; Point in time; Protectin; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Report; WB; Whole blood	4180186
40759266	红细胞+粒细胞.CD55+59 缺乏型:印象:时间点:全血:叙述型	4182948
40759268	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Gastro; Gastroenterology; GI; Hematology; Heme; IAA; MEIA; PCA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40759268	PCA Ab Ser IA-aCnc	4180186
40759268	壁细胞 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759276	受托实验室检验项目结果接收日期:时间戳:XXX:受托实验室检验项目:定量型	4182948
40759276	?Tm; Date and time; Date Ref lab test results received; MISC; QNT; Quan; Quant; Quantitative; Ref Lab Test; Ref Lab Test Results; Time stamp; Timestamp	4180186
40759276	Date ref lab test received	4180186
40759278	CRL4; EVI27; homeobox B13; IL17BR; IL17RH1; interleukin 17 receptor B; Molecular genetics; Molecular pathology; MOLPATH; PCR; Point in time; PSGD; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Tissue; Tissue, unspecified	4180186
40759278	HOXB13 gene/IL17BR gene Tiss-Rto	4180186
40759278	HOXB13 基因/IL17BR 基因:比率:时间点:组织与涂片:定量型:分子遗传学类实验室方法	4182948
40759279	Blood; Convertase subtilisin/kexin type 9 preproprotein; FH3; Genetics; HCHOLA3; Heredity; Heritable; Hypercholesterolemia, autosomal dominant 3; Identity or presence; Inherited; LDLCQ1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; NARC1; NARC-1; Neural apoptosis regulated convertase 1; Neural apoptosis-regulated convertase 1; Nominal; PC9; PCR; Point in time; Proprotein convertase PC9; Proprotein convertase subtilisin/kexin type 9; Random; Subtilisin/kexin-like protease PC9; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40759279	PCSK9 gene Mut Anl Bld/T	4180186
40759279	PCSK9 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40759282	Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Kidney; Nephrology; Nominal; Point in time; Random; Renal; Stn; Stone; Stone Analysis; Stone Analysis+Photography; Stones	4180186
40759282	Stone Analysis+Photography-Imp	4180186
40759282	采用结石摄影术的结石分析:印象:时间点:结石:名义型	4182948
40759283	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759283	Hand dominance - 42Mo Imp ALSPAC	4180186
40759283	手部优势 - 42个月:印象:时间点:^患者:名义型:ALSPAC	4182948
40759284	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759284	Hand dominance - 12Y Imp EHI	4180186
40759284	手部优势 - 12 岁:印象:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759286	Blood; CPC9; CYP2C; CYP2C10; CYP2C9 allele; CYP2C9 allele 3; CYPIIC9; Cytochrome P450 2C9 Genotyping; cytochrome P450, family 2, subfamily C, polypeptide 9; Genetics; Heredity; Heritable; Identity or presence; III; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; P450IIC9; PCR; Point in time; Random; WB; Whole blood	4180186
40759286	CYP2C9 allele 3 Bld	4180186
40759286	CYP2C9 基因 等位基因 3:存在与否或特征标识:时间点:全血:名义型:分子遗传学类实验室方法	4182948
40759287	ABS; Aby; Acacia gum; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f297; f373; Gum acacia; Gum senegal; Gum sudan; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf297; Senegal gum; Serum; SR; Sudan gum	4180186
40759287	Gum Arabic IgG4-mCnc	4180186
40759287	阿拉伯树胶 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759288	ACTH IgG4-mCnc	4180186
40759288	ABS; Aby; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c206; c74; Cortrosyn; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Serum; SR; Tumor marker	4180186
40759288	促肾上腺皮质激素 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759289	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allspice; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Clove pepper; f310; f339; Jamaica pepper; Level; Mass concentration; P dioica; P officinalis; Pimenta officinalis; Pimento; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf339; Serum; SR	4180186
40759289	Allspice IgG4-mCnc	4180186
40759289	多香果树 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759290	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Almond; Amygdalus communis; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f020; f20; Level; Mass concentration; Point in time; Prunus amygdalus; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759290	Almond IgG4-mCnc	4180186
40759290	杏树 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759292	美国水青冈 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759292	Amer Beech IgG4-mCnc	4180186
40759292	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Amer Beech; American beech; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t005; t5	4180186
40759293	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; American Cheese; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f122; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759293	American Cheese IgG4-mCnc	4180186
40759293	美国干酪 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759295	White Elm IgG4-mCnc	4180186
40759295	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; American elm; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Elm; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t008; t8; White elm	4180186
40759295	美国榆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759298	Apricot IgG4-mCnc	4180186
40759298	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Apricot; Autoantibodies; Autoantibody; f237; Level; Mass concentration; Point in time; Prunus armeciaca; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759298	杏 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759300	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Asparagus; Autoantibodies; Autoantibody; f261; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf261; Serum; SR	4180186
40759300	Asparagus IgG4-mCnc	4180186
40759300	药用芦笋 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759304	Australian pine IgG4-mCnc	4180186
40759304	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Australian pine; Autoantibodies; Autoantibody; Casaurina equisetifolia; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t073; t73	4180186
40759304	木麻黄 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759306	Bahia grass IgG4-mCnc	4180186
40759306	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bahia grass; g017; g17; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759306	美洲雀稗 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759308	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Barley; f006; f6; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759308	Barley IgG4-mCnc	4180186
40759308	大麦 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759309	Basil IgG4-mCnc	4180186
40759309	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Basil; f269; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf269; Serum; SR	4180186
40759309	罗勒 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759310	Bayleaf IgG4-mCnc	4180186
40759310	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bay leaf; Bay sweet; Bayleaf; f278; Laurel; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf278; Serum; SR	4180186
40759310	月桂树 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759312	Cherry IgG4-mCnc	4180186
40759312	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bing cherry; Cherry; f242; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759312	甜樱桃 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759314	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Black willow; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t032; t32	4180186
40759314	Black Willow IgG4-mCnc	4180186
40759314	黑柳 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759316	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Black-eye bean; Blackeye pea; Black-eye Pea; Black-eyed bean; Cowpea; f127; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; V senensis; Vigna bean	4180186
40759316	Black-eye Pea IgG4-mCnc	4180186
40759316	豇豆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759319	Brazil Nut IgG4-mCnc	4180186
40759319	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brazil nut; f018; f18; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759319	巴西坚果 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759321	Broccoli IgG4-mCnc	4180186
40759321	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brassica oleracea cymosa; Brassica oleracea var italics; Broccoli; f260; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759321	花茎甘蓝 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759322	Brussel Sprouts IgG4-mCnc	4180186
40759322	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brassica oleracea gemmifera; Brussel sprouts; Brussels sprouts; f217; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf217; Serum; SR	4180186
40759322	抱子甘蓝 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759323	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Buchwheat; Buckwheat; f011; f11; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759323	Buckwheat IgG4-mCnc	4180186
40759323	荞麦 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759324	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brassica aleraceae; Brassica oleracea capitata; Cabbage; f216; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759324	Cabbage IgG4-mCnc	4180186
40759324	卷心菜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759327	Carrot IgG4-mCnc	4180186
40759327	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carrot; f031; f31; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759327	胡萝卜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759328	a167; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f078; f78; Level; Mass concentration; nBos d 8; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759328	Casein IgG4-mCnc	4180186
40759328	酪蛋白 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759329	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cashew; Cashew nut; f202; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759329	Cashew nut IgG4-mCnc	4180186
40759329	腰果 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759330	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Castor bean; castor-oil plant; k071; k71; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759330	Castor Bean IgG4-mCnc	4180186
40759330	蓖麻 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759331	Cat Dander IgG4-mCnc	4180186
40759331	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cat epithelium; Cat hair; e1; Feline; Felis domesticus; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759331	猫毛屑 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759334	Celery IgG4-mCnc	4180186
40759334	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celery; f085; f85; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759334	芹菜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759335	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cephalosporium; Level; m202; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR	4180186
40759335	Acremonium IgG4-mCnc	4180186
40759335	枝顶孢属单个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759336	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f081; f81; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759336	Cheddar IgG4-mCnc	4180186
40759336	切达干酪 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759337	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f082; f82; Level; Mass concentration; Mould; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759337	Cheese Mold IgG4-mCnc	4180186
40759337	长霉干酪 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759339	Chicken IgG4-mCnc	4180186
40759339	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f083; f83; Gallus spp; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759339	鸡 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759340	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chicory; f371; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759340	Chicory IgG4-mCnc	4180186
40759340	菊苣 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759343	Chocolate IgG4-mCnc	4180186
40759343	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f052; f52; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759343	巧克力 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759344	Cinnamon IgG4-mCnc	4180186
40759344	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cinnamate; Cinnamon; f220; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf220; Serum; SR	4180186
40759344	樟属多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759345	C herbarum IgG4-mCnc	4180186
40759345	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C herbarum; Hormodendrum; Level; m002; m2; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759345	多主枝孢 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759346	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Clam; f207; Level; Mass concentration; Mollusc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759346	Clam IgG4-mCnc	4180186
40759346	蛤蜊科多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759349	Codfish IgG4-mCnc	4180186
40759349	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cod; Codfish; f003; f3; Fish; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrod; Serum; SR	4180186
40759349	鳕鱼 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759350	Coffee IgG4-mCnc	4180186
40759350	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Coffee; f221; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf221; Serum; SR	4180186
40759350	咖啡属多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759352	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corn; f008; f141; f8; Level; Maize; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759352	Corn IgG4-mCnc	4180186
40759352	玉蜀黍 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759353	Corn smut IgG4-mCnc	4180186
40759353	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corn smut; Level; m215; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759353	玉米黑粉病菌 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759354	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cottonwood; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t014; t14	4180186
40759354	Cottonwood IgG4-mCnc	4180186
40759354	三角叶杨 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759355	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f002; f2; f43; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders	4180186
40759355	Cow Milk IgG4-mCnc	4180186
40759355	牛奶 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759356	Crab IgG4-mCnc	4180186
40759356	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Crab; f023; f23; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759356	食用黄道蟹 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759358	Crawfish IgG4-mCnc	4180186
40759358	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Crawfish; Crayfish; f320; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf320; Serum; SR	4180186
40759358	正螯虾 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759359	Cucumber IgG4-mCnc	4180186
40759359	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cucumber; f244; Gherkin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759359	黄瓜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759360	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f281; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf281; Santa maria; Serum; SR	4180186
40759360	Curry IgG4-mCnc	4180186
40759360	咖哩 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759361	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cuttlefish; f258; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf258; Serum; species; spp; Squid; SR	4180186
40759361	Squid IgG4-mCnc	4180186
40759361	乌贼单个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759366	Deer Fly IgG4-mCnc	4180186
40759366	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; bod; Bodies; Deer fly; i049; i49; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; WB	4180186
40759366	鹿虻(整体) 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759367	Dill IgG4-mCnc	4180186
40759367	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bastard fennel; Dill; f277; False anise; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf277; Russian parsley; Serum; SR; Swedish parsley	4180186
40759367	草茴香 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759368	Dog Epith IgG4-mCnc	4180186
40759368	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Canine; e002; e2; Epithelia; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759368	狗上皮细胞 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759370	Douglas Fir IgG4-mCnc	4180186
40759370	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Douglas fir; Douglas spruce; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rt207; Serum; SR; t207	4180186
40759370	花旗松 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759371	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e086; e86; Feathers; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759371	Duck Feather IgG4-mCnc	4180186
40759371	鸭羽毛 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759372	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f157; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759372	Duck Meat IgG4-mCnc	4180186
40759372	鸭肉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759375	Egg Yolk IgG4-mCnc	4180186
40759375	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f075; f75; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759375	卵黄 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759377	Eggplant IgG4-mCnc	4180186
40759377	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Aubergine; Autoantibodies; Autoantibody; Eggplant; f262; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf262; Serum; SR	4180186
40759377	茄子 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759379	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Eucalyptus; Gum-tree; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t018; t18	4180186
40759379	Gum-Tree IgG4-mCnc	4180186
40759379	按树属多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759381	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Fire ant; i070; i70; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red Imp Fire Ant; Red imported fire ant; Serum; SR	4180186
40759381	Red Imp Fire Ant IgG4-mCnc	4180186
40759381	入侵红火蚁 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759382	Flax IgG4-mCnc	4180186
40759382	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f198; f333; Flax; Flaxseed; Level; Linseed; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf333; Serum; SR	4180186
40759382	亚麻 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759383	Flea IgG4-mCnc	4180186
40759383	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Flea; i054; i54; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR	4180186
40759383	跳蚤单个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759384	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f147; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759384	Flounder IgG4-mCnc	4180186
40759384	鲆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759386	Garlic IgG4-mCnc	4180186
40759386	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f047; f47; Garlic; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759386	大蒜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759388	Ginger IgG4-mCnc	4180186
40759388	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f270; Ginger; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf270; Serum; SR	4180186
40759388	姜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759389	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f079; f79; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759389	Gluten IgG4-mCnc	4180186
40759389	谷蛋白 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759391	Hmtr Epith IgG4-mCnc	4180186
40759391	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e084; e84; Epithelia; Golden hamster epithelium; Hmtr Epith; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759391	仓鼠上皮细胞 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759392	Goldenrod IgG4-mCnc	4180186
40759392	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Golden rod; Goldenrod; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w012; w12	4180186
40759392	毛果一枝黄花 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759395	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f209; Grapefruit; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759395	Grapefruit IgG4-mCnc	4180186
40759395	葡萄柚 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759397	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Black olive; f342; Level; Mass concentration; Olive; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759397	Olive IgG4-mCnc	4180186
40759397	橄榄 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759398	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f012; f12; Green pea; Level; Mass concentration; Pea; peas; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759398	Pea IgG4-mCnc	4180186
40759398	豌豆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759400	Guinea Pig Epith IgG4-mCnc	4180186
40759400	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e006; e6; Epithelia; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759400	豚鼠上皮细胞 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759402	Halibut IgG4-mCnc	4180186
40759402	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f303; Halibut; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf303; Serum; SR	4180186
40759402	庸鲽 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759403	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Barcelona nut; Cob nut; f017; f17; Filbert; Filbert tree; Hazel nut; Hazel nut tree; Hazelnut; Hazelnut Poln; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t004; t040; t4; t40	4180186
40759403	Hazelnut Poln IgG4-mCnc	4180186
40759403	榛子花粉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759404	Hazelnut IgG4-mCnc	4180186
40759404	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Barcelona nut; Cob nut; f017; f17; Filbert; Hazel nut; Hazelnut; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759404	榛子 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759405	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f205; Herring; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759405	Herring IgG4-mCnc	4180186
40759405	大西洋鲱 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759406	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f247; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf247; Serum; SR	4180186
40759406	Honey IgG4-mCnc	4180186
40759406	蜂蜜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759408	Deprecated Melon IgG4-mCnc	4180186
40759408	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f87; Honey dew; Honeydew; Level; Mass concentration; Melon; melons; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759409	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f324; Fruit cone; Hop; Hops; Hops oil; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf324; Serum; SR	4180186
40759409	Hop IgG4-mCnc	4180186
40759409	啤酒花 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759411	House Dust Greer IgG4-mCnc	4180186
40759411	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; h001; h1; Housedust; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759411	室内灰尘 Greer 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759412	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; American house dust mite; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B germanica; Cockroach; D farinae; D pteronyss; D pteronyssinus; d001; d002; d1; d2; Dermatophagoides farianae; Dust Allerg Mix2; Dust mix; European house dust mite; German cockroach; h2; HDM; House Dust HS; House dust mite; Housedust; hx02; hx2; i006; i6; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Roach; Serum; SR	4180186
40759412	Dust Allerg Mix2 IgG4-mCnc	4180186
40759412	(德国小蠊+粉尘螨+屋尘螨+屋尘 Hollister Stier) 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759413	Insulin Human IgG4-mCnc	4180186
40759413	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c073; c73; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; Serum; Sliding; SR; Ultralente	4180186
40759413	人胰岛素 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759414	Italian Cypress IgG4-mCnc	4180186
40759414	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Funeral cypress; Italian cypress; Level; Mass concentration; Mediterranean cypress; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t023; t23	4180186
40759414	地中海柏树 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759416	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f374; Indian tragacanth; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759416	Karaya Gum IgG4-mCnc	4180186
40759416	刺梧桐树胶 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759417	Kent blue grass IgG4-mCnc	4180186
40759417	肯塔基蓝草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759417	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g008; g8; June blue grass; June grass; June Kentucky blue grass; Junegrass; Kent blue grass; Kentucky blue grass; Kentucky bluegrass; Level; Mass concentration; Meadow grass; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759418	Red Kidney Bean IgG4-mCnc	4180186
40759418	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beans; f287; Level; Mass concentration; Phaseolus vulgaris; Point in time; QNT; Quan; Quant; Quantitative; Random; Red Kidney Bean; Rf287; Serum; SR	4180186
40759418	红芸豆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759420	Firebush IgG4-mCnc	4180186
40759420	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Burning bush; Firebrush; Firebush; Kocha scoparia; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w017; w17	4180186
40759420	地肤 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759422	A-Lactalb IgG4-mCnc	4180186
40759422	a163; ABS; Aby; A-Lactalb; Alfa; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f076; f76; Level; Mass concentration; nBos d 4; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759422	乳白蛋白 alpha 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759423	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B; B-Lactoglob; f077; f77; Level; Mass concentration; nBos d 5; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759423	B-Lactoglob IgG4-mCnc	4180186
40759423	Beta 乳球蛋白 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759424	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Goosefoot; Lamb's quarter; Lambs quarters; Lamb's quarters; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Quinoa; Random; Serum; SR; w010; w10	4180186
40759424	Goosefoot IgG4-mCnc	4180186
40759424	藜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759425	Lemon IgG4-mCnc	4180186
40759425	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f208; Lemon; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759425	柠檬 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759427	Lentils IgG4-mCnc	4180186
40759427	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f235; Lentil; Lentils; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759427	兵豆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759428	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f215; Lettuce; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759428	Lettuce IgG4-mCnc	4180186
40759428	莴苣 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759429	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f182; Level; Lima bean; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759429	Lima Bean IgG4-mCnc	4180186
40759429	利马豆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759432	Locust Tree IgG4-mCnc	4180186
40759432	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t280	4180186
40759432	洋槐 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759435	ABS; Aby; Acer; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f377; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759435	Maple Syrup IgG4-mCnc	4180186
40759435	槭糖浆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759438	Meadow Fescue IgG4-mCnc	4180186
40759438	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Festuca elator; Festuca pratensis; g004; g4; Level; Mass concentration; Meadow Fescue; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759438	牛尾草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759440	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cajeput tree; Level; Mass concentration; Point in time; Punk tree; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t021; t21	4180186
40759440	Cajeput tree IgG4-mCnc	4180186
40759440	白千层 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759442	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common millet; f055; f55; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759442	Common Millet IgG4-mCnc	4180186
40759442	狗尾草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759443	ABS; Aby; Aedes mosquito; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; i071; i71; Level; Mass concentration; Mosquito; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759443	Aedes mosquito IgG4-mCnc	4180186
40759443	普通伊蚊 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759444	Mt Juniper IgG4-mCnc	4180186
40759444	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Juniper sabinoides; Juniperus ashei; Level; Mass concentration; Mountain cedar; Mountain juniper; Mt Juniper; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t006; t6	4180186
40759444	北美圆柏 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759445	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; M racemosus; m004; m4; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759445	M racemosus IgG4-mCnc	4180186
40759445	总状毛霉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759448	Blue mussel IgG4-mCnc	4180186
40759448	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue mussel; f037; f37; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759448	紫贻贝 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759449	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brassica/Sinapis spp; f089; f89; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759449	Mustard IgG4-mCnc	4180186
40759449	芥菜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759450	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f095; f162; f95; Level; Mass concentration; Nectarine; Peach; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759450	Nectarine IgG4-mCnc	4180186
40759450	油桃 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759453	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f282; Level; Mass concentration; Myristica fragrans; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf282; Serum; SR	4180186
40759453	Nutmeg IgG4-mCnc	4180186
40759453	肉豆蔻 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759454	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f007; f7; Level; Mass concentration; Oat; Oats; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759454	Oat IgG4-mCnc	4180186
40759454	野燕麦 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759457	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Black olive; f342; Level; Mass concentration; Olive; Olive Poln; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t009; t9	4180186
40759457	Olive Poln IgG4-mCnc	4180186
40759457	油橄榄花粉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759458	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allium salota Dostál; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f048; f48; Level; Mass concentration; Onion; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759458	Onion IgG4-mCnc	4180186
40759458	洋葱 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759460	Cocksfoot IgG4-mCnc	4180186
40759460	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cocksfoot; g003; g3; Level; Mass concentration; Orchard grass; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759460	鸭茅 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759461	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f283; Level; Mass concentration; Oregano; Oreganum; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf283; Serum; SR	4180186
40759461	Oregano IgG4-mCnc	4180186
40759461	牛至 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759464	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f293; Level; Mass concentration; Papaw; Papaya; Paw Paw; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf293; Serum; SR; Tree Melon	4180186
40759464	Papaya IgG4-mCnc	4180186
40759464	番木瓜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759465	Paper Wasp IgG4-mCnc	4180186
40759465	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; i004; i4; Level; Mass concentration; Paper Wasp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759465	马蜂属多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759468	ABS; Aby; African Gray Parrot; African Grey Parrot; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e213; e91; Feathers; Level; Macaw; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759468	Parrot Feather IgG4-mCnc	4180186
40759468	鹦鹉羽毛 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759471	Peach IgG4-mCnc	4180186
40759471	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f095; f95; Level; Mass concentration; Peach; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759471	桃子 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759475	Pecan/Hick Tree IgG4-mCnc	4180186
40759475	美洲山核桃树 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759475	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carya pecan; Hickory; Level; Mass concentration; Pecan; Pecan pollen; Pecan/Hick; Pecan/Hick Tree; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t022; t22	4180186
40759477	Perch IgG4-mCnc	4180186
40759477	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f065; f65; Level; Mass concentration; Perch; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759477	鲈属多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759479	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f210; Level; Mass concentration; Pineapple; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759479	Pineapple IgG4-mCnc	4180186
40759479	凤梨 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759480	Pinto Bean IgG4-mCnc	4180186
40759480	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beans; f121; f300; Level; Mass concentration; Phaseolus vulgaris; Pinto Bean; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759480	斑豆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759481	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f203; Green almond; Level; Mass concentration; Pistachio; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759481	Pistachio IgG4-mCnc	4180186
40759481	阿月浑子 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759482	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f255; Level; Mass concentration; Plum; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759482	Plum IgG4-mCnc	4180186
40759482	欧洲李 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759486	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arecastrum romanzoffianum; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Queen Palm; Random; Serum; SR; t072; t72	4180186
40759486	Queen Palm IgG4-mCnc	4180186
40759486	皇后葵 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759487	Rabbit IgG4-mCnc	4180186
40759487	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f213; Level; Mass concentration; Oryctalagus spp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759487	家兔 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759488	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e082; e82; Epithelia; f213; Level; Mass concentration; Oryctalagus spp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759488	Rabbit Epith IgG4-mCnc	4180186
40759488	家兔上皮细胞 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759489	Radish IgG4-mCnc	4180186
40759489	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f119; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Radish; Random; Serum; SR	4180186
40759489	萝卜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759490	False ragweed IgG4-mCnc	4180186
40759490	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; False ragweed; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w004; w4	4180186
40759490	假豚草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759491	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Giant ragweed; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w003; w3	4180186
40759491	Giant Ragweed IgG4-mCnc	4180186
40759491	三裂叶豚草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759492	Common Ragweed IgG4-mCnc	4180186
40759492	A artemisiifolia; A elatior; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Ambrosia artemisiifolia; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common ragweed; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Short ragweed; SR; w001; w1	4180186
40759492	豚草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759495	Rat Epith IgG4-mCnc	4180186
40759495	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e073; e73; Epithelia; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759495	大鼠上皮细胞 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759498	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bent grass; Bentgrass; g009; g9; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red top bent grass; Red top grass; Redtop; Serum; SR	4180186
40759498	Red top grass IgG4-mCnc	4180186
40759498	剪股颖 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759503	Safflower IgG4-mCnc	4180186
40759503	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f229; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Safflower; Serum; SR	4180186
40759503	红花 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759507	Sesame Seed IgG4-mCnc	4180186
40759507	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f010; f10; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Sesame Seed; Sesamum orientale; SR	4180186
40759507	胡麻 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759508	Sheep Sorrel IgG4-mCnc	4180186
40759508	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Sheep Sorrel; SR; w018; w18	4180186
40759508	小酸模 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759509	Shrimp IgG4-mCnc	4180186
40759509	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f024; f24; Level; Mass concentration; Point in time; Prawns; QNT; Quan; Quant; Quantitative; Random; Serum; Shrimp; SR	4180186
40759509	长额虾 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759511	Soybean IgG4-mCnc	4180186
40759511	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f014; f14; Gly; Largest; Level; Mass concentration; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Soja hispida; Soy bean; Soya bean; Soyabean; Soybean; SR	4180186
40759511	大豆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759514	Strawberry IgG4-mCnc	4180186
40759514	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f044; f44; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Strawberry	4180186
40759514	草莓 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759516	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f183; k84; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Seeds; Serum; SR; Sunflower; Sunflower pip; Sunflower Seed	4180186
40759516	Sunflower Seed IgG4-mCnc	4180186
40759516	向日葵种子 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759517	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chestnut; European chestnut; f299; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sweet chestnut	4180186
40759517	Chestnut IgG4-mCnc	4180186
40759517	欧洲板栗 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759521	Mandarin IgG4-mCnc	4180186
40759521	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C reticula; Clementine; f302; Level; Mandarin; Mandarine; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf302; satsumas; Serum; SR; tangerine	4180186
40759521	柑橘 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759523	Thyme IgG4-mCnc	4180186
40759523	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f273; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf273; Serum; SR; Thyme	4180186
40759523	普通百里香 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759525	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; o201; Point in time; QNT; Quan; Quant; Quantitative; Random; Ro201; Serum; SR; Tobacco; Tobacco dust; Tobacco leaf	4180186
40759525	Tobacco IgG4-mCnc	4180186
40759525	烟草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759530	Turkey IgG4-mCnc	4180186
40759530	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Meleagis gallopavo; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759530	吐绶鸡 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759533	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Deer meat; f120; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759533	Venison IgG4-mCnc	4180186
40759533	鹿肉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759535	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f256; Juglans sp; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Walnut; Walnuts	4180186
40759535	Walnut IgG4-mCnc	4180186
40759535	胡桃属多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759537	West Water Hemp IgG4-mCnc	4180186
40759537	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w039; w39; West Water Hemp; Western water hemp; Western waterhemp	4180186
40759537	西部水麻 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759540	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f236; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf236; Serum; SR	4180186
40759540	Cow Whey IgG4-mCnc	4180186
40759540	乳清 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759541	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t015; t15; White ash	4180186
40759541	White Ash IgG4-mCnc	4180186
40759541	美洲梣木 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759545	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bald-faced hornet; i002; i2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Wasp; White faced hornet; Whitefaced Hornet	4180186
40759545	Whitefaced Hornet IgG4-mCnc	4180186
40759545	白脸大黄蜂 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759548	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; East White Pine; Eastern white pine; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t016; t16; White pine	4180186
40759548	East White Pine IgG4-mCnc	4180186
40759548	五针松 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759549	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t096; t96; White poplar	4180186
40759549	White Poplar IgG4-mCnc	4180186
40759549	银白杨 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759561	Clove IgG4-mCnc	4180186
40759561	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Clove; Cloves; f268; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf268; Serum; SR	4180186
40759561	丁香树 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759562	Ltx IgG4-mCnc	4180186
40759562	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hevea braziliensis; k082; k82; Level; Ltx; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759562	乳胶 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759563	Pork IgG4-mCnc	4180186
40759563	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f026; f26; Level; Mass concentration; Pig; Point in time; Porcine; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sus spp; Swine	4180186
40759563	猪肉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759564	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f005; f5; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rye; Serum; SR	4180186
40759564	Rye IgG4-mCnc	4180186
40759564	黑麦 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759565	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40759565	Healthcare communication Doc	4180186
40759565	医疗保健服务沟通:发现:时间点:^患者:文档型	4182948
40759567	Appointment summary Doc	4180186
40759567	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40759567	预约摘要:发现:时间点:^患者:文档型	4182948
40759568	Care plan; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Treatment plan; Visit note	4180186
40759569	Chloride Sweat Scn-sCnc	4180186
40759569	Chemistry; Cl; Cl-; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Substance concentration; SWT	4180186
40759569	氯:物质的量浓度:时间点:汗液:定量型:毒理学筛查试验	4182948
40759570	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; ASCA; Autoantibodies; Autoantibody; Bakers yeast; Baker's yeast; f045; f403; f45; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SCA; Serum; SR; Yeast	4180186
40759570	Baker's yeast IgG4-mCnc	4180186
40759570	酿酒酵母 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759572	Chymopapain IgG4-mCnc	4180186
40759572	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c003; c209; c3; Chymodiactin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc209; Serum; SR	4180186
40759572	木瓜凝乳蛋白酶 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759574	Cow Dander IgG4-mCnc	4180186
40759574	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e004; e4; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759574	奶牛毛屑 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759576	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c13; c74; f340; gelatine; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759576	Gelatin IgG4-mCnc	4180186
40759576	动物胶 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759581	Pepper tree IgG4-mCnc	4180186
40759581	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Pepper tree; Peppertree; Point in time; QNT; Quan; Quant; Quantitative; Random; Rt217; Serum; SR; t105; t217	4180186
40759581	胡椒树 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759583	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f280; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red Pepper; Serum; SR	4180186
40759583	Red Pepper IgG4-mCnc	4180186
40759583	红辣椒 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759585	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f219; f344; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf344; Sage; Serum; SR	4180186
40759585	Sage IgG4-mCnc	4180186
40759585	鼠尾草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759587	Swordfish IgG4-mCnc	4180186
40759587	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f227; f312; f313; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf312; Serum; SR; Swordfish	4180186
40759587	箭鱼 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759588	Horse Fly IgG4-mCnc	4180186
40759588	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Horse fly; i204; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Ri204; Serum; SR	4180186
40759588	虻属多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759591	Blasts CSF Manual	4180186
40759591	Blast; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; HEMATOLOGY/CELL COUNTS; Manl; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40759591	幼稚细胞:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
40759592	Antiglob; BLOOD BANK; Comp; Complmt; DAGT; DAT; DAT C3c-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; Spec	4180186
40759592	DAT C3c-Sp Reag RBC Ql	4180186
40759592	直接抗球蛋白试验.补体 C3c 特异性试剂:存在情况或阈值:时间点:红细胞:序数型	4182948
40759599	Alc; Alcohol; Blood; DRUG/TOXICOLOGY; Drugs; Ethyl alcohol; EtOH; Gas chromatography; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40759599	Ethanol Bld GC-mCnc	4180186
40759599	乙醇:质量浓度:时间点:全血:定量型:气相色谱分析法	4182948
40759600	SOD RBC-cCnt	4180186
40759600	Catalytic Content; Chemistry; Erythrocytes; HSOD; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; SOD	4180186
40759600	超氧物歧化酶:催化含量:时间点:红细胞:定量型	4182948
40759601	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cysticercosis; Cysticercus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; T sol; T sol lar; T solium; Tapeworm	4180186
40759601	T sol lar Ab CSF Ql IA	4180186
40759601	猪囊尾蚴 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
40759603	Arbitrary concentration; BS; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40759603	Insulin BS SerPl-aCnc	4180186
40759603	胰岛素^基线:任意型浓度:时间点:血清/血浆:定量型	4182948
40759606	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; T sol; T solium; Tapeworm	4180186
40759606	T sol IgG Ser Ql IA	4180186
40759606	猪带绦虫 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40759608	1 day; 24 hours; 24HR; Androster; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40759608	Androsterone 24h Ur-mCnc	4180186
40759608	雄酮:质量浓度:24小时:尿液:定量型	4182948
40759612	Hemoccult sp3 Stl Ql IA	4180186
40759612	Bowel movement; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Fecal occult blood; Feces; FIT; FOB; FOBT; Gastrocult; Gastrointest blood; GI; Guiac; Haemoglobin; Hb; Hemoccult; Hemocult; Hgb; IAA; iFOBT; Low; MEIA; Occult blood; Occult blood in stool; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; sp3; Spec; Stl; Stool = Fecal; SUDS	4180186
40759612	血红蛋白.胃肠道.下段^第3个标本:存在情况或阈值:时间点:大便:序数型:免疫测定法	4182948
40759613	6M p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40759613	Insulin 6M p chal SerPl-aCnc	4180186
40759613	胰岛素^在XXX刺激之后6分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40759615	120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759615	LH 2h p chal SerPl-aCnc	4180186
40759615	促黄体素^在XXX刺激之后2小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40759616	3h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759616	LH 3h p chal SerPl-aCnc	4180186
40759616	促黄体素^在XXX刺激之后3小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40759617	120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; p chal; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759617	Prolactin 2h p chal SerPl-aCnc	4180186
40759617	催乳素^在XXX刺激之后2小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40759619	30M p chal; After; CHEMISTRY.CHALLENGE TESTING; gamma-4-Androstenedione; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759619	Androst 30M p chal SerPl-mCnc	4180186
40759619	雄烯二酮^在XXX刺激之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759621	3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759621	GH 3h p chal SerPl-mCnc	4180186
40759621	生长激素^在XXX刺激之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759624	8h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759624	GH 8h p chal SerPl-aCnc	4180186
40759624	生长激素^在XXX刺激之后8小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40759626	45M p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40759626	ACTH 45M p chal Plas-mCnc	4180186
40759626	促肾上腺皮质激素^在XXX刺激之后45分钟:质量浓度:时间点:血浆:定量型	4182948
40759627	ACTH 2h p chal Plas-mCnc	4180186
40759627	120 min; 120 minutes; 120min; 2 hours; 2h p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40759627	促肾上腺皮质激素^在XXX刺激之后2小时:质量浓度:时间点:血浆:定量型	4182948
40759629	DHEA-S 1h p chal SerPl-mCnc	4180186
40759629	1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; adrenal dysfunction; After; CHEMISTRY.CHALLENGE TESTING; DHEA; DHEAS; DHEA-S; DHEA-SO4; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf	4180186
40759629	硫酸脱氢表雄甾酮^在XXX刺激之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759630	1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759630	DHEA 1h p chal SerPl-mCnc	4180186
40759630	脱氢表雄酮^在XXX刺激之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759631	2M p chal; After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker	4180186
40759631	Calcit 2M p chal SerPl-mCnc	4180186
40759631	降钙素^在XXX刺激之后2分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759632	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Mass Content; Point in time; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40759632	Porphyrins Stl-mCnt	4180186
40759632	卟啉类:质量含量:时间点:大便:定量型	4182948
40759633	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Hep; Hep E; Hepatis; Hepatit; HEV; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
40759633	HEV IgG SerPl IA-aCnc	4180186
40759633	戊型肝炎病毒 抗体.IgG:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
40759634	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; Legion; Legionela; Microbiology; Ordinal; Pneu; pneum; Pneumophilia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40759634	L pneumo IgG Ser Ql IF	4180186
40759634	嗜肺军团菌 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40759637	11DC 2h p chal SerPl-mCnc	4180186
40759637	11DC; 120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759637	11-脱氧皮质醇^在XXX刺激之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759638	11DC 15M p chal SerPl-mCnc	4180186
40759638	11DC; 15M p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759638	11-脱氧皮质醇^在XXX刺激之后15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759639	11DC; 30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759639	11DC 30M p chal SerPl-mCnc	4180186
40759639	11-脱氧皮质醇^在XXX刺激之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759641	11DC 1.5h p chal SerPl-mCnc	4180186
40759641	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 11DC; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759641	11-脱氧皮质醇^在XXX刺激之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759642	17OH-Preg 30M p chal SerPl-mCnc	4180186
40759642	17 hydroxy pregnenolone; 17-alpha-Hydroxypregnenolone; 17OH-Preg; 30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759642	17-羟基孕烯醇酮^在XXX刺激之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759645	5OH-Tryptophan Ur-mCnc	4180186
40759645	5-HTP; 5-Hydroxy tryptophan; 5OH-Tryptophan; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40759645	5-羟色氨酸脱羧醇:质量浓度:时间点:尿液:定量型	4182948
40759646	30M p Exc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; EXCZ; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p Exc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759646	GH 30M p Exc SerPl-mCnc	4180186
40759646	生长激素^在运动之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759649	Ma+Ta Ab Titr CSF IF	4180186
40759649	Ma+Ta 抗体:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40759649	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MA1; MA-1; Ma2; MATA; Paraneoplastic Ag Ma 1; Paraneoplastic syndrome; PNMA1; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759651	Amphiphysin Ab Titr CSF IF	4180186
40759651	双载蛋白 抗体:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40759651	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; breast cancer; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Paraneoplastic syndrome; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stiff Man Syndrome; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759653	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Endocrine; Endocrinology; HUM; Humulin; IH7; Immune globulin G; Immunoglobulin G; Insul; Lente; NPH; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; Serology; Serum; Sliding; SR; Ultralente	4180186
40759653	Insulin IgG Ser-aCnc	4180186
40759653	胰岛素 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
40759659	ABS; Absorbing intrinsic; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; Hematology; Heme; IAA; IF; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40759659	IF Ab Ser IA-aCnc	4180186
40759659	内因子 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759662	GD1b Gangl IgM CSF IA-aCnc	4180186
40759662	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Disialolganglioside; Disialylganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1b; GD1b Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40759662	神经节苷脂 GD1b 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40759665	GQ1b Gangl IgM Ser IA-aCnc	4180186
40759665	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GQ1b; GQ1b Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; Tetrasialylganglioside	4180186
40759665	神经节苷脂 GQ1b 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759666	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; HUM; Humulin; IAA; IH7; Insul; Lente; MEIA; NPH; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; Serology; Serum; Sliding; SR; SUDS; Ultralente	4180186
40759666	Insulin Ab Ser IA-aCnc	4180186
40759666	胰岛素 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759667	TBM IgG Titr Ser IF	4180186
40759667	小管基底膜 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40759667	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Basem; Basemt; BM; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Point in time; Random; Serology; Serum; SmQn; SR; TBM; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759669	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA SS-A; ENA SS-A 52kD; Enzyme immunoassay; IAA; MEIA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ro; Ro AB; Serology; Serum; Sjogren; SR; SS; SSA; SS-A; SUDS	4180186
40759669	ENA SS-A 52kD Ab Ser IA-aCnc	4180186
40759669	Sjogrens 综合征-a 可提取性核 52kD 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759675	11DOC; 11-DOC; 21-Hydroxyprogesterone; BS; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759675	11DOC BS SerPl-mCnc	4180186
40759675	11-脱氧皮质酮^基线:质量浓度:时间点:血清/血浆:定量型	4182948
40759678	10M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759678	Aldost 10M p chal SerPl-mCnc	4180186
40759678	醛固酮^在XXX刺激之后10分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759679	Deprecated Norepineph pre/p chal SerPl-m	4180186
40759679	After; Before; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759681	5.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759681	GH 5.5h p chal SerPl-mCnc	4180186
40759681	生长激素^在XXX刺激之后5.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759682	6.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759682	GH 6.5h p chal SerPl-mCnc	4180186
40759682	生长激素^在XXX刺激之后6.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759684	8h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759684	GH 8h p chal SerPl-mCnc	4180186
40759684	生长激素^在XXX刺激之后8小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759685	9h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759685	GH 9h p chal SerPl-mCnc	4180186
40759685	生长激素^在XXX刺激之后9小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759687	10h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759687	GH 10h p chal SerPl-mCnc	4180186
40759687	生长激素^在XXX刺激之后10小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759688	10.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759688	GH 10.5h p chal SerPl-mCnc	4180186
40759688	生长激素^在XXX刺激之后10.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759690	11.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759690	GH 11.5h p chal SerPl-mCnc	4180186
40759690	生长激素^在XXX刺激之后11.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759692	20H p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759692	GH 20H p chal SerPl-mCnc	4180186
40759692	生长激素^在XXX刺激之后20小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759693	30M p chal; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40759693	Renin 30M p chal Plas-cCnc	4180186
40759693	肾素^在XXX刺激之后30分钟:催化浓度:时间点:血浆:定量型	4182948
40759694	1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40759694	Renin 1h p chal Plas-cCnc	4180186
40759694	肾素^在XXX刺激之后1小时:催化浓度:时间点:血浆:定量型	4182948
40759696	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759696	17OHP 45M p chal SerPl-mCnc	4180186
40759696	17-羟孕酮^在XXX刺激之后45分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759697	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40759697	Renin 1.5h p chal Plas-cCnc	4180186
40759697	肾素^在XXX刺激之后1.5小时:催化浓度:时间点:血浆:定量型	4182948
40759701	12M p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40759701	Insulin 12M p chal SerPl-aCnc	4180186
40759701	胰岛素^在XXX刺激之后12分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40759704	12M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759704	C peptide 12M p chal SerPl-mCnc	4180186
40759704	C 肽^在XXX刺激之后12分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759706	DHEA 15M p chal SerPl-mCnc	4180186
40759706	15M p chal; After; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759706	脱氢表雄酮^在XXX刺激之后15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759708	45M p chal; adrenal dysfunction; After; CHEMISTRY.CHALLENGE TESTING; DHEA; DHEAS; DHEA-S; DHEA-SO4; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf	4180186
40759708	DHEA-S 45M p chal SerPl-mCnc	4180186
40759708	硫酸脱氢表雄甾酮^在XXX刺激之后45分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759709	DHEA 1.5h p chal SerPl-mCnc	4180186
40759709	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759709	脱氢表雄酮^在XXX刺激之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759710	DHEA 2h p chal SerPl-mCnc	4180186
40759710	120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759710	脱氢表雄酮^在XXX刺激之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759711	3h p chal; adrenal dysfunction; After; CHEMISTRY.CHALLENGE TESTING; DHEA; DHEAS; DHEA-S; DHEA-SO4; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf	4180186
40759711	DHEA-S 3h p chal SerPl-mCnc	4180186
40759711	硫酸脱氢表雄甾酮^在XXX刺激之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759712	FSH 10M p chal SerPl-aCnc	4180186
40759712	10M p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759712	促卵泡激素^在XXX刺激之后10分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40759713	3h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759713	FSH 3h p chal SerPl-aCnc	4180186
40759713	促卵泡激素^在XXX刺激之后3小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40759714	3h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH	4180186
40759714	TSH 3h p chal SerPl-aCnc	4180186
40759714	促甲状腺激素^在XXX刺激之后3小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40759721	Hyaluronate Prt-mCnc	4180186
40759721	Ascites; Ascitic fluid; Ascitis; DRUG/TOXICOLOGY; Drugs; HA; Hyaluronan; Hyaluronic acid; Level; Mass concentration; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random	4180186
40759721	透明质酸:质量浓度:时间点:腹膜液:定量型	4182948
40759722	11DOC sp1 p chal SerPl-mCnc	4180186
40759722	11DOC; 11-DOC; 21-Hydroxyprogesterone; Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; DOC; First; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR	4180186
40759722	11-脱氧皮质酮^在XXX刺激之后的第1个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40759723	11DOC sp2 p chal SerPl-mCnc	4180186
40759723	11DOC; 11-DOC; 21-Hydroxyprogesterone; After; CHEMISTRY.CHALLENGE TESTING; Convalescent; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p chal; Spec; SR	4180186
40759723	11-脱氧皮质酮^在XXX刺激之后的第2个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40759724	11DOC sp3 p chal SerPl-mCnc	4180186
40759724	11DOC; 11-DOC; 21-Hydroxyprogesterone; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p chal; Spec; SR	4180186
40759724	11-脱氧皮质酮^在XXX刺激之后的第3个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40759725	11DOC sp4 p chal SerPl-mCnc	4180186
40759725	11DOC; 11-DOC; 21-Hydroxyprogesterone; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p chal; Spec; SR	4180186
40759725	11-脱氧皮质酮^在XXX刺激之后的第4个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40759726	11DOC; 11-DOC; 21-Hydroxyprogesterone; Before; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759726	11DOC pre chal SerPl-mCnc	4180186
40759726	11-脱氧皮质酮^在 XXX 刺激之前:质量浓度:时间点:血清/血浆:定量型	4182948
40759729	11DOC; 11-DOC; 21-Hydroxyprogesterone; 40M p chal; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759729	11DOC 40M p chal SerPl-mCnc	4180186
40759729	11-脱氧皮质酮^在XXX刺激之后40分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759734	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 20M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759734	17OHP 20M p chal SerPl-mCnc	4180186
40759734	17-羟孕酮^在XXX刺激之后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759735	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759735	17OHP 1.5h p chal SerPl-mCnc	4180186
40759735	17-羟孕酮^在XXX刺激之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759738	IGF-I 20M p chal SerPl-mCnc	4180186
40759738	20M p chal; After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; SR; Ultralente	4180186
40759738	胰岛素样生长因子-I^在XXX刺激之后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759739	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40759739	Elastase Ab Ser IA-aCnc	4180186
40759739	弹性蛋白酶 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759741	ECV IgG Titr CSF IF	4180186
40759741	艾柯病毒 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40759741	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; ECV; EV; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759742	ECV IgM Titr CSF IF	4180186
40759742	艾柯病毒 抗体.IgM:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40759742	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; ECV; EV; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759746	Procollagen III Ser-mCnc	4180186
40759746	3; Chemistry; Level; Mass concentration; Point in time; Procollagen III; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759746	前胶原肽.III 型:质量浓度:时间点:血清:定量型	4182948
40759749	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bruc; Brucellosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR; SUDS	4180186
40759749	Brucella IgG Ser IA-aCnc	4180186
40759749	布鲁氏菌属单个未知种 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759752	Myocardium IgG Titr Ser IF	4180186
40759752	心肌 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40759752	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antimyocardial; Antisarcolemma; Autoantibodies; Autoantibody; Cardio; Cardiology; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Heart; Heart Disease; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Intermyofibrillar Antibodies; Myocardial; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759753	Nuclear IgG Titr Ser IF	4180186
40759753	细胞核 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40759753	ABS; Aby; ACIF; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; NA; Nuc; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759754	ABS; Aby; Antby; Anti; Antibodies; Antibody; Antithyroglob; Arbitrary concentration; Autoantibodies; Autoantibody; Endocrine; Endocrinology; Hashimoto's thyroiditis; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Tg; TgAbs; Thyglobulin; Thyroglbn; Thyroglob; Tumor marker	4180186
40759754	Thyroglob IgG Ser-aCnc	4180186
40759754	甲状腺球蛋白 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
40759756	MI2 Ab Ser IA-aCnc	4180186
40759756	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CHD2; Chromodomain-helicase-DNA-binding protein 2; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; II; MEIA; MI2; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40759756	Mi-2 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759757	ABS; Aby; ACIF; ANA; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Arth; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MDAS; Multi-biomarker disease activity score; NA; Nuc; Ordinal; Point in time; QL; Qual; Qualitative; RA; RA Nuc; RANA; Random; Rheum; Rheumatology; Screen; Serology; Serum; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759757	Deprecated RA Nuc Ab Titr Ser Ql IF	4180186
40759758	2-Butanone; 3-butanone; Butanone; DRUG/TOXICOLOGY; Drugs; Ethyl methyl ketone; Level; MEK; Methyl acetone; Methylethylketone; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40759758	MEK Ur-sCnc	4180186
40759758	甲基乙基甲酮:物质的量浓度:时间点:尿液:定量型	4182948
40759762	Asparagine/Creat 24h Ur-Rto	4180186
40759762	1 day; 24 hours; 24HR; Asn; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759762	天冬酰胺/肌酐:比率:24小时:尿液:定量型	4182948
40759763	1 day; 24 hours; 24HR; c707; Chemistry; CR; Crea; Creat; Glu; Glutamic acid; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759763	Glutamate/Creat 24h Ur-Rto	4180186
40759763	谷氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759764	VMA/Creatine 24h Ur-Rto	4180186
40759764	香草扁桃酸/肌酸:比率:24小时:尿液:定量型	4182948
40759764	1 day; 24 hours; 24HR; 3-methoxy-4-hydroxymandelate; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; Catecholamine metabolite; Chemistry; HMMA; Hydroxy-methoxy-mandelate; Hydroxy-methoxy-mandelic acid; MHMA; QNT; Quan; Quant; Quantitative; Ratios; Rto; Tumor marker; UA; UR; Urn; Vanillylmandelic acid; Vanilmandelate; VMA	4180186
40759765	TCA/Creat Ur-Rto	4180186
40759765	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; TCA; Trichloroacetic acid; UA; UCr; UR; Urn	4180186
40759765	三氯乙酸/肌酐:比率:时间点:尿液:定量型	4182948
40759766	1 day; 24 hours; 24HR; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Oxybenzene; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759766	Phenol/Creat 24h Ur-Rto	4180186
40759766	苯酚/肌酐:比率:24小时:尿液:定量型	4182948
40759767	Phenylglyoxylate/Creat 24h Ur-Rto	4180186
40759767	1 day; 24 hours; 24HR; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Phenylglyoxylic acid; PhGA; QNT; Quan; Quant; Quantitative; Ratios; Rto; Styrene metabolite; UA; UCr; UR; Urn	4180186
40759767	苯基乙醛酸/肌酐:比率:24小时:尿液:定量型	4182948
40759769	铬/肌酐:比率:时间点:尿液:定量型	4182948
40759769	c609; Chrome; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759769	Cr/Creat Ur-Rto	4180186
40759771	Arsenic/Creat Ur-Rto	4180186
40759771	AS; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759771	砷/肌酐:比率:时间点:尿液:定量型	4182948
40759772	Mercury/Creat Ur-Rto	4180186
40759772	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; HG; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759772	汞/肌酐:比率:时间点:尿液:定量型	4182948
40759774	Bromide/Creat Ur-Rto	4180186
40759774	BR; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759774	溴/肌酐:比率:时间点:尿液:定量型	4182948
40759775	Fluoride/Creat Ur-Rto	4180186
40759775	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Fl; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759775	氟化物/肌酐:比率:时间点:尿液:定量型	4182948
40759778	4-aminophenol; 4-hydroxyaniline; Aniline metabolite; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; p-Aminophenol; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759778	p-Aminophenol/Creat Ur-Rto	4180186
40759778	对氨基苯酚/肌酐:比率:时间点:尿液:定量型	4182948
40759779	C2H5NO; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; EK 7011; Mehyl Formamide; Methylformamide; Monomethylformamide; n-methyl-formamide; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn; X 188	4180186
40759779	Mehyl Formamide/Creat Ur-Rto	4180186
40759779	甲基甲酰胺/肌酐:比率:时间点:尿液:定量型	4182948
40759780	MBP Ser-mCnc	4180186
40759780	Chemistry; Level; Mass concentration; MBP; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759780	髓磷脂碱性蛋白:质量浓度:时间点:血清:定量型	4182948
40759789	Adrenal cortex IgG Ser-aCnc	4180186
40759789	ABS; Aby; ACA; Adrnl; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
40759789	肾上腺皮质 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
40759790	1 day; 24 hours; 24HR; Ala; Alpha alanine; Chemistry; CR; Crea; Creat; L-alanine; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759790	Alanine/Creat 24h Ur-Rto	4180186
40759790	丙氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759792	B-AIB/Creat 24h Ur-Rto	4180186
40759792	1 day; 24 hours; 24HR; 3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759792	Beta 氨基异丁酸/肌酐:比率:24小时:尿液:定量型	4182948
40759794	1 day; 24 hours; 24HR; Car; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759794	Carnosine/Creat 24h Ur-Rto	4180186
40759794	肌肽/肌酐:比率:24小时:尿液:定量型	4182948
40759795	Citrulline/Creat 24h Ur-Rto	4180186
40759795	1 day; 24 hours; 24HR; Chemistry; CIT; Citr; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759795	瓜氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759796	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Cys-Cys; Dicysteine; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759796	Cystine/Creat 24h Ur-Rto	4180186
40759796	胱氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759798	1 day; 24 hours; 24HR; 4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Aminobutric; Aminobutyric; Amino-n-butyrate; Chemistry; CR; Crea; Creat; GABA; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Piperidic acid; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759798	GABA/Creat 24h Ur-Rto	4180186
40759798	Gamma 氨基丁酸/肌酐:比率:24小时:尿液:定量型	4182948
40759799	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Gln; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759799	Glutamine/Creat 24h Ur-Rto	4180186
40759799	谷氨酰胺/肌酐:比率:24小时:尿液:定量型	4182948
40759801	(Hcys)2; 1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Homocyst(e)ine; Homocystin; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759801	(Hcys)2/Creat 24h Ur-Rto	4180186
40759801	同型胱氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759802	Histidine/Creat 24h Ur-Rto	4180186
40759802	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Formiminoglutamic Acidemia; His; Histidinemia; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759802	组氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759803	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Hydroxy lysine; Hydroxyl; OH-Lysine; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759803	OH-Lysine/Creat 24h Ur-Rto	4180186
40759803	羟基赖氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759808	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Ile; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759808	Isoleucine/Creat 24h Ur-Rto	4180186
40759808	异亮氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759814	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cefadine; GRACEF; Immune globulin E; Immunoglobulin E; Keflex; Losporal; Palitrex; Point in time; QNT; Quan; Quant; Quantitative; Random; Salitex; Serum; SR	4180186
40759814	Cephalexin IgE Qn	4180186
40759814	头孢氨苄 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759817	Atropine IgE Qn	4180186
40759817	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Enlon; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759817	阿托品 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759818	Bupivacaine IgE Qn	4180186
40759818	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c285; Immune globulin E; Immunoglobulin E; Marcain; Marcaine; Point in time; QNT; Quan; Quant; Quantitative; Random; Sensorcaine; Serum; SR; Vivacaine	4180186
40759818	丁哌卡因 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759821	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759821	Ciprofloxacin IgE Qn	4180186
40759821	环丙沙星 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759822	Piroxicam IgE Qn	4180186
40759822	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c304; Feldene; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759822	吡氧噻嗪 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759824	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Aminoglycosides; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; NEBCIN; NEBDIN; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; TOBJ; TOBRA	4180186
40759824	Tobramycin IgE Qn	4180186
40759824	妥布霉素 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759832	Dog Dander+Epith IgE Qn	4180186
40759832	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Canine; Dog Dander+Epith; Dog hair; e002; e005; e2; e5; Epithelia; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759832	狗毛屑+狗上皮细胞 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759833	Bact; C&S; Cont lens; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
40759833	Bacteria Cont lens Cult	4180186
40759833	细菌 已鉴定的:存在与否或特征标识:时间点:隐形眼镜:名义型:培养	4182948
40759835	Nuclear pore prot gp210 Ab Ser Ql IB	4180186
40759835	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; Nuc; Nuclear pore glycoprotein-210; Nuclear pore prot gp210; Nucleoporin 210kDa; NUP210; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759835	核孔蛋白 gp210 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759836	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759836	Histone Ab Ser Ql IB	4180186
40759836	组蛋白 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759837	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; IA2; IA-2; IA2-ab; IAA; ICA; ICA512; ICA-512; Islet Cell512; MEIA; Point in time; protein tyrosine phosphatase-like protein IA2; PtP-IA2; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; Tyrosine phosphatase	4180186
40759837	Islet Cell512 Ab Ser IA-aCnc	4180186
40759837	岛细胞 512 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759838	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Hepatology; IMMUNE BLOT; Immunobl; Immunoblot; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759838	Liver Cytosol Ab Ser Ql IB	4180186
40759838	肝脏细胞溶质 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759839	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; MA1; MA-1; Ma2; MATA; Neuro; Neurology; Ordinal; Paraneoplastic Ag Ma 1; Paraneoplastic syndrome; PNMA1; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759839	Ma+Ta Ab Ser Ql IB	4180186
40759839	Ma+Ta 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759840	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Blt; ENA; ENA PM/SCL; Evening; Immune blot; Immunobl; Immunoblot; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Scleroderma; Scleroderma ab; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759840	ENA PM/SCL Ab Ser Ql IB	4180186
40759840	PM-SCL 可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759842	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Blt; ENA; ENA RNP; IMMUNE BLOT; Immunobl; Immunoblot; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Ribonuclear protein; RNP; Ro; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759842	ENA RNP Ab Ser Ql IB	4180186
40759842	核糖核酸蛋白可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759843	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Blt; ENA; ENA SS-A; IMMUNE BLOT; Immunobl; Immunoblot; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Ro; Ro AB; Screen; Serology; Serum; Sjogren; SR; SS; SSA; SS-A; WB; WBLOT; West blot; West blt; Western blot	4180186
40759843	ENA SS-A Ab Ser Ql IB	4180186
40759843	Sjogrens 综合征-a 可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759846	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Black olive; f342; II; Immune globulin E; Immunoglobulin E; Olive; Olive (rOle e) 2; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759846	Olive (rOle e) 2 IgE Qn	4180186
40759846	油橄榄 重组 (rOle e) 2 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759847	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Farmers lung; Immune globulin E; Immunoglobulin E; m23; m51; Point in time; QNT; Quan; Quant; Quantitative; Random; Rm213; Serum; SR; T vulgaris; Thermoactnom	4180186
40759847	T vulgaris IgE Qn	4180186
40759847	普通高温放线菌 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759849	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Blt; ENA; ENA SM; IMMUNE BLOT; Immunobl; Immunoblot; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SM; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759849	ENA SM Ab Ser Ql IB	4180186
40759849	Smith 可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759850	ENA Jo1 Ab Ser Ql IB	4180186
40759850	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Blt; ENA; ENA Jo1; Histidyl-tRNA synthease; i; Immune blot; Immunobl; Immunoblot; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759850	Jo-1 可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759852	ENA PCNA Ab Ser Ql IB	4180186
40759852	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Blt; ENA; ENA PCNA; IMMUNE BLOT; Immunobl; Immunoblot; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759852	PCNA 可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759854	ABS; Aby; AMA-M2; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Hepatology; IMMUNE BLOT; Immunobl; Immunoblot; Liver; Microtubule Associated Protein 2; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial m2; Ordinal; Point in time; PR; Pyruvate dehydrogenase ab; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759854	Mitochondria M2 Ab Ser Ql IB	4180186
40759854	线粒体 M2 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759856	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; GM2 Gangl; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759856	Deprecated GM2 Gangl IgG Ser Ql IB	4180186
40759857	Deprecated GM2 Gangl IgM Ser Ql IB	4180186
40759857	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; GM2 Gangl; IMMUNE BLOT; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin M; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759860	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; GQ1b; GQ1b Gangl; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; Tetrasialylganglioside; WB; WBLOT; West blot; West blt; Western blot	4180186
40759860	GQ1b Gangl IgG Ser Ql IB	4180186
40759860	神经节苷脂 GQ1b 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759862	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; CHD2; Chromodomain-helicase-DNA-binding protein 2; II; Immune blot; Immunobl; Immunoblot; MI2; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759862	MI2 Ab Ser Ql IB	4180186
40759862	Mi-2 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759863	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; CADM; Clinically amyopathic DM; Dermatomyositis, Adult Type; Immune blot; Immunobl; Immunoblot; Ordinal; PL7; Point in time; Polymyositis, Idiopathic; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; Threonyl tRNA Synthetase; WB; WBLOT; West blot; West blt; Western blot	4180186
40759863	PL7 Ab Ser Ql IB	4180186
40759863	Pl-7 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759865	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allium porrum; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Leek; Leeks; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759865	Leeks IgE Qn	4180186
40759865	南欧蒜 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759867	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Norwalk virus; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40759867	Norovirus RNA Spec Ql NAA+probe	4180186
40759867	诺如病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40759868	Estradiol 30M p chal SerPl-mCnc	4180186
40759868	17-beta estradiol; 30M p chal; After; CHEMISTRY.CHALLENGE TESTING; E2; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759868	雌二醇^在XXX刺激之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759870	130 minutes; 130M; 2.17h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759870	Glucose 2.17h p chal SerPl-mCnc	4180186
40759870	葡萄糖^在XXX刺激之后2.17小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759872	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; MYL; Ordinal; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; PR; Promyelocytic leukemia; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759872	PML Ab Ser Ql IB	4180186
40759872	PML 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759873	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Hepatology; IMMUNE BLOT; Immunobl; Immunoblot; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759873	sp100 Ab Ser Ql IB	4180186
40759873	sp100 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759877	70M p chal; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40759877	Renin 70M p chal Plas-cCnc	4180186
40759877	肾素^在XXX刺激之后70分钟:催化浓度:时间点:血浆:定量型	4182948
40759883	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; IEF; Immune globulin G; Immunoglobulin G; M-spikes; Neuro; Neurology; Oligoclonal Bands IgG; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; UniversalLabOrders	4180186
40759883	Oligoclonal Bands IgG CSF Ql IEF	4180186
40759883	蛋白质成分.寡克隆区带.IgG:存在情况或阈值:时间点:脑脊液:序数型:等电聚焦电泳	4182948
40759884	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; IEF; Immune globulin M; Immunoglobulin M; M-spikes; Neuro; Neurology; Oligoclonal Bands IgM; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40759884	Oligoclonal Bands IgM CSF Ql IEF	4180186
40759884	蛋白质成分.寡克隆区带.IgM:存在情况或阈值:时间点:脑脊液:序数型:等电聚焦电泳	4182948
40759886	B; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Kidney; Level; M Protein; M protein beta; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; PEUR; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UPEP; UR; Urn	4180186
40759886	M protein beta Ur Elph-mCnc	4180186
40759886	蛋白质.单克隆型.beta:质量浓度:时间点:尿液:定量型:电泳	4182948
40759887	M protein beta MFr Ur Elph	4180186
40759887	B; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; M Protein; M protein beta; Mass Fraction; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; Percent; PEUR; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
40759887	蛋白质.单克隆型.beta/蛋白质.总计:质量分数:时间点:尿液:定量型:电泳	4182948
40759889	100WBC; Bro; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lung; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; WBC; WBCs; White blood cell; White blood cells	4180186
40759889	Neutrophils/leuk NFr Bronch FC	4180186
40759889	嗜中性粒细胞/100 个白细胞:计数型分数:时间点:支气管来源的标本:定量型:流式细胞测量术	4182948
40759890	100WBC; Bro; Dynamic; Eos; Eosin; Eosino; Eosinophil; Eosins; FC; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
40759890	Eosinophil/leuk NFr Bronch FC	4180186
40759890	嗜酸性粒细胞/100 个白细胞:计数型分数:时间点:支气管来源的标本:定量型:流式细胞测量术	4182948
40759892	CD1a Cells NFr Bronch	4180186
40759892	Bro; CD1a Cells; Cell; CELL MARKERS; Cellularity; Gated cells; HTA1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; R4; Random	4180186
40759892	细胞.CD1a/100 个细胞:计数型分数:时间点:支气管来源的标本:定量型	4182948
40759893	Lymphocytes/leuk NFr Tiss	4180186
40759893	100WBC; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WBC; WBCs; White blood cell; White blood cells	4180186
40759893	淋巴细胞/100 个白细胞:计数型分数:时间点:组织与涂片:定量型	4182948
40759895	Alpha amylase; Ams; Amyl; Amylase S3; Amylase S3+S4; Catalytic Fraction; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
40759895	Amylase S3+S4 CFr SerPl	4180186
40759895	淀粉酶.S3+S4/淀粉酶.总计:催化分数:时间点:血清/血浆:定量型	4182948
40759898	Ascorbic acid; c702; Chemistry; Ejaculate; Genitourinary; GU; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Substance concentration; URO; Urology; Vit C; Vitamin C	4180186
40759898	Vit C Smn-sCnc	4180186
40759898	抗坏血酸:物质的量浓度:时间点:精液:定量型	4182948
40759900	Epid Allerg MixC IgE Ql	4180186
40759900	(金丝雀羽毛+长尾鹦鹉羽毛+鹦鹉羽毛) 抗体.IgE:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
40759900	ABS; Aby; African Gray Parrot; African Grey Parrot; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dander; e196; e201; e213; e91; Epid Allerg MixC; Feathers; Immune globulin E; Immunoglobulin E; Macaw; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40759903	COAGULATION; Coagulation factor I; FgDP; FGN; Fibrinogen Frg; Frag; Fragment; Hematology; Heme; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40759903	Fibrinogen Frg Ur-mCnc	4180186
40759903	纤维蛋白原片段:质量浓度:时间点:尿液:定量型	4182948
40759904	Baker's yeast Ab Qn	4180186
40759904	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; ASCA; Autoantibodies; Autoantibody; Bakers yeast; Baker's yeast; f045; f403; f45; Point in time; QNT; Quan; Quant; Quantitative; Random; SCA; Serum; SR; Yeast	4180186
40759904	酿酒酵母 抗体:任意型浓度:时间点:血清:定量型	4182948
40759907	28h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40759907	Insulin 28h p chal SerPl-aCnc	4180186
40759907	胰岛素^在XXX刺激之后28小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40759908	Insulin 32h p chal SerPl-aCnc	4180186
40759908	32h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40759908	胰岛素^在XXX刺激之后32小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40759909	Insulin 36h p chal SerPl-aCnc	4180186
40759909	36h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40759909	胰岛素^在XXX刺激之后36小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40759911	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LdT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tyzeka	4180186
40759911	Telbivudine Islt Genotyp	4180186
40759911	替比夫定:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
40759914	Account #; ADMIN; ADMIN.PATIENT; ADMIN.PATIENT.ID; Ident; Identifier; Intradermal; No; Nominal; Num; Point in time; Random	4180186
40759914	Account #	4180186
40759914	账号:标识符:时间点:^患者:名义型	4182948
40759915	ADMIN; Emergency contact info Pnl; Pan; PANEL.ADMIN; Panl; Pnl; Point in time; Random	4180186
40759915	Emergency contact info Pnl	4180186
40759915	应急联系方式信息组套:-:时间点:^应急联系人:-	4182948
40759916	Episode unique ID	4180186
40759916	ADMIN; ADMIN.PATIENT; ADMIN.PATIENT.ID; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
40759916	病程唯一性标识符:标识符:时间点:^患者:名义型	4182948
40759920	Date and time; Date+time; Date+time ED consult starts; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40759920	Date+time ED consult starts	4180186
40759920	急诊科会诊开始日期和时间:时间戳:时间点:^患者:定量型	4182948
40759921	ADMIN; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
40759921	Primary care provider	4180186
40759921	初级保健服务提供者:标识符:时间点:服务提供者:名义型	4182948
40759922	ED attending physician	4180186
40759922	ADMIN; Emergency Department; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
40759922	急诊科主治医师:标识符:时间点:服务提供者:名义型	4182948
40759924	ED accepting/admitting provider	4180186
40759924	ADMIN; ED accepting/admitting provider; Emergency Department; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
40759924	急诊科接收或入院服务提供者:标识符:时间点:服务提供者:名义型	4182948
40759925	ED transferring provider	4180186
40759925	ADMIN; Emergency Department; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
40759925	急诊科移交服务提供者:标识符:时间点:服务提供者:名义型	4182948
40759927	ADMIN; Emergency Department; Ident; Identifier; Nominal; Point in time; Random	4180186
40759927	ED accepting or admitting facility	4180186
40759927	急诊科接收或入院设施:标识符:时间点:设施:名义型	4182948
40759928	ADMIN; Emergency Department; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
40759928	ED tech Provider	4180186
40759928	急诊科技术人员:标识符:时间点:服务提供者:名义型	4182948
40759932	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Identity or presence; Nominal; Point in time; Random	4180186
40759932	陪伴患者到急诊科的个人:存在与否或特征标识:时间点:^患者:名义型	4182948
40759933	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Identity or presence; Nominal; Point in time; Random	4180186
40759933	院前医疗护理服务:存在与否或特征标识:时间点:^患者:名义型	4182948
40759934	Date and time; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp; Tx	4180186
40759934	放入治疗区域的时间:时间戳:时间点:^患者:定量型	4182948
40759935	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Location; Nominal; Point in time; Random	4180186
40759935	患者位置:位置:时间点:^患者:名义型	4182948
40759937	Problem description	4180186
40759937	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Identity or presence; Nominal; Point in time; Random	4180186
40759937	问题描述:存在与否或特征标识:时间点:^患者:名义型	4182948
40759941	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Finding; Findings; Nominal; Point in time; Random	4180186
40759941	针对治疗的问题反应:发现:时间点:^患者:名义型	4182948
40759942	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Finding; Findings; Nominal; Point in time; Random	4180186
40759942	问题性质或描述:发现:时间点:^患者:名义型	4182948
40759943	Anatomy; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Nominal; Point in time; Random	4180186
40759943	问题位置:解剖学:时间点:^患者:名义型	4182948
40759945	Count/time; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759945	问题频率:计数型速率:时间点:^患者:定量型	4182948
40759947	Date and time; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40759947	收缩变得规律的时间:时间戳:时间点:^患者:定量型	4182948
40759948	Date and time; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40759948	胎膜破裂时间:时间戳:时间点:^患者:定量型	4182948
40759949	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Finding; Findings; Hx; Nominal; Point in time; Random	4180186
40759949	历史获取方面的限制:发现:时间点:^患者:名义型	4182948
40759950	Assoc; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Finding; Findings; Nominal; Point in time; Problem associated signs+symptoms; Random; Sx	4180186
40759950	Problem associated signs+symptoms	4180186
40759950	与问题相关联的症状与体征:发现:时间点:^患者:名义型	4182948
40759953	Fetal; Finding; Findings; Gyn; Gynecology; H+P; H+P.HX; Narrative; OB; ObGyn; Obstetrics; P prime; Point in time; Random; Report	4180186
40759953	Fet Movement	4180186
40759953	运动:发现:时间点:^胎儿:叙述型	4182948
40759955	H+P; H+P.HX; History; Narrative; P prime; Point in time; Random; Report; Tx	4180186
40759955	Hx of Blood transfusion	4180186
40759955	输血:历史记录:时间点:^患者:叙述型	4182948
40759956	Hx of Neoplastic disease	4180186
40759956	Dis; Diseases; Dz; H+P; H+P.HX; History; Narrative; P prime; Point in time; Random; Report	4180186
40759956	肿瘤病史:历史记录:时间点:^患者:叙述型	4182948
40759959	Pain severity verbal numeric scale Score	4180186
40759959	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
40759959	疼痛严重程度语言数字量表:评分:时间点:^患者:定量型	4182948
40759960	Arbitrary; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40759960	疼痛严重程度描述性类别:任意型:时间点:^患者:序数型	4182948
40759962	Exam; Examination; Finding; Findings; H+P; H+P.PX; Nails; Narrative; P prime; Phys find; Point in time; Random; Report; Ungal nail	4180186
40759962	Phys find Nail Bed	4180186
40759962	体格检查发现:发现:时间点:甲床:叙述型	4182948
40759963	IOP Eye	4180186
40759963	Eyeball; H+P; H+P.PX; IOP; Occular; Oculis; Ophthalmologic; Optic globe; P prime; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
40759963	眼内压:压力或压强:时间点:眼睛:定量型	4182948
40759964	Finding; Findings; H+P; H+P.PX; Narrative; P prime; Point in time; Random; Report	4180186
40759964	Pulse strength on exam	4180186
40759964	检查时的脉搏强度:发现:时间点:^患者:叙述型	4182948
40759966	Calc & deriv values; Complex; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS)	4180186
40759966	Calc and deriv values	4180186
40759966	计算值与推导值:复合型属性:-:^患者:集合型	4182948
40759967	Invasive hemodynamic monitoring	4180186
40759967	Complex; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS)	4180186
40759967	创伤性血流动力学监测:复合型属性:-:^患者:集合型	4182948
40759968	Cardio; Cardiology; Complex; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Heart Disease	4180186
40759968	Cardiac rhythm monitoring	4180186
40759968	心律监测:复合型属性:-:^患者:集合型	4182948
40759969	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Imp & review of lab results; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Nominal; Point in time; Random	4180186
40759969	Imp & review of lab results	4180186
40759969	实验室检验结果的解释与审核:印象:时间点:^患者:名义型	4182948
40759973	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); IP practitioner; Nominal; Point in time; Random; Typ	4180186
40759973	IP practitioner	4180186
40759973	住院患者执业人员:类型:时间点:服务提供者:名义型	4182948
40759977	Time received by accepting fac or unit	4180186
40759977	Date and time; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Time received by accepting fac or unit; Time stamp; Timestamp	4180186
40759977	接受设施或小组的接收时间:时间戳:时间点:^患者:定量型	4182948
40759979	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Nominal; Point in time; Random; Typ	4180186
40759979	急诊科随访医疗护理协助:类型:时间点:^患者:名义型	4182948
40759980	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Nominal; Person name; Point in time; Random	4180186
40759980	名称:人员姓名:时间点:^应急联系人:名义型	4182948
40759983	Emergency contact Relationship to pt	4180186
40759983	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Nominal; Point in time; Random; Relationship to pt; Typ	4180186
40759983	相对于患者的关系:类型:时间点:^应急联系人:名义型	4182948
40759985	Date and time; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40759985	疼痛性收缩的发作:时间戳:时间点:^患者:定量型	4182948
40759986	Exam; Examination; Finding; Findings; H+P; H+P.PX; Narrative; P prime; Phys find; Point in time; Random; Report	4180186
40759986	Phys find Throat	4180186
40759986	体格检查发现:发现:时间点:咽喉:叙述型:观察法	4182948
40759987	ED procedure indication Imp	4180186
40759987	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random	4180186
40759987	急诊科操作适应症:印象:时间点:^患者:名义型	4182948
40759989	ADMIN; Emergency Department; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
40759989	急诊科设施标识符:标识符:时间点:设施:名义型	4182948
40759992	Phys find Brain stem reflexes	4180186
40759992	Cerebral; Cerebrum; Exam; Examination; Finding; Findings; H+P; H+P.PX; Head; Intracranial; Narrative; P prime; Phys find; Point in time; Random; Report	4180186
40759992	体格检查发现:发现:时间点:脑干反射:叙述型	4182948
40759993	Serology and blood bank studies	4180186
40759993	Complex; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS)	4180186
40759993	血清学与血库检查:复合型属性:-:^患者:集合型	4182948
40759994	Mixed venous O2 sat monitoring	4180186
40759994	Complex; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Mixed venous O2 sat monitoring; O2; SaO2; SAT; Satn; SO2; tO2	4180186
40759994	混合静脉血氧饱和度监测:复合型属性:-:^患者:集合型	4182948
40759995	Phys find Primitive reflexes	4180186
40759995	Exam; Examination; Finding; Findings; H+P; H+P.PX; Narrative; P prime; Phys find; Point in time; Random; Report	4180186
40759995	体格检查发现:发现:时间点:原始反射:叙述型	4182948
40759999	Arbitrary; Blood; Clonality; Genetics; Heredity; Heritable; Inherited; Leukemia; Lymphoma; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; T-cell rearranging gene gamma; TCR genes; Tissue; Tissue, unspecified; TRG; WB; Whole blood; Whole blood or Tissue	4180186
40759999	TCRB gene+TCRD gene+TCRG gene Bld/T Ql	4180186
40759999	TCRB 基因+TCRD 基因+TCRG 基因重排:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40760000	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Endemic typhus; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Murine typhus; Ordinal; Point in time; PR; QL; Qual; Qualitative; R typhi; Random; Ricket; Rickettsial; Screen; Serum; SR; Time Resolved Fluorescence; TRF; Typh; Typhus	4180186
40760000	R typhi IgG Ser Ql IF	4180186
40760000	斑疹伤寒立克次体 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760001	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; II; Immune globulin E; Immunoglobulin E; Pellitory (judaic); Pellitory (rPar j) 2; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w21; w211; Wall pellitory	4180186
40760001	Pellitory (rPar j) 2 IgE Qn	4180186
40760001	犹太墙草 重组 (rPar j) 2 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40760003	160M p Exc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; EXCZ; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p Exc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40760003	GH 160M p Exc SerPl-mCnc	4180186
40760003	生长激素^在运动之后160分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760004	3h P Exc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; EXCZ; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p Exc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40760004	GH 3h P Exc SerPl-mCnc	4180186
40760004	生长激素^在运动之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760005	IAT Titr SerPl	4180186
40760005	间接抗球蛋白试验.XXX 试剂:滴定度:时间点:血清/血浆:定量型	4182948
40760005	Antiglob; BLOOD BANK; Dilution factor; Dilution Factor (Titer); Hematology; Heme; IAGT; IAT; IDC; Ind; Ind Coombs; Indir; Indirect Coomb; Indirect Coombs; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40760006	Cardio; Cardiology; Chemistry; Heart Disease; Level; Mb; Myog; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760006	Myoglobin SerPl-sCnc	4180186
40760006	肌红蛋白:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760007	AIDS; Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; HIV 1 & 2; HIV 1 and 2 Ab; HIV 1+2 Ab+HIV1p24; HIV type 1; HIV type I; HIV1; HIV1+2; HIV1+2 Ab+HIV1p24Ag; Human immunodeficiency virus; i; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
40760007	HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA	4180186
40760007	HIV 1 型+2 型抗体+HIV 1 型 p24 抗原:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
40760008	CD13+HLA-DR+ Cells NFr Tiss	4180186
40760008	Aminopeptidase n; APN; CD13 Cells; CD13+HLA-DR+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; gp150; Human Leukocyte Antigen; I3; LeuM7; Leu-M7; My7; My-7; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40760008	细胞.CD13+HLA-DR+/100 个细胞:计数型分数:时间点:组织与涂片:定量型	4182948
40760009	Aminopeptidase n; APN; Aspirate; CD13 Cells; CD13+HLA-DR+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; gp150; Human Leukocyte Antigen; I3; LeuM7; Leu-M7; My7; My-7; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760009	CD13+HLA-DR+ Cells NFr Aspirate	4180186
40760009	细胞.CD13+HLA-DR+/100 个细胞:计数型分数:时间点:吸出物:定量型	4182948
40760010	CD13+HLA-DR+ Cells NFr Spec	4180186
40760010	Aminopeptidase n; APN; CD13 Cells; CD13+HLA-DR+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; gp150; Human Leukocyte Antigen; I3; LeuM7; Leu-M7; Misc; Miscellaneous; My7; My-7; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40760010	细胞.CD13+HLA-DR+/100 个细胞:计数型分数:时间点:XXX:定量型	4182948
40760011	Aminopeptidase n; APN; Blood; CD13 Cells; CD13+HLA-DR+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; gp150; Human Leukocyte Antigen; I3; LeuM7; Leu-M7; My7; My-7; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40760011	CD13+HLA-DR+ Cells NFr Bld	4180186
40760011	细胞.CD13+HLA-DR+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40760012	Aminopeptidase n; APN; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD13 Cells; CD13+HLA-DR+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; gp150; Human Leukocyte Antigen; I3; LeuM7; Leu-M7; My7; My-7; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760012	CD13+HLA-DR+ Cells NFr Fld	4180186
40760012	细胞.CD13+HLA-DR+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760014	Aminopeptidase n; APN; BM; BON; Bone marrow; CD13 Cells; CD13+HLA-DR+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; gp150; Human Leukocyte Antigen; I3; LeuM7; Leu-M7; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; My7; My-7; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760014	CD13+HLA-DR+ Cells NFr Mar	4180186
40760014	细胞.CD13+HLA-DR+/100 个细胞:计数型分数:时间点:骨髓:定量型	4182948
40760018	BM; BON; Bone marrow; CD5 Cells; CD5+FMC7+ Cells; Cell; CELL MARKERS; Cellularity; FMC-7; Gated cells; Leu1; Leu-1; Ly-1; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T1; Tp67	4180186
40760018	CD5+FMC7+ Cells NFr Mar	4180186
40760018	细胞.CD5+FMC7+/100 个细胞:计数型分数:时间点:骨髓:定量型	4182948
40760022	1 day; 24 hours; 24HR; beta -alanyl-N-methylhistidine; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760022	Anserine/Creat 24h Ur-Rto	4180186
40760022	鹅肌肽/肌酐:比率:24小时:尿液:定量型	4182948
40760023	Deprecated APOE gene Mut Anal Bld	4180186
40760023	AD2; APO-E; apolipoprotein E; Apolipoprotein E gene; Blood; Identity or presence; LDLCQ5; LPG; MGC1571; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; Nominal; PCR; Point in time; Random; WB; Whole blood	4180186
40760025	Alb; Ascites; Ascitic fluid; Ascitis; Associated; Bc; Bili; Bili.delta; Bili-alb; Bilirub Conj; Bilirub Delta; Bilirub Direct; Bilirubin conjugated; Bilirubin direct; Bilirubin glucuronides; Bilirubins; Billirubin; bnd; Chemistry; DELB; Delta bilirubin; Deltab; Level; Mass concentration; Peritoneal fluid; Point in time; Protein.albumin; Prt; QNT; Quan; Quant; Quantitative; Random; TBIL; TBIL-(Bu+Bc); TBIL-Bu	4180186
40760025	Bilirub Direct Prt-mCnc	4180186
40760025	胆红素.葡糖醛酸化+胆红素.白蛋白结合型:质量浓度:时间点:腹膜液:定量型	4182948
40760027	CD3+CD8+CD45+ Cells NFr Bld	4180186
40760027	B220; Blood; CD3 Cells; CD3+CD8+ Cells; CD3+CD8+CD45+ Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; CD8 T cells; Cell; CELL MARKERS; Cellularity; Gated cells; LCA; Leu2; Leu-2; Leu4; Leu-4; Leukocyte common antigen; Ly5; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T200; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; Whole blood	4180186
40760027	细胞.CD3+CD8+CD45+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40760029	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chlam; Chlamid; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Serum; sp1; Spec; species; spp; SR; SUDS	4180186
40760029	Chlamydia IgG sp1 Ser IA-aCnc	4180186
40760029	衣原体属单个未知种 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760032	ACTH AM Plas-mCnc	4180186
40760032	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; AM; c206; c74; Chemistry; Cortrosyn; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Tumor marker	4180186
40760032	促肾上腺皮质激素^上午标本:质量浓度:时间点:血浆:定量型	4182948
40760033	ACTH evening Plas-mCnc	4180186
40760033	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; Chemistry; Cortrosyn; Level; Mass concentration; Pl; Plasma; Plsm; PM; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Tumor marker	4180186
40760033	促肾上腺皮质激素^晚上标本:质量浓度:时间点:血浆:定量型	4182948
40760034	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnetii; Coxiella burnettii; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Q fev; Q fever; Qfever; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40760034	C burnet IgG Ser Ql IF	4180186
40760034	贝氏柯克斯体 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760036	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnetii; Coxiella burnettii; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Q fev; Q fever; Qfever; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40760036	C burnet IgM Ser Ql IF	4180186
40760036	贝氏柯克斯体 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760040	ABS; Aby; ACIF; Ameba; Amebiasis; Amebic; Amoeba; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; E histolyt; E histolytica; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40760040	E histolyt Ab Ser Ql IF	4180186
40760040	溶组织内阿米巴 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760042	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; F hepatica; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
40760042	F hepatica Ab Ser Ql IA	4180186
40760042	肝片吸虫 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760044	1 day; 24 hours; 24HR; Chemistry; Fract excret PO4; i Phos; Inorganic phosphate; Phos; Phosphate reabsorption; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pl; Plasma; Plsm; PO4; QNT; Quan; Quant; Quantitative; Ratios; Rto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn	4180186
40760044	Fract excret PO4 24h Ur+SerPl-Rto	4180186
40760044	磷酸盐排泄分数:比率:24小时:尿液+血清/血浆:定量型	4182948
40760051	1 hour; 1.0Hr; 1h p Lac; 60 min; 60 minutes; 60M; 60min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40760051	Breath H2 1h p Lac	4180186
40760051	氢/已呼出的气体^在给予剂量乳果糖之后1小时:体积分数:时间点:呼出的气体:定量型	4182948
40760055	1 1/2 hours; 1 1/2 HR; 1.5h p Lac; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40760055	Breath H2 1.5h p Lac	4180186
40760055	氢/已呼出的气体^在给予剂量乳果糖之后1.5小时:体积分数:时间点:呼出的气体:定量型	4182948
40760058	OH-Proline/Creat 24h Ur-Rto	4180186
40760058	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Ohpro; OH-Proline; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760058	羟基脯氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40760060	8h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760060	Insulin 8h p chal SerPl-aCnc	4180186
40760060	胰岛素^在XXX刺激之后8小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760062	68h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760062	Insulin 68h p chal SerPl-aCnc	4180186
40760062	胰岛素^在XXX刺激之后68小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760064	56h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760064	Insulin 56h p chal SerPl-aCnc	4180186
40760064	胰岛素^在XXX刺激之后56小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760067	Insulin 44h p chal SerPl-aCnc	4180186
40760067	44h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760067	胰岛素^在XXX刺激之后44小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760071	L inter Ab Titr Ser Aggl	4180186
40760071	致病性钩端螺旋体 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40760071	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40760072	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; L inter; L interrogans; Leptospirosis; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
40760072	L inter IgM Ser Ql IA	4180186
40760072	致病性钩端螺旋体 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760073	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Leu; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760073	Leucine/Creat 24h Ur-Rto	4180186
40760073	亮氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40760076	Methionine/Creat 24h Ur-Rto	4180186
40760076	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Met; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760076	蛋氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40760080	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Niacinamide; Nicobion; Nicotylamide; Papulex; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Ucemine PP; Vit PP; Vitamin PP	4180186
40760080	Nicotinamide SerPl-mCnc	4180186
40760080	烟酰胺:质量浓度:时间点:血清/血浆:定量型	4182948
40760082	pH Sal	4180186
40760082	pH:对数型物质的量浓度:时间点:唾液:定量型	4182948
40760082	Chemistry; Log molar concentration; Oral fluid; Point in time; Random; Sal; SmQn	4180186
40760084	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; i Phos; Inorganic phosphate; Kidney; Nephrology; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; QNT; Quan; Quant; Quantitative; Ratios; Renal; Rto; UA; UCr; UR; Urn	4180186
40760084	Phosphate/Creat 24h Ur-Rto	4180186
40760084	磷酸盐/肌酐:比率:24小时:尿液:定量型	4182948
40760085	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; PEA; PETN; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760085	PETN/Creat 24h Ur-Rto	4180186
40760085	磷酸乙醇胺/肌酐:比率:24小时:尿液:定量型	4182948
40760086	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Malaria; Malarial; MEIA; Microbiology; Ordinal; P falciparum; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
40760086	P falciparum Ab Ser Ql IA	4180186
40760086	恶性疟原虫 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760087	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Malaria; Malarial; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; Time Resolved Fluorescence; TRF	4180186
40760087	Plasmodium Ab Ser Ql IF	4180186
40760087	疟原虫亚属单个未知种 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760088	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; i004; i4; Paper wasp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40760088	Paper Wasp IgG4 Qn	4180186
40760088	马蜂属多个未知种 抗体.IgG4:任意型浓度:时间点:血清:定量型	4182948
40760089	1 day; 24 hours; 24HR; Chemistry; Hematology; Heme; Level; Mass concentration; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760089	Porphyrins 24h Ur-mCnc	4180186
40760089	卟啉类:质量浓度:24小时:尿液:定量型	4182948
40760090	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; k; K+; Kidney; Nephrology; Potass; QNT; Quan; Quant; Quantitative; Ratios; Renal; Rto; UA; UCr; UR; Urn	4180186
40760090	Potassium/Creat 24h Ur-Rto	4180186
40760090	钾/肌酐:比率:24小时:尿液:定量型	4182948
40760091	Prolactin post precipitation SerPl-mCnc	4180186
40760091	After; Chemistry; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; Mass concentration; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760091	催乳素^在沉淀之后:质量浓度:时间点:血清/血浆:定量型	4182948
40760092	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Pro; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760092	Proline/Creat 24h Ur-Rto	4180186
40760092	脯氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40760093	Oligoclonal Bands SerPl IEF-Imp	4180186
40760093	Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; IEF; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; M-spikes; Nominal; Pl; Plasma; Plsm; Point in time; PR; Prot; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760093	蛋白质成分.寡克隆区带:印象:时间点:血清/血浆:名义型:等电聚焦电泳	4182948
40760094	30M p chal; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; CHEMISTRY.CHALLENGE TESTING; Direct renin; DRC; Endocrine; Endocrinology; Erect; Heart Disease; Kidney; Level; Mass concentration; Nephrology; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Renal; Standing; Upr; upr+30M p chal; Uprt	4180186
40760094	Renin upr+30M p chal Plas-mCnc	4180186
40760094	肾素^直立位+在XXX刺激之后30分钟:质量浓度:时间点:血浆:定量型	4182948
40760095	1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; CHEMISTRY.CHALLENGE TESTING; Direct renin; DRC; Endocrine; Endocrinology; Erect; Heart Disease; Kidney; Level; Mass concentration; Nephrology; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Renal; Standing; Upr; upr+1h p chal; Uprt	4180186
40760095	Renin upr+1h p chal Plas-mCnc	4180186
40760095	肾素^直立位+在XXX刺激之后1小时:质量浓度:时间点:血浆:定量型	4182948
40760096	RA Nuc Ab Titr Ser IF	4180186
40760096	类风湿关节炎细胞核 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40760096	ABS; Aby; ACIF; ANA; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Arth; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MDAS; Multi-biomarker disease activity score; NA; Nuc; Point in time; RA; RA Nuc; RANA; Random; Rheum; Rheumatology; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40760097	Serotonin 24h Ur-mCnc	4180186
40760097	1 day; 24 hours; 24HR; 5-HT; 5-hydroxytryptamine; 5-hydroxytryptophane; C10H12N2O; Chemistry; Enteramine; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760097	5-羟色胺:质量浓度:24小时:尿液:定量型	4182948
40760098	Chemistry; Level; Na; Na+; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
40760098	Sodium Sal-sCnc	4180186
40760098	钠:物质的量浓度:时间点:唾液:定量型	4182948
40760099	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Kidney; Na; Na+; Nephrology; QNT; Quan; Quant; Quantitative; Ratios; Renal; Rto; UA; UCr; UR; Urn	4180186
40760099	Sodium/Creat 24h Ur-Rto	4180186
40760099	钠/肌酐:比率:24小时:尿液:定量型	4182948
40760105	1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Non-protein bound; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
40760105	T4 Free 1h p chal SerPl-mCnc	4180186
40760105	甲状腺素.游离型^在XXX刺激之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760108	20M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Non-protein bound; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
40760108	T4 Free 20M p chal SerPl-mCnc	4180186
40760108	甲状腺素.游离型^在XXX刺激之后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760109	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Serum; SR; SUDS; T gondii; Toxo; Toxoplasmosis	4180186
40760109	T gondii IgG Avidity Ser IA-Rto	4180186
40760109	刚地弓形虫 抗体.IgG 亲合力:比率:时间点:血清:定量型:免疫测定法	4182948
40760112	Tryptophan/Creat 24h Ur-Rto	4180186
40760112	1 day; 24 hours; 24HR; c244; Chemistry; CR; Crea; Creat; L-tryptophan; QNT; Quan; Quant; Quantitative; Ratios; Rto; Trp; UA; UCr; UR; Urn	4180186
40760112	色氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40760113	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; Tyr; UA; UCr; UR; Urn	4180186
40760113	Tyrosine/Creat 24h Ur-Rto	4180186
40760113	酪氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40760114	Urea Plr-mCnc	4180186
40760114	Chemistry; Level; Mass concentration; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid	4180186
40760114	尿素:质量浓度:时间点:胸膜液:定量型	4182948
40760115	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn	4180186
40760115	Urea/Creat 24h Ur	4180186
40760115	尿素/肌酐:质量比率:24小时:尿液:定量型	4182948
40760117	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn; Val	4180186
40760117	Valine/Creat 24h Ur-Rto	4180186
40760117	缬氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40760120	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR; SUDS	4180186
40760120	Yersinia IgA Ser IA-aCnc	4180186
40760120	耶尔森氏菌属单个未知种 抗体.IgA:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760122	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 4h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760122	17OHP 4h p chal SerPl-mCnc	4180186
40760122	17-羟孕酮^在XXX刺激之后4小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760124	Glutathione SerPl-sCnc	4180186
40760124	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760124	谷胱甘肽:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760125	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HCV; HCVAB; Hep; Hep C; Hepatis; Hepatit; Hepatology; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
40760125	HCV IgG Ser IA-aCnc	4180186
40760125	丙型肝炎病毒 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760126	Insulin 52h p chal SerPl-aCnc	4180186
40760126	52h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760126	胰岛素^在XXX刺激之后52小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760127	L pneumo IgG sp1 Titr Ser IF	4180186
40760127	嗜肺军团菌 抗体.IgG^第1个标本:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40760127	ABS; Aby; ACIF; Acute specimen; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; First; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; Legion; Legionela; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Pre immunization; Random; Serum; SmQn; sp1; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40760129	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lung; MEIA; NA; Nuc; Ordinal; Pleural; Pleural fluid; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Serology; SUDS; thoracentesis fluid	4180186
40760129	ANA Plr Ql IA	4180186
40760129	细胞核 抗体:存在情况或阈值:时间点:胸膜液:序数型:免疫测定法	4182948
40760130	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Orn; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760130	Ornithine/Creat 24h Ur-Rto	4180186
40760130	鸟氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40760131	BM; BON; Bone marrow; Cell; Cellularity; Gated cells; HEMATOLOGY/CELL COUNTS; Manl; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760131	Osteoblasts NFr Mar Manual	4180186
40760131	成骨细胞/100 个细胞:计数型分数:时间点:骨髓:定量型:手工方法	4182948
40760132	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; PS; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760132	Phosphoserine/Creat 24h Ur-Rto	4180186
40760132	磷酸丝氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40760134	Lac PO Dose	4180186
40760134	Dose med or substance; DRUG DOSES; Lac PO; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760134	乳果糖.口服:质量:时间点:剂量药物或剂量物质:定量型	4182948
40760135	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40760135	Privacy policy acknowledgment Doc	4180186
40760135	隐私政策确认:发现:时间点:^患者:文档型	4182948
40760136	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40760136	Privacy policy Organization Doc	4180186
40760136	隐私政策:发现:时间点:组织机构:文档型	4182948
40760137	3h p lactulose; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40760137	Breath H2 3h p lactulose	4180186
40760137	氢/已呼出的气体^在给予剂量乳果糖之后3小时:体积分数:时间点:呼出的气体:定量型	4182948
40760138	UA dipstick W Reflex Culture pnl Ur	4180186
40760138	Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UA dipstick W Reflex Culture pnl; UR; Urn	4180186
40760138	带有伺机追加型培养项目的尿液分析测试棒组套:-:时间点:尿液:-	4182948
40760139	Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UA dipstick W Reflex Micro pnl; UniversalLabOrders; UR; Urn	4180186
40760139	UA dipstick W Reflex Micro pnl Ur	4180186
40760139	带有伺机追加型肉眼检查项目的尿液分析测试棒组套:-:时间点:尿液:-	4182948
40760140	Auto Diff Pnl; Blood; CBC W Auto Diff; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood	4180186
40760140	CBC W Auto Diff Bld	4180186
40760140	带有自动化细胞分类的全血细胞计数组套:-:时间点:全血:定量型	4182948
40760141	Blood; CBC W Reflex Manual Diff; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood	4180186
40760141	CBC W Reflex Manual Diff Bld	4180186
40760141	带有伺机追加型手工细胞分类的全血细胞计数组套:-:时间点:全血:定量型	4182948
40760142	Auto Diff Pnl Bld	4180186
40760142	Auto Diff Pnl; Blood; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40760142	自动化分类组套:-:时间点:全血:定量型	4182948
40760144	DOCUMENT QUALITY; Finding; Findings; Narrative; Point in time; Quality; Random; Report	4180186
40760144	Data criteria	4180186
40760144	数据判定准则:发现:时间点:^患者:叙述型	4182948
40760146	Measure observations	4180186
40760146	DOCUMENT QUALITY; Finding; Findings; Narrative; Point in time; Quality; Random; Report	4180186
40760146	指标观测结果:发现:时间点:^患者:叙述型	4182948
40760148	Chr 13+18+21+X+Y aneup; Chromosom; Chromosomes; Fetal; Finding; Findings; Gyn; Gynecology; Molecular genetics; Molecular pathology; MOLPATH; Nominal; OB; ObGyn; Obstetrics; PCR; Point in time; Random; Tissue; Tissue, unspecified	4180186
40760148	Chr 13+18+21+X+Y aneup Tiss Fetus	4180186
40760148	胎儿染色体 13+18+21+X+Y 非整倍体性:发现:时间点:组织与涂片^胎儿:名义型:分子遗传学类实验室方法	4182948
40760150	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesviruses 6 DNA pnl; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40760150	Herpesviruses 6 DNA pnl Spec NAA+probe	4180186
40760150	疱疹病毒 6 型 DNA 组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
40760152	A alternata; A tenuis; ABS; Aby; Alternaria tenuis; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious Disease; InfectiousDisease; m006; m6; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40760152	A alternata Ab Ser Ql ID	4180186
40760152	链格孢 抗体:存在情况或阈值:时间点:血清:序数型:免疫扩散法	4182948
40760153	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Gm27; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious Disease; InfectiousDisease; m27; Microbiology; Ordinal; Penicillium spp; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR	4180186
40760153	Penicillium Ab Ser Ql ID	4180186
40760153	青霉属单个未知种 抗体:存在情况或阈值:时间点:血清:序数型:免疫扩散法	4182948
40760155	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Alrgen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Phadia differentiate atopy; Phadiotop; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40760155	Phadiatop inhalant allergen IgE Qn	4180186
40760155	Phadiotop 吸入性变应原 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40760157	AF; Amn; Amn fl; Amn/CVS; Amnio; Amniotic flu; Amniotic fluid; Chorionic villi; Chorionic villus sample; Chr 12 aneup; Chromosom; Chromosomes; Finding; Findings; Fluorescent in situ hybridization; Genetics; Gyn; Gynecology; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Nominal; OB; ObGyn; Obstetrics; Point in time; Random	4180186
40760157	Chr 12 aneup Amn/CVS FISH	4180186
40760157	染色体 12 非整倍体性:发现:时间点:羊水/绒毛膜绒毛样本:名义型:FISH	4182948
40760158	Form version; OASIS-C; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760159	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40760160	Hx; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Patient Hx; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760162	Housing; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760163	Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760164	Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40760165	Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760166	Neuro & emot & behav status - start care; Neuro emotional behavioral status; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Started; Survey	4180186
40760167	Activities of Daily Living; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760169	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40760170	Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760171	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40760174	Antepartum note; APS; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760174	Antepartum note	4180186
40760174	分娩前摘要记录:发现:时间点:{环境}:文档型:{角色}	4182948
40760175	L&D admin H&P note	4180186
40760175	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; L&D admin H&P note; notes; Point in time; Random; Visit note	4180186
40760175	临产和分娩入院病史与体格检查记录:发现:时间点:{环境}:文档型:{角色}	4182948
40760178	DOC.MISC; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gestation; Gestations; Gravida; MISC; Narrative; notes; Point in time; Pregnancies; Random; Report; Visit note	4180186
40760178	Pregnancy visit summary	4180186
40760178	妊娠就诊摘要:发现:时间点:^患者:叙述型	4182948
40760179	Est date of delivery	4180186
40760179	CLIN; EDC; EDD; Est date of delivery; Finding; Findings; Narrative; Point in time; Random; Report	4180186
40760179	预产期:发现:时间点:^患者:叙述型	4182948
40760182	Date of confinement; Deliv date; Due date; EDC; EDD; Est; Est from quickening date; estimation; Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; predicted; QNT; Quan; Quant; Quantitative; Random	4180186
40760182	Deliv date Est from quickening date	4180186
40760182	分娩日期:日期:时间点:^患者:定量型:依据胎动初感日期的估计法	4182948
40760183	Date of confinement; Deliv date; Due date; EDC; EDD; Est; Est from date FH reaches umb; estimation; Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; predicted; QNT; Quan; Quant; Quantitative; Random	4180186
40760183	Deliv date Est from date FH reaches umb	4180186
40760183	分娩日期:日期:时间点:^患者:定量型:依据宫高达到脐部日期的估计法	4182948
40760184	Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760184	胎动初感日期:日期:时间点:^患者:定量型:报告法	4182948
40760185	Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760185	宫高达到脐部日期:日期:时间点:^患者:定量型	4182948
40760186	Bdy weight; bod; Bodies; EFW; Est; Est by palpation; Estimated fetal weight; estimation; Fetal; Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
40760186	Fet Weight Est by palpation	4180186
40760186	体重:质量:时间点:^胎儿:定量型:触诊估计法	4182948
40760188	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Sx	4180186
40760188	早产症状:发现:时间点:^患者:名义型	4182948
40760190	Finding; Findings; H+P; H+P.HX; Meth; Method of; Nominal; OB; Obstetrical; Obstetrics; P prime; Point in time; Pregnancy; Prenatal; Random	4180186
40760190	产科学分娩方法:发现:时间点:^患者:名义型	4182948
40760191	IV fluids administered	4180186
40760191	Finding; Findings; H+P; H+P.PX; IV fluids administered; Narrative; P prime; Point in time; Random; Report	4180186
40760191	所施用的静脉内液体:发现:时间点:^患者:叙述型	4182948
40760193	Finding; Findings; H+P; H+P.PX; L&D process; Narrative; P prime; Point in time; Random; Report	4180186
40760193	L&D process	4180186
40760193	临产和分娩过程:发现:时间点:^患者:叙述型	4182948
40760195	Finding; Findings; H+P; H+P.PX; Hospitalization hx; Narrative; P prime; Point in time; Postpart; Postpartm; Random; Report; Tx	4180186
40760195	Postpartum hospitalization treatment	4180186
40760195	产后住院治疗:发现:时间点:^患者:叙述型	4182948
40760196	Disch; Finding; Findings; H+P; H+P.PX; Narrative; NB; NB status at maternal discharge; New born; P prime; Point in time; Random; Report	4180186
40760196	NB status at maternal discharge NB	4180186
40760196	产妇出院时的新生儿状态:发现:时间点:^新生儿:叙述型	4182948
40760200	Finding; Findings; H+P; H+P.PX; Narrative; P prime; Point in time; Random; Report	4180186
40760200	Anesthesia risk review of systems	4180186
40760200	麻醉风险系统评审:发现:时间点:^患者:叙述型	4182948
40760203	Acd; Acids; Blood; Chemistry; DBS; Dried blood spot; FA Oxidation; FA oxidation NB scn pnl; FAO; Filter paper; FP; Gyn; Gynecology; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; WB; Whole blood	4180186
40760203	FA oxidation NB scn pnl DBS	4180186
40760203	脂肪酸氧化新生儿筛查组套:-:时间点:全血.斑点:-	4182948
40760204	Acd; Acids; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; New born; OA NB scn pnl; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; WB; Whole blood	4180186
40760204	OA NB scn pnl DBS	4180186
40760204	有机酸新生儿筛查组套:-:时间点:全血.斑点:-	4182948
40760205	21-hydroxylase deficiency; Adrnl; Asympt; Asymptomatic; Blood; CAH; CAH NB scn pnl; Chemistry; DBS; Dried blood spot; Filter paper; FP; NB Screen Pnl; NBS; New born; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood	4180186
40760205	CAH NB scn pnl DBS	4180186
40760205	先天性肾上腺皮质增生新生儿筛查组套:-:时间点:全血.斑点:-	4182948
40760206	Asympt; Asymptomatic; BIO NB scn pnl; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; NB Screen Pnl; NBS; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood	4180186
40760206	BIO NB scn pnl DBS	4180186
40760206	生物素酶新生儿筛查组套:-:时间点:全血.斑点:-	4182948
40760208	ECP Nasal fluid-mCnc	4180186
40760208	Allergen; Allergens; ALLERGY TESTING; ECP; Eos; Eosin; Eosino; Eosinophils; Level; Mass concentration; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random	4180186
40760208	嗜酸性粒细胞阳离子蛋白:质量浓度:时间点:鼻腔液体:定量型	4182948
40760209	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40760209	HLA-DQA1*05:01 Ql	4180186
40760209	HLA-DQA1*05:01:存在情况或阈值:时间点:全血/组织:序数型	4182948
40760210	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40760210	HLA-DQB1*02:01 Ql	4180186
40760210	HLA-DQB1*02:01:存在情况或阈值:时间点:全血/组织:序数型	4182948
40760212	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; cCP; CCP3; Cyclic Citrulinated Peptide; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; MEIA; Pept; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatoid arthritis; Rheumatology; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders	4180186
40760212	cCP IgA+IgG SerPl IA-aCnc	4180186
40760212	环瓜氨酸肽 抗体.IgA+IgG:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
40760213	adj; adj SG 1.024; Conc; Concentration; Den; Density; DRUG/TOXICOLOGY; Drugs; Grav; Level; Mass concentration; Oxybenzene; Point in time; QNT; Quan; Quant; Quantitative; Random; SG; Sp G; Sp Gr; Sp Grav; Spec; Spec grav; UA; UR; Urn	4180186
40760213	Phenol adj SG 1.024 Ur-mCnc	4180186
40760213	苯酚^^调整至比重 1.024的:质量浓度:时间点:尿液:定量型	4182948
40760216	10M pre GnRH; Arbitrary Concentration; Before; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; GHR; GnRH; Horm; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Pl; Plasma; Plsm; Point in time; pre GnRH; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760216	FSH 10M pre GnRH SerPl-aCnc	4180186
40760216	促卵泡激素^在给予剂量促性腺激素释放激素之前10分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40760219	30M p GnRH; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; GHR; GnRH; Horm; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760219	FSH 30M p GnRH SerPl-aCnc	4180186
40760219	促卵泡激素^在剂量促性腺激素释放激素之后30分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40760221	120 min; 120 minutes; 120min; 2 hours; 2h p GnRH; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GHR; GnRH; Horm; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; LHRH; Luliberin; Luteinizing hormone; Luteinizing hormone releasing hormone; Lutenin; Lutenizing hormone; Lutropin release factor; Ovulation test; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760221	LH 2h p GnRH SerPl-aCnc	4180186
40760221	促黄体素^在剂量促性腺激素释放激素之后2小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760222	1 1/2 hours; 1 1/2 HR; 1.5h p GnRH; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GHR; GnRH; Horm; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; LHRH; Luliberin; Luteinizing hormone; Luteinizing hormone releasing hormone; Lutenin; Lutenizing hormone; Lutropin release factor; Ovulation test; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760222	LH 1.5h p GnRH SerPl-aCnc	4180186
40760222	促黄体素^在剂量促性腺激素释放激素之后1.5小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760225	20M p GnRH; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GHR; GnRH; Horm; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; LHRH; Luliberin; Luteinizing hormone; Luteinizing hormone releasing hormone; Lutenin; Lutenizing hormone; Lutropin release factor; Ovulation test; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760225	LH 20M p GnRH SerPl-aCnc	4180186
40760225	促黄体素^在剂量促性腺激素释放激素之后20分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40760227	Eye; EYE.OCT; Eyeball; Length; Macular grid.CP thickness; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Vision; Visual	4180186
40760227	Macular grid.CP thickness OCT	4180186
40760227	黄斑格栅.中心点厚度:长度:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760229	Eye; EYE.OCT; Eyeball; Length; Macular grid.ISS thickness; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Vision; Visual	4180186
40760229	Macular grid.ISS thickness OCT	4180186
40760229	黄斑格栅.内上区厚度:长度:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760230	Eye; EYE.OCT; Eyeball; Length; Macular grid.INS thickness; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Vision; Visual	4180186
40760230	Macular grid.INS thickness OCT	4180186
40760230	黄斑格栅.内鼻侧区厚度:长度:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760231	Eye; EYE.OCT; Eyeball; Inf; Length; Macular grid.IIS thickness; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Vision; Visual	4180186
40760231	Macular grid.IIS thickness OCT	4180186
40760231	黄斑格栅.内下区厚度:长度:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760233	Eye; EYE.OCT; Eyeball; Length; Macular grid.OSS thickness; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Vision; Visual	4180186
40760233	Macular grid.OSS thickness OCT	4180186
40760233	黄斑格栅.外上区厚度:长度:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760235	Eye; EYE.OCT; Eyeball; Inf; Length; Macular grid.OIS thickness; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Vision; Visual	4180186
40760235	Macular grid.OIS thickness OCT	4180186
40760235	黄斑格栅.外下区厚度:长度:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760242	estimation; Nursing Management Minimum Data Set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.NMMDS	4180186
40760246	Meth; Nominal; Nursing Management Minimum Data Set; Point in time; Random; Survey; SURVEY.NMMDS; Typ	4180186
40760247	Asympt; Asymptomatic; Chemistry; NBS report summary pnl; New born; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Rpt summ; Scn	4180186
40760247	NBS report summary pnl Patient	4180186
40760247	新生儿筛查报告摘要组套:-:时间点:^患者:-	4182948
40760248	Asympt; Asymptomatic; Chemistry; Document; Full NBS summary for display & print; New born; Point in time; Random; Scn	4180186
40760248	Full NBS summary for display/printing	4180186
40760248	适用于显示或打印的全面新生儿筛查摘要报告:-:时间点:^患者:文档型	4182948
40760250	NB conditions positive DBS	4180186
40760250	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Identity or presence; NB conditions positive; New born; Nominal; Point in time; Pos; Random; WB; Whole blood	4180186
40760250	带有阳性标志的新生儿健康状况:存在与否或特征标识:时间点:全血.斑点:名义型	4182948
40760251	Blood; CPCJ; CYP2C; CYP2C19 allele; CYPIIC17; CYPIIC19; cytochrome P-450 II C; cytochrome P450, family 2, subfamily C, polypeptide 19; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; P450C2C; P450IIC19; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40760251	CYP2C19 allele Geno Bld/T	4180186
40760251	CYP2C19 基因等位基因:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760255	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760255	转诊记录:发现:时间点:{环境}:文档型:糖尿病学	4182948
40760257	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gastro; Gastroenterology; GI; notes; Point in time; Random; Visit note	4180186
40760257	转诊记录:发现:时间点:{环境}:文档型:胃肠病学	4182948
40760259	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
40760260	Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; ID; Infectious Disease; InfectiousDisease; notes; Point in time; Random; Visit note	4180186
40760260	转诊记录:发现:时间点:{环境}:文档型:感染性疾病	4182948
40760262	DOC.ONT; Document; Emotional stability; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760262	转诊记录:发现:时间点:{环境}:文档型:心理健康	4182948
40760263	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Kidney; Nephrology; notes; Point in time; Random; Renal; Visit note	4180186
40760263	转诊记录:发现:时间点:{环境}:文档型:肾病学	4182948
40760264	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro; Neurology; notes; Point in time; Random; Visit note	4180186
40760264	转诊记录:发现:时间点:{环境}:文档型:神经病学	4182948
40760265	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro; Neuro surgery; Neurology; notes; Point in time; Random; Surg; Visit note	4180186
40760265	Neuro surgery Referral note	4180186
40760265	转诊记录:发现:时间点:{环境}:文档型:神经外科学	4182948
40760266	Occup med Referral note	4180186
40760266	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Occup med; Occupational health; Point in time; Random; Visit note	4180186
40760266	转诊记录:发现:时间点:{环境}:文档型:职业医学	4182948
40760271	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Pharmacy; Point in time; Random; Visit note	4180186
40760271	转诊记录:发现:时间点:{环境}:文档型:药理学	4182948
40760272	PM+R Referral note	4180186
40760272	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; PM+R; Point in time; Random; Visit note	4180186
40760272	转诊记录:发现:时间点:{环境}:文档型:物理医学与康复学	4182948
40760277	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760277	Psych Referral note	4180186
40760277	转诊记录:发现:时间点:{环境}:文档型:心理学	4182948
40760279	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Rec therapy; Visit note	4180186
40760279	Rec therapy Referral note	4180186
40760279	转诊记录:发现:时间点:{环境}:文档型:娱乐疗法	4182948
40760281	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Lung; notes; Point in time; Pulmonary; Pulmonology; Random; Resp therapy; Respiratory; Visit note	4180186
40760281	Resp therapy Referral note	4180186
40760281	转诊记录:发现:时间点:{环境}:文档型:呼吸疗法	4182948
40760282	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760282	转诊记录:发现:时间点:{环境}:文档型:风湿病学	4182948
40760285	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
40760285	转诊记录:发现:时间点:{环境}:文档型:外科学	4182948
40760288	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
40760288	转诊记录:发现:时间点:{环境}:文档型:血管外科学	4182948
40760289	cardiology; cards; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760289	转诊记录:发现:时间点:{环境}:文档型:心血管疾病	4182948
40760290	Geri med Referral note	4180186
40760290	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Geri med; Gerontology; notes; Point in time; Random; Visit note	4180186
40760290	转诊记录:发现:时间点:{环境}:文档型:老年医学	4182948
40760291	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Hematology and Oncology; Hematology+Oncology; Heme; HemOnc; notes; Oncology; Point in time; Random; Visit note	4180186
40760291	HemOnc Referral note	4180186
40760291	转诊记录:发现:时间点:{环境}:文档型:血液学+内科肿瘤学	4182948
40760292	Nutr+diet Referral note	4180186
40760292	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nutr+diet; Nutrition+Dietetics; Point in time; Random; Visit note	4180186
40760292	转诊记录:发现:时间点:{环境}:文档型:营养学与膳食学	4182948
40760296	Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Lung; notes; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Respirology; Visit note	4180186
40760296	Pulmonary disease Referral note	4180186
40760296	转诊记录:发现:时间点:{环境}:文档型:肺病	4182948
40760298	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; OBGYN; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
40760298	OBGYN Referral note	4180186
40760298	转诊记录:发现:时间点:{环境}:文档型:产科学与妇科学	4182948
40760299	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40760299	N gonorrhoea DNA Nph Ql NAA+probe	4180186
40760299	淋病奈瑟菌 DNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
40760300	Anticoag; Anti-phospholipid antibody; Clot; Clottable; COAGULATION; Coagulation assay; Coagulation inhibiting antibody; Dil; Dilut; Dilute prothrombin time; dPT; dRVVT; Hematology; Heme; LA; LA Nt dPL; LA Nt HPL; LAC; Lipid; Lupus inhibitor; Neut; Neutr; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Tilt tube; Tissue thromboplastin inhibition; TTI; TTIT	4180186
40760300	LA Nt dPL/LA Nt HPL PPP-Rto	4180186
40760300	狼疮抗凝物质中和作用.稀释磷脂/狼疮抗凝物质中和作用.高磷脂:比率:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40760301	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; HIV type 1; HIV type I; HIV1; HIV1 RNA tropism; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; Ribonucleic acid	4180186
40760301	HIV1 RNA tropism Plas	4180186
40760301	HIV 1 型 RNA 嗜性:存在与否或特征标识:时间点:血浆:叙述型	4182948
40760303	Finding; Findings; Ordinal; Outcome and assessment information set; Point in time; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; Survey.OASIS	4180186
40760306	No; Num; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; Survey.OASIS	4180186
40760307	III; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; Random; Surf; Survey; Survey.OASIS; Ulcer	4180186
40760308	Finding; Findings; Ordinal; Outcome and assessment information set; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Survey.OASIS	4180186
40760312	Form version; OASIS-C; OASIS-C - Transfer to facility; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760314	Centers for Medicare and Medicaid Assessment; Drugs; Finding; Findings; Ordinal; Patient/caregiver drug education intervention; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760315	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40760319	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40760323	Centers for Medicare and Medicaid Assessment; Disch; Last; Nominal; Survey; Typ	4180186
40760325	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760328	Finding; Findings; FLUV; Influ; Nominal; Outcome and assessment information set; Point in time; Random; Survey; Survey.OASIS	4180186
40760329	Finding; Findings; Ordinal; Outcome and assessment information set; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Survey.OASIS	4180186
40760331	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40760334	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760335	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760336	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760337	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760338	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760340	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; Ulcer	4180186
40760341	Centers for Medicare and Medicaid Assessment; Disch; Finding; Findings; II; Nominal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; Random; Survey; Ulcer	4180186
40760343	Cnt; Count; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS	4180186
40760344	Cnt; Count; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS; Ulcer	4180186
40760349	Finding; Findings; i; No; Num; Ordinal; Outcome and assessment information set; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Survey.OASIS	4180186
40760350	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; Ulcer	4180186
40760351	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; Ulcer	4180186
40760353	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; Ulcer	4180186
40760355	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Surg; Survey	4180186
40760356	Centers for Medicare and Medicaid Assessment; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760357	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey; Tx; Txs	4180186
40760359	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40760362	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40760363	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40760364	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40760365	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40760367	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760368	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760370	Finding; Findings; Ordinal; Outcome and assessment information set; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Survey.OASIS	4180186
40760373	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40760374	Centers for Medicare and Medicaid Assessment; Drugs; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760375	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760376	Centers for Medicare and Medicaid Assessment; Drugs; Finding; Findings; Ordinal; Patient/caregiver high risk drug education; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760378	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760379	Activities of Daily Living; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760381	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760387	Centers for Medicare and Medicaid Assessment; Cnt; Count; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40760388	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; Survey	4180186
40760389	Centers for Medicare and Medicaid Assessment; Finding; Findings; Lower extremity; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760395	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760396	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40760397	Centers for Medicare and Medicaid Assessment; Disch; Discharge location; Discharge status; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40760400	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760402	Finding; Findings; Nominal; Outcome and assessment information set; Point in time; Random; Survey; Survey.OASIS	4180186
40760404	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760405	Finding; Findings; Nominal; Outcome and assessment information set; Point in time; Random; Survey; Survey.OASIS	4180186
40760406	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anus; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rectal specimen; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification	4180186
40760406	C trach rRNA Anal Ql NAA+probe	4180186
40760406	沙眼衣原体 rRNA:存在情况或阈值:时间点:肛门:序数型:探针法.基因扩增.靶向	4182948
40760409	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40760409	HLA-A High Res	4180186
40760409	HLA-A:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
40760410	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40760410	HLA-B High Res	4180186
40760410	HLA-B:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
40760411	Arbitrary concentration; Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40760411	Deprecated HLA-B57*01 Ql	4180186
40760414	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40760414	HLA-DRB4 High Res	4180186
40760414	HLA-DRB4:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
40760415	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40760415	HLA-DRB5 High Res	4180186
40760415	HLA-DRB5:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
40760417	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40760417	HLA-DRB1	4180186
40760417	HLA-DRB1:类型:时间点:全血/组织:名义型	4182948
40760418	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40760418	HLA-DQB1 High Res	4180186
40760418	HLA-DQB1:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
40760419	6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin metabolite; Illicit; Level; MAM; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40760419	6MAM Sal-mCnc	4180186
40760419	6-单乙酰吗啡:质量浓度:时间点:唾液:定量型	4182948
40760426	Arterial Stenosis; Finding; Findings; II; Nominal; Outcome and assessment information set; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; Random; Survey; Survey.OASIS; Ulcer	4180186
40760428	AltPrP; ASCR; Blood; CD230; CJD; Genetics; GSS; Heredity; Heritable; Identity or presence; Inherited; KURU; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; p27-30; PCR; Point in time; prion protein; Prion protein gene; PRIP; PrP; PrP27-30; PrP33-35C; PrPc; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40760428	PRNP gene Mut Anl Bld/T	4180186
40760428	PRNP 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760430	Blood; CPN1; CYP11B; Cytochrome P450, family 11, subfamily B, polypeptide 1; FHI; Gene mut tested; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; P450C11; PCR; Point in time; Random; Steroid 11-beta-hydroxylase gene; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40760430	CYP11B1 gene Mut Tested Bld/T	4180186
40760430	CYP11B1 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760431	AltPrP; ASCR; Blood; CD230; CJD; Gene mut tested; Genetics; GSS; Heredity; Heritable; Identity or presence; Inherited; KURU; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; p27-30; PCR; Point in time; prion protein; Prion protein gene; PRIP; PrP; PrP27-30; PrP33-35C; PrPc; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40760431	PRNP gene Mut Tested Bld/T	4180186
40760431	PRNP 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760443	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; First; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Serum; sp1; Spec; SR; SUDS	4180186
40760443	FLUAV IgG sp1 Ser IA-aCnc	4180186
40760443	流感病毒 A 型 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760447	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; FLUB; FLUBV; FLUV; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; MEIA; Microbiology; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Serum; sp1; Spec; SR; SUDS	4180186
40760447	FLUBV IgM sp1 Ser IA-aCnc	4180186
40760447	流感病毒 B 型 抗体.IgM^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760452	Calcium 2h Ur-mCnc	4180186
40760452	120 min; 120 minutes; 120min; 2 hours; 2HR; Ca; Cal; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760452	钙:质量浓度:2小时:尿液:定量型	4182948
40760453	12 hours; 12HR; Ca; Cal; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760453	Calcium 12h Ur-mCnc	4180186
40760453	钙:质量浓度:12小时:尿液:定量型	4182948
40760457	12 hours; 12HR; Chemistry; Citric acid; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760457	Citrate 12h Ur-mRate	4180186
40760457	柠檬酸:质量速率:12小时:尿液:定量型	4182948
40760458	Chloride 12h Ur-sCnc	4180186
40760458	12 hours; 12HR; Chemistry; Cl; Cl-; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
40760458	氯:物质的量浓度:12小时:尿液:定量型	4182948
40760460	12 hours; 12HR; Chemistry; Cl; Cl-; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40760460	Chloride 12h Ur-sRate	4180186
40760460	氯:物质的量速率:12小时:尿液:定量型	4182948
40760461	120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; CR; Crea; Creat; Kidney; Level; Mass concentration; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UR; Urn	4180186
40760461	Creat 2h Ur-mCnc	4180186
40760461	肌酐:质量浓度:2小时:尿液:定量型	4182948
40760464	Copper Dial fld-mCnc	4180186
40760464	Cu; Diaf; Dialysate; Dialysis fluid; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760464	铜:质量浓度:时间点:透析液:定量型	4182948
40760467	1M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760467	Glucose 1M p chal SerPl-mCnc	4180186
40760467	葡萄糖^在XXX刺激之后1分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760468	5M p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760468	Insulin 5M p chal SerPl-aCnc	4180186
40760468	胰岛素^在XXX刺激之后5分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40760470	Lactate 1M p chal SerPl-mCnc	4180186
40760470	1M p chal; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760470	乳酸^在XXX刺激之后1分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760474	20M p chal; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760474	Lactate 20M p chal SerPl-mCnc	4180186
40760474	乳酸^在XXX刺激之后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760475	Lactate 3M p chal SerPl-mCnc	4180186
40760475	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 3M p chal; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760475	乳酸^在XXX刺激之后3分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760477	Lactate 5M p chal SerPl-mCnc	4180186
40760477	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 5M p chal; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760477	乳酸^在XXX刺激之后5分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760478	1 hour; 1.0Hr; 1h p chal; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760478	Lactate 1h p chal SerPl-mCnc	4180186
40760478	乳酸^在XXX刺激之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760479	Lactate 1.5h p chal SerPl-mCnc	4180186
40760479	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760479	乳酸^在XXX刺激之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760481	Magnesium 12h Ur-mCnc	4180186
40760481	12 hours; 12HR; Chemistry; Level; MAG; Magnes; Mass concentration; Mg; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760481	镁:质量浓度:12小时:尿液:定量型	4182948
40760484	12 hours; 12HR; Chemistry; Level; Na; Na+; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
40760484	Sodium 12h Ur-sCnc	4180186
40760484	钠:物质的量浓度:12小时:尿液:定量型	4182948
40760486	12 hours; 12HR; Chemistry; Kidney; Nephrology; Osmo; Osmol; Osmolality; osmolarity; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn	4180186
40760486	Osmolality 12h Ur	4180186
40760486	渗透压:渗透压:12小时:尿液:定量型	4182948
40760488	Oxalate 2h Ur-mCnc	4180186
40760488	120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; Ethanedioate; Ethanedioic acid; Level; Mass concentration; Oxal; Oxalic acid; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760488	草酸:质量浓度:2小时:尿液:定量型	4182948
40760489	Oxalate 12h Ur-mRate	4180186
40760489	12 hours; 12HR; Chemistry; Ethanedioate; Ethanedioic acid; Mass rate; mRate; Oxal; Oxalic acid; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760489	草酸:质量速率:12小时:尿液:定量型	4182948
40760494	Potassium 12h Ur-sRate	4180186
40760494	12 hours; 12HR; Chemistry; k; K+; Potass; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40760494	钾:物质的量速率:12小时:尿液:定量型	4182948
40760500	1 day; 24 hours; 24HR; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Level; Mass concentration; Peritoneal Dialysis fluid; QNT; Quan; Quant; Quantitative	4180186
40760500	Urea 24h DiafP-mCnc	4180186
40760500	尿素:质量浓度:24小时:腹膜透析液:定量型	4182948
40760504	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760504	Urea Fld-mCnc	4180186
40760504	尿素:质量浓度:时间点:体液:定量型	4182948
40760505	CD11a Cells NFr Fld	4180186
40760505	AlphaL integrin chain; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD11a Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; LFA-1alpha; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760505	细胞.CD11a/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760508	CD19+CD56+ Cells NFr Fld	4180186
40760508	B cells expressing CD19 as a percent of total lymphocytes; B/F; B4; B-4; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD19 Cells; CD19+CD56+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; HD-37; Leu12; Leu-12; Leu19; Leu-19; NCAM; Neural cell adhesion molecule; NKH1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760508	细胞.CD19+CD56+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760515	2H4; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD45RA Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Leu18; Leu-18; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760515	CD45RA Cells NFr Fld	4180186
40760515	细胞.CD45RA/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760516	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD45RO Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; UCHL-1	4180186
40760516	CD45RO Cells NFr Fld	4180186
40760516	细胞.CD45RO/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760521	CD3+TCR A-B+ Cells NFr Fld	4180186
40760521	Alfa; B; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD3 Cells; CD3+TCR A-B+ Cells; CD3+TCR Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; TCR A-B	4180186
40760521	细胞.CD3+TcR alpha beta+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760523	Desmoglein 1 Ab Ser IA-aCnc	4180186
40760523	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Desmogelin; DSG; DSG1; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40760523	桥粒芯蛋白 1 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760524	Desmoglein 3 Ab Ser IA-aCnc	4180186
40760524	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Desmogelin; DSG; DSG3; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; III; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40760524	桥粒芯蛋白 3 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760528	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; SR; SUDS; Thyroid stimulating hormone; Thyroid stimulating hormone receptor antibody; Thyrotropic hormone; TRAb; TSH; TSH Recep; UniversalLabOrders	4180186
40760528	TSH Recep Ab Ser IA-aCnc	4180186
40760528	促甲状腺激素受体 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760529	B/F; Beta2; Beta-2 integrin; Beta-2 integrin chain; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD11a beta subunit; CD11b beta subunit; CD11c beta subunit; CD18 Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760529	CD18 Cells NFr Fld	4180186
40760529	细胞.CD18/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760530	B/F; B1; B-1; BF; bod; Bodies; Body fluid; Body fluid, unsp; Bp35; CD20 Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Leu16; Leu-16; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760530	CD20 Cells NFr Fld	4180186
40760530	细胞.CD20/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760533	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD34 Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; gp105-120; Hematopoietic stem cell; HSC; My10; My-10; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells	4180186
40760533	CD34 Cells NFr Fld	4180186
40760533	细胞.CD34/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760534	CD40 Cells NFr Fld	4180186
40760534	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Bp50; CD40 Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760534	细胞.CD40/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760535	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD5 Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Leu1; Leu-1; Ly-1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T1; Tp67	4180186
40760535	CD5 Cells NFr Fld	4180186
40760535	细胞.CD5/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760539	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CALLA; CD10 Cells; CD10+FMC7+ Cells; Cell; CELL MARKERS; Cellularity; Common acute lymphoblastic leukemia; Common acute lymphoblastic leukemia antigen; Enkephalinase; Fl; Fld; FLU; Fluid; FMC-7; Gated cells; gp100; J5; NEP; Neprilysin; Neutral endopeptidase metalloendopeptidase; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760539	CD10+FMC7+ Cells NFr Fld	4180186
40760539	细胞.CD10+FMC7+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760540	FMC7 Cells NFr Fld	4180186
40760540	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; FMC-7; FMC7 Cells; Gated cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760540	细胞.FMC7/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760548	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Musc; Muscl; MuSK; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; Spec; SR; SUDS; Tyr	4180186
40760548	MuSK Ab Ser IA-aCnc	4180186
40760548	肌肉特异性受体酪氨酸激酶 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760549	CD56+CD138+ Cells NFr Fld	4180186
40760549	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD56 Cells; CD56+CD138+ Cells; CD56-CD138+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Heparan sulfate proteoglycan; Leu19; Leu-19; NCAM; Neural cell adhesion molecule; NKH1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Syndecan-1	4180186
40760549	细胞.CD56+CD138+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760550	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD56 Cells; CD56+CD138+ Cells; CD56-CD138+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Heparan sulfate proteoglycan; Leu19; Leu-19; NCAM; Neural cell adhesion molecule; NKH1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Syndecan-1	4180186
40760550	CD56-CD138+ Cells NFr Fld	4180186
40760550	细胞.CD56-CD138+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760551	TdT Cells Fld Ql	4180186
40760551	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; TdT; TdT Cells	4180186
40760551	细胞.末端脱氧核苷酸转移酶:存在情况或阈值:时间点:体液:序数型	4182948
40760552	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Circulating platelet ab; COAGULATION; FA; Fluorescent antibody; Fluoresent; Hematology; Heme; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Pl; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Thrombocyte; Thrombocytes; Time Resolved Fluorescence; TRF	4180186
40760552	Platelet Ab Ser Ql IF	4180186
40760552	血小板 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760553	T gondii DNA Fld Ql NAA+probe	4180186
40760553	刚地弓形虫 DNA:存在情况或阈值:时间点:体液:序数型:探针法.基因扩增.靶向	4182948
40760553	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T gondii; T gondii DNA; TMA; Toxo; Toxoplasmosis; Transcription mediated amplification	4180186
40760554	After; Ejaculate; FERTILITY TESTING; Genitourinary; GU; p conc; Point in time; post washing; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Spec; URO; Urology; Vol; Volume	4180186
40760554	Specimen vol p conc Smn	4180186
40760554	标本体积^在浓缩之后:体积型属性:时间点:精液:定量型	4182948
40760555	After; Ejaculate; FERTILITY TESTING; Genitourinary; GU; III; Number fraction; p conc; Percent; Point in time; post washing; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Prog; Sperm Prog 3; URO; Urology	4180186
40760555	Sperm Prog 3 p conc NFr Smn	4180186
40760555	精子.前向运动型.3 级/100 个精子^在浓缩之后:计数型分数:时间点:精液:定量型	4182948
40760558	After; Ejaculate; FERTILITY TESTING; Genitourinary; GU; immobile; nonmotile; Number fraction; p conc; Percent; Point in time; post washing; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Immotile; Spermatozoa.non-motile; URO; Urology	4180186
40760558	Sperm Immotile p conc NFr Smn	4180186
40760558	精子.不活动性/100 个精子^在浓缩之后:计数型分数:时间点:精液:定量型	4182948
40760562	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cytokeratin; EIA; ELFA; ELISA; Enzyme immunoassay; Hepatology; IAA; Liver; Liver-pancreas antigen; MEIA; O-phosphoseryl-tRNA(Sec) selenium transferase; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SLA; Soluble liver antigen; SR; SUDS	4180186
40760562	Deprecated Soluble liver Ab Ser Ql IA	4180186
40760563	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; Collapsin response mediator protein 5; Collapsin response mediator protein 5 Ab; CRMP5; CRMP-5; Immune blot; Immunobl; Immunoblot; Neuro; Neurology; Ordinal; Point in time; POP66; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; ULIP; WB; WBLOT; West blot; West blt; Western blot	4180186
40760563	CV2 Ab CSF Ql IB	4180186
40760563	CV2 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫印迹法	4182948
40760565	AF; Amn; Amn fl; Amn/CVS; Amnio; Amniotic flu; Amniotic fluid; Chorionic villi; Chorionic villus sample; Chr 18 aneup; Chromosom; Chromosomes; Finding; Findings; Fluorescent in situ hybridization; Genetics; Gyn; Gynecology; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Nominal; OB; ObGyn; Obstetrics; Point in time; Random	4180186
40760565	Chr 18 aneup Amn/CVS FISH	4180186
40760565	染色体 18 非整倍体性:发现:时间点:羊水/绒毛膜绒毛样本:名义型:FISH	4182948
40760567	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; T sol; T solium; Tapeworm	4180186
40760567	T sol IgG Ser-aCnc	4180186
40760567	猪带绦虫 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
40760568	#; ABS; absolute; absolutes; After; Cnt; Count; Count/volume; CT; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Number concentration; Number Concentration (count/vol); p conc; Point in time; post washing; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Prog; URO; Urology	4180186
40760568	Sperm Prog p conc # Smn	4180186
40760568	精子.前向运动型^在浓缩之后:计数型浓度:时间点:精液:定量型	4182948
40760572	Activ; Activ T Lymphs; Bronchial alveolar lavage; Bronchoalveolar lavage; Cell; CELL MARKERS; Cellularity; Lung; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; T prime	4180186
40760572	Activ T Lymphs NFr BAL	4180186
40760572	淋巴细胞.活化型 T 细胞/100 个淋巴细胞.小:计数型分数:时间点:支气管肺泡灌洗液:定量型	4182948
40760576	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp11; Spec; SR	4180186
40760576	Cortis sp11 SerPl-mCnc	4180186
40760576	皮质醇^第11个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760578	Cortis sp9 SerPl-mCnc	4180186
40760578	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp9; Spec; SR	4180186
40760578	皮质醇^第9个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760579	1,25(OH)2D3 pre Ca SerPl-mCnc	4180186
40760579	1,25(OH)2D3; 1,25-Calcitriol; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D; 1,25-Dihydroxyvitamin D3; Before; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre Ca; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760579	钙三醇^在给予剂量钙之前:质量浓度:时间点:血清/血浆:定量型	4182948
40760580	1,25(OH)2D3 pre Ca SerPl-sCnc	4180186
40760580	1,25(OH)2D3; 1,25-Calcitriol; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D; 1,25-Dihydroxyvitamin D3; Before; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; pre Ca; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760580	钙三醇^在给予剂量钙之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760583	1,25(OH)2D3 3h p Ca SerPl-sCnc	4180186
40760583	1,25(OH)2D3; 1,25-Calcitriol; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D; 1,25-Dihydroxyvitamin D3; 3h p Ca; After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760583	钙三醇^在给予剂量钙之后3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760584	1,25(OH)2D3; 1,25-Calcitriol; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D; 1,25-Dihydroxyvitamin D3; 3h p Ca; After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760584	1,25(OH)2D3 3h p Ca SerPl-mCnc	4180186
40760584	钙三醇^在给予剂量钙之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760585	1 hour; 1,25(OH)2D3; 1,25-Calcitriol; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D; 1,25-Dihydroxyvitamin D3; 1.0Hr; 1h p Ca; 60 min; 60 minutes; 60M; 60min; After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760585	1,25(OH)2D3 1h p Ca SerPl-sCnc	4180186
40760585	钙三醇^在给予剂量钙之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760587	1 day; 11Ketoandros; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Ketoandrost; Level; Mass concentration; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760587	11Ketoandros pre hi Dex 24h Ur-mCnc	4180186
40760587	11-酮雄酮^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760590	1 day; 11Ketoandros; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Ketoandrost; Mass rate; mRate; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760590	11Ketoandros 2D p high Dex 24h Ur-mRate	4180186
40760590	11-酮雄酮^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760591	11Ketoandros Pre Dex 24h Ur-mCnc	4180186
40760591	1 day; 11Ketoandros; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Ketoandrost; Level; Mass concentration; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760591	11-酮雄酮^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760593	11Ketoandros 2D p Dex 24h Ur-mCnc	4180186
40760593	1 day; 11Ketoandros; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Ketoandrost; Level; Mass concentration; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760593	11-酮雄酮^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760594	11Ketoandros 2D p Dex 24h Ur-mRate	4180186
40760594	1 day; 11Ketoandros; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Ketoandrost; Mass rate; mRate; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760594	11-酮雄酮^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760596	11Ketoetioch pre hi Dex 24h Ur-mRate	4180186
40760596	1 day; 11Ketoetioch; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Ketoetiochol; Mass rate; mRate; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760596	11-酮本胆烷醇酮^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760597	1 day; 11Ketoetioch; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Ketoetiochol; Level; Mass concentration; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760597	11Ketoetioch 2D p high Dex 24h Ur-mCnc	4180186
40760597	11-酮本胆烷醇酮^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760600	1 day; 11Ketoetioch; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Ketoetiochol; Mass rate; mRate; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760600	11Ketoetioch Pre Dex 24h Ur-mRate	4180186
40760600	11-酮本胆烷醇酮^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760601	11Ketoetioch 2D p Dex 24h Ur-mCnc	4180186
40760601	1 day; 11Ketoetioch; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Ketoetiochol; Level; Mass concentration; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760601	11-酮本胆烷醇酮^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760602	1 day; 11Ketoetioch; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Ketoetiochol; Mass rate; mRate; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760602	11Ketoetioch 2D p Dex 24h Ur-mRate	4180186
40760602	11-酮本胆烷醇酮^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760603	11DOC; 11-DOC; 21-Hydroxyprogesterone; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; DOC; Level; mcg; Pl; Plasma; Plsm; Point in time; pre 250 ug ACTH; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760603	11DOC pre 250 ug ACTH SerPl-sCnc	4180186
40760603	11-脱氧皮质酮^在给予250 ug促肾上腺皮质激素之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760605	1 hour; 1.0Hr; 11DOC; 11-DOC; 1h p 250 ug ACTH; 21-Hydroxyprogesterone; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; DOC; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760605	11DOC 1h p 250 ug ACTH SerPl-sCnc	4180186
40760605	11-脱氧皮质酮^在给予250 ug促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760607	11DC Pre Dex SerPl-mCnc	4180186
40760607	11DC; Before; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Metopirone; Pl; Plasma; Plsm; Point in time; Pre Dex; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760607	11-脱氧皮质醇^在给予地塞米松之前:质量浓度:时间点:血清/血浆:定量型	4182948
40760610	11DC 2D p Dex SerPl-sCnc	4180186
40760610	11DC; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; Level; Metopirone; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760610	11-脱氧皮质醇^在给予剂量地塞米松之后2天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760611	11DC; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Metopirone; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760611	11DC 2D p Dex SerPl-mCnc	4180186
40760611	11-脱氧皮质醇^在给予剂量地塞米松之后2天:质量浓度:时间点:血清/血浆:定量型	4182948
40760615	11DC; 1D p MTP; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p dose; p metyraPONE; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760615	11DC 1D p MTP SerPl-mCnc	4180186
40760615	11-脱氧皮质醇^在给予剂量美替拉酮之后1天:质量浓度:时间点:血清/血浆:定量型	4182948
40760616	11DC 2D p MTP SerPl-sCnc	4180186
40760616	11DC; 2D p MTP; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Metopirone; p dose; p metyraPONE; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760616	11-脱氧皮质醇^在给予剂量美替拉酮之后2天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760617	11DC; 2D p MTP; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p dose; p metyraPONE; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760617	11DC 2D p MTP SerPl-mCnc	4180186
40760617	11-脱氧皮质醇^在给予剂量美替拉酮之后2天:质量浓度:时间点:血清/血浆:定量型	4182948
40760619	11DC; 45M p 250 ug ACTH; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Cortrosyn; Deoxycortisol; Desoxycortisol; Level; Mass concentration; mcg; Metopirone; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
40760619	11DC 45M p 250 ug ACTH SerPl-mCnc	4180186
40760619	11-脱氧皮质醇^在给予250 ug促肾上腺皮质激素之后45分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760620	1 day; 11-beta-hydroxyandrosterone; 11-Hydroxy androsterone; 11OH-Androst; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760620	11OH-Androst pre hi Dex 24h Ur-mCnc	4180186
40760620	11-羟雄酮^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760621	11OH-Androst pre hi Dex 24h Ur-mRate	4180186
40760621	1 day; 11-beta-hydroxyandrosterone; 11-Hydroxy androsterone; 11OH-Androst; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760621	11-羟雄酮^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760622	11OH-Androst 2D p high Dex 24h Ur-mCnc	4180186
40760622	1 day; 11-beta-hydroxyandrosterone; 11-Hydroxy androsterone; 11OH-Androst; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760622	11-羟雄酮^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760623	11OH-Androst 2D p high Dex 24h Ur-mRate	4180186
40760623	1 day; 11-beta-hydroxyandrosterone; 11-Hydroxy androsterone; 11OH-Androst; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760623	11-羟雄酮^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760625	11OH-Androst Pre Dex 24h Ur-mRate	4180186
40760625	1 day; 11-beta-hydroxyandrosterone; 11-Hydroxy androsterone; 11OH-Androst; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760625	11-羟雄酮^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760626	11OH-Androst 2D p Dex 24h Ur-mCnc	4180186
40760626	1 day; 11-beta-hydroxyandrosterone; 11-Hydroxy androsterone; 11OH-Androst; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760626	11-羟雄酮^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760627	11OH-Androst 2D p Dex 24h Ur-mRate	4180186
40760627	1 day; 11-beta-hydroxyandrosterone; 11-Hydroxy androsterone; 11OH-Androst; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760627	11-羟雄酮^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760628	1 day; 11 beta-hydroxyandrosterone; 11-Hydroxy etiocholanolone; 11OH-Etioch; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760628	11OH-Etioch pre hi Dex 24h Ur-mCnc	4180186
40760628	11-羟本胆烷醇酮^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760631	11OH-Etioch 2D p high Dex 24h Ur-mRate	4180186
40760631	1 day; 11 beta-hydroxyandrosterone; 11-Hydroxy etiocholanolone; 11OH-Etioch; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760631	11-羟本胆烷醇酮^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760632	11OH-Etioch Pre Dex 24h Ur-mCnc	4180186
40760632	1 day; 11 beta-hydroxyandrosterone; 11-Hydroxy etiocholanolone; 11OH-Etioch; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760632	11-羟本胆烷醇酮^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760633	11OH-Etioch Pre Dex 24h Ur-mRate	4180186
40760633	1 day; 11 beta-hydroxyandrosterone; 11-Hydroxy etiocholanolone; 11OH-Etioch; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760633	11-羟本胆烷醇酮^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760637	1 day; 17KGS; 17-KGS; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Ketogen; Ketogenc; Ketognc; Level; Mass concentration; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; Ste; Steriods; Steroid; UA; UR; Urn	4180186
40760637	17KGS 2D p Dex 24h Ur-mCnc	4180186
40760637	17-羟基生酮类固醇^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760640	17OHCS Pre Dex 24h Ur-mCnc	4180186
40760640	1 day; 17-CS; 17-hydroxy corticosteroids; 17OHCS; 17-OHCS; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760640	17-羟基皮质类固醇^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760641	17OHCS 2D p Dex 24h Ur-mCnc	4180186
40760641	1 day; 17-CS; 17-hydroxy corticosteroids; 17OHCS; 17-OHCS; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760641	17-羟基皮质类固醇^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760643	17 hydroxy pregnenolone; 17-alpha-Hydroxypregnenolone; 17OH-Preg; 1D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760643	17OH-Preg 1D p Dex SerPl-sCnc	4180186
40760643	17-羟基孕烯醇酮^在给予剂量地塞米松之后1天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760646	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp11; sp11 p chal; Spec; SR	4180186
40760646	17OHP sp11 p chal SerPl-mCnc	4180186
40760646	17-羟孕酮^在XXX刺激之后的第11个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760648	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR	4180186
40760648	17OHP sp8 p chal SerPl-mCnc	4180186
40760648	17-羟孕酮^在XXX刺激之后的第8个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760650	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; First; Genetics; GHR; GnRH; Heredity; Heritable; Horm; Hydroxyproges; Hydroxyprogstron; Inherited; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p GnRH; Spec; SR	4180186
40760650	17OHP sp1 p GnRH SerPl-mCnc	4180186
40760650	17-羟孕酮^在剂量促性腺激素释放激素之后的第1个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760652	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; GHR; GnRH; Heredity; Heritable; Horm; Hydroxyproges; Hydroxyprogstron; Inherited; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p GnRH; Spec; SR	4180186
40760652	17OHP sp3 p GnRH SerPl-mCnc	4180186
40760652	17-羟孕酮^在剂量促性腺激素释放激素之后的第3个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760654	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; GHR; GnRH; Heredity; Heritable; Horm; Hydroxyproges; Hydroxyprogstron; Inherited; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p GnRH; Spec; SR	4180186
40760654	17OHP sp5 p GnRH SerPl-mCnc	4180186
40760654	17-羟孕酮^在剂量促性腺激素释放激素之后的第5个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760658	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hexadrol; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Pl; Plasma; Plsm; Point in time; Pre Dex; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760658	17OHP Pre Dex SerPl-sCnc	4180186
40760658	17-羟孕酮^在给予地塞米松之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760660	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 1D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hexadrol; Hydroxyproges; Hydroxyprogstron; Inherited; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760660	17OHP 1D p Dex SerPl-sCnc	4180186
40760660	17-羟孕酮^在给予剂量地塞米松之后1天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760662	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hexadrol; Hydroxyproges; Hydroxyprogstron; Inherited; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760662	17OHP 2D p Dex SerPl-sCnc	4180186
40760662	17-羟孕酮^在给予剂量地塞米松之后2天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760664	18OH-DOC 30M p ACTH SerPl-sCnc	4180186
40760664	18-Hydroxy deoxycorticosterone; 18-OH-DOC; 18OH-DOC; 30M p ACTH; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760664	18-羟基脱氧皮质酮^在给予剂量促肾上腺皮质激素之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760666	18OHB; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Pl; Plasma; Plsm; Point in time; Pre ACTH; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760666	18OHB Pre ACTH SerPl-sCnc	4180186
40760666	18-羟基皮质酮^在剂量促肾上腺皮质激素之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760667	18OHB; 30M p ACTH; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760667	18OHB 30M p ACTH SerPl-sCnc	4180186
40760667	18-羟基皮质酮^在给予剂量促肾上腺皮质激素之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760668	18OHB 1h p ACTH SerPl-sCnc	4180186
40760668	1 hour; 1.0Hr; 18OHB; 1h p ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760668	18-羟基皮质酮^在给予剂量促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760681	25(OH)D3 1h p Ca SerPl-sCnc	4180186
40760681	1 hour; 1.0Hr; 1h p Ca; 25(OH)D3; 25-hydroxycholecalciferol; 25-hydroxyvitamin D 3; 25-hydroxyvitamin D3; 60 min; 60 minutes; 60M; 60min; After; Ca; Cal; Calciderol; Calcifediol; CHEMISTRY.CHALLENGE TESTING; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vitamin D 25 hydroxy	4180186
40760681	钙二醇^在给予剂量钙之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760683	3A-diol G 1D p Dex SerPl-sCnc	4180186
40760683	1D p Dex; 3A-diol G; 3-alpha-diol G; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Gluc; Glucouronide; Hexadrol; III; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760683	Alpha-二氢雄酮葡糖苷酸^在给予剂量地塞米松之后1天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760684	2D p Dex; 3A-diol G; 3-alpha-diol G; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Gluc; Glucouronide; Hexadrol; III; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760684	3A-diol G 2D p Dex SerPl-sCnc	4180186
40760684	Alpha-二氢雄酮葡糖苷酸^在给予剂量地塞米松之后2天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760686	30M p ACTH; 3A-diol G; 3-alpha-diol G; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; Alfa; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Gluc; Glucouronide; III; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760686	3A-diol G 30M p ACTH SerPl-sCnc	4180186
40760686	Alpha-二氢雄酮葡糖苷酸^在给予剂量促肾上腺皮质激素之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760688	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; DHT; Dihydrotestosterone; Level; Pl; Plasma; Plsm; Point in time; Pre ACTH; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760688	Androstanolone Pre ACTH SerPl-sCnc	4180186
40760688	双氢睾酮^在剂量促肾上腺皮质激素之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760690	Androstanolone 1h p ACTH SerPl-sCnc	4180186
40760690	1 hour; 1.0Hr; 1h p ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; DHT; Dihydrotestosterone; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760690	双氢睾酮^在给予剂量促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760691	After; c246; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p 25 mg Cpl PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760691	Aldost p 25 mg Cpl PO SerPl-mCnc	4180186
40760691	醛固酮^在口服25 mg卡托普利之后:质量浓度:时间点:血清/血浆:定量型	4182948
40760692	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760692	Aldost p chal SerPl-mCnc	4180186
40760692	醛固酮^在 XXX 刺激之后:质量浓度:时间点:血清/血浆:定量型	4182948
40760693	Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760693	Aldost pre chal SerPl-mCnc	4180186
40760693	醛固酮^在 XXX 刺激之前:质量浓度:时间点:血清/血浆:定量型	4182948
40760696	3h p 25 mg Cpl PO; After; c246; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p 25 mg Cpl PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760696	Aldost 3h p 25 mg Cpl PO SerPl-sCnc	4180186
40760696	醛固酮^在口服25 mg卡托普利之后3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760697	3h p 25 mg Cpl PO; After; c246; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p 25 mg Cpl PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760697	Aldost 3h p 25 mg Cpl PO SerPl-mCnc	4180186
40760697	醛固酮^在口服25 mg卡托普利之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760698	1 hour; 1.0Hr; 1h p 25 mg Cpl PO; 60 min; 60 minutes; 60M; 60min; After; c246; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p 25 mg Cpl PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760698	Aldost 1h p 25 mg Cpl PO SerPl-sCnc	4180186
40760698	醛固酮^在口服25 mg卡托普利之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760699	120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760699	Aldost 2h p chal SerPl-sCnc	4180186
40760699	醛固酮^在XXX刺激之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760700	15M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760700	Aldost 15M p chal SerPl-mCnc	4180186
40760700	醛固酮^在XXX刺激之后15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760702	3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760702	Aldost 3h p chal SerPl-mCnc	4180186
40760702	醛固酮^在XXX刺激之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760703	3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760703	Aldost 3h p chal SerPl-sCnc	4180186
40760703	醛固酮^在XXX刺激之后3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760704	30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760704	Aldost 30M p chal SerPl-sCnc	4180186
40760704	醛固酮^在XXX刺激之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760707	1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760707	Aldost 1h p chal SerPl-sCnc	4180186
40760707	醛固酮^在XXX刺激之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760710	1 day; 11DC; 24 hours; 24HR; 6A-OH-THS; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; Metopirone; mRate; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760710	6A-OH-THS pre hi Dex 24h Ur-mRate	4180186
40760710	6-alpha 羟基四氢-11-脱氢皮质醇^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760713	6A-OH-THS Pre Dex 24h Ur-mCnc	4180186
40760713	1 day; 11DC; 24 hours; 24HR; 6A-OH-THS; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Metopirone; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760713	6-alpha 羟基四氢-11-脱氢皮质醇^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760714	1 day; 11DC; 24 hours; 24HR; 6A-OH-THS; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; Mass rate; Metopirone; mRate; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760714	6A-OH-THS Pre Dex 24h Ur-mRate	4180186
40760714	6-alpha 羟基四氢-11-脱氢皮质醇^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760715	6A-OH-THS 2D p Dex 24h Ur-mCnc	4180186
40760715	1 day; 11DC; 24 hours; 24HR; 2D p Dex; 6A-OH-THS; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Metopirone; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760715	6-alpha 羟基四氢-11-脱氢皮质醇^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760718	6A-OH-THA pre hi Dex 24h Ur-mRate	4180186
40760718	1 day; 24 hours; 24HR; 6A-OH-THA; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760718	6-alpha 羟基四氢-11-脱氢皮质酮^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760721	1 day; 24 hours; 24HR; 6A-OH-THA; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760721	6A-OH-THA Pre Dex 24h Ur-mCnc	4180186
40760721	6-alpha 羟基四氢-11-脱氢皮质酮^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760722	6A-OH-THA Pre Dex 24h Ur-mRate	4180186
40760722	1 day; 24 hours; 24HR; 6A-OH-THA; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760722	6-alpha 羟基四氢-11-脱氢皮质酮^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760724	1 day; 24 hours; 24HR; 2D p Dex; 6A-OH-THA; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760724	6A-OH-THA 2D p Dex 24h Ur-mRate	4180186
40760724	6-alpha 羟基四氢-11-脱氢皮质酮^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760725	5-A THF pre hi Dex 24h Ur-mCnc	4180186
40760725	1 day; 24 hours; 24HR; 5-A THF; 5A-tetrahydrocortisol; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; pre hi Dex; QNT; Quan; Quant; Quantitative; THC; THF; UA; UR; Urn	4180186
40760725	5-Alpha 四氢皮质醇^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760726	1 day; 24 hours; 24HR; 5-A THF; 5A-tetrahydrocortisol; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; pre hi Dex; QNT; Quan; Quant; Quantitative; THC; THF; UA; UR; Urn	4180186
40760726	5-A THF pre hi Dex 24h Ur-mRate	4180186
40760726	5-Alpha 四氢皮质醇^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760727	1 day; 24 hours; 24HR; 2D p high Dex; 5-A THF; 5A-tetrahydrocortisol; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; p high Dex; PST; QNT; Quan; Quant; Quantitative; THC; THF; UA; UR; Urn	4180186
40760727	5-A THF 2D p high Dex 24h Ur-mCnc	4180186
40760727	5-Alpha 四氢皮质醇^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760728	5-A THF 2D p high Dex 24h Ur-mRate	4180186
40760728	1 day; 24 hours; 24HR; 2D p high Dex; 5-A THF; 5A-tetrahydrocortisol; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; p high Dex; PST; QNT; Quan; Quant; Quantitative; THC; THF; UA; UR; Urn	4180186
40760728	5-Alpha 四氢皮质醇^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760730	1 day; 24 hours; 24HR; 5-A THF; 5A-tetrahydrocortisol; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; Pre Dex; QNT; Quan; Quant; Quantitative; THC; THF; UA; UR; Urn	4180186
40760730	5-A THF Pre Dex 24h Ur-mRate	4180186
40760730	5-Alpha 四氢皮质醇^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760733	A-Cortol pre hi Dex 24h Ur-mCnc	4180186
40760733	1 day; 24 hours; 24HR; A-Cortol; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760733	Alpha 皮五醇^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760743	1 day; 24 hours; 24HR; 2D p high Dex; A-cortolone; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760743	A-cortolone 2D p high Dex 24h Ur-mCnc	4180186
40760743	Alpha-皮酮四醇^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760744	A-cortolone 2D p high Dex 24h Ur-mRate	4180186
40760744	1 day; 24 hours; 24HR; 2D p high Dex; A-cortolone; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760744	Alpha-皮酮四醇^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760747	A-cortolone 2D p Dex 24h Ur-mCnc	4180186
40760747	1 day; 24 hours; 24HR; 2D p Dex; A-cortolone; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760747	Alpha-皮酮四醇^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760749	1 day; 24 hours; 24HR; Androster; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760749	Androsterone pre hi Dex 24h Ur-mCnc	4180186
40760749	雄酮^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760750	Androsterone pre hi Dex 24h Ur-mRate	4180186
40760750	1 day; 24 hours; 24HR; Androster; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760750	雄酮^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760752	Androsterone 2D p high Dex 24h Ur-mRate	4180186
40760752	1 day; 24 hours; 24HR; 2D p high Dex; After; Androster; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760752	雄酮^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760753	1 day; 24 hours; 24HR; Androster; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760753	Androsterone Pre Dex 24h Ur-mCnc	4180186
40760753	雄酮^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760755	Androsterone 2D p Dex 24h Ur-mCnc	4180186
40760755	1 day; 24 hours; 24HR; 2D p Dex; After; Androster; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760755	雄酮^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760756	Androsterone 2D p Dex 24h Ur-mRate	4180186
40760756	1 day; 24 hours; 24HR; 2D p Dex; After; Androster; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760756	雄酮^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760768	Dynamic; Flow; Flow by; Flow triggered; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume Rate; vRate	4180186
40760768	Flow trigger setting Vent	4180186
40760768	流量触发设置:体积速率:时间点:呼吸机:定量型	4182948
40760769	Lung; Percent; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Vent alarm; Volfr; Volume fraction	4180186
40760769	Disconnect sensitivity VFr Vent alarm	4180186
40760769	断开灵敏度设置:体积分数:时间点:呼吸机.警报:定量型	4182948
40760770	Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Time ratio	4180186
40760770	Rise time Vent	4180186
40760770	上升时间设置:时间比率:时间点:呼吸机:定量型	4182948
40760772	TBM Ab Titr Ser IF	4180186
40760772	小管基底膜 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40760772	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Basem; Basemt; BM; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; TBM; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40760777	Oligoclonal Bands IgM SerPl Ql IEF	4180186
40760777	Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; IEF; Immune globulin M; Immunoglobulin M; M-spikes; Oligoclonal Bands IgM; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760777	蛋白质成分.寡克隆区带.IgM:存在情况或阈值:时间点:血清/血浆:序数型:等电聚焦电泳	4182948
40760781	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B melitensis; Bruc; Brucellosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Malta fever; Mediterranean fever; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; Undulant fever	4180186
40760781	B melitensis IgG Ser IA-aCnc	4180186
40760781	羊种布鲁氏菌 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760782	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B melitensis; Bruc; Brucellosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Malta fever; Mediterranean fever; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; Undulant fever	4180186
40760782	B melitensis IgM Ser IA-aCnc	4180186
40760782	羊种布鲁氏菌 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760783	11DC 2D p chal SerPl-mCnc	4180186
40760783	11DC; 2D p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760783	11-脱氧皮质醇^在XXX刺激之后2天:质量浓度:时间点:血清/血浆:定量型	4182948
40760785	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnetii; Convalescent; Coxiella burnettii; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; Post immunization; PR; Q fev; Q fever; Qfever; QL; Qual; Qualitative; Random; Screen; Second; Serum; sp2; Spec; SR; Time Resolved Fluorescence; TRF	4180186
40760785	C burnet IgM sp2 Ser Ql IF	4180186
40760785	贝氏柯克斯体 抗体.IgM^第2个标本:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760786	ABS; Aby; ACIF; Acute specimen; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; First; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; Legion; Legionela; Microbiology; Ordinal; Pneu; pneum; Pneumophilia; Point in time; PR; Pre immunization; QL; Qual; Qualitative; Random; Screen; Serum; sp1; Spec; SR; Time Resolved Fluorescence; TRF	4180186
40760786	L pneumo IgG sp1 Ser Ql IF	4180186
40760786	嗜肺军团菌 抗体.IgG^第1个标本:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760788	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzootic pneumonia; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; M pneumo; M pneumonia; M pneumoniae; MEIA; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Ordinal; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; PR; Pre immunization; QL; Qual; Qualitative; Random; Screen; Serum; sp1; Spec; SR; SUDS	4180186
40760788	M pneumo IgG sp1 Ser Ql IA	4180186
40760788	肺炎支原体 抗体.IgG^第1个标本:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760789	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzootic pneumonia; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; M pneumo; M pneumonia; M pneumoniae; MEIA; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Ordinal; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Post immunization; PR; QL; Qual; Qualitative; Random; Screen; Second; Serum; sp2; Spec; SR; SUDS	4180186
40760789	M pneumo IgG sp2 Ser Ql IA	4180186
40760789	肺炎支原体 抗体.IgG^第2个标本:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760795	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; sp11; Spec	4180186
40760795	Cortis sp11 Sal-mCnc	4180186
40760795	皮质醇^第11个标本:质量浓度:时间点:唾液:定量型	4182948
40760797	Cortis sp12 Sal-mCnc	4180186
40760797	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; sp12; Spec	4180186
40760797	皮质醇^第12个标本:质量浓度:时间点:唾液:定量型	4182948
40760798	Cortis sp1 Sal-mCnc	4180186
40760798	17-Hydroxycorticosterone; Acute specimen; Chemistry; Compound F; Coritsol; Cort; F; First; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Sal; sp1; Spec	4180186
40760798	皮质醇^第1个标本:质量浓度:时间点:唾液:定量型	4182948
40760799	Cortis sp3 Sal-mCnc	4180186
40760799	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; sp3; Spec	4180186
40760799	皮质醇^第3个标本:质量浓度:时间点:唾液:定量型	4182948
40760800	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; sp4; Spec	4180186
40760800	Cortis sp4 Sal-mCnc	4180186
40760800	皮质醇^第4个标本:质量浓度:时间点:唾液:定量型	4182948
40760802	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; sp9; Spec	4180186
40760802	Cortis sp9 Sal-mCnc	4180186
40760802	皮质醇^第9个标本:质量浓度:时间点:唾液:定量型	4182948
40760806	Cortis sp8 Sal-mCnc	4180186
40760806	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; sp8; Spec	4180186
40760806	皮质醇^第8个标本:质量浓度:时间点:唾液:定量型	4182948
40760810	Asympt; Asymptomatic; BIOT; BIOT NBS comment; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40760810	BIOT NBS comment	4180186
40760810	生物素化物酶缺陷 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40760811	Asympt; Asymptomatic; cmmt; cmnt; Com; Comm; Comments; Commt; H&P.HX.LAB; H+P; H+P.HX; Hearing; Hearing loss NBS comment; Lab; Narrative; NBS comment; New born; Otologic; P prime; Point in time; Random; Remarks; Report; Scn; Text	4180186
40760811	Hearing loss NBS comment/discussion	4180186
40760811	听力损失 新生儿筛查注释-讨论:文本型属性:时间点:耳:叙述型	4182948
40760812	Infectious diseases NBS comment	4180186
40760812	Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; ID NBS comment; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40760812	传染病类 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40760814	Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; Haemoglobin; Hb; Hemoglobinopathies; Hgb; Hgb disorders NBS comment; Narrative; NBS comment; New born; OB; ObGyn; Obstetrics; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40760814	Hemoglobin disorders NBS comment	4180186
40760814	血红蛋白病 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40760817	CAH NBS comment	4180186
40760817	21-hydroxylase deficiency; Adrnl; Asympt; Asymptomatic; Blood; CAH; CAH NBS comment; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40760817	先天性肾上腺皮质增生症 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40760818	Asympt; Asymptomatic; Blood; CF; CF NBS comment; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; Cystic fibr; DBS; Dried blood spot; Filter paper; FP; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40760818	CF NBS comment	4180186
40760818	囊性纤维化 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40760819	Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; Narrative; NBS comment; New born; OA; OA defects; OA defects NBS comment; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40760819	OA defects NBS comment	4180186
40760819	有机酸血症缺陷 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40760821	Amino acidemias NBS comment	4180186
40760821	AA; AA NBS comment; Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; Urea Cyle; WB; Whole blood	4180186
40760821	氨基酸血症 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40760825	GA; Gest; Gestation; Gyn; Gynecology; H+P; H+P.HX; OB; OB est of GA; ObGyn; Obstetrical; Obstetrics; P prime; Point in time; Pregnancy; Prenatal; QNT; Quan; Quant; Quantitative; Random	4180186
40760825	OB est of GA	4180186
40760825	孕龄的产科学估计:时间:时间点:^患者:定量型	4182948
40760830	Conditions tested for in NBS study DBS	4180186
40760830	Asympt; Asymptomatic; Blood; Chemistry; Conditions tested for in NBS study; DBS; Dried blood spot; Filter paper; FP; Ident; Identifier; New born; Nominal; Point in time; Random; Scn; Study report; WB; Whole blood	4180186
40760830	这项新生儿筛查检查当中的试验所针对的情况:标识符:时间点:全血.斑点:名义型	4182948
40760833	Birth pleurality; Cnt; Count; Gestation; Gestations; Gravida; H+P; H+P.PX; Number; Ordinal; P prime; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen	4180186
40760833	Birth plurality	4180186
40760833	出生胎儿数量:数量(计数):时间点:妊娠:序数型	4182948
40760834	Unique bar code # Current sample	4180186
40760834	Ident; Identifier; No; Nominal; Num; Point in time; Random; SPEC; Unique bar code #	4180186
40760834	唯一性条形码编号:标识符:时间点:当前样品:名义型	4182948
40760837	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Diaf; DiafP; Dialysate; Dialysis fluid; Kidney; Level; Mass concentration; Nephrology; Peritoneal Dialysis fluid; QNT; Quan; Quant; Quantitative; Renal	4180186
40760837	Creat 24h DiafP-mCnc	4180186
40760837	肌酐:质量浓度:24小时:腹膜透析液:定量型	4182948
40760838	Desmethylolanzapine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Olanzapine metabolite; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760838	Norolanzapine SerPl-mCnc	4180186
40760838	去甲基奥氮平:质量浓度:时间点:血清/血浆:定量型	4182948
40760840	Lactate 6M p chal SerPl-mCnc	4180186
40760840	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 6M p chal; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760840	乳酸^在XXX刺激之后6分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760848	BMZ BP180 Ab Ser IA-aCnc	4180186
40760848	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Basem; Basemt; BM; BMZ; BMZ BP180; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pemphigoid; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40760848	基底膜带 BP180 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760849	Centromere Ab Ser Ql IB	4180186
40760849	ABS; Aby; ACA; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cen; CRST syndrome; Immune blot; Immunobl; Immunoblot; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40760849	着丝点 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40760850	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD3 Cells; CD3+HLA-DR+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Human Leukocyte Antigen; I3; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3	4180186
40760850	CD3+HLA-DR+ Cells NFr Fld	4180186
40760850	细胞.CD3+HLA-DR+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760851	LPT OKT3 Bld-nRate	4180186
40760851	Blood; Count/time; LPA; LPT; LPT OKT3; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; Murine monoclonal anti-human CD3 ab; nRate; Number rate; Number Rate = Count/Time; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Stim; Transplant therapy drug; WB; Whole blood	4180186
40760851	淋巴细胞增殖.OKT3 刺激:计数型速率:时间点:全血:定量型	4182948
40760852	Phadiatop infant IgE Qn	4180186
40760852	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Phadia differentiate atopy; Phadiotop; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40760852	Phadiotop 婴幼儿 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40760854	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Musc; Muscl; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; Skeletal muscle; SMA; SR; Stria Mus; Time Resolved Fluorescence; TRF	4180186
40760854	Stria Mus Ab Ser Ql IF	4180186
40760854	横纹肌 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760856	G-OH-Butyr Ur Ql Cfm	4180186
40760856	4-hydroxybutyrate; 4-hydroxybutyric acid; Cfm; Chemistry; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Gamma hydroxy butyrate; Gamma-hydroxybutyrate; Gamma-OH; GBH; GCMS; Georgia home boy; GHb; G-OH-Butyr; Goop; Hydroxybutyric acid; Liquidx; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40760856	Gamma 羟基丁酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40760857	RBC # Ur Strip.auto	4180186
40760857	红细胞:计数型浓度:时间点:尿液:定量型:试纸条.自动化法	4182948
40760857	#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Dip stick; Dipstick; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; Number concentration; Number Concentration (count/vol); Point in time; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; SmQn; UA; UR; URINALYSIS; Urn	4180186
40760858	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Hepatology; IAA; Liver; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40760858	Liver Cytosol Ab Ser Ql IA	4180186
40760858	肝脏细胞溶质 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760859	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; breast cancer; Immune blot; Immunobl; Immunoblot; Neuro; Neurology; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; Stiff Man Syndrome; WB; WBLOT; West blot; West blt; Western blot	4180186
40760859	Amphiphysin Ab Ser Ql IB	4180186
40760859	双载蛋白 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40760863	AMCBX1; Blood; FIP3; FIP-3; Fip3p; Genetics; Heredity; Heritable; Identity or presence; IKKAP1; IKKG; IKK-gamma; IMD33; Inherited; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; IP; IP1; IP2; IPD2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; NEMO; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; ZC2HC9	4180186
40760863	IKBKG gene Mut Anl Bld/T	4180186
40760863	IKBKG 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760865	Blood; Gene mut tested; Genetics; Heredity; Heritable; Identity or presence; IMD2; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; Random; SCNX; THC; THC1; Tissue; Tissue, unspecified; Wasp; WB; Whole blood; Whole blood or Tissue; Wiskott-Aldrich syndrome; Wiskott-Aldrich syndrome (eczema-thrombocytopenia)	4180186
40760865	WAS gene Mut Tested Bld/T	4180186
40760865	WAS 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760869	Blood; Genetics; Heredity; Heritable; Identity or presence; IMD2; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; SCNX; THC; THC1; Tissue; Tissue, unspecified; Wasp; WB; Whole blood; Whole blood or Tissue; Wiskott-Aldrich syndrome; Wiskott-Aldrich syndrome (eczema-thrombocytopenia)	4180186
40760869	WAS gene Mut Anl Bld/T	4180186
40760869	WAS 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760873	Activated partial thromboplastin time; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; imm NP; Immediatedly after 1:1 addition of; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube; Time ratio	4180186
40760873	aPTT imm NP/pre NP PPP	4180186
40760873	表面诱导型凝血过程.因子替换^紧接着在添加正常血浆之后/表面诱导型凝血过程:时间比率:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40760875	Chemistry; Disaccharidase panel; Disaccharidases pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue small intestine	4180186
40760875	Disaccharidases pnl TSMI	4180186
40760875	二糖酶组套:-:时间点:小肠组织:定量型	4182948
40760876	Antigen; Antigens; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760876	H capsul Ag Fld-mCnc	4180186
40760876	荚膜组织胞浆菌 抗原:质量浓度:时间点:体液:定量型	4182948
40760877	Trimipram + Nor pnl SerPl	4180186
40760877	Cotrimazine; Desmeth; Desmethyltrimipramine; DRUG/TOXICOLOGY; Drugs; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Surmontil; TMP; Trimipram + Nor pnl; Trimipram+Nor; Trimipramine metabolite	4180186
40760877	三甲丙咪嗪与去甲基三甲丙咪嗪组套:-:时间点:血清/血浆:定量型	4182948
40760881	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Serology; Serum; SR	4180186
40760881	Paraneoplastic Ab Ser-Imp	4180186
40760881	副肿瘤型 抗体:印象:时间点:血清:叙述型	4182948
40760882	Metaneph+Normetaneph free Pnl SerPl-sCnc	4180186
40760882	Chemistry; FR; Level; Metaneph; Metaneph Free; Metaneph+Normetaneph free Pnl; Metanephrne; Metenephrine; Non-protein bound; Normeta; Normetaneph; Normetaneph Free; Normetanephrn; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Unconjugated metanephrine; Unconjugated normetanephrine	4180186
40760882	间甲肾上腺素.游离型与去甲间肾上腺素.游离型组套:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760884	CTFV IgG+IgM Pnl Titr Ser	4180186
40760884	科罗拉多蜱媒热病毒抗体.IgG 与 IgM 组套:滴定度:时间点:血清:定量型	4182948
40760884	CTFV; CTFV IgG+IgM Pnl; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40760885	Depakene; Divalproex; DRUG/TOXICOLOGY; Drugs; FR; Neuro; Neurology; Non-protein bound; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VALP; Valproate Free; Valproate.free + Valproate pnl; Valproic acid	4180186
40760885	Valproate.free + Valproate pnl SerPl	4180186
40760885	2-丙基戊酸.游离型与2-丙基戊酸.游离型组套:-:时间点:血清/血浆:定量型	4182948
40760888	Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; FLC; FR; Immune globulin; Immuno; Immunoglob; Immunoglobin; Immunoglobulin LC free Pnl; Imunoglbon; Imunoglobn; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders	4180186
40760888	Immunoglobulin LC free Pnl Ser	4180186
40760888	免疫球蛋白轻链.游离型 组套:-:时间点:血清:定量型	4182948
40760891	Blood; Chrom Break; Chromosom; Chromosomes; DEB; Identity or presence; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; WB; Whole blood	4180186
40760891	Chrom Break Bld DEB	4180186
40760891	染色体断裂:存在与否或特征标识:时间点:全血:叙述型:二氧桥丁烷法	4182948
40760892	Blood; CBC W ordered manual diff; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood	4180186
40760892	CBC W ordered manual diff Bld	4180186
40760892	带有医嘱申请型手工细胞分类的全血细胞计数组套:-:时间点:全血:定量型	4182948
40760895	1 day; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; DHEA; Hexadrol; hi dose; Level; Mass concentration; p high Dex; Prasterone; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760895	DHEA 2D p high Dex 24h Ur-mCnc	4180186
40760895	脱氢表雄酮^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760896	1 day; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; DHEA; Hexadrol; hi dose; Mass Rate; mRate; p high Dex; Prasterone; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760896	DHEA 2D p high Dex 24h Ur-mRate	4180186
40760896	脱氢表雄酮^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760897	DHEA Pre Dex 24h Ur-mCnc	4180186
40760897	1 day; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; DHEA; Hexadrol; Level; Mass concentration; Prasterone; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760897	脱氢表雄酮^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760899	DHEA 2D p Dex 24h Ur-mCnc	4180186
40760899	1 day; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; DHEA; Hexadrol; Level; Mass concentration; p Dex; p dose; Prasterone; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760899	脱氢表雄酮^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760901	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Identity or presence; Nominal; OA conditions suspected; Point in time; Random; WB; Whole blood	4180186
40760901	OA conditions suspected DBS	4180186
40760901	所怀疑的有机酸血症情况:存在与否或特征标识:时间点:全血.斑点:名义型	4182948
40760904	Asympt; Asymptomatic; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; NBS test results pnl; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood	4180186
40760904	NBS test results pnl DBS	4180186
40760904	新生儿筛查试验结果组套:-:时间点:全血.斑点:-	4182948
40760905	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Fecal hydrolysis pnl; Feces; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Stl; Stool = Fecal	4180186
40760905	Fecal hydrolysis pnl Stl	4180186
40760905	粪便水解组套:-:时间点:大便:-	4182948
40760906	Reducing Subs Stl Ql Post hydrolysis	4180186
40760906	After; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Ordinal; Point in time; PR; PST; QL; Qual; Qualitative; Random; Reduc; Reduc subs; Reducing substance; Screen; Stl; Stool = Fecal	4180186
40760906	还原性物质:存在情况或阈值:时间点:大便:序数型:在水解之后	4182948
40760907	After; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40760907	Glucose Stl Post hydrolysis-mCnc	4180186
40760907	葡萄糖:质量浓度:时间点:大便:定量型:在水解之后	4182948
40760908	20M p chal; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760908	Progest 20M p chal SerPl-mCnc	4180186
40760908	孕酮^在XXX刺激之后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760910	Anatomy; Blood; Lung; Nominal; Point in time; PULMONARY; Pulmonology; Random; Respiratory; WB; Whole blood	4180186
40760910	Oximetry site Bld	4180186
40760910	血氧定量部位:解剖学:时间点:全血:名义型	4182948
40760911	Bld/Mar; Blood; BM; BON; Bone marrow; Chrom analy; Chrom analy interphase; Chromosom; Chromosomes; Cytogenetics; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Karyotype; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; WB; Whole blood; Whole blood or Bone marrow	4180186
40760911	Chrom analy interphase Bld/Mar FISH-Imp	4180186
40760911	染色体分析.分裂间期:印象:时间点:全血/骨髓:叙述型:FISH	4182948
40760912	OB Pnl Stl IA	4180186
40760912	Bowel movement; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; Gastrointestinal hemoglobin; IAA; MEIA; OB Pnl; Occ; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Stl; Stool = Fecal; SUDS	4180186
40760912	潜血组套:-:时间点:大便:-:免疫测定法	4182948
40760920	CR; Crea; Creat; HEDIS 2010-11 MPM-A SCr; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Ser; SR	4180186
40760920	HEDIS 2010-11 MPM-A SCr	4180186
40760920	用于标识生理监测试验的 HEDIS 2010, 2011 代码 - 血清肌酐 (SCr) (MPM-A):-:时间点:^患者:-	4182948
40760923	Asympt; Asymptomatic; HEDIS 2010 CDC-J; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn	4180186
40760923	HEDIS 2010 CDC-J	4180186
40760923	用于标识肾病筛查试验的 HEDIS 2010 代码 (CDC-J):-:时间点:^患者:-	4182948
40760924	HEDIS 2010 CDC-H	4180186
40760924	Asympt; Asymptomatic; HEDIS 2010 CDC-H; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn	4180186
40760924	用于标识 LDLc 筛查的 HEDIS 2010 代码 (CDC-H):-:时间点:^患者:-	4182948
40760926	Asympt; Asymptomatic; Chlam; Chlamid; HEDIS 2010-13 CHL-C; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn	4180186
40760926	HEDIS 2010-13 CHL-C	4180186
40760926	HEDIS 2010-2013 用于标识衣原体筛查的代码 (CHL-C):-:时间点:^患者:-	4182948
40760929	Pan; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40760929	HEDIS 2010 组套:-:时间点:^患者:-	4182948
40760931	Document; Finding; Findings; Imaging; Lung; PET Scan; Point in time; Position Emmision Tomography; Positron Emission Tomography; Pulmonary; Pulmonology; Rad; Radiology; Radnuc.PET; Random; Respiratory; RN; RNC; Scan; Thorax; W RNC IV	4180186
40760931	PT Lung W RNC IV	4180186
40760931	多层^采用静脉注射放射性核素:发现:时间点:胸部>肺:文档型:PT	4182948
40760937	Prescriptions	4180186
40760937	DOC.ONT; Document; Finding; Findings; Point in time; Prescriptions; Random; Rx	4180186
40760937	处方列表:发现:时间点:{环境}:文档型:{角色}	4182948
40760938	Rx for medical equipment or product	4180186
40760938	DOC.ONT; Document; Finding; Findings; Point in time; Random; Rx; Rx for medical equipment or product	4180186
40760938	医疗器械或产品处方:发现:时间点:{环境}:文档型:{角色}	4182948
40760939	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40760939	Admission request Doc	4180186
40760939	入院申请:发现:时间点:^患者:文档型	4182948
40760941	Rx for Dx or specialist care	4180186
40760941	DOC.ONT; Document; Finding; Findings; Point in time; Random; Rx; Rx for Dx or specialist care	4180186
40760941	诊断性或专科医疗护理服务处方:发现:时间点:{环境}:文档型:{角色}	4182948
40760943	Patient transportation request Doc	4180186
40760943	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40760943	患者运送请求:发现:时间点:^患者:文档型	4182948
40760945	Basophils/leuk NFr Snv Manual	4180186
40760945	100WBC; Baso; Basophil; Basos; Bph; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
40760945	嗜碱性粒细胞/100 个白细胞:计数型分数:时间点:滑液:定量型:手工计数方法	4182948
40760946	B; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; i; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Siderophilin; Tf; Trf; TRFRN	4180186
40760946	Beta-1 transferrin Fld Ql	4180186
40760946	Beta-1 转铁蛋白:存在情况或阈值:时间点:体液:序数型	4182948
40760947	Coag; Coagulation dilute Russell viper venom induced confirmatory test; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; dRVVT confirm; EXS; Hematology; Heme; Lipid; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant	4180186
40760947	Confirm dRVVT	4180186
40760947	稀释蝰蛇毒诱导型凝血过程.过量磷脂:时间:时间点:贫血小板血浆:定量型	4182948
40760949	100WBC; Diaf; Dialysate; Dialysis fluid; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
40760949	Eosinophil/leuk NFr Dial fld Manual	4180186
40760949	嗜酸性粒细胞/100 个白细胞:计数型分数:时间点:透析液:定量型:手工计数方法	4182948
40760950	RBC # Dial fld Auto	4180186
40760950	#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Diaf; Dialysate; Dialysis fluid; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
40760950	红细胞:计数型浓度:时间点:透析液:定量型:自动化计数方法	4182948
40760953	DRUG/TOXICOLOGY; Drugs; Gleevac; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760953	Imatinib mesylate SerPl-mCnc	4180186
40760953	甲磺酸伊马替尼:质量浓度:时间点:血清/血浆:定量型	4182948
40760954	WBC # Fld Auto	4180186
40760954	#; ABS; absolute; absolutes; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
40760954	白细胞:计数型浓度:时间点:体液:定量型:自动化计数方法	4182948
40760960	Genital tract; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Prep; Random; Urth; Wet mount; Wet prep	4180186
40760960	Wet Prep Urth	4180186
40760960	显微镜观察:存在与否或特征标识:时间点:尿道:名义型:湿片法	4182948
40760961	Finding; Findings; H+P; H+P.HX; Narrative; P prime; Point in time; Random; Report	4180186
40760961	Problem list Reported	4180186
40760961	问题列表:发现:时间点:^患者:叙述型:报告法	4182948
40760963	5M p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH	4180186
40760963	TSH 5M p chal SerPl-aCnc	4180186
40760963	促甲状腺激素^在XXX刺激之后5分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40760965	Carisoma; DRUG/TOXICOLOGY; Drugs; Flexartal; Isopropylmeprobamate; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Rela; Sanoma; Soma; Somadril; Somalgit; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760965	Carisoprodol Spec-sCnc	4180186
40760965	异丙基甲丁双脲:物质的量浓度:时间点:XXX:定量型	4182948
40760967	Desmethylmaprotiline; DRUG/TOXICOLOGY; Drugs; Level; Maprotiline metabolite; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760967	Normaprotiline Spec-sCnc	4180186
40760967	去甲基马普替林:物质的量浓度:时间点:XXX:定量型	4182948
40760969	Diethylamine Spec-sCnc	4180186
40760969	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760969	二乙胺:物质的量浓度:时间点:XXX:定量型	4182948
40760970	Addiction; Anexsia; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Misc; Miscellaneous; Other; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified; Vicodin	4180186
40760970	HYDROcodone Spec-sCnc	4180186
40760970	氢可酮:物质的量浓度:时间点:XXX:定量型	4182948
40760971	Hydrocortisone Spec-sCnc	4180186
40760971	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760971	氢化可的松:物质的量浓度:时间点:XXX:定量型	4182948
40760973	Addiction; Algil; Alodan; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Misc; Miscellaneous; Other; Pethidine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760973	Meperidine Spec-sCnc	4180186
40760973	哌替啶:物质的量浓度:时间点:XXX:定量型	4182948
40760974	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Lortab; Misc; Miscellaneous; Other; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified; Vicodin	4180186
40760974	oxyCODONE Spec-sCnc	4180186
40760974	羟考酮:物质的量浓度:时间点:XXX:定量型	4182948
40760981	Strychnine Spec-sCnc	4180186
40760981	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760981	番木鳖碱:物质的量浓度:时间点:XXX:定量型	4182948
40760983	Cantaloupe BasoBnd Ab Qn	4180186
40760983	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Associated; Autoantibodies; Autoantibody; Baso; BasoBnd Ab; Basophil release; Basophils; Basos; Blood; bnd; Bph; Cantalope; Cantaloup; Cantaloupe; f102; Leukocyte histamine reaction; Leukocyte histamine release; Musk melon; Muskmelon; Point in time; QNT; Quan; Quant; Quantitative; Random; Rock melon; WB; WBC release; Whole blood	4180186
40760983	罗马甜瓜 嗜碱性粒细胞结合型抗体:任意型浓度:时间点:全血:定量型:白细胞组胺释放法	4182948
40760984	Cantaloupe IgG4-mCnc	4180186
40760984	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cantalope; Cantaloup; Cantaloupe; f102; Level; Mass concentration; Musk melon; Muskmelon; Point in time; QNT; Quan; Quant; Quantitative; Random; Rock melon; Serum; SR	4180186
40760984	罗马甜瓜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40760988	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cantalope; Cantaloup; Cantaloupe; f102; Immune globulin G; Immunoglobulin G; Musk melon; Muskmelon; Point in time; QNT; Quan; Quant; Quantitative; Random; Rock melon; Serum; SR	4180186
40760988	Cantaloupe IgG Qn	4180186
40760988	罗马甜瓜 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
40760989	Melon IgG Qn	4180186
40760989	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f87; Honey dew; Honeydew; Immune globulin G; Immunoglobulin G; Melon; melons; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40760989	甜瓜多个未知种 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
40760990	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cantalope; Cantaloup; Cantaloupe; f102; IgE RAST; Immune globulin E; Immunoglobulin E; Musk melon; Muskmelon; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rock melon; Screen; Serum; SR	4180186
40760990	罗马甜瓜 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40760990	Deprecated Cantaloupe IgE RAST Ql	4180186
40760994	Melon BasoBnd Ab Qn	4180186
40760994	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Associated; Autoantibodies; Autoantibody; Baso; BasoBnd Ab; Basophil release; Basophils; Basos; Blood; bnd; Bph; f87; Honey dew; Honeydew; Leukocyte histamine reaction; Leukocyte histamine release; Melon; melons; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC release; Whole blood	4180186
40760994	甜瓜多个未知种 嗜碱性粒细胞结合型抗体:任意型浓度:时间点:全血:定量型:白细胞组胺释放法	4182948
40760995	Pregnanediol pre hi Dex 24h Ur-mCnc	4180186
40760995	1 day; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; pre hi Dex; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760995	孕二醇^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760996	Pregnanediol pre hi Dex 24h Ur-mRate	4180186
40760996	1 day; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; pre hi Dex; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760996	孕二醇^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760997	Pregnanediol 2D p high Dex 24h Ur-mCnc	4180186
40760997	1 day; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; p high Dex; Pregnanedi; PST; PTL; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760997	孕二醇^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760998	Pregnanediol 2D p high Dex 24h Ur-mRate	4180186
40760998	1 day; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; p high Dex; Pregnanedi; PST; PTL; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760998	孕二醇^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760999	Pregnanediol Pre Dex 24h Ur-mCnc	4180186
40760999	1 day; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Pre Dex; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760999	孕二醇^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40761000	Pregnanediol Pre Dex 24h Ur-mRate	4180186
40761000	1 day; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; Pre Dex; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40761000	孕二醇^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40761003	100M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761003	C peptide 100M p chal SerPl-sCnc	4180186
40761003	C 肽^在XXX刺激之后100分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761007	Addiction; Benzoylmethylecgonine; Coke; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Illicit; Level; Misc; Miscellaneous; Other; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Snow; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40761007	Cocaine Spec-sCnc	4180186
40761007	可卡因:物质的量浓度:时间点:XXX:定量型	4182948
40761010	Bowel movement; C diff; C diff GDH; C difficile; c707; Clostridium difficile; Dehydrog; Dehyrdogenase; Faecal; Faeces; Fecal; Feces; GDH; GLD; GLDH; Glu; Glutamate oxidase; Glutamic acid; GMD; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal	4180186
40761010	C diff GDH Stl Ql	4180186
40761010	艰难梭菌谷氨酸脱氢酶:存在情况或阈值:时间点:大便:序数型	4182948
40761011	Bg sup(a) Ab SerPl Ql	4180186
40761011	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bg sup(a); BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761011	Bg^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761012	Bg sup(a) Ab Titr SerPl	4180186
40761012	Bg^a 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40761012	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bg sup(a); BLOOD BANK; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40761015	Blood; Chromosom; Chromosomes; Del; Deletions; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761015	9p21 chrom Del Bld/T FISH	4180186
40761015	9号染色体短臂2区1带 缺失:存在与否或特征标识:时间点:全血/组织:名义型:FISH	4182948
40761016	ANTIBIOTIC SUSCEPTIBILITIES; AST; ATV; ATV/r; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Norvir; Pheno; Phenotype; Phenotypic; Point in time; Random; Reyataz; RTV; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Virtual Phenotype	4180186
40761016	Atazanavir+Ritonavir Islt Phenotyp	4180186
40761016	阿扎那韦+利托那韦:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
40761017	AIRE1; AIRE-Human; APECED; APS1; APSI; ASP1; ASPI; Autoimmune polyendocrinology candiadiasis dystrophy protein; autoimmune regulator; Blood; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; PGA1; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761017	AIRE gene Mut Anl Bld/T	4180186
40761017	AIRE 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761021	Green Bean IgE/IgE total %	4180186
40761021	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beans; f315; Green Bean; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf315; Serum; SR; Tot; Total IgE; Totl	4180186
40761021	青豆 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761023	B-Lactoglob IgE/IgE total %	4180186
40761023	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B; B-Lactoglob; f077; f77; IgE total; Immune globulin E; Immunoglobulin E; nBos d 5; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40761023	Beta 乳球蛋白 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761028	Calcium Fld.NB-mCnc	4180186
40761028	Ca; Cal; Chemistry; Fld.NB; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761028	钙:质量浓度:时间点:液体.非生物性:定量型	4182948
40761031	CO2 SerPl Calc-sCnc	4180186
40761031	Calc; Calculation; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; tCO2	4180186
40761031	二氧化碳:物质的量浓度:时间点:血清/血浆:定量型:计算法	4182948
40761036	ABC35; ABCC7; Blood; CBAVD; CF; CFA; CFTR p.D1152H; CFTR/MRP; Cystic fibrosis transmembrane conductance regulator; cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7); dJ760C5.1; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MRP7; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; TNR-CFTR; WB; Whole blood; Whole blood or Tissue	4180186
40761036	CFTR p.D1152H Bld/T Ql	4180186
40761036	CFTR 基因.p.D1152H:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40761037	Blood; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; Pancreatic secretory trypsin inhibitor precursor; PCR; PCTT; Point in time; PSTI; Random; serine peptidase inhibitor, Kazal type 1; Serine protease inhibitor, Kazal type 1; Spink3; TATI; TCP; Tissue; Tissue, unspecified; Tumor-associated trypsin inhibitor; WB; Whole blood; Whole blood or Tissue	4180186
40761037	CFTR+PRSS1+SPINK1 gene Mut Anl Bld/T	4180186
40761037	CFTR+PRSS1+SPINK1 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761038	Cheddar IgE/IgE total %	4180186
40761038	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f081; f81; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40761038	切达干酪 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761039	Cheese Mold IgE/IgE total %	4180186
40761039	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f082; f82; IgE total; Immune globulin E; Immunoglobulin E; Mould; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40761039	长霉干酪 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761040	基孔肯亚病毒 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761040	CHIKV IgM SerPl Ql	4180186
40761040	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CHIKV; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761042	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; HDLc 2a; Heart Disease; High density lipoprotein cholesterols; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCHHDL	4180186
40761042	HDLc 2a SerPl-mCnc	4180186
40761042	胆固醇.HDL 2a 之中的:质量浓度:时间点:血清/血浆:定量型	4182948
40761044	Cardio; Cardiology; Chemistry; Heart Disease; LDL5; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761044	LDL5 SerPl-mCnc	4180186
40761044	胆固醇.LDL 5 之中的:质量浓度:时间点:血清/血浆:定量型	4182948
40761045	铬:质量浓度:时间点:脑脊液:定量型	4182948
40761045	Cr CSF-mCnc	4180186
40761045	c609; Cerebral spinal fluid; Cerebrospinal Fl; Chrome; CR; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40761049	Clenbuterol Ur Ql	4180186
40761049	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spiropent; UA; UR; Urn	4180186
40761049	氨哮素:存在情况或阈值:时间点:尿液:序数型	4182948
40761050	c617; Cerebral spinal fluid; Cerebrospinal Fl; CO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40761050	Cobalt CSF-mCnc	4180186
40761050	钴:质量浓度:时间点:脑脊液:定量型	4182948
40761052	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Cerebral spinal fluid; Cerebrospinal Fl; CF; Coccidioides esteriformis; Coccidiomycosis; Coccio; Comp fixation; Compfix; Complement fixation; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; PR; Pseudococcidioides mazzai; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T proteolyticum; Trichosporon proteolyticum; Valley fever	4180186
40761052	C immitis IgG CSF Ql CF	4180186
40761052	粗球孢子菌 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:补体结合试验	4182948
40761053	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beans; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40761053	咖啡豆 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40761053	Deprecated Coffee Bean IgE RAST Ql	4180186
40761055	Complement C4c SerPl-mCnc	4180186
40761055	Comp; Complmt; HEMATOLOGY/CELL COUNTS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761055	补体 C4c:质量浓度:时间点:血清/血浆:定量型	4182948
40761056	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f236; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf236; Serum; SR; Tot; Total IgE; Totl	4180186
40761056	Cow Whey IgE/IgE total %	4180186
40761056	乳清 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761060	Darunavir SerPl-mCnc	4180186
40761060	DRUG/TOXICOLOGY; Drugs; DRV; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Prezista; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TMC114	4180186
40761060	地瑞那韦:质量浓度:时间点:血清/血浆:定量型	4182948
40761061	ANTIBIOTIC SUSCEPTIBILITIES; AST; DRV; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Norvir; Pheno; Phenotype; Phenotypic; Point in time; Prezista; Random; RTV; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TMC114; Virtual Phenotype	4180186
40761061	Darunavir+Ritonavir Islt Phenotyp	4180186
40761061	地瑞那韦+利托那韦:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
40761062	Addiction; Desoxy MeT; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761062	Desoxy MeT Ur Ql	4180186
40761062	脱氧甲基睾酮:存在情况或阈值:时间点:尿液:序数型	4182948
40761067	DRUG/TOXICOLOGY; Drugs; Intelence; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TMC125	4180186
40761067	Etravirine SerPl-mCnc	4180186
40761067	依曲韦林:质量浓度:时间点:血清/血浆:定量型	4182948
40761075	GD1a Gangl IgM Ser Ql	4180186
40761075	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Disialolganglioside; GD1a; GD1a Gangl; Immune globulin M; Immunoglobulin M; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
40761075	神经节苷脂 GD1a 抗体.IgM:存在情况或阈值:时间点:血清:序数型	4182948
40761076	3h p 75 g Glc PO; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 75 g Glc PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40761076	Glucose 3h p 75 g Glc PO Ur-mCnc	4180186
40761076	葡萄糖^在口服75 g葡萄糖之后3小时:质量浓度:时间点:尿液:定量型	4182948
40761077	4sp p Lact; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; Spec; SR	4180186
40761077	Glucose 4sp p Lact SerPl-mCnc	4180186
40761077	葡萄糖^在剂量乳糖之后第4个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761078	5sp p Lact; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; Spec; SR	4180186
40761078	Glucose 5sp p Lact SerPl-mCnc	4180186
40761078	葡萄糖^在剂量乳糖之后第5个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761079	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40761079	H capsul IgM CSF Ql	4180186
40761079	荚膜组织胞浆菌 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型	4182948
40761080	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot	4180186
40761080	HIV1 Ab CSF Ql IB	4180186
40761080	HIV 1 型 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫印迹法	4182948
40761081	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40761081	HIV 1+O+2 Ab Fld Ql	4180186
40761081	HIV 1 型+O+2 型 抗体:存在情况或阈值:时间点:体液:序数型	4182948
40761083	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HIV type 2; HIV type II; Human immunodeficiency virus; ID; II; Immune blot; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40761083	HIV 2 p16 Ab Ser Ql IB	4180186
40761083	HIV 2 p16 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40761086	Arbitrary concentration; Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761086	Deprecated HLA-B51 Ql	4180186
40761089	Blood; Genetics; Heredity; Heritable; IDA; Identity or presence; iduronidase, alpha-L-; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MPS1; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761089	IDUA gene Mut Anl Bld/T	4180186
40761089	IDUA 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761090	ANTIBIOTIC SUSCEPTIBILITIES; AST; Crixivan; ID; IDV; IDV/r; Infectious Disease; InfectiousDisease; Islt; Isol; Norvir; Pheno; Phenotype; Phenotypic; Point in time; Random; RTV; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Virtual Phenotype	4180186
40761090	Indinavir+Ritonavir Islt Phenotyp	4180186
40761090	茚地那韦+利托那韦:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
40761093	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f054; f54; IgE total; Immune globulin E; Immunoglobulin E; Ipomea batatas; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sweet potato; Tot; Total IgE; Totl	4180186
40761093	Sweet potato IgE/IgE total %	4180186
40761093	甘薯 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761094	Iron CSF-mCnc	4180186
40761094	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Fe; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40761094	铁:质量浓度:时间点:脑脊液:定量型	4182948
40761104	Manganese CSF-mCnc	4180186
40761104	Cerebral spinal fluid; Cerebrospinal Fl; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MN; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40761104	锰:质量浓度:时间点:脑脊液:定量型	4182948
40761105	Maple sugar IgE/IgE total %	4180186
40761105	%; ABS; Aby; Acer; Acer saccarum; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40761105	糖枫 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761106	Blood; Chemistry; Level; Mass concentration; MMP9; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761106	MMP9 Bld-mCnc	4180186
40761106	基质金属肽酶 9:质量浓度:时间点:全血:定量型	4182948
40761107	DRUG/TOXICOLOGY; Drugs; Metab; Metabolites; Metb; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761107	Mestanolone metab Ur Ql	4180186
40761107	美雄诺龙代谢产物:存在情况或阈值:时间点:尿液:序数型	4182948
40761109	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761109	Methasterone Ur Ql	4180186
40761109	甲基屈他雄酮:存在情况或阈值:时间点:尿液:序数型	4182948
40761110	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761110	Methylnortestosterone Ur Ql	4180186
40761110	甲诺酮:存在情况或阈值:时间点:尿液:序数型	4182948
40761112	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgG RAST; Immune globulin G; Immunoglobulin G; Mulberry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; t070; t70; White mulberry	4180186
40761112	白桑树 抗体.IgG.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40761112	Deprecated White mulberry IgG RAST Ql	4180186
40761117	Clomipramine metabolite; Desmeth; Desmethylclomip; Desmethylclomipramine; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761117	Norclomipramine Ur Ql	4180186
40761117	去甲基氯米帕明:存在情况或阈值:时间点:尿液:序数型	4182948
40761118	Nordoxepin Ur Ql	4180186
40761118	Desdoxepin; Desdoxepine; Desmeth; Desmethyl; Desmethyldox; Desmethyldoxepin; Doxepin metabolite; DRUG/TOXICOLOGY; Drugs; N-desmethyldoxepin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761118	去甲基多虑平:存在情况或阈值:时间点:尿液:序数型	4182948
40761119	Addiction; Desmeth; Desmethyltrimipramine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Trimipramine metabolite; UA; UR; Urn	4180186
40761119	Nortrimipramine Ur Ql	4180186
40761119	去甲基三甲丙咪嗪:存在情况或阈值:时间点:尿液:序数型	4182948
40761121	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Black olive; f342; IgE total; Immune globulin E; Immunoglobulin E; Olive; Olive Poln; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t009; t9; Tot; Total IgE; Totl	4180186
40761121	Olive Poln IgE/IgE total %	4180186
40761121	油橄榄花粉 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761122	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761122	Oxabolone Ur Ql	4180186
40761122	羟勃龙:存在情况或阈值:时间点:尿液:序数型	4182948
40761123	Phosphate Fld.NB-mCnc	4180186
40761123	Chemistry; Fld.NB; i Phos; Inorganic phosphate; Level; Mass concentration; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761123	磷酸盐:质量浓度:时间点:液体.非生物性:定量型	4182948
40761125	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cottonwood; IgG RAST; Immune globulin G; Immunoglobulin G; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; t014; t14	4180186
40761125	三角叶杨 抗体.IgG.RAST 类:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761125	Deprecated Cottonwood IgG RAST Ql	4180186
40761126	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761126	Prostanozol Ur Ql	4180186
40761126	[3,2-c]吡唑-5Alpha-苯别胆烷-17Beta-4氢吡喃醇:存在情况或阈值:时间点:尿液:序数型	4182948
40761129	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cultivated rye; Cultivated rye grass; f005; f5; g012; g12; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rye; Serum; SR; Tot; Total IgE; Totl	4180186
40761129	Cultivated Rye IgE/IgE total %	4180186
40761129	黑麦花粉 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761130	Selenium Fld.NB-mCnc	4180186
40761130	DRUG/TOXICOLOGY; Drugs; Fld.NB; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SE	4180186
40761130	硒:质量浓度:时间点:液体.非生物性:定量型	4182948
40761133	ANTIBIOTIC SUSCEPTIBILITIES; Aptivus; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Norvir; Pheno; Phenotype; Phenotypic; Point in time; Random; RTV; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TPV; TPV/r; Virtual Phenotype	4180186
40761133	Tipranavir+Ritonavir Islt Phenotyp	4180186
40761133	替拉那韦+利托那韦:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
40761134	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Parnate; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761134	Tranylcypromine Ur Ql	4180186
40761134	反苯环丙胺:存在情况或阈值:时间点:尿液:序数型	4182948
40761135	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Syphilis; T pallidum; Treponemal	4180186
40761135	T pallidum IgG CSF Ql	4180186
40761135	梅毒螺旋体 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型	4182948
40761136	White Elm IgG-mCnc	4180186
40761136	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; American elm; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Elm; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t008; t8; White elm	4180186
40761136	美国榆 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40761137	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; Nettle; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl; w20	4180186
40761137	Nettle IgE/IgE total %	4180186
40761137	异株荨麻 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761138	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bermuda grass smut; IgE total; Immune globulin E; Immunoglobulin E; m213; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40761138	Bermuda grass smut IgE/IgE total %	4180186
40761138	狗牙根黑粉菌 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761140	Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; Kidney; Mass fraction; Nephrology; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Stn; Stone; Stones; Tot; Totl	4180186
40761140	Xanthine MFr Stone	4180186
40761140	黄嘌呤/总计:质量分数:时间点:结石:定量型	4182948
40761141	Cerebral spinal fluid; Cerebrospinal Fl; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Zn	4180186
40761141	Zinc CSF-mCnc	4180186
40761141	锌:质量浓度:时间点:脑脊液:定量型	4182948
40761146	Amer Sycamore IgE/IgE total %	4180186
40761146	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Amer Sycamore; American sycamore; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Eastern sycamore; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sycamore; t061; t61; Tot; Total IgE; Totl	4180186
40761146	美国梧桐 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761147	Blood; CCO; Genetics; Heredity; Heritable; Identity or presence; Inherited; MHS; MHS1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; PPP1R137; Random; ryanodine receptor 1 (skeletal); RYDR; RYR; RYR-1; SKRR; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761147	RYR1 gene Mut Anl Bld/T	4180186
40761147	RYR1 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761148	Blood; Genetics; Heredity; Heritable; HOKPP2; HYKPP; HYPP; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Na(V)1.4; NAC1A; Nav1.4; Nominal; PCR; Point in time; Random; SkM1; sodium channel, voltage gated, type IV alpha subunit; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761148	SCN4A gene Mut Anl Bld/T	4180186
40761148	SCN4A 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761150	Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; GCMS; Marijuana; Nabilone; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; THC; WB; Whole blood	4180186
40761150	THC Bld Ql Cfm	4180186
40761150	四氢大麻酚:存在情况或阈值:时间点:全血:序数型:毒理学确认试验	4182948
40761151	Nominal; Outcome and assessment information set; Point in time; Random; Survey; Survey.OASIS; Typ	4180186
40761152	Dx; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Payment Dx; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40761154	Antigen; Antigens; BLOOD BANK; C (little h)(little a); Ch sup(a); Ch^a; Ch1; Chido; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
40761154	Ch sup(a) Ag RBC Ql	4180186
40761154	Ch^a 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761156	Antigen; Antigens; BLOOD BANK; Co sup(a); Co^a; Colton Blood Group System; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
40761156	Co sup(a) Ag RBC Ql	4180186
40761156	Co^a 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761159	Antigen; Antigens; BLOOD BANK; Cs sup(a); Cs^a; Hematology; Heme; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; s; S prime; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761159	Cs sup(a) Ag SerPl Ql	4180186
40761159	Cs^a 抗原:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761161	Antigen; Antigens; BLOOD BANK; Dextro; Do sup(b); Do^b; Dombrock; Dombrock Blood Group System; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
40761161	Do sup(b) Ag RBC Ql	4180186
40761161	Do^b 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761162	Go sup(a) Ab SerPl Ql	4180186
40761162	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Go sup(a); Go^a; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761162	Go^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761164	In sup (b) Ab SerPl Ql	4180186
40761164	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; In sup (b); In^b; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761164	In^b 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761165	Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; Jr sup(a); Jr^a; Ordinal; Point in time; PR; QL; Qual; Qualitative; R prime; Random; Red blood cells; Red blood corpusles; Right; Screen	4180186
40761165	Jr sup(a) Ag RBC Ql	4180186
40761165	Jr^a 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761167	Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; Kn sup(a); Kn^a; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
40761167	Kn sup(a) Ag RBC Ql	4180186
40761167	Kn^a 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761168	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Kell Blood Group System; Kn sup(a); Kn^a; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761168	Kn sup(a) Ab SerPl Ql	4180186
40761168	Kn^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761176	Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; k; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; Yk sup(a); Yk^a	4180186
40761176	Yk sup(a) Ag RBC Ql	4180186
40761176	Yk^a 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761177	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; k; Kell Blood Group System; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Yk sup(a); Yk^a	4180186
40761177	Yk sup(a) Ab SerPl Ql	4180186
40761177	Yk^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761178	Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UA complete W Reflex Culture pnl; UniversalLabOrders; UR; Urn	4180186
40761178	UA complete W Reflex Culture pnl Ur	4180186
40761178	带有伺机追加型培养项目的尿液分析全项组套:-:时间点:尿液:-	4182948
40761180	JMH Ab SerPl Ql	4180186
40761180	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761180	JMH 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761181	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Islt.mening; Isol; Mening; PCN; Pen; Penicillin Parenteral; Penicilloyl; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Wycillin	4180186
40761181	Penicillin Parenteral Susc Islt.mening	4180186
40761181	青霉素.胃肠外:抗生素敏感性:时间点:分离株.脑膜炎:定量型或序数型	4182948
40761182	Vel Ab SerPl Ql	4180186
40761182	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Velocity	4180186
40761182	Vel 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761188	Deprecated Other Ab SerPl Ql Cold Abs	4180186
40761188	ABS; Absorp; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Other; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761189	Acyl carnitine; Acylcarni; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; WB; Whole blood	4180186
40761189	Acylcarnitine DBS-Imp	4180186
40761189	酰基肉碱:印象:时间点:全血.斑点:叙述型	4182948
40761191	G6PD NBS comment	4180186
40761191	Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dehydrog; Dehyrdogenase; Dried blood spot; Filter paper; FP; G6PD; G-6-PD; G6PD NBS comment; G6PDH; Glu; Gluc; Glucose-6-PD; Glucose-6-PDH; Glucoseur; GPD; i Phos; Inorganic phosphate; Narrative; NBS comment; New born; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40761191	葡萄糖-6-磷酸脱氢酶 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40761192	Blood; Chemistry; DBS; Dehydrog; Dehyrdogenase; Dried blood spot; Filter paper; FP; G6PD; G-6-PD; G6PD NBS pnl; G6PDH; Glu; Gluc; Glucose-6-PD; Glucose-6-PDH; Glucoseur; GPD; Gyn; Gynecology; Hematology; Heme; i Phos; Inorganic phosphate; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pnl; PO4; Point in time; Random; Scn; Scr; Scrn; WB; Whole blood	4180186
40761192	G6PD NBS pnl DBS	4180186
40761192	葡萄糖-6-磷酸脱氢酶新生儿筛查组套:-:时间点:全血.斑点:-	4182948
40761195	# pressure ulcers at assessment - stage 3; Cnt; Count; III; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS	4180186
40761196	# pressure ulcers at assessment - stage 4; Cnt; Count; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS	4180186
40761203	No; Num; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; Survey.OASIS	4180186
40761204	# pressure ulcers at assessment - stage 2; Cnt; Count; II; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS	4180186
40761205	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; When confused reported or observed within the last 14D	4180186
40761208	Centers for Medicare and Medicaid Assessment; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey	4180186
40761210	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40761213	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40761215	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.MDS	4180186
40761216	Finding; Findings; MDS version 3; Ordinal; Othr; Past; QL; Qual; Qualitative; Schizophrenia in last 7D; Screen; SCZ; Survey; SURVEY.MDS	4180186
40761218	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40761219	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
40761221	14 days; 2 weeks; II; Pan; Panel; PANEL.SURVEY.CMS; Panl; Patient Health Questionnaire; PHQ; PHQ 2; PHQ2; PHQ-2; Pnl; Survey	4180186
40761224	Centers for Medicare and Medicaid Assessment; II; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; Ulcer	4180186
40761225	Finding; Findings; Lower extremity; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761228	#days insulin injections were received in last 7D or since admission &or reentry if less than 7D; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; HUM; Humulin; IH7; Insul; Lente; No; NPH; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Semilente; Sliding; Survey; Ultralente	4180186
40761230	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40761234	Centers for Medicare and Medicaid Assessment; Past; Path; QNT; Quan; Quant; Quantitative; Survey	4180186
40761236	MDS version 3; OT; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761241	Centers for Medicare and Medicaid Assessment; Past; PT; QNT; Quan; Quant; Quantitative; Survey	4180186
40761242	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40761243	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40761244	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40761246	Finding; Findings; MDS version 3; Nominal; Point in time; Random; Source of info; Srce; Survey; SURVEY.MDS	4180186
40761250	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40761254	MDS version 3; Mental health; MentalHealth; Patient Health Questionnaire; PHQ9; Point in time; Psych; Psychiatry; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MDS; Tot; Totl	4180186
40761255	MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761258	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761260	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761261	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761267	Cath; Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761268	Finding; Findings; MDS version 3; Ordinal; Point in time; Psychosocial well-being - care area triggered; Ql; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761269	Finding; Findings; MDS version 3; Ordinal; Point in time; Psychosocial well-being - addressed in care plan; Ql; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761270	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761276	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761277	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761279	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761282	Finding; Findings; Fld; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761287	Finding; Findings; MDS version 3; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Ulcer	4180186
40761288	Drugs; Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761289	Drugs; Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761291	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761293	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761294	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761295	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761296	MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS	4180186
40761297	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761299	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
40761300	MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761301	Centers for Medicare and Medicaid Assessment; Cnt; Correctn; Count; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40761302	MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Typ	4180186
40761305	MDS version 3; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Typ	4180186
40761308	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761310	Finding; Findings; MDS version 3; Nominal; Othr; Point in time; Random; Survey; SURVEY.MDS	4180186
40761312	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Resource Utilization Groups; Survey; Typ	4180186
40761313	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Resource Utilization Groups; Survey; Typ	4180186
40761315	Centers for Medicare and Medicaid Assessment; Finding; Findings; i; Ordinal; Point in time; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40761318	Centers for Medicare and Medicaid Assessment; HUM; Humulin; IH7; Insul; Lente; NPH; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Semilente; Sliding; Survey; Ultralente	4180186
40761319	Centers for Medicare and Medicaid Assessment; Past; Path; QNT; Quan; Quant; Quantitative; Survey	4180186
40761321	Centers for Medicare and Medicaid Assessment; Past; PT; QNT; Quan; Quant; Quantitative; Survey	4180186
40761322	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40761324	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761325	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761328	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761332	Asympt; Asymptomatic; BIOPT; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; Narrative; NBS comment; New born; OB; ObGyn; Obstetrics; PKU; PKU+Var/BIOPT Defects; PKU+Var/BIOPT Defects NBS comment; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40761332	PKU+Var/BIOPT Defects NBS comment	4180186
40761332	苯丙酮尿症和变种和或生物蝶呤缺陷 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40761333	听力损失风险指标:存在与否或特征标识:时间点:^患者:名义型	4182948
40761333	Hearing loss risk indicators	4180186
40761333	H+P; H+P.HX; Identity or presence; Indicator; Nominal; P prime; Point in time; Random	4180186
40761334	Age 1st heart attack occurred; Bro; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761334	Age 1st heart attack occurred Brother	4180186
40761334	首次出现心脏病发作时的年龄:发现:时间点:^兄弟:序数型	4182948
40761337	PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761337	心肌梗死日期:日期:时间点:^患者:定量型	4182948
40761338	Hosp; Ident; Identifier; Inpatient; Nominal; PhenX; Point in time; Random	4180186
40761338	名称:标识符:时间点:医院:名义型	4182948
40761339	H/O; Hx; Measure - fam hx heart attack; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40761341	BP; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40761342	BP; Gestation; Gestations; Gravida; Measure - high BP during pregnancy; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Pregnancies; Random	4180186
40761343	FCN; Func; Funct; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40761344	Measure- angina; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40761346	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40761347	Dis; Diseases; Dz; Pan; Panel; PANEL.PHENX; Panl; Periph; Pnl; Point in time; Random	4180186
40761351	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Pulm; Random	4180186
40761352	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40761354	ECG; EKG; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761354	心电图已记录:发现:时间点:^患者:序数型	4182948
40761355	Cardiac enzyme tests done during adm	4180186
40761355	Cardiac enzyme tests done during adm; Enz; Enzymes; Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40761355	在此次住院期间所进行的心肌酶检测:发现:时间点:^患者:名义型	4182948
40761356	Dis; Diseases; Dz; Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40761356	参与者当时患有活动性肝病:发现:时间点:^患者:名义型	4182948
40761359	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761359	心肌梗死:发现:时间点:^患者:序数型	4182948
40761362	Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40761362	心电图连续读取:发现:时间点:^患者:名义型	4182948
40761367	Abd; Abdo; Abdomen; Arterial Stenosis; Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40761367	Abdominal aortic aneurysm	4180186
40761367	曾经被某位医生诊断患有腹主动脉瘤:发现:时间点:^患者:名义型	4182948
40761368	Finding; Findings; Nominal; Othr; PhenX; Point in time; Random; Surg	4180186
40761368	动脉瘤外科手术或其他修复术:发现:时间点:^患者:名义型	4182948
40761369	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761369	Atrial fibrillation	4180186
40761369	曾经告诉您现在或过去患有心房颤动:发现:时间点:^患者:序数型	4182948
40761370	Date of 1st episode atrial fibrillation	4180186
40761370	Date of 1st episode atrial fibrillation; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761370	首次发生心房颤动的日期:日期:时间点:^患者:定量型	4182948
40761372	Finding; Findings; insertions; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761372	永久性起搏器插入:发现:时间点:^患者:序数型	4182948
40761375	Antiarrhythmics for treatment of AF; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Tx	4180186
40761375	Antiarrhythmics for treatment of AF	4180186
40761375	服用任何旨在治疗心房颤动的抗心律失常药物:发现:时间点:^患者:序数型	4182948
40761376	DVT	4180186
40761376	DVT; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761376	医生曾经告诉您患有深静脉血栓形成:发现:时间点:^患者:序数型	4182948
40761377	OP test(s) for DVT	4180186
40761377	Date and time; DVT; OP; OP test(s) for DVT; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Time stamp; Timestamp; Ven; Venous	4180186
40761377	曾经因为深静脉血栓形成进行过门诊试验:时间戳:时间点:^患者:定量型	4182948
40761378	DVT; DVT Dx; Dx; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Ven; Venous	4180186
40761378	DVT Dx	4180186
40761378	深部静脉血栓形成诊断:发现:时间点:^患者:序数型	4182948
40761379	Date of deep vein thrombosis Dx; DVT; DVT Dx; Dx; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Ven; Venous	4180186
40761379	Date of deep vein thrombosis Dx	4180186
40761379	深静脉血栓诊断日期:日期:时间点:^患者:定量型	4182948
40761380	Dx; Finding; Findings; Nominal; PE dix category; PhenX; Point in time; Pulm; Random	4180186
40761380	PE dix category	4180186
40761380	肺栓塞诊断类别:发现:时间点:^患者:名义型	4182948
40761383	PE	4180186
40761383	Finding; Findings; Ordinal; PE; PhenX; Point in time; Pulm; QL; Qual; Qualitative; Random; Screen	4180186
40761383	医生曾经告诉您患有肺栓塞:发现:时间点:^患者:序数型	4182948
40761387	Dx; Finding; Findings; Nominal; PhenX; Point in time; Pulm; Random; Source of evidence PE Dx; Srce	4180186
40761387	Source of evidence PE Dx	4180186
40761387	肺栓塞诊断依据:发现:时间点:^患者:名义型	4182948
40761389	1 year; 12Mos; Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Rheumatic fever in the past 12 months; Screen	4180186
40761389	过去的那12个月当中的风湿热:发现:12个月:^患者:序数型	4182948
40761390	Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40761390	服用针对风湿热的药物:发现:时间点:^患者:名义型	4182948
40761391	Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40761391	风湿热治疗药物名称:发现:时间点:^患者:名义型	4182948
40761395	Age began taking BP med; BP; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761395	Age began taking BP med	4180186
40761395	开始服用高血压治疗药物的年龄:时间:时间点:^患者:定量型	4182948
40761396	High blood pressure	4180186
40761396	BP; Finding; Findings; nursing; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761396	医生或护士曾经告诉您患有高血压:发现:时间点:^患者:序数型	4182948
40761397	Age when told have high BP; BP; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761397	Age when told have high BP	4180186
40761397	被告知患有高血压时的年龄:时间:时间点:^患者:定量型	4182948
40761399	Medication taken for high BP	4180186
40761399	BP; Finding; Findings; Medication taken for high BP; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761399	已服用针对高血压的药物:发现:时间点:^患者:序数型	4182948
40761400	Age began taking cholest med; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Lipid; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761400	Age began taking cholest med	4180186
40761400	开始服用高血胆固醇治疗药物的年龄:时间:时间点:^患者:定量型	4182948
40761401	Alb; BP; Finding; Findings; Gestation; Gestations; Gravida; Ordinal; PhenX; Point in time; Pregnancies; Protein.albumin; QL; Qual; Qualitative; Random; Screen; Toxemia during preg	4180186
40761401	Toxemia during preg	4180186
40761401	此次妊娠期间包括有高血压、尿液白蛋白以及踝关节肿胀的毒血症:发现:时间点:^患者:序数型	4182948
40761404	Angina	4180186
40761404	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761404	医生曾经告诉您患有心绞痛:发现:时间点:^患者:序数型	4182948
40761405	Chest discomfort ever/since last exam; Date and time; Hx; Ordinal; Past; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Time stamp; Timestamp	4180186
40761405	Chest discomfort ever/since last exam	4180186
40761405	曾经或者自从最后一次检查或病史更新以来胸部不适:时间戳:时间点:^患者:序数型	4182948
40761409	Durat; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761409	胸部不适通常持续时间:时间:时间点:^患者:定量型	4182948
40761411	Anatomy; Nominal; PhenX; Point in time; Random	4180186
40761411	Location of chest discomfort	4180186
40761411	胸部不适位置:解剖学:时间点:^患者:名义型	4182948
40761414	Count/time; Freq (past year) of chest discomf; Last; No; nRate; Num; Number rate; Number Rate = Count/Time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761414	Freq (past year) of chest discomf	4180186
40761414	胸部不适的频率 (去年当中的次数):计数型速率:时间点:^患者:定量型	4182948
40761417	Chest discomfort relief by rest; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761417	Chest discomfort relief by rest	4180186
40761417	在少于15分钟的时间内通过休息缓解胸部不适:发现:时间点:^患者:序数型	4182948
40761419	Chest discomfort relief by other; Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761419	Chest discomfort relief by other	4180186
40761419	在少于15分钟的时间内由于其他原因缓解胸部不适:发现:时间点:^患者:序数型	4182948
40761420	Told by a doctor had heart attack	4180186
40761420	Finding; Findings; Ordinal; Past; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Told by a doctor had heart attack	4180186
40761420	自从您最后一次检查以来,医生告知您有过心脏病发作:发现:时间点:^患者:序数型	4182948
40761421	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761421	暂时性心绞痛:发现:时间点:^患者:序数型	4182948
40761422	AP since revascularization proc; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761422	AP since revascularization proc	4180186
40761422	自从血管重建术之后的心绞痛:发现:时间点:^患者:序数型	4182948
40761423	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761423	在此期间冠状动脉功能不全:发现:时间点:^患者:序数型	4182948
40761424	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761424	在此期间心肌梗死:发现:时间点:^患者:序数型	4182948
40761426	Finding; Findings; Nominal; PhenX; Point in time; Random; S prime	4180186
40761426	服务提供者见证了死者的死亡:发现:时间点:^患者:名义型	4182948
40761428	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761428	疼痛当时包括了胸部:发现:时间点:^患者:序数型	4182948
40761429	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761429	当时疼痛为心脏来源:发现:时间点:^患者:序数型	4182948
40761430	CPR; CPR/CV within 24H of death; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761430	CPR/CV within 24H of death	4180186
40761430	死亡24小时之内所进行的心肺复苏和或心脏复律:发现:时间点:^患者:序数型	4182948
40761432	Decedent's CoD due to CHD	4180186
40761432	Decedent's CoD due to CHD; Dis; Diseases; Dz; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; S prime; Screen	4180186
40761432	死者的死亡原因为冠心病:发现:时间点:^患者:序数型	4182948
40761435	MESA class of underlying cause of death	4180186
40761435	MESA class of underlying cause of death; Nominal; PhenX; Point in time; Random; Study report; Typ	4180186
40761435	根本死因的动脉粥样硬化多种族研究分类:类型:时间点:^患者:名义型	4182948
40761436	Dis; Diseases; Dz; Nominal; PhenX; Point in time; Random; Typ	4180186
40761436	致死性冠心病类型:类型:时间点:^患者:名义型	4182948
40761437	Est time acute cardiac sympt+death; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Sx	4180186
40761437	Est time acute cardiac sympt+death	4180186
40761437	急性心脏症状发作与死亡之间的估计时间:时间:时间点:^患者:序数型	4182948
40761439	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761439	Myocardial infarction or heart attack	4180186
40761439	医生曾经告诉您患有心肌梗死或心脏病发作:发现:时间点:^患者:序数型	4182948
40761440	OP proced to unblock heart vessels	4180186
40761440	Finding; Findings; OP; OP proced to unblock heart vessels; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Surg	4180186
40761440	旨在疏通阻塞或狭窄的心脏血管的门诊或日间外科手术操作:发现:时间点:^患者:序数型	4182948
40761441	Acute episode within 72h of hosp; Finding; Findings; Hosp; Hospitalization hx; L; LT; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Upper extremity	4180186
40761441	Acute episode within 72h of hosp	4180186
40761441	住院治疗或院内事件的72小时内胸部、左臂或颌部出现疼痛、不适或紧张憋闷的急性事件:发现:时间点:^患者:序数型	4182948
40761442	Shots at home/OP for DVT	4180186
40761442	Arterial Stenosis; DVT; Finding; Findings; nursing; OP; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Shots at home/OP for DVT; Ven; Venous	4180186
40761442	曾经因为深静脉血栓形成而在家中或作为门诊患者由某位医生或护士进行过治疗:发现:时间点:^患者:序数型	4182948
40761447	Age 1st heart attack occurred Father	4180186
40761447	Age 1st heart attack occurred; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761447	首次出现心脏病发作时的年龄:发现:时间点:^父亲:序数型	4182948
40761449	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ivilco; Level; Mass concentration; Me-ePHEDrine; Pholcomed; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tossamine plus	4180186
40761449	Me-ePHEDrine SerPl Cfm-mCnc	4180186
40761449	甲基麻黄碱:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40761450	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761450	操作相关:发现:时间点:^患者:序数型	4182948
40761451	Imm Plasma Cells NFr Bld	4180186
40761451	Blood; Cell; Cellularity; Gated cells; HEMATOLOGY/CELL COUNTS; Imm; Imm Plasma Cells; Immat; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761451	浆细胞.不成熟/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40761452	Connective tissue GF Ur-mCnc	4180186
40761452	Chemistry; Conn tiss; Connective tissue GF; CTGF; Fac; Fact; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40761452	结缔组织生长因子:质量浓度:时间点:尿液:定量型	4182948
40761454	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chemistry; HAHA; Human anti-human Ab; Human anti-human Ab protein; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761454	HAHA Ab Plas-mCnc	4180186
